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INTRODUCTION  
 
Presently, a large number of drugs are used to treat and prevent 
different diseases. Doctor of any speciality should be able to know them 
well for correct prescribing pharmacotherapy to patients. In this regard, 
there is a need for quality training of students of higher medical educational 
institutions in pharmacology, knowledge of which is basic and integrates 
theoretical and clinical disciplines. Pharmacology finishes theoretical 
training of future doctors and is a logical continuation of courses of normal 
and pathological physiology, biochemistry, microbiology, and anatomy. 
Therefore, the authors, when presenting the material, considered it 
necessary to briefly recall physiological, biochemical, immunological, and 
anatomical knowledge that is necessary for understanding of 
pharmacodynamics of drugs and their mechanisms of action.  
Suggested textbook contains main rules of drug prescription, data of 
general and special pharmacology. With the aim to form stable skills in 
students to work with drug nomenclature, the unified nomenclature system 
of drugs, based on International Nonproprietary Names (INN), is given in 
the textbook. This system is used in modern educational literature of 
different countries. In most cases, the authors indicate both INN and most 
commonly used trade names of drugs. 
All chapters of the textbook are given in volume that is necessary for 
clear understanding of principles of action and effective and safe use of 
drugs. Each pharmacological group is constructed in a unified and logical 
sequence which facilitates the perception, assimilation and use of 
information.  
Due to large volume of information which should be mastered by 
students, the authors focus on group properties of drugs and describe the 
main representatives of groups. At the same time, the same drugs, used for 
different indications, are described in different chapters (e. g., -adrenergic 
antagonists are given in chapters “Antiadrenergic drugs”, “Drugs for 
treatment of hypertension”, “Drugs for treatment of ischemic heart 
disease”, and “Antiarrhythmic drugs”). 
Main data about drugs are given in one main chapter, and additional 
information is given in other chapters. Data about pharmacodynamics, 
pharmacokinetics, clinical applications, and side effects are given for each 
group of drugs; and, if it is necessary, corresponding data about individual 
drugs are additionally given.  
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Suggested textbook contains data about new drugs and modern 
scientific data. Mechanisms of action and therapeutic indications for drugs 
are given considering modern data of biochemistry, pathological 
physiology and fundamental pharmacology. This textbook contains some 
elements of clinical pharmacology. 
A separate chapter of the textbook describes general principles of 
treatment of acute poisoning by drugs and other toxic substances. Measures 
to prevent the ingress of poison into the body, inactivation of poisons by 
antidotes, restriction of poisons action by physiological antagonists, 
acceleration of poison elimination from the body, and resuscitation 
measures are given in this chapter. Besides, resuscitation measures at cases 
of inhibited respiration, collapse, acute heart failure, and 
bronchoconstriction are considered, especially in acute period of poisoning.    
The textbook is recommended for third-year students of higher 
medical educational institutions. Its structure and content correspond to the 
curriculum of pharmacology, approved at an interdepartmental meeting of 
heads of pharmacological departments of higher medical educational 
institutions.  
We will be grateful for any comments and suggestions that may arise 
from the readers of this textbook. 
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MEDICAL PRESCRIPTION  
 
Introduction to Medical Prescription 
 
The science about drugs consists of two branches of knowledge: 
pharmacology and pharmacy.  
Pharmacology is the science about interaction between an organism 
and a drug.  
Pharmacy is the science which studies questions of search, 
processing, preparation, and standardization of medicines. Pharmacy is 
complex science which includes pharmacognosy, pharmaceutical 
chemistry, technology of the medicinal form preparation, and prescription.  
Prescription is a section of pharmacy, which consists of the 
prescribing rules and rules of the drug preparations. Accordingly, 
prescription is divided into pharmaceutical and medical one. 
Pharmaceutical prescription contains the drug preparation rules. Practically, 
pharmaceutical prescription is separated in the special sector – medicinal 
form technology.   
Medical prescription includes the rules of drug prescribing. Namely, 
medical prescription has the important role in the physician’s practical 
activity.  
Most important terms of medical prescription are the following.  
Medicinal  substance (in Latin – “substantia pharmaceutica”) is 
one chemical substance or chemical element which is used as the medicinal 
remedy.  
Medicinal  remedy (in Latin – “medicamentum”) is natural or 
synthetic substance or mixture of some substances which are permitted by 
the Ministry of Public Health Services for the treatment and prophylactic of 
the certain diseases.     
Pharmacological  remedy is substance or mixture of substances 
with determined pharmacological activity and toxicity which is object for 
clinical trials. After receiving the sanction for the use in medical practice, 
the pharmacological remedy is registered in the state register of 
medications. 
Medicinal  form is the created state of medicinal remedy (remedies) 
which is appropriate for the practical use and provides the ability to reach 
the necessary therapeutic effect and drug stability during the storage. In 
dependence to consistency, there are solid, soft, and liquid medicinal forms. 
In turn, liquid medicinal forms are divided into forms for external use, 
forms for internal intake, and injections.  
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The same medicinal remedy may be prescribed in different medicinal 
forms.  
A drug (preparatum) is the medicinal remedy in certain medicinal 
form. 
Nowadays, the sources of medications are very diverse. They include 
mineral substances, nonorganic and organic compounds, vegetable raw 
materials, animal organs, microbial metabolic products, etc. Prior to the 
use, medicinal raw materials undergo the appropriate processing. 
Processing may be simple (drying, grinding) or complex (isolation of active 
substances). Due to complex processing of vegetable raw material, so-
called galenic medications or galenic formulations (tinctures, extracts) are 
derived. 
Galenic medications are drugs which are derived due to maceration of 
extraction of medicinal raw materials. Besides active substances, galenic 
medications contain also ballast substances (cellulose, mucus, proteins, 
tars, etc.). Therefore, galenic medications are not appropriate for parenteral 
administration. Besides galenic drugs, pharmaceutical industry produces 
more purified drugs containing maximum of active substances from herbal 
raw material and minimum of ballast substances. Such medications are 
called novogalenic drugs. They are appropriate for parenteral 
administration. For example, opium is medicinal raw material; opium 
powder is simple preparation; opium tincture is galenic formulation; 
omnoponum is novogalenic drug; morphine is pure opium alkaloid which is 
used for parenteral administration in the form of hydrochloride salt 
solution. 
The relationship of different pharmacological terms may be considered 
by the example of atropine sulfate: 
– Belladonna – herbal raw material; 
– alkaloid atropine – medicinal substance;    
– atropine sulfate – medicinal remedy; 
– atropine sulfate in powders, in tablets, in ampules, in eye  
ointment – drugs.  
All drugs are divided into three groups in dependence to a degree of 
expressiveness of their action upon an organism. 
Poisonous drugs  (Venena, the list A). Drugs with very high toxicity 
are included into this group. In hospital, these drugs should be stored in a 
special safe box constantly under lock and key. The safe box should be 
sealed up after the end of the working day. The strict control should be 
carried out about an expenditure of these drugs.   
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Potent medicines  (Heroica, the list B). Drugs, using of which 
without medical control can cause different complications, are included 
into this group. These drugs should be kept in a separate cupboard with an 
inscription “Heroica”. After the end of the working day, the cupboard 
should be closed.   
A storage, account, and delivery of poisonous and drastic drugs should 
be carried out according to the rules approved by the Ministry of 
Healthcare.  
Low-poisonous drugs  (Varia) are stored in usual cupboards 
according to the general rules of their storage.  
The list of manufactured medicinal remedies and drugs is in the 
special book called Pharmacopoeia . Pharmacopoeia is the collection of 
State standards and the obligatory norms determining drug qualities. The 
following information is in Pharmacopoeia: description of properties, the 
physical and chemical qualities of medicinal remedies in alphabetic order, 
and the ways of definition of their suitability to the use. Methods of 
quantitative definition of medicinal components are also located in 
Pharmacopoeia.  
Based on Pharmacopoeia specifications, it allows to carry out the 
control over the drug manufacturing and their usage. In Pharmacopoeia, 
we can find also such important information: the lists of poisonous and 
drastic drugs, the tables with the maximal single and daily doses for 
poisonous and drastic drugs (both for adults and children), conditions of 
the drug storage and delivery, ways of manufacturing of medicinal forms, 
the methods of biological standardization and so on.  
Drugs included in Pharmacopoeia are referred to officinal  drugs  
(“officina” – “workshop”, “drugstore”).  
Magistral  drugs  are medicines prescribed by a physician for a 
particular case. They are made by a pharmacist in a drugstore (“magister” 
in Latin is “teacher”).  
There are two groups of the drug administration routes: enteral  routes 
(through gastro-intestinal tract) and parenteral  ones (passing a digestive 
tube). The enteral routes are oral (by mouth), sublingual (under tongue), 
transbuccal (behind a cheek), into duodenum, and rectal (per rectum). The 
parenteral routes of drug administration are subcutaneous, intramuscular, 
intravenous, intra-arterial, inhalations, subarachnoidal, intraperitoneal, and 
other. 
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A dose is the drug quantity which is administered to the patient. A 
word “dose” is of the Greek origin and in translation to English means a 
“portion”. The following dose kinds are distinguished:  
– single dose (Dosis pro dosi) is the drug quantity for the single 
perception; 
– daily dose (Dosis pro die) is the drug quantity for a patient to take 
during a day; 
– course dose (Dosis pro curso) is the drug quantity which is 
prescribed for full treatment course.  
 
Drug Nomenclature. Elements of  Latin Grammar 
 
Each drug which is manufactured by different pharmaceutical plants 
has only one officially accepted name specified by Pharmacopoeia. But 
globally, the drug can have dozens of synonyms. For elimination of 
negative influence of this fact, the special expert commission of the World 
Health Organization works on creation of unified international unlicensed 
drug names. These drugs names may be used by any country.  
Almost all drug names are nouns of an average sort of II declination 
(Barbamylum, Validolum). The names of acids are expressed by adjectives 
coordinated with a noun Acidum: Acidum nicotinicum, Acidum boricum.  
Latin names of the salts are constructed according to the following 
principle: the cation name (alkaloid or metal) is tied to the first place and is 
expressed by a noun in Genitive case. The anion name is expressed by a 
noun in Nominative case (Codeini phosphas, Morphini hydrochloridum). 
Anion name depends on its structure and is formed by adding different 
suffixes to the word root: 
– -idum (Genitive case -i) – for salts of oxygen-free acids with 
inorganic basis (Natrii chloridum);  
–  prefix hydro- and suffix -idum are used in anion names of oxygen-
free acid salts with inorganic bases (Adrenalini hydrochloridum); 
– -as (Genitive case -atis) is used in anion names of oxygen-
containing acids with maximal oxygen content (arsenas, nitras, 
benzoas); 
– -is (Genitive case -itis) is used for salt anion of oxygen-containing 
acids with less oxygen content (arsenis, nitris).       
Also, the following international Latin names are used: oxide – 
oxidum, peroxide – peroxidum, hydroxide – hydroxidum.   
Other drug names and words used in prescription (names of medicinal 
forms and plants, etc.) are also written in corresponding case according to 
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general rules of the Latin grammar. The table of the words endings in cases 
which are most commonly used in prescriptions is given below. 
 
Table 1 – Most commonly used words endings in prescriptions 
 
Number Case Declination 
I II III IV V 
Singular N.  a um, us different 
endings 
us es 
G. ae i is us ei 
Acc.  am us    
Abl. a o    
Plural 
 
N.  ae i, a    
G. arum orum    
Acc.  as os, a    
Abl. is is    
 
In prescription, only one noun of IV declination is used – “spiritus”, 
and only one noun – “species”– of V declination.  
It is necessary to remember, that the prepositions “in” and “cum” 
require Instrumental case of noun which is written after them, and the 
expression “ut fiat” requires Nominative case of noun written after it. 
 
Prescription: Structure and Registration Rules  
 
A prescription is the written physician direction to the pharmacy about 
the drug preparation and its handing over to the patient with the indication 
of its usage mode. A prescription is important medical and juridical 
document. A doctor carries the juridical responsibility for correctness of 
drug prescriptions. When the drug is released for free, the prescription is 
also a financial document.  
Prescriptions should be written only by pen (not by pencil). A doctor 
should fill all the stipulated columns in the prescription blank. After the last 
prescription, physician should put the signature and personal seal. 
Corrections are not permitted in the prescriptions. The prescribed treatment 
should be entered in an outpatient card of the patient.  
The doctors have no right to prescribe the prescriptions of drugs, 
which are not permitted to application in the country, and at the patient’s 
request without examining the patient and establishing diagnosis. 
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In English countries as well as in the countries where the training is 
carried out in English, the prescription is prescribed in English on the 
special form or on a paper sheet. The following structural elements should 
be specified in the prescription: 
1 – surname and name of the doctor; 
2 – license qualification of the doctor or his professional degree; 
3 – address of the doctor; 
4 – the doctor’s office telephone number; 
5 – date of registration of the prescription; 
6 – surname and name of the patient; 
7 – address of the patient.  
The scheme of prescription blank which is used in English countries is 
given below. The order of prescription registration in English countries is 
the following.  
A doctor writes the mark “R” in the right top corner, which means “to 
take”. After that, the doctor writes the drug name with a capital letter in the 
Nominative case (8). In the same line, the doctor also indicates the drug 
dose (9) and its general amount for the treatment course (10). 
In the right corner after “Sig.” (11), physician writes the detailed 
instruction for the patient about the drug usage and the need for repeated 
drug prescription (12). Also, doctor writes information about the need of 
drug storage in the place which is inaccessible for children (13).  
After that, a physician gives (14) the information about observance 
necessity of the certain rules of safety in drug reception (for example “It is 
prohibited to use alcohol”, “Causes drowsiness”, etc.). In the left corner 
below, doctor puts the signature (15), indicates the identification data (16), 
and the number of the license state registration (17). 
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1                           2 
JOHN B.         DOE, M. D. 
                 1234 SOUTH NORTHEAST DR.          3  
                            WEST CITY, CA 94999 
                                         (234)555-6789                 4 
 
FOR:                 6 DATE:                    5 
ADDRESS:       7 
R                        8                                 9 
(DRUG NAME AND STRENGTH) 
(QUANTITY) 
                                                            10 
 
 
 
 
Sig:                                  11 
REFILL             TIMES  
OR 
UNTIL        12 
 
NO 
CHILDPROOF 
CONTAINER 
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WARNING: 
 
 
                          14 
 
15 
 
                                M. D.          
ID 1234567                                 16 
STATE LICENSE NO.               17 
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In Ukraine, the prescription form contains the same important 
information. The following prescription structure is standard (Table 2). 
 
Table 2 – The standard structure of prescription  
 
№ Latin name of 
the prescription 
graph 
Contained information 
1 Inscriptio I        Medical institution stamp (its name, the address, a 
phone number, and a code) is in this inscription  
2 Inscriptio II       This inscription includes the age category of the 
patient (child or adult) and date of registration of 
prescription 
3 Nomen aegroti  Name and surname of the patient and his (or her) 
age 
4 Nomen medici  Name and surname of the doctor who writes out 
this prescription 
5 Invocatio  
s. praepositio 
The reference of the doctor to the pharmacist with 
the request to manufacture and give out (or only to 
give out) a medicine to the patient: the word “take” 
written in Latin: “Recipe” (commonly it is written 
in abbreviated form “Rp.:”) 
6 Designatio        
materialum  
s. ordinatio  
Name of medicinal remedy or the list of medicinal 
remedies included into the complex drug which 
will be manufactured in a drugstore 
7 Subscriptio  
s. praescriptio 
The doctor’s instructions for a pharmacist about 
preparation of a certain medicinal form and its 
distribution in necessary quantities 
8 Signature            It is the recommendation of the doctor for the 
patient about the manner of drug’s use. In this part 
the following must be necessarily indicated: 
– the method of dosing: to accept 1 teaspoon; 1 ml; 
2 tablets and so on; 
– the route of drug’s administration: 
subcutaneously, intramuscularly, intravenously, 
perorally and so on;  
– frequency or time of the drug’s reception (3 times 
per day, before meal, at headache, at bedtime) 
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A prescription is separated from the next prescription by short line. 
New prescription is started with an abbreviation “Rp.:”. After the last 
prescription, doctor puts the signature. 
A prescription of different medicinal forms can be short or full 
(unwrapped). A short variant is used basically for prescription of the 
officinal (ready-made) medicinal forms, and full – for the forms prepared in 
the drugstore. Nowadays, most drugs are manufactured by pharmaceutical 
industry. Therefore, they are prescribed only by short form. The examples 
of both short and full forms of prescriptions are given in the material about 
different medicinal forms. 
 
Rules of  Dosage. Measure of  Weight and Volume  
 
In modern medical practice, the drug doses are specified in decimal 
measurement system. A gram is the weight unit that is mass of 1 ml of 
distilled water at temperature 4 
°С. In the prescription, it is designated as 
1.0. The following sizes are used for the drug dosage: 0.1 – one decigram; 
0.01 – one centigram; 0.001 – one milligram; 0.0001 – one decimilligram; 
0.00001 – one centimilligram; 0.000001 – one microgram. It is necessary to 
remember, that dry substance quantities should be given in grams. 
Liquid substance quantities are given in milliliters, grams or drops. 
Most commonly, quantity of liquid substance is given in milliliters (ml). If 
several drops of some substance are included in medicinal form, the 
quantity of drops is designated by the Roman digits, e. g.: “5 drops” –  
“gt. V” (“gt.” is abbreviation of a word “guttas” – “drops” in Instrumental 
case of plural). 
 
Most Important Abbreviations Used in Prescription  
 
Only abbreviations which do not cause confusion are permitted in 
prescriptions.  
The list of abbreviations most commonly used in prescriptions is given 
below.  
 
Table 3 – Most commonly used abbreviations in prescriptions 
Used abbreviation Meaning  
1 2 
āā – ana fifty-fifty 
Ac. – Acidum acid 
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Continuation of the table 3 
1 2 
amp. – ampulla ampoule 
Aq. – Aqua water 
But. – Butyrum oil (solid) 
D. – Da  give out 
D. t. d. – Da tales doses give out such doses  
S. – Signa designate 
dil. – dilutus the dissolved 
Emuls. – Emulsum emulsion 
Empl. – Emplastrum plaster 
Extr. – Extractum extract 
f. – fiat it is formed 
fol. – folium leaf 
in amp. – in ampoules in ampoules 
in caps. – in capsulis in capsules 
in tab. – in tabulettis in tablets 
Inf. – Infusum infusion 
Lin. – Linimentum liniment 
M. – Misce admix 
N. – numero quantity 
pulv. – Pulvis powder 
q. s. – quantum satis how many it is required 
rad. – radix root 
Rp. – Recipe take 
rhiz. – rhizoma rootstock 
S. – Signa designate 
sicc. – siccus (a, um) dry 
simpl. – simplex simple 
Sol. – Solutio solution 
Steril.! – Sterilisetur! sterilize 
supp. rect. (vag.) – suppositorium 
rectale (vaginale) 
suppository rectal (vaginal)  
Tinct., T-ra – tinctura tincture 
ung. – unguentum ointment 
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Rules for the Prescription of Medicinal Forms 
 
Solid Medicinal Forms 
 
The solid medicinal forms are powders, tablets, dragee, granules and 
medicinal herb compositions.   
 
Powders –  Pulveres (Pulv.)  
(Nominative case, singular – Pulvis,  
Genitive case, singular – Pulveris) 
 
Powder is a solid medicinal form used externally or internally. 
Different synthetic agents, medications of herbal and animal origin, and 
products of bacterial vital activity may be prescribed in form of powders. 
In dependence of quantity of medicinal remedies, there are simple 
(containing only one remedy) and complex (containing two or more 
remedies) powders. Also, powders are divided into dosed (commonly used 
for peroral administration) and non-dosed (commonly used for external 
application) powders.  
For peroral intake, only non-toxic agents may be prescribed as non-
dosed powders. Patients take such powders either for one intake or for 
several perceptions dosing it by spoons (tea-spoons, dessert spoons, or 
table-spoons).     
According to degree of grinding, there are coarse (pulvis grossus), fine 
(pulvis subtilis), and ultrafine (pulvis subtilissimus) powders. Substances, 
which are used in large quantity, are prescribed in form of coarse powders. 
Fine powders are prescribed for peroral intake. Smallest powders are used 
externally. For oral intake, the finer is the powder the faster it is dissolved 
and absorbed. For external use, ultrafine powder exhibits the marked 
mechanical influence and has high absorptive surface.  
 
Powders for External  Use  
 
The finest powder (Lat. – “pulvis subtilissimus”) for external use is 
called dusting powder (Lat. – “Aspersio”). This medicinal form is most 
commonly used for processing of injured part of skin. Dusting powders are 
prescribed as non-dosed powders. The weight of dusting powder is from 
5 g to 100 g or more. Dusting powders are prescribed both in full and in 
short form. In dusting powders, the medicinal remedies are used either in 
pure state or in combination with indifferent substances which are used as 
excipients. Such substances as talc (Talcum), starch (Amylum) or zinc oxide 
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(Zinci oxydum) are used as excipients. The dusting powders containing two 
or more medicinal remedies are prescribed only in full form. 
The examples of prescription of dusting powders in full and in short 
forms are given below.  
Prescribe both in full and in short forms of prescription 50 g of 
dusting powder which contains 5 % of anaesthesine 
(Anaesthesinum). Use for the patient’s injured part of skin 
preparation. 
Full form of prescription. In the full form, a doctor should list all the 
ingredients of this medicinal form and indicate their weight in grams.  
A calculation of anaesthesine’s weight is the following. The total 
weight of dusting powder is 50 g. It is 100 %. Anaesthesin’s weight is 
designated as x g; but it is known that is it 5 %. On the base of these data 
we make the following proportion:     
50 g    –  100 % 
x g   –   5 % 
We find the necessary anaesthesin’s weight as result of this proportion 
decision: 
x = 50· 5 : 100 = 2.5 g 
That is, 2.5 g of anaesthesine should be taken. As excipient, any of possible 
substances may be used, e. g., starch. It is the starch weight calculation: 
50 g – 2.5 g = 47.5 g. 
A full form of prescription is the following: 
Rp.: Anaesthesini 2.5 
        Amyli 47.5 
        M. f. pulv. subtilissimus    
        D. S. To use for the treatment of injured skin part. 
An order of short form of prescription for this drug is the following: 
Rp.: Aspersionis Anaesthesini 5 % – 50.0 
        D. S. To use for treatment of the injured skin part. 
In a short form of prescription, the name of medicinal form is written 
after “Rp.:”, after that – the medicinal substance name, its percentage, and 
total dusting powder weight. It is necessary to notice, that short prescription 
form is possible only in case when dusting powder consists of two 
substances: medicinal remedy and excipient.  
Sometimes, medicinal remedy is used in dusting powders in pure form 
without excipients.   
Prescribe 30 g of anaesthesine in dusting powder. To use for 
treatment of the injured skin part.  
Rp.: Anaesthesini subtilissimi 30.0 
D. S. to use for treatment of the injured skin part.   
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Powders for Internal Use 
 
Powders for internal use may be both simple (consist of one medicinal 
remedy) and complex (consist of two or more medicinal remedies). 
Powders for internal use are prescribed with indication of single doses of 
medicinal remedies and general amount of powders. A powder weight 
should be within the range from 0.1 g to 1.0 g. If total weight of medicinal 
remedies in one powder is less than 0.1 g (or 0.05 g for herbal powders), 
the indifferent substance should be added to such powder (sugar 
(Saccharum) or glucose (Glucosum)).  The optimal weight of dosed powder 
is 0.3–0.5 g.  
The examples of dosed powders for internal use are given below.  
Prescribe 20 powders of calcium gluconate (Calcii gluconas, the 
single dose is 0.5 g) for oral intake 3 times a day.    
Rp.: Calcii gluconatis 0.5 
       D. t. d. N. 20 
       S. Orally 1 powder 3 times a day. 
Prescribe 10 powders of papaverine hydrochloride (Papaverini 
hydrochloridum, the single dose is 0.02 g) for oral intake twice 
a day.  
Rp.: Papaverini hydrochloridi 0.02 
        Sacchari 0.3 
        M. f. pulv.  
 D. t. d. N. 10 
 S. Orally 1 powder twice a day.  
Prescribe 10 powders containing platyphyline hydrotartrate 
(Platyphyllini hydrotartras, single dose is 0.003 g) and papaverine 
hydrochloride (Papaverini hydrochloridum, single dose is 0.03 g) for 
oral intake 3 times a day. 
Rp.: Platyphyllini hydrotartratis 0.003 
 Papaverini hydrochloridi 0.03 
 Sacchari 0.3 
 M. f. pulv.  
 D. t. d. N. 10 
 S. Orally 1 powder 3 times a day.    
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Capsules – Capsulae (Caps.) 
(Nominative case, singular – Capsula;  
Instrumental case, plural – Capsulis) 
 
Medicinal remedies having unpleasant smell or taste, or irritating the 
mucosa are taken up in the capsules. Capsules are membrane cases for oral 
intake containing dosed powders, granules, pasty or liquid medicinal 
remedies.  
There are starch capsules or cachets (Capsulae amylaceae seu oblatae) 
and gelatin capsules (Capsulae gelatinosae). Presently, gelatin capsules are 
mainly used.  
Capsules are prescribed according to the following rules: 
1. Medicinal remedy weight is given after its name.  
2. Independently of the drug dose, indifferent substances are not added 
to medicinal remedy. 
3. After “D. t. d. N….”, the indication on the issuing of the drug in 
capsules is necessary. 
4. If the drug dose is higher than quantity of the drug in a capsule, 
several capsules are prescribed for each intake.       
 An order of the capsules prescription is the following: 
Prescribe 12 capsules, each contains 0.05 g of Doxycycline 
hydrochloride (Doxycyclini hydrochloridum, the single dose is 
0.1 g). Take orally once a day. 
Rp.: Doxycyclini hydrochloridi 0.05 
        D. t. d. N. 12 in caps.  
        S. Take orally 2 capsules once a day.  
Microcapsules are microscopic particles of medicinal remedies which 
are put into cachets. Particles with size from 100 to 500 μm are most 
commonly used in medicine. Particles with size 1 μm and less are called 
nanocapsules. Microcapsulation enables to protect the medicinal remedies 
(vitamins, antibiotics, nitroglycerin, enzymes, vaccine, etc.) from the 
influence of external environment and is used to mask undesirable taste. 
Microcapsules provide the release of medicinal remedy in the necessary 
part of gastrointestinal tract (enteric-soluble microcapsules) and prolong the 
drug action (spansules). Due to the usage of separating coatings, 
microcapsules make possible the combination of inconsistent substances in 
one capsule. Also, microcapsulation is used for transformation of liquids in 
pseudo-solid state (microcapsules filled with liquid medicinal remedies). 
Presently, a variety of drugs is manufactured in microcapsules. 
Microcapsulated drugs are also manufactured in tablets, suspensions, 
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spansules, and rectal capsules. Spansules are solid gelatin capsules 
containing certain quantity of granules, microdragee, or microcapsules of 
medicinal remedies. There are investigations about a possibility of the 
microcapsules use in injections, eye drops, and tablets for implantation. The 
patches with deposited thin layer of microcapsulated medicinal remedies 
are of particular interest.               
 
Tablets – Tabulettae (Tab.) 
(Nominative case, singular – Tabuletta; Genetive case, singular – 
Tabulettae; Genetive case, plural – Tabulettarum;  
Instrumental case, plural – in tabulettis)   
 
Tablet is the dosed solid medicinal form produced by the 
pharmaceutical industry by means of components pressing. As a rule, 
tablets are used for oral administration, but some tablets are used 
sublingually (nitroglycerin, methyltestosterone), or for implantation 
(Esperal). Also, tablets are sometimes used for preparation of solutions for 
external use (furacilinum). 
Tablets are comfortable medicinal form. Their advantages over 
powders consist in the following:  
– tablets are better stored because protected from influence of light, 
air, and moisture;  
– tablets mask the undesirable taste of remedies; 
– tablets prevent the undesirable influence of medicinal remedies upon 
the tooth enamel; 
– multilayer tablets provide the consistent absorption of several 
medicinal remedies and ensure the prolonged drug action. 
Negative influence of tablets is the following: 
– in some cases, tablets (sodium bromide, potassium bromide) can 
cause mechanical or chemical irritation of esophageal and gastric mucosa; 
– due to improper storage, tablets can lose the ability to break up in 
gastrointestinal tract; 
– due to prolonged tablets storage, medicinal remedies can undergo 
chemical transformation. 
Tableted drugs act more slowly than corresponding powders because 
tablets should be initially broken up and only after this undergo the 
dissolution and absorption. Tablets are not prescribed for children, 
seriously sick in unconscious state, and for persons who cannot swallow 
tablets due to different causes. 
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Tablets consist of medicinal remedies, excipients, and thinners. The 
following substances are used as excipients: lactose, starch, glucose, 
sodium hydrocarbonate, sodium chloride, calcium phosphate, 
acetylcellulose, talc, cocoa, etc. Total quantity of excipients should be not 
more than 20 % of summary mass of thinners and medicinal remedies. 
Thinners are used for formation of tablets with necessary weight in cases 
when dose of remedies is very small. 
Tablets for external use containing poisoning substances are 
respectively colored. For example, tablets containing mercuric chloride 
(corrosive sublimate) are colored by eosin, all other poisoning tablets – by 
methylene blue.  
Tablets which are stored during prolonged time should be tested for 
disintegration before their usage. 
Tablet weight is within 0.1–2 g. Average tablet mass is 0.3–0.5 g.                   
The following information should be given in prescriptions of tablets: 
information about drug product (manufactured by pharmaceutical industry 
form), general quantity of prescribed tablets, single dose of a drug, and 
mode of drug usage.  
If the drug single dose is more than contained in one tablet, the 
necessary quantity of tablets is prescribed for each intake. In cases when 
single dose of the drug is less than contained in one tablet, the necessary 
part of one tablet is prescribed.  
The tablets are prescribed only with the short form of prescription. 
Magistral (full) form of prescription of tablets does not exist.    
Prescribe 100 tablets containing 0.3 g of isoniazid (Isoniazidum, the 
single dose is 0.3 g) for oral intake 3 times a day. 
Rp.: Tab. Isoniazidi 0.3 N. 100 
        D. S. Take 1 tablet orally 3 times a day. 
Also, the following variants of this prescription are possible: 
Rp.: Isoniazidi 0.3 
        D. t. d. N. 100 in tab.  
        S. Perorally 1 tablet 3 times per day. 
Or:  
Rp.: Tab. Isoniazidi 0.3 
        D. t. d. N. 100  
        S. Perorally 1 tablet 3 times per day. 
A doctor can use any of these forms in prescriptions.  
Prescribe 20 tablets, each contains 0.0001 g of Digitoxine 
(Digitoxinum, the single dose is 0.00005 g) for oral intake once a day.  
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Calculation of the tablet part for one intake:  
0.00005 : 0.0001 = 0.5 tablet. 
Rp.: Digitoxini 0.0001 
       D. t. d. N. 20 in tab. 
       S. ½ tablet orally once a day.  
 
Rp.: Tab. Digitoxini 0.0001 
D. t. d. N. 20 in tab. 
S. ½ tablet orally once a day.  
 
Rp.: Tab. Digitoxini N. 20 
D. S. ½ tablet orally once a day.   
 
The following structure of prescription is used for tablets having 
special name and containing several medicinal remedies (e. g., “Aeron”, 
“Allocholum”, etc.). 
 
Prescribe 30 tablets of “Allocholum” (the single dose is one tablet) for 
oral intake 3 times a day before meal.  
 
Rp.: Tab. “Allocholum” N. 30 
        D. S. Use 1 tablet orally 3 times a day before meal. 
  
Dragée (Dragee) 
(Genetive case, singular – Dragee;  
Instrumental case, singular – Dragee)  
 
Dragée is solid dosed medicinal form for internal use, manufactured 
by the pharmaceutical industry by repeated overlay of medicinal remedies 
and excipients around the sugar pellet. The following substances are used 
in dragée as excipients: sugar, magnesium carbonate starch, talc, cacao, 
wheat flour, etc. For protection of medicinal remedies from action of 
gastric juice, dragées are covered by special coating dissolved in basic 
environment of intestine. Weight of a dragée is from 0.1 g to 0.5 g, but not 
more than 1 g. After oral intake, dragée is dissolved for 30 minutes. 
A form of dragée prescription is like the form of tablets prescription.  
 
Prescribe 30 dragées containing 0.025 g of propazine (Propazinum, 
the single dose is 0.05 g). Take orally 2 times a day after meal.  
 
Rp.: Dragée Propazini 0.025 N. 30 
        D. S. 2 dragées orally 2 times a day after meal. 
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Rp.: Propazini 0.025 
        D. t. d. N. 30 in dragée 
        S. 2 dragées orally 2 times a day after meal. 
 
Rp.: Dragée Propazini 0.025 
        D. t. d. N. 30 
        S. 2 dragées orally 2 times a day after meal. 
 
Prescribe 30 dragées Undevitum (single dose is 1 dragee) for oral 
intake 2 times a day.  
 
Rp.: Dragée Undeviti N. 30 
D.S. 1 dragee orally 2 times a day.  
 
Some medicines are manufactured in the form of microdragée that 
provides prolongation of their action. Microdragées are formed by applying 
of medicinal remedies and sugar syrup (used as glue) around the fine sugar 
grains. The presence or absence of the coating around microdragée defines 
the time of the medicinal remedies absorption.       
 
Eye Membranes – Membranulae ophthalmicae 
(Nominative case, singular – Membranulae ophthalmicae, s. Lamellae, 
Instrumental case, singular – Membranulas ophthalmicas, s. Lamellas) 
 
The eye membranes are sterile polymeric plates with the size of 
9×4.5×0.35 mm, which contain medicinal remedies in definite doses and 
are dissolved in lacrimal fluid. The eye membranes can be stored in 
hermetically closed containers nearly 1 year.    
After applying on the eye conjunctive, the dissolution of polymer is 
beginning.  
In case of using the eye membrane, the therapeutic concentration of 
medicinal remedy can be maintained for 24 hours.    
In comparison with eye drops, the eye membranes have the following 
advantages:  
– the support of stable therapeutic concentration of medicinal remedy 
during long period of time; 
– the high stability of medicinal form; 
– the maintenance of sterility during significant period; 
– more exact dosage of a drug. 
Nowadays in medical practice the eye membranes (Membranulae 
ophthalmicae) with pilocarpine hydrochloride, atropine sulphate, 
neomycine sulphate, and other medicines are used.  
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The eye membranes are prescribed with short form.  
 
Prescribe 30 eye membranes containing pilocarpine hydrochloride 
(Membranulae ophthalmicae cum Pilocarpini hydrochlorido). Use one 
membrane for the side of a lower eyelid 1 time daily. 
 
Rp.: Membranulas ophthalmicas cum Pilocarpini hydrochlorido N. 30 
D. S. Use one membrane for the side of a lower eyelid 1 time daily. 
 
Hometasks for Prescription 
 
1. Prescribe both in short and in full form 40 g of powder for external 
use containing 2 % of salicylic acid (Acidum salicylicum). Use for 
treatment of the injured part of skin. 
2. Prescribe 20 powders of nicotinic acid (Acidum nicotinicum, single 
dose is 0.03 g) for oral intake 3 times a day. 
3. Prescribe 30 powders of platyphylline (Platyphyllini hydrotartras, 
single dose is 0.003 g). Take orally twice a day. 
4. Prescribe 10 powders of Aspirin (Aspirinum, single dose is 0.25 g) 
for oral intake at headache.  
5. Prescribe 30 capsules containing 0.15 g of rifampicine 
(Rifampicinum, single dose is 0.3 g) for oral intake 2 times a day.  
6. Prescribe 50 tablets of dexamethasone (Dexamethasonum, single 
dose is 0.0005 g). The drug product: tablets, containing 0.0005 g of 
dexamethasone. Take orally 3 times a day.  
7. Prescribe 30 tablets of mellictinum (Mellictinum, the single dose is 
0.02 g) for oral intake 3 times a day. Drug product: tablets containing 
0.02 g of mellictinum.   
8. Prescribe 20 tablets of “Bellataminalum” (single dose is one tablet). 
Take orally 3 times a day.  
9. Prescribe diazolin (Diazolinum, the single dose is 0.05 g). The drug 
product: dragee, containing 0.05 g of diazolin. Take orally 3 times a day.  
10. Prescribe nimodipine for oral intake 2 times a day (Nimodipinum, 
the single dose is 0.06 g). The drug product: tablets containing 0.03 g of 
nimodipine.  
11. Prescribe picamilon for oral intake 3 times a day (Picamilonum, 
the single dose is 0.02 g). The drug product: tablets containing 0.02 g of 
picamilon. 
12. Prescribe 20 commercial tablets of “Nacom” for oral intake 2 times 
a day (the single dose is ½ tablet).  
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Soft Medicinal Forms 
 
The soft medicinal forms are ointments, pastes, liniments (or liquid 
ointments), suppositories, plasters, and creams.   
 
Ointments – Unguenta (Ung.) 
(Nominative case, singular – Unguentum;  
Genitive case, singular – Unguenti) 
 
Ointment is soft non-dosage complex medicinal form with viscous 
homogeneous consistency for external use. 
Ointments are prepared by mixing various medicinal substances with 
the form-building substances, which are called ointment bases. Ointments 
form an equal film (which does not slip) on the skin or mucosa surface. 
Antibiotics, hormones, heavy metal salts, astringing, irritating and other 
substances are used as medicinal remedies in ointments. 
Animal or vegetable fats and oils, their derivatives, fat-like substances, 
carbohydrates, and other substances are used as ointment bases. Lanolin 
and vaseline are most frequently used among them. The base for ointment 
should be indifferent, mix well with remedy and easily give back, remain 
constant under the influence of light or heat, do not interact with medicinal 
substances, and thaw at body temperature. The base for eye ointment 
should be also sterile and neutral.  
The amount of prescribed ointment depends on a way of its use. The 
eye ointments are prescribed in amount of 5–10 grams, ointments for lips 
and nose – in amount of 10–20 grams, for application on injured parts of 
the skin – 15–100 grams and more.  
Ointments are non-dosed medicinal forms. Therefore, the amount of 
ointment in a prescription is prescribed as a total unit. Simple ointments 
consist of two ingredients: one active and one inert substance. Complex 
ointments consist of more than two ingredients.  
The percentage of powder-like substances in ointment should be no 
more than 25 %. Otherwise, ointment turns to paste. Ointments are 
prescribed both in short and in full form of prescription. Most ointments are 
prescribed in a short form.  
In the short form of prescription, the amount of active substance is 
given in percent or in mass units. The short form of prescription begins 
with the word “Unguenti” (“Ung.”). After that the name of medicinal 
remedy is written, its concentration in percents, and general amount of 
ointment.  
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In the full form of the prescription, the names of all ingredients of this 
ointment are listed. The weight of substance is indicated after the substance 
name. Also, the indication about preparation of ointment from these 
components (“M. f. ung.”) is given. 
Prescribe 50 g of ointment based on vaseline (Vaselinum) which 
contains 1 % of tetracycline hydrochloride (Tetracyclinum 
hydrochloridum). To use for application on the injured parts of skin.     
 
Rp.: Ung. Tetracyclini hydrochloridi 1 % – 50.0 
D. S. To use for application on the injured parts of skin.  
 
The following is a full form of this prescription: 
 
Rp.: Tetracyclini hydrochloridi 0.5 
Vaselini 49.5 
M. f. ung.  
D. S. To use for application on the injured parts of skin.  
 
The ointments are widely used in ophthalmology. Slowly developing 
effect is the feature of eye ointments. In comparison with eye drops, the 
duration of eye ointments action is longer. The indication “Eye ointment” 
should be written in a signature before the indication about the mode of its 
use. 
 
Prescribe 10 g of eye ointment with 2 % of polymyxine M sulfate 
(Polymyxinum M sulfas). To put behind a lower eyelid 4 times daily. 
 
Rp.: Ung. Polymyxini M sulfatis 2 % – 10.0 
D. S. Eye ointment. To put behind a lower eyelid 4 times daily. 
 
Example of prescription for ointment, containing medicinal remedy 
the activity of which is expressed in action units, is given below.    
 
Prescribe both in short and in full form 50 g of ointment, each gram of 
which contains 10 000 of international units (IU) of erythromycine 
(Erythromycinum). Use for application on the injured parts of skin. 
 
The full form: 
 
Rp.: Erythromycini 500 000 IU 
Vaselini 50.0 
M. f. ung. 
D. S. Use for application on the injured parts of skin. 
 
The short form: 
 
Rp.: Ung Erythromycini 50.0 (1,0 – 10,000 IU) 
       D. S. Use for application on the injured parts of skin. 
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Pastes – Pastae 
(Nominative case, singular – Pasta; Genitive case, singular – Pastae) 
 
The paste is non-dosed medicinal form. Paste is thick ointment 
containing dry substances in amount from 25 to 65 %. Due to thicker 
consistency, paste can remain on the body surface during longer time than 
ointment. The pastes have adsorbing, drying and anti-inflammatory 
properties. As a rule, the pastes are used for applying on purulent and wet 
surfaces, e. g., for eczema. 
Paste consists of medicinal remedy (remedies) and basis. Substances 
used as basis for pastes are the same as for ointments. If the amount of 
medicinal remedies in paste is less than 25 %, one or more inert powders 
(starch (Amylum), talc (Talcum), zinc oxide (Zinci oxidum), white clay 
(Bolus alba)) should be added. In the prescription, inert powders are 
indicated before bases. 
There are officinal and magistral pastes. The magistral paste is 
prescribed only in full form of prescription. The paste prescription is like 
the ointment, only the word “Unguenti” is replaced by a word “Pastae”. 
 
Prescribe 50 g of paste based on vaseline, which contains 5 % 
anaesthesine (Anaesthesinum). Use for application on the injured 
parts of skin. 
 
Rp.: Anaesthesini 2.5 
Talci 10.0 
Vaselini ad 50.0 
M. f. pasta 
D. S. Apply on the injured parts of skin. 
 
Because amount of anaesthesine is 5 %, we should add talc for paste 
formation. Minimum amount of talc is 20 % that is equal to 10 g. 
 
Note. The word “ad” before weight of vaseline means “up to” (“up to 
total weight of paste”). This word is used in full forms of prescription for 
both ointments and pastes when the percentage of dry substances is more 
than 5 %. 
 
Prescribe 40 g of paste containing 3 % of salicylic acid (Acidum 
salicylicum), 2 % of boric acid (Acidum Boricum), and 10 % of zinc 
oxide (Zincum oxydum). Apply on the injured parts of skin in the 
morning and in the evening. 
 
Rp.: Acidi salicylici 1.2 
Acidi borici 0.8 
Zinci oxydi 4.0 
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Talci 12.0 
Vaselini ad 40.0 
M. f. pasta 
D. S. Apply on the injured parts of skin, morning and evening.  
 
In this case, the quantity of dry powders equals 15 %. Therefore, for 
paste formation it is necessary to add talc. 12 g of added talc is 30 % of the 
total amount of paste.  
Thus, the prescribed paste contains 45 % of dry substances. 
The officinal pastes are prescribed only with a short form.  
 
Prescribe 100 g of zinc-salicylic paste (Pasta Zinci-salicylata). Use 
for application on the injured parts of skin.  
 
Rp.: Pastae Zinci-salicylatae 100.0 
D. S. Apply on the injured parts of skin.  
 
This paste also may be prescribed as Lassar’s paste: 
 
Rp.: Pastae Lassari 100.0 
D. S. Apply on the injured parts of skin.  
 
Lassar’s paste composition is the following: 
–  Acidum salicylicum – 2.0; 
–  Zinci oxidum – 25.0; 
–  Amylum – 25.0; 
–  Vaselinum – 48.0. 
 
Suppositories – Suppositoria (Supp.) 
(Nominative case of singular – Suppositorium;  
Genitive case of singular – Suppositorii;  
Dative case of singular – Suppositorium;  
Dative case of plural – Suppositoria) 
 
Suppository is the soft dosed medicinal form which stays in a firm 
condition at room temperature and thaws at body temperature. The 
suppositories are divided into rectal (administered into the rectum) and 
vaginal (administered into the vagina) ones.  
In comparison with oral drug intake, medicinal substances are soaked 
up faster from the rectum. Rectally administered drugs are not destroyed by 
enzymes of gastrointestinal tract. These drugs are not exposed to primary 
passage through the liver and do not show unpleasant taste and smell. In 
certain cases, the rectal form can replace the form for injection.  
Suppositories consist of medicinal substances and basis. The basis 
should be indifferent, it should not irritate mucous, poorly soak up through 
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mucous, and to be steady at a storage. Most often used basis in 
suppositories are: 
– cocoa oil obtained from cocoa seeds (melting temperature is 30–
34
 °
C); 
– butyrol – mixture of hydrogenated fats with melting temperature 35–
36 
°
C;  
– gelatin-glycerol mass containing 1 part of gelatin, 5 parts of glycerol, 
and 2 parts of water.  
If the basis is not specified in the prescription, a pharmacist uses cocoa 
oil as basis for suppositories.  
Rectal suppositories are used both for local and systemic action. 
Vaginal suppositories are used basically for local action. 
Weight of rectal suppositories is 1.1–4 g, weight of vaginal suppositories 
is 1.5–6 g. If suppository weight is not specified in the prescription, rectal 
suppositories are made with weight of 3 g, and vaginal – 4 g. 
The suppositories are prescribed in both short and in full forms. In the 
full form of prescription, a quantity of the basis can be not specified. 
Instead, we can indicate “quantum satis” – “as much as necessary”. 
 
Prescribe 6 rectal suppositories containing 0.2 g of euphylline 
(Euphyllinum). Use 1 suppository into the rectum twice a day. 
 
Rp.: Euphyllini 0.2 
Butyri Cacao 2.8 
M. f. supp. rect. 
D. t. d. N. 6 
S. Use 1 suppository rectally 2 times a day.  
 
Or: 
 
           Rp.: Euphyllini 0.2 
Butyri Cacao q.s. 
ut f. supp. rect.  
D. t. d. N. 6 
S. One suppository rectally 2 times a day.  
 
Prescriptions of vaginal suppositories are like the rectal ones. Only the 
words “supp. vag.” should be indicated instead “supp. rect.”. 
 
Prescribe 12 vaginal suppositories containing 0.2 g of ichthyol 
(Ichthyolum). Use 1 suppository into the vagina 2 times a day. 
 
Rp.: Ichthyoli 0.2 
Butyri Cacao 4.0 
M. f. supp. vag. 
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D. t. d. N. 12 
S. Use 1 suppository in vagina twice a day.  
 
Or: 
Rp.: Ichthyoli 0.2 
Butyri Cacao q.s. 
ut. f. supp. vag. 
D. t. d. N. 12 
S. Use 1 suppository in vagina 2 times a day.  
 
Presently, most suppositories are manufactured by the pharmaceutical 
industry. Such suppositories are prescribed only in short form. The 
prescription is begun from the indication of the medicinal form (Supp.). 
After that the conjunction “cum” (“with”) is written and the name of 
medicinal substance in an instrumental case with its dose. In the next line 
we indicate “D. t. d. N.” and then make out the signature. 
 
Prescribe 10 officinal rectal suppositories containing 0.1 g of 
anaesthesine. Use 1 suppository rectally for pain relief. 
  
Rp.: Supp. cum Anaesthesino 0.1 
D. t. d. N. 10 
S. Use 1 suppository rectally at pains.  
 
There are suppositories having the commercial names. For example, 
“Bethiolum”, “Anusol” and others. Such suppositories are prescribed only 
in short form without conjunction “cum”. 
 
Prescribe 10 vaginal suppositories “Osarbonum”. Use one 
suppository into vagina in the evening.  
 
Rp.: Supp. “Osarbonum” N. 10 
D. S. Use 1 suppository into vagina in the evening.  
 
Hometasks for Prescription 
 
1. Prescribe both in short and full forms of prescription 50 g of 
ointment containing 0.5 % of neomycin sulfate (Neomycinum sulfas). To 
use for application on the injured parts of skin. 
2. Prescribe 2.5 g of eye ointment with 0.5 % of hydrocortisone 
(Hydrocortisonum). To put behind the lower eyelid in the morning and in 
the evening. 
3. Prescribe 10 g of sulfuric ointment (Unguventum sulfuratum). To 
use for application on the injured parts of skin 3 times a day. 
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4. Prescribe both in short and full forms 50 g of ointment containing 
15 000 international units (IU) of mycoheptin (Mycoheptinum) in each 
gram. To use for application on the injured parts of skin.  
5. Prescribe 10 g of ointment containing 0.3 g of salicylic acid 
(Acidum salicylicum) and 0.6 g of benzoic acid (Acidum benzoicum). To 
use for application on the injured parts of skin.  
6. Prescribe 10 g of officinal eye ointment with erythromycin 
(Erytromycinum). To put behind the lower eyelid 4 times a day. 
7. Prescribe 10 g of paste containing 5 % of resorcinol (Resorcinum). 
To use for application on the injured parts of skin.  
8. Prescribe 40 g of paste containing 3 % of salicylic acid (Acidum 
salicylicum), 2 % of boric acid (Acidum boricum), and 10 % of zinc oxide 
(Zincum oxidum). To use for application on the injured parts of skin in the 
morning and in the evening.  
9. Prescribe 30 g of paste containing 10 % of anaesthesine 
(Anaesthesinum) and 4 % of iodoform (Iodoformium). To use for 
application on the injured parts of skin once a day.  
10. Prescribe 30 g of officinal paste with gramicidin (Pasta 
Gramicidini). To put bandage with paste on the wound 1 time for two days. 
11. Prescribe both in short and full forms 10 vaginal suppositories, 
each contains 0.5 g of trichomonacid (Trichomonacidum). To use  
1 suppository into the vagina in the evening.  
12. Prescribe 20 vaginal suppositories, each contains 0.5 g of 
metronidazole (Metronidasolum). To use 1 suppository into vagina in the 
evening. 
13. Prescribe 10 officinal rectal suppositories, each contains 0.5 g of 
levomycetin (Laevomycetinum). To use 1 suppository rectally  
3 times a day.  
14. Prescribe 20 officinal rectal suppositories “Bethiolum”. To use  
1 suppository rectally 2 times a day.  
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Liquid Medicinal Forms 
 
Liquid medicinal forms include such forms as solutions, suspensions, 
emulsions, infusions, broths, liquid extracts, mixtures, tinctures, and some 
others.  
 
Solutions – Solutiones (Sol.) 
(Nominative case, singular – Solutio;  
Genetive case, singular – Solutionis) 
 
Solutions are divided into solutions for external use, solutions for 
internal use, and solutions for parenteral (intravenous, intramuscular, etc.) 
administration.  
 
Solutions for External Use 
 
Solutions for external use are non-dosed medicinal forms. For 
prescribing these solutions it is necessary to know the concentration and 
general amount of solution (volume). Distilled water (Aqua destillata), 
ethyl alcohol (Spiritus aethylicus), glycerol (Glycerinum), or different 
liquid oils are used as solvents. Accordingly, solutions are divided into 
water, alcoholic (in Latin – spirituosae), and oil (in Latin – oleosae) 
solutions.  
Volume of solution for external use depends on the mode of its use. 
Such medicinal forms as eye drops, ear drops, and nasal drops are 
prescribed in volume 5–10 ml. Solutions for washing of wounds, skin or for 
rinsing are prescribed in volume 50–500 ml. Solutions for gastric lavage 
and disinfection are prescribed in amount 1–2 L.   
Certain examples of prescription of solutions for external use are given 
bellow.  
 
Prescribe 200 ml of 0.02 % furaciline (Furacilinum) solution for 
bathing of wounds.  
 
The general scheme of short form of prescriptions for external use is 
following: you indicate the name of medicinal form, next – the name of 
medicinal remedy and its percentage, and after dash – volume of the 
solution.  
 
Rp.: Sol. Furacilini 0.02 % – 200 ml  
D. S. Use for bathing of wounds.  
 
Eye drops (guttae ophtalmicae) are water or oil solutions of medicinal 
remedy (or several remedies) used for application in the eye conjunctiva.  
32 
 
The eye drops should be sterile and isotonic to lacrimal fluid. Water for 
injections, peach-kernel oil, or sweet-almond oil are used as dissolvent in 
the eye drops. The eye drops are prescribed both in full and short forms of 
the prescription. Doctor should indicate in signature “Eye drops” that 
confirms its sterility. After this, the doctor describes the mode of drug use.  
 
Prescribe eye drops containing 0.3 % of zinc sulfate (Zinci sulfas) and 
2 % of boric acid (Acidum boricum). Instill 1–2 drops into each eye  
3 times a day. 
 
Rp.: Zinci sulfatis 0.03 
Acidi borici 0.2 
Aquae pro injectionibus 10 ml 
M. D. S. Eye drops. Instill 1–2 drops into each eye 3 times a day. 
 
The volume of medicine is given according to the above-stated rule 
(10 ml). Because the percentage of zinc sulfate is 0.3 % (that is 0.3 g of 
substance is contained in 100 ml of solution), 0.03 g of zinc sulfate should 
be taken:  
 
0.3 g –  in 100 ml; 
х – in 10 ml; 
х = 0.3  10 : 100 = 0.03 (g). 
 
A calculation for boric acid is the following: 
 
2.0 g – in 100 ml; 
х – in 10 ml; 
х = 2.0  10 : 100 = 0.2 (g). 
 
Prescribe eye drops containing 1 % of pilocarpine hydrochloride 
(Pilocarpini hydrochloridum). Instill 2 drops into each eye 3 times a 
day.  
 
Rp.: Sol. Pilocarpini hydrochloridi 1 % – 5 ml 
        D. S. Eye drops. Instill 2 drops into each eye 3 times a day.  
 
The example of prescription of nasal drops is given below. 
 
Prescribe 1 % solution of Ephedrine hydrochloride (Ephedrini 
hydrochloridum). Instill 3 drops into the nose 3 times a day.  
 
Rp.: Sol. Ephedrini hydrochloridi 1 % – 10 ml 
        D. S. Instill 3 drops into the nose 3 times a day. 
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Solutions for Oral Intake 
 
Solutions for oral intake are dosed with a medicine glass, spoon 
(tablespoon, dessert spoon, or teaspoon), or drops.  
It is necessary to remember that 1 tablespoon contains 15 ml, 1 dessert 
spoon – 10 ml, and 1 teaspoon – 5 ml. One ml of water solution contains 
20 drops, one ml of alcoholic solution contains 50 drops, and one ml of oil 
solution contains 40 drops. It is most rationally to prescribe the solutions, 
which are dosed in drops, in amount of 10–20 drops for 1 intake.  
Traditionally, the solution is dosed with drops if single dose of 
medicinal remedy is less than 0.05 g. If a single dose of medicinal remedy 
equals 0.05 g or more, its solution is dosed with tablespoons (for adults).  
Solutions for oral intake are prescribed for 10–30 intakes.  
Solutions for oral intake may be prescribed both in full and in short 
forms of prescriptions.  
The examples of solutions, which are dosed by tablespoon and drops, 
are given below.   
Prescribe solution of calcium gluconate (Calcium gluconas, single 
dose is 0.5 g) for oral intake 3 times a day.  
 
A course of necessary reasoning is the following.  
1. First, it is necessary to determine the measure which should be used 
for dosing the solution. In this case, the single dose is more than 0.05 g. 
Therefore, this solution is dosed by tablespoons (1 tablespoon contains 
15 ml).  
2. Next step: it is necessary to determine the amount of intakes. Let’s 
prescribe this drug for 10 intakes.  
3. Now we have enough information for calculation of solution 
volume and concentration: 
– for 1 intake patient takes 1 tablespoon or 15 ml of solution. 
Therefore, for 10 intakes it is necessary to prescribe 150 ml of solution;  
– calculation of percentage concentration for this solution:  0.5 g is 
contained in 15 ml; x g is contained in 100 ml. Decide the proportion: 
0.5  100 : 15 = 3.3 %. That is, the concentration of this solution is 3.3 %.  
Now we have all the necessary data for this prescription. 
 
Rp.: Sol. Calcii gluconatis 3.3 % – 150 ml 
        D. S. Take orally 1 tablespoon 3 times a day. 
 
Prescribe solution of promedol (Promedolum, the single dose is 
0.02 g) for oral intake once a day.  
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Because the single dose is less than 0.05 g, this solution is dosed in 
drops. Let’s prescribe 10 drops for 1 intake and total quantity of receptions 
is 20. Because 10 drops are 0.5 ml, the total volume of this solution is 
10 ml (0.5 ml  20 receptions = 10 ml).  
The total amount of promedol is 0.4 g:  
0.02 g (single dose)  20 (amount of intakes) = 0.4 g. 
Now we have all the necessary information for the full form of 
prescription: 
Rp.: Promedoli 0.4 
        Aq. destill. 10 ml 
        M. D. S. 10 drops orally once a day.  
 
Pay your attention that “M. f. sol.” is not written. 
For a short form of this prescription, we should calculate the 
percentage concentration of promedol in solution: 0.4 g  100 : 10 = 4 %.   
 
Rp.: Sol. Promedoli 4 % – 10 ml 
        D. S. 10 drops orally once a day.  
 
Solutions for Injections 
 
Injection is a medicinal form, used for parenteral administration. 
Water and oil solutions, sometimes – suspensions, emulsions, sterile 
powders or tablets (which should be dissolved directly prior to 
administration) may be administered parenterally.  
Parenteral routes of drug administration are subcutaneous, 
intramuscular, intravenous, intra-arterial, etc. Most commonly, the 
following volumes are administered parenterally: 1–2 ml – subcutaneously, 
3–5 ml – intramuscularly, 5–10 ml (or more) – intravenously. But 
sometimes there are exceptions. 
The water solutions are more often used for subcutaneous 
administration. The water or oil solutions and suspensions are used for 
intramuscular administration. For intravenous administration, the water 
solutions are used. Solutions for parenteral administration must be sterile.  
The term “infusion” is frequently used alongside with the term 
“injection”. The distinction between them is following: relatively small 
volume of solution is administered in injection; but in infusion, the large 
volume of solution is administered.  
Presently, injection solutions are manufactured by the pharmaceutical 
industry. But sometimes these solutions may be prepared by pharmacists.  
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In this material, the prescription rules only for ready-made injection 
forms are considered.  
The pharmaceutical industry manufactures injection forms both in 
ampoules and in vials.   
The prescription rules for ampoules are the following. As a rule, the 
volume of ampoule is in a range from 1 to 100 ml. Ampoules are the dosed 
medicinal forms. But the single dose may vary from an amount of drug in 
an ampoule. Therefore, it is necessary to calculate the amount (or volume) 
of a drug for 1 administration. The quantity of ampoules which are 
prescribed to a patient depends on the duration of treatment. As a rule, 5–
10 ampoules are prescribed, sometimes – 20–50 ones.  
Ampoules are prescribed only with the short form of prescription. 
After abbreviation “Rp.:” it is necessary to indicate the liquid form which is 
in an ampoule (for example: “Sol.” or “Susp.”). Sometimes the sterile 
powder is in ampoules. After that you write the name of the medicinal 
remedy, its percentage concentration, and the volume of solution in one 
ampoule (for liquid form) or weight of remedy in one ampoule (for sterile 
powder). In the next line you indicate “D. t. d. N. 10 (or other amount) in 
amp.”. The next line is “Signa”.  
Certain examples of ampoule prescriptions are given below.  
 
Prescribe solution of ephedrine hydrochloride (Ephedrini 
hydrochloridum, the single dose is 0.1 g) for subcutaneous 
administration once a day. The drug product: ampoules containing 
1 ml of 5 % ephedrine hydrochloride solution. 
 
Rp.: Sol. Ephedrini hydrochloridi 5 % – 1 ml 
        D. t. d. N. 10 in amp. 
        S. 2 ml subcutaneously once a day. 
 
It is known that 0.05 g of ephedrine hydrochloride is contained in 1 ml 
of 5 % solution. The single dose (0.01 g) is contained in 2 ml of this 
solution. Therefore, 2 ml of solution are administered.  
The ampouled solutions may be officinal or novogalenic and have 
special commercial name. In such cases, only the drug name and its amount 
in ampoule is specified in prescriptions. The concentration and word “Sol.” 
are not written. 
 
Prescribe cordiamin (Cordiaminum, the single dose is 1 ml) for 
subcutaneous administration 3 times a day. The drug product: 
ampoules containing 1 ml of the drug.  
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 Rp.: Cordiamini 1 ml 
          D. t. d. N. 10 in amp.  
          S. Administer 1 ml subcutaneously 3 times a day. 
 
The powder-like substances, water solutions of which are destroyed 
during storage, also may be produced in ampoules. Such powder is 
dissolved directly before administration. Relevant information about this 
should be given in “Signa”. 
 
Prescribe hexenal (Hexenalum, the single dose is 0.5 g) for 
intravenous administration. The drug product: ampoules containing 
1 g of dry substance.  
 
Rp.: Hexenali 1.0 
       D. t. d. N. 10 in amp.  
       S. Dissolve the substance of one ampoule in 20 ml of sterile  
      water.  Administer 10 ml intravenously.  
 
Besides ampoules, the drugs for parenteral administration are 
manufactured in vials. Unlike ampoules, the word “vial” is not written in 
their prescriptions.   
 
Prescribe 20 vials containing 500 000 IU of dry benzylpenicillin 
sodium (Benzylpenicillinum natrium, the single dose is 250 000 IU). 
Administer intramuscularly 4 times a day.  
 
Rp.: Benzylpenicillini natrii 500 000 IU 
D. t. d. N. 20 
S. Dissolve the substance of 1 vial in 5 ml of sterile water.  
            Administer 2.5 ml intramuscularly 4 times a day.  
 
Hometasks for Prescription 
 
1. Prescribe 1 000 ml of 2 % chloramine B (Chloraminum B) solution. 
Use for disinfection of instruments.   
2. Prescribe 300 ml of 5 % aethacridine lactate (Aethacridini lactas) 
solution. Use for bathing of wounds.  
3. Prescribe 0.5 % atropine sulfate (Atropini sulfas) solution. Instill 
2 drops into each eye once a day.  
4. Prescribe both in full and in short form atropine sulfate (Atropini 
sulfas, the single dose is 0.0005 g) for oral intake 3 times a day.  
5. Prescribe analgin (Analginum, the single dose is 0.5 g) with 
dimedrol (Dimedrolum, the single dose is 0.01 g) in solution for oral intake 
3 times a day.  
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6. Prescribe platyphyllin hydrotartrate (Platyphyllini hydrotartras,  
the single dose is 0.002 g) in solution for oral intake 3 times a day. 
7. Prescribe atropine sulfate (Atropini sulfas, the single dose is 
0.00025 g) for subcutaneous administration once a day. Drug product: 
ampoules containing 1 ml of 0.1 % solution.  
8. Prescribe platyphyllin hydrotartrate (Platyphyllini hydrotartras,  
the single dose is 0.004 g) for subcutaneous administration 2 times a day. 
The drug product: ampoules containing 1 ml of 0.2 % solution. 
9. Prescribe hygronium (Hygronium, the single dose is 0.04 g) for 
intravenous administration drop-by-drop. The drug product: ampoules 
containing 0.1 g of dry substance. Before administration, medicinal remedy 
of one ampoule is dissolved in 100 ml of sterile isotonic sodium chloride 
solution.  
10. Prescribe adrenaline hydrochloride (Adrenalini hydrochloridum, 
the single dose is 0.0003 g) for subcutaneous administration. The drug 
product: ampoules containing 1 ml of 0.1 % solution. 
11. Prescribe tropafen (Tropaphenum, the single dose is 0.02 g) for 
intramuscular administration once a day. The drug product: ampoules 
containing 0.02 g of dry medicinal remedy. 
12. Prescribe cyanocobalamin (Cyanocobalaminum, the single dose is 
0.0005 g) for intramuscular administration once in 2 days. The drug 
product: ampoules containing 1 ml of 0.05 % solution.  
13. Prescribe streptokinase (Streptokinasum, the single dose is 
250 000 IU) for intravenous administration drop-by-drop once a day. The 
drug product: ampoules containing 500 000 IU of dry medicinal remedy. 
Before administration, medicinal remedy is dissolved according to the ratio 
250 000 IU : 50 ml of sterile isotonic sodium chloride solution.   
14. Prescribe aminocapronic acid (Acidum aminocapronicum,  
the single dose is 5.0 g) for intravenous administration drop-by-drop once a 
day. The drug product: vials containing 100 ml of 5 % solution. 
15. Prescribe retabolil (Retabolilum, the single dose is 0.025 g) for 
intramuscular administration 1 time in 3 weeks. The drug product: 
ampoules containing 1 ml of 5 % oil solution.  
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Suspensions – Suspensiones (Susp.) 
(Nominative case, singular – Suspensio;  
Genitive case, singular – Suspensionis)  
 
Suspension is a liquid medicinal form, in which the firm and very 
small insoluble medicinal substances are in the weighed condition in the 
liquid (water, vegetable oil, glycerin, etc.). 
Suspensions may be used for external application, for oral intake, and 
for subcutaneous or intramuscular administration. Also, suspensions are 
administered into body cavities. Suspensions are prescribed both in short 
and in full form. Short form is used when suspension is prepared on the 
base of water. The structure of suspension prescription is like solution 
prescription. Only the word “Suspensionis” (“Susp.”) is written instead of 
the word “Solutionis” (“Sol.”). In the signature, a doctor should indicate 
“Shake up before the use” after the instruction about mode of the 
suspension use. 
 
Prescribe 10 ml of water suspension containing 0.5 % of 
hydrocortisone acetate (Hydrocortisoni acetas). Instill 2 drops into 
each eye 4 times a day. Shake up before the use. 
 
Rp.: Susp. Hydrocortisoni acetatis 0.5 % – 10 ml 
       D. S. Eye drops. To instill 2 drops into both eyes 4 times a day.  
                Shake up before the use. 
 
Prescribe the Hydrocortisone acetate (Hydrocortisoni acetas) 
suspension for injections into the joint cavity (the single dose is 0.05 g) 
once every three days. The drug product: vials containing 5 ml of 
2.5 % suspension.  
 
Rp.: Susp. Hydrocortisoni acetatis 2.5 % – 5 ml 
        D. t. d. N. 2 
        S. Administer 2 ml into the joint cavity once every 3 days.  
            Shake up before using. 
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Tinctures and Liquid Extracts – Tincturae et extracta  
(Tinct., Extr.) 
(Tincture – Nominative case, singular – Tinctura;  
Genitive case, singular – Tincturae;  
Extract – Nominative case, singular – Extractum;  
Genitive case, singular – Extracti) 
 
Tinctures and liquid extracts are named “Galenic” drugs after the 
doctor Galen who suggested their preparation. These medicinal forms are 
alcoholic (less often alcohol-water or alcohol-ether) extractions from 
medicinal plant raw material. Tinctures and liquid extracts are prepared 
without heating. Both tinctures and liquid extracts are dosed in drops. They 
are stable medicinal forms which can be stored for a long time at room 
temperature. When preparing tincture, 5 or 10 volumetric parts of the 
tincture are derived from 1 part of plant raw material. When preparing 
liquid extract, 1 or 2 volumetric parts of the extract are derived from 1 part 
of raw material. 
Tinctures and extracts are officinal medicinal forms. Therefore, they 
are prescribed only in the short form. A doctor designates in the 
prescription the following information: the medicinal form, the plant name, 
and total volume of the drug in milliliters (5–30 ml).  
 
Prescribe 20 ml of valerian (Valeriana) tincture. Use 20 drops orally 
4 times a day.  
 
Rp.: Tinct. Valerianae 20 ml 
D. S. 20 drops orally 4 times a day.  
 
Similar structure of prescription is used for liquid extracts.  
 
Prescribe the liquid extract of motherwort (Leonurum). The single 
dose is 25 drops. Take orally 3 times a day.  
 
Rp.: Extr. Leonuri fluidi 20 ml  
D. S. 25 drops orally 3 times a day.  
 
Except liquid extracts, the pharmaceutical industry manufactures 
dense extracts (extracta spissa) and dry extracts (extracta sicca). Therefore, 
it is necessary to designate in a prescription the information which extract 
(liquid, dense or dry) is prescribed. Dense and dry extracts are prepared in 
capsules, powders, tablets, suppositories, and pills.  
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Infusions and Broths  
(Infusion – Nominative case, singular – Infusum;  
Genitive case, singular – Infusi   
Broth – Nominative case, singular – Decoctum;  
Genitive case, singular – Decocti) 
 
The infusions and broths are the water extraction from plant raw 
materials which is obtained by heating. The infusions are prepared from 
soft parts of plants (leaves, flowers, and stalks) or from the raw material 
containing volatile or unstable substances. For preparation, infusions are 
heated in a boiling water bath for 15 minutes. The broths are obtained from 
the dense parts of plants – roots, rhizomes, tubers, bark, etc. Broths are 
heated in a boiling water bath for 30 minutes. After heating, infusions are 
cooled at room temperature at least for 45 minutes, and broths – for 
10 minutes. Then infusions and broths are filtered. If it is necessary, water 
is added to infusion or broth to the required volume.       
The infusions and broths are used both for internal and for external 
use. For oral intake, infusions and broths are dosed by tablespoons (for 
adults), dessert spoons or teaspoons.  
Infusions and broths are prescribed only in the short form of 
prescription. They are unstable medicinal forms and should be stored no 
more than 4 days. They are prescribed for 10–16 intakes. The following 
information should be designated in the prescription: the name of the 
medicinal form (“Infusi” or “Decocti”), the used part of a plant, the plant’s 
name, its weight in grams, and the total volume of infusion or broth.  
 
Prescribe the infusion with digitalis leaves (fol. Digitalis, single dose 
is 0.05 g). Take orally 3 times a day.  
 
Rp.: Inf. fol. Digitalis 0.5 – 150 ml 
D. S. 1 tablespoon orally 3 times a day. 
 
In this case, the quantity of intakes is 10 (it is determined by the 
doctor). Therefore, the total weight of leaves is 0.05 g  10 = 0.5 g, and the 
total volume of infusion is 15 ml  10 = 150 ml (15 ml is the volume of  
1 tablespoon). 
The broths are prescribed similarly.  
 
Prescribe the broth with the ipecacuanha roots (rad. Ipecacuanha, 
single dose is 0.03 g). Take orally 5 times a day.  
 
Rp.: Dec. rad. Ipecacuanhae 0.3 – 150 ml 
D. S. Take orally 1 tablespoon 5 times a day.  
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Mixtures 
 
Mixtures are liquid medicinal forms. The mixtures are prepared by 
mixing or diluting some firm medicinal remedies in various liquids (water, 
alcohol, glycerin, vegetable oil), or by mixing liquids (solutions, infusions, 
broths, tinctures, liquid extracts). Mixtures contain 3 or more ingredients. 
This medicinal form is used mainly for oral intake and dosed by spoon (for 
adults – tablespoon). Mixtures are non-stable medicinal forms and 
prescribed for 10–12 intakes, that is, for 3–4 days. Mixtures are prescribed 
only in the full form. In prescription, doctor enumerates all ingredients 
contained in this mixture. After the name of each component, doctor 
indicates its amount. The next line is “M. D. S.” in which the information 
for patient about the mode of mixture use is contained.   
 
Prescribe the mixture containing sodium bromide (Natrii bromidum, 
single dose is 0.5 g) and caffeine benzoate (Coffeini-natrii benzoas, 
single dose is 0.05 g). Take orally 3 times a day.  
 
Rp.: Natrii bromidi 5.0 
Coffeini-natrii benzoatis 0.5 
Aquae destillatae ad 150 ml 
M. D. S. Take orally 1 tablespoon 3 times a day. 
 
In this example the calculation is fulfilled for 10 intakes. The single 
dose of sodium bromide is 0.5 g, hence for 10 intakes it is necessary to take 
0.5 (g)  10 (quantity of intakes) = 5.0 (g). The single dose of caffeine 
benzoate equals 0.05 g, hence for 10 receptions necessary to take  
0.05 (g)  10 (quantity of receptions) = 0.5 (g). For adult patients, mixtures 
are dosed by tablespoon. One tablespoon contains 15 ml of water. As the 
total quantity of intakes is 10, it is necessary to take 150 ml of water  
(15 ml  10 = 150 ml).  
If the mixture contains infusion or broth, it is written in the first line. 
In such cases, infusion or broth also carries out the function of dissolvent.  
 
Prescribe the mixture containing the infusion of Adonis vernalis grass 
(herba Adonis vernalis, single dose is 0.5 g), sodium bromide (Natrii 
bromidum, single dose is 0.5 g), and codeine phosphate (Codeini 
phosphas, single dose is 0.01 g). Use for oral intake 3 times a day.  
 
Rp.: Inf. herbae Adonidis vernalis 5.0 – 150 ml 
Natrii bromidi 5.0 
Codeini phosphatis 0.1 
M. D. S. Take orally 1 tablespoon 3 times a day. 
 
42 
 
Prescribe infusion of Adonis vernalis grass (herba Adonis vernalis, 
single dose is 0.5 g) with may-lily tincture (Convallaria, single dose is 
10 drops). Use for oral intake 3 times a day.  
 
Rp.: Inf. herbae Adinidis vernalis 5.0 – 150 ml 
Tinct. Convallariae 2 ml 
M. D. S. Take 1 tablespoon orally 3 times a day. 
 
The order of calculation of the may-lily tincture volume is the 
following. It is known, that 50 drops are contained in 1 ml of alcoholic 
solution. It is the proportion for calculation of milliliter quantity in which 
the single dose is contained: 
50 drops – 1 ml; 
10 drops – x ml; 
x = 10  1 : 50 = 0.2 ml. 
The total quantity of mixture intakes is 10. Therefore, 2 ml of tincture 
is necessary for 10 intakes: 0.2 ml  10 = 2.0 ml. 
 
Liniments 
(Nominative case, singular – Linimentum,  
Genitive case, singular – Linimenti) 
 
Liniment (or liquid ointment) is non-dosed medicinal form for external 
application. Liniment is dense fluid or gelatinous mass which softens at the 
body temperature. Unlike ordinary ointments, liniments have more liquid 
consistence. Liniments are rubbed into the skin.  
Liquid oils are used as bases for liniments: liquid paraffin (Oleum 
Vaselini), linseed oil (Oleum Lini), sunflower-seed oil (Oleum Helianthi), 
olive oil (Oleum Olivarum), etc.  
Depending on physico-chemical properties, the liniments are divided 
into two groups.  
1. Homogeneous liniments or liniments-solutions. They are molecular 
solutions or mixtures of two or more mutually soluble ingredients (for 
example, mixtures of oils with ether, methyl salicylate, chloroform, etc.) or 
semi-transparent homogeneous gelatinous mixtures (soaps in alcohol). 
Also, some solid medicinal substances (menthol, camphor, anaesthesinum, 
etc.) may be the components of homogeneous liniments. 
2. Liniments-suspensions or liniments-emulsions. They are thin 
colloids of substances unsolvable in a dispersion medium (smallest 
powders of zinc oxide, starch in water, glycerin, and oils). Certain 
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emulsifiers are added for the preparation of such liniments. Before the use, 
these liniments should be shaken up. 
Liniment is a convenient form for treatment of burns, frostbites, for 
cosmetic use, etc.  
The liniments are prescribed both in full and in short form of 
prescription in amount of 50–100 ml.  
 
Prescribe in the full form 100 ml of liquid ointment containing 20 % of 
chloroform (Chloroformium) and 20 % of methyl salicylate (Methylii 
salicylas). Use for anointment of the joints.   
 
Rp.: Chloroformii  
Methylii salicylatis ana 20 ml 
Olei Helianthi ad 100 ml 
M. f. linimentum 
D. S. Use for anointment of the joints. Shake up before the use.  
 
Prescribe in the short form 50 ml of liniment containing aloe (Aloe).  
 
Rp.: Lin. Aloes 50 ml 
D. S. Apply on the injured surface of skin 2 times a day. 
 
The concentration of medicinal remedy in liniment is specified in 
prescription only if this liniment manufactured with different 
concentrations.  
 
Prescribe 10 ml of liniment containing 1 % of sanguirithrin 
(Sanguitrinum). Use for applying on the injured parts of skin 2 times 
a day.    
 
Rp.: Lin. Sanguitrini 1 % – 10 ml 
D. S. Apply on the injured parts of skin 2 times a day. 
 
Aerosols – Aerosola 
(Nominative case, singular – Aerosolum,  
Genitive case, singular – Aerosoli) 
 
Aerosol is dispersing system with gas, or gas mixture as dispersed 
system. The dispersed phase consists of solid particles or liquids. In 
comparison with usual solutions, aerosols have many advantages in the use. 
Aerosol provides the highest dispersity of matter, simultaneous and 
uniform coating of skin or mucosa by medicinal remedies. This medicinal 
form protects medicinal remedies from aggressive influence of air and light 
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and provides the stable sterility for repeated use. Aerosols are used 
externally for topical application or for inhalations.          
Pharmaceutical industry manufactures different drugs in aerosols. This 
medicinal form is prescribed only in a short form of the prescription.  
 
Prescribe aerosol “Ingaliptum”. Use for inhalation 3 times a day. 
 
Rp.: Aerosoli “Ingalyptum” 30,0 
D. S. 1 inhalation 3 times a day. 
 
Hometasks for Prescription 
 
1. Prescribe infusion of Thermopsis grass (Thermopsis, single dose is 
0.05 g) for oral intake 3 times a day.  
2. Prescribe infusion of the roots with rhizomes of Valeriana 
(Valeriana, single dose is 0.5 g) for oral intake 3 times a day. 
3. Prescribe wormwood tincture (Absinthium, single dose is 10 drops). 
Use for oral intake 3 times a day before meal.   
4. Prescribe Buckthorn liquid extract (Frangula, single dose is 
30 drops) for oral intake in the evening.   
5. Prescribe infusion of Adonis vernalis grass (Adonis vernalis, single 
dose is 0.3 g) with tincture of Lily of the valley (Convallaria, single dose is 
20 drops) and sodium bromide (Natrii bromidum, single dose is 0.3 g). 
Take orally 3 times a day.  
6. Prescribe infusion of Digitalis leaves (Digitalis, single dose is 0.1 g) 
with Strophantus tincture (Strophantus, single dose is 5 drops) for oral 
intake 3 times a day.  
7. Prescribe 0.25 % hydrocortisone acetate suspension (Hydrocortisini 
acetas, single dose is 0.025 g). The drug product: vials containing 5 ml of 
suspension. Administer into the joint cavity once a week. 
8. Prescribe zinc-insulin suspension (Zinc-insulinum, single dose is 
20 IU) in vials containing 5 ml of the drug (in 1 ml – 40 IU of insulin). 
Administer subcutaneously once a day.   
9. Prescribe mixture containing pepsin (Pepsinum, single dose is 0.2 g) 
and hydrochloric acid (Acidum hydrochloricum dilutum, single dose is 
10 drops). Take orally during a meal.   
10. Prescribe infusion of Ipecacuanha roots (Ipecacuanha, single dose 
is 0.05 g) with sodium hydrocarbonate (Natrii hydrocarbonas, single dose 
is 0.5 g). Take orally 4 times a day.  
11. Prescribe 10 ml of salbutamol aerosol (Salbutamolum). Use for 
inhalation 3 times a day.  
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GENERAL PHARMACOLOGY 
 
Pharmacology is the science about interaction between drugs and 
human organism. Pharmacology is divided into general and special 
pharmacology. General pharmacology studies the general laws of drug 
interaction with human organism. Special pharmacology studies the 
pharmacological groups of drugs and individual drugs. Both general and 
special pharmacology are divided into pharmacokinetics  and 
pharmacodynamics . 
Pharmacokinetics is the section of pharmacology which studies the 
influence of human body upon drugs (absorption, distribution, deposition, 
biotransformation, and excretion from the body).      
Pharmacodynamics is the section of pharmacology which studies the 
action of drugs upon the human organism (biological effects, localization, 
and mechanism of action).  
 
Drug Pharmacokinetics  
 
Penetration of  Drugs through Biological Membranes  
 
Prior to the influence upon the target organs, drugs penetrate through 
some tissue barriers. There are 5 main mechanisms of substance transport 
through biological membranes (tissue barriers).  
1. Simple diffusion through cellular membranes. It is the most 
important mechanism of drug penetration which depends on the 
concentration gradient of substance. Lipophilic drugs penetrate through 
cellular membranes by means of simple diffusion. Drug lipophilicity 
depends on the amount of molecular charge. The higher molecular charge, 
the worse is drug solubility in lipids and vice versa. The degree of drug 
ionization depends on pH of tissues and fluids. If a drug is the weak acid, it 
will be weakly ionized in acidic environment and its molecules can easily 
penetrate through biological membranes by diffusion. Such drug is 
prescribed right after meals, when a gastric content has extremely low pH. 
Vice versa, weakly basic drug should be taken orally before meals or in 
1.5–2 hours after meals (when gastric acidity is minimal). Besides, weakly 
acidic drugs should be washed down with acidic solutions and weakly basic 
drugs – by basic solutions (e. g., milk or mineral water). 
Plasma pH is 7.4, but different fluids of human organism may have 
other values. Thus, urine pH of adults in the morning is 4.8, in the evening 
– 7.4. Therefore, weak acids (e. g., aspirin) are reabsorbed better from the 
morning urine that provides its retention in the body.     
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2. Filtration through membrane pores is a secondary way of drug 
penetration through biological barriers. Pore diameter is small (nearly 4 Å) 
that makes penetration of larger molecules impossible. Only water and 
small uncharged water-soluble molecules (urea, sugars) penetrate through 
pores by means of filtration. The direction of movement depends on 
concentration difference on both sides of the membrane and on the speed of 
fluid flow through the membrane.  
Drugs with marked polarity are easily ionized and have a heavy 
charge. These drugs do not penetrate through pores and membranes  
(e. g., heparin, myorelaxants). Such drugs are administered by means of 
injection because they are not absorbed in gastrointestinal tract. These 
drugs cannot penetrate through blood-brain and placental barriers. 
3. Facilitated diffusion through membrane is possible for some 
substances (glucose, amino acids, etc.). This mode of transport is carried 
out by means of channels with special transporter proteins (permeases). 
Permeases selectively bind with certain substances and transport them 
inside of the cells. Facilitated diffusion is possible against concentration 
gradient.   
4. Active transport is characterized by selectivity to certain substances. 
Unlike facilitated diffusion, active transport needs the use of energy which 
is released due to ATP (adenosine triphosphate) hydrolysis. Active 
transport is carried out against concentration and electrochemical gradients. 
Thus, some amino acids, nitrogen compounds and their derivatives are 
transported through membranes by means of active transport. 
5. Pinocytosis is the uptake of substances by means of vesicle 
formation. The substance contacts with a part of membrane, with the 
following membrane invagination and formation of the vesicle with the 
substance inside. This vesicle is separated from the membrane and 
transported inside the cell. For instance, some proteins and peptide 
hormones are transported into the cells by means of pinocytosis.  
 
Routes of  Drug Administration  
 
There are enteral and parenteral routes of drug administration. Enteral 
routes include routes of drug administration through gastrointestinal tract: 
peroral (oral), sublingual, rectal, and administration into duodenum by 
means of a feeding tube.  
Peroral drug administration is most natural, simple, and comfortable 
route. But this route is not the best one for the urgent care. In 
gastrointestinal tract, drug may be changed under the influence of gastric 
juice and intestinal enzymes. Thus, drug activity is reduced or lost 
completely. A degree and speed of drug absorption from gastrointestinal 
tract depends on presence and quality of food because the food components 
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can slow down the drug absorption due to formation of inactive complexes 
with it. But, sometimes, the increase of speed of drug absorption under 
influence of food components is possible.  
Most commonly, drugs are taken in 30–40 minutes prior or in  
1–2 hours after meal. As a rule, the onset of drug action is in 15– 
40 minutes after peroral intake. Drugs in coated tablets or in capsules are 
absorbed in small intestine. Lipid-soluble substances are absorbed after 
emulsification by bile acids. After absorption, drug is transported through 
the portal venous system in the liver with the following partial 
biotransformation. After this, drug enters the bloodstream and starts acting. 
As a rule, the drug dose for peroral intake is 2–3 times more than for 
parenteral administration.  It is due to drug biotransformation during the 
first passage through the liver. 
Since the drug action is developed only when it is entering 
bloodstream, the term “bioavailability” was proposed. The bioavailability is 
the part of administered drug dose which reaches the systemic circulation in 
unchanged form. Bioavailability is given in the percentage of the 
administered dose. In intravenous administration, medication 
bioavailability is 100 %.  
When medication is taken sublingually, its absorption develops 
quickly due to intense blood supply of the mucous membrane of the mouth. 
The sublingually taken drug does not undergo the influence of gastric juice 
and gastrointestinal enzymes. Sublingual drug absorption is performed 
through superior vena cava system that provides the drug entering the 
bloodstream, bypassing the liver. These factors provide the faster and more 
marked drug effect than during peroral intake.   
Rectal drug administration is used if peroral intake is impossible or for 
the medication influence on mucous membrane of rectum. This route 
provides quite fast onset of drug action. Nearly 50 % of rectally 
administered dose enters inferior vena cava and then the liver. Another part 
of the dose enters the bloodstream bypassing the liver. Therefore, the drug 
effect in case of rectal administration is 20–25 % higher than in case of 
peroral intake. A volume of the therapeutic enema is about 25–100 ml. If 
administered rectally, drug irritates the mucosa, therefore the starch mucus 
is added to the drug solution (in amount 30–50 % of general volume of 
enema). For the drug influence on rectal mucosa (hemorrhoids, rectal 
cracks, etc.), the drugs are administered in a form of rectal suppositories 
that provide prolonged local effect.  
48 
 
Parenteral routes of drug administration are used for both resorptive 
(subcutaneously, intramuscularly, intravenously, etc.) and local 
(administration into body cavities) effects. Parenteral drug administration is 
characterized by some advantages: dosing accuracy, fast effect 
development, less dose in comparison with enteral intake, etc. But along 
with it, injections can cause contamination (must adhere to sterility), 
possibility of overdose, or local complications on the injection site 
(thrombosis, damage of vascular endothelium, etc.).  
Intravenous route provides the fast effect and fast appearance of high 
drug concentration in the heart and CNS (although subsequently the drug 
redistribution takes place). As a rule, drugs are administered intravenously 
slowly. The bolus administration, drop-by-drop administration, and 
infusion are possible. Non-soluble substances, oil solutions, drugs with 
marked irritating activity, and drugs provoking blood clotting or hemolysis 
are not administered intravenously. 
Intra-arterial route provides the high drug concentration in the region 
receiving blood through this artery. Intra-arterial rout is used in treatment 
of endarteritis and chilblains, for X-ray examination, etc.  
Intraosseous drug administration is used in traumatology for regional 
anaesthesia of extremities, for administration of plasma-substituting drugs 
(and even blood) in patients with massive burns, including children 
(administration into the heel bone). The speed of drug effect development 
for intraosseous administration is approximately the same as for 
intravenous route.  
Intracardial route of drug administration is used in case of the heart 
arrest. The aim of this administration is to restore the activity of sinoatrial 
node. Drug injection is accompanied by the following heart massage. 
Subarachnoidal route is used for the administration into the spinal 
canal (with piercing meninges) of such drugs as local anaesthetics, 
morphine, some antibiotics (for treatment of meningitis). Subarachnoidal 
injection is performed by an experienced surgeon or anaesthesiologist.  
Epidural route provides the drug administration into the spinal canal, 
but dura must not be pierced. This route is used for anaesthesia of internal 
organs of the body regions which are located below the level of injection or 
for pain relief during delivery.  
Intraperitoneal drug administration is used seldom. For example, 
antibiotics may be administered intraperitoneally during the surgery on 
abdominal organs.  
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In intramuscular administration, the injection is most commonly made 
into the external outer quadrant of the gluteus maximus muscle. When 
administering oil-based solution or suspension, it is necessary to make sure 
that the needle does not hit a blood vessel. The speed of drug absorption may 
be increased or decreased by using heat or ice pack. 
Subcutaneous route is widely used for administration of different 
drugs, insulin, and vaccines. Subcutaneous injections are painful. The speed 
of subcutaneous drug absorption is lower than in case of intramuscular 
administration. If intravenous drug administration is impossible  
(e. g., in patients with extensive burns), subcutaneous administration is 
used for elimination of dehydration, disturbances of electrolyte balance or 
acid-base balance, and for parenteral feeding. About 1.5–2 l of fluids may 
be administered subcutaneously for 24 hours. The solutions must be 
isotonic. 
Endolymphatic route provides the drug administration in the lymphatic 
system. As a rule, the drug is administered in lymphatic vessels of the rear 
side of the foot, catheterization of which is fulfilled by means of 
microsurgical techniques. The drug is administered through a special 
batcher at 0.3 ml/min flow rate. The administered solution must be warm. 
Endolymphatic route is used in diseases which are characterized by active 
participation of the lymphatic system in pathogenesis (e. g., bacterial 
infections and before the surgery for prevention of purulent complications). 
Inhaled route of drug administration is used for the influence upon 
bronchial smooth muscles in patients with asthma, for treatment of purulent 
infective diseases of bronchi and lungs, inflammation of trachea and 
pharynx, for oxygen therapy, and for inhaled narcosis. A drug with airflow 
is administered into the airways by means of inhalers or spray-bottles. The 
contact between inhaled air and blood provides the fast drug absorption. 
The effect of the drug depends on its concentration in the inhaled air.  
Transdermal route of administration is used for providing resorptive 
effects of the drugs with marked lipophilic properties. The degree of drug 
absorption depends on its lipid solubility. The skin lesions (maceration, 
cracks, etc.) increase the absorption speed. The ability to be absorbed 
significantly depends on the properties of the ointment base of a drug 
product. Such ointment bases, as lanoline, pig fat, dimethyl sulfoxide, and 
spermaceti, increase the transdermal drug absorption.  Dimethyl sulfoxide 
also exhibits anti-inflammatory, antiallergic, and antibacterial effects. 
Transdermal medicines provide stable drug concentration in the blood for 
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extended time periods. Nowadays, transdermal drug products are becoming 
more widespread. 
Intranasal route is used mainly for treatment of rhinitis. Medicinal 
forms for intranasal administration include the nasal drops, ointments, and 
emulsions. It is necessary to notice that nasal mucosa is characterized by 
significant blood flow and provides the high degree of drug absorption.  
Conjunctival route of drug administration is used in treatment of 
glaucoma, conjunctivitis, trachoma, initial stage of cataract, etc. Solutions 
of eye drops, eye ointments, and eye membranes are medicinal forms which 
are used for application into conjunctival sac.  
 
Drug Distribution in Organism 
 
After absorption in the blood, drugs undergo the uneven distribution in 
internal organs and tissues. The tissue barriers significantly influence the 
drug distribution. The tissue barriers include the capillary wall, cytoplasmic 
membrane, the blood-brain barrier, and the placental barrier.  
Most drugs easily penetrate through the capillary wall. Some drugs 
penetrate through pores by means of filtration; other drugs penetrate 
through the capillary wall due to diffusion. Some hydrophilic agents are 
transported through the capillary wall by means of energy called “active 
transport”.  
The blood-brain barrier is the significant obstacle for drug penetration 
into the central nervous system. The cerebral capillaries have no pores. 
Pinocytosis is also impossible in them. Besides, the external surface of the 
vascular endothelium is covered by astroglia that creates the additional 
barrier for a drug. In general, hydrophilic agents poorly penetrate the brain, 
but lipophilic drugs penetrate well. The permeability of the blood-brain 
barrier increases due to inflammation of the meninges.  
The placenta is a significant barrier for drug penetration into the fetus. 
But lipophilic and some hydrophilic (ionized) agents penetrate through the 
placenta. 
After absorption, a significant amount of the drug binds with plasma 
proteins, mainly – with albumins. The high degree of binding is typical for 
sulfonamides of prolonged action, for semisynthetic penicillins and for 
some other antibiotics and anti-inflammatory agents, etc. The drugs 
associated with proteins do not penetrate the tissues, are poorly filtered in 
kidneys, accumulated in the body, and lack pharmacological activity. There 
is dynamic equilibrium between free drug fraction and associated part of 
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drug. As free fraction penetrates the tissues, its amount in plasma is 
maintained due to the drug releasing from the associated fraction.  
In intravenous administration, the drug distribution is carried out in 
two steps. Initially, the drug concentration quickly achieves the maximal 
level and drug enters tissues together with intensive blood flow (heart, 
brain, lungs, and kidneys). Figuratively speaking, these organs are taking 
“the first pharmacological blow”. During the following 10 minutes after 
injection, the drug is distributed between the blood and the extra vascular 
fluids and tissues of the body, including organs with low intensity of blood 
flow (muscles, subcutaneous fat, etc.). In intramuscular and subcutaneous 
administration, the first phase of drug distribution is weak, because the 
drug absorption from the injection site and its distribution in the organism 
occur simultaneously. 
The following drug distribution depends on its lipophilic or hydrophilic 
properties and affinity to certain tissues. Lipophilic agents undergo intensive 
uptake by fat tissue with depositing in it. Drug release from depot depends 
on drug excretion and reduction of its concentration in the blood. Some 
drugs exhibit selective affinity to certain organs and tissues. The drug 
fraction is released from depot and exhibits its pharmacological effects 
when the blood drug concentration becomes quite low.  
 
Drug Biotransformation 
 
Most drugs undergo metabolic changes in the organism. This process 
is called “biotransformation”. As a rule, due to metabolic changes, the drug 
is transformed into water-soluble substance which is easily excreted with 
urine, bile, or sweat. Polar metabolites are badly dissolved in lipids and 
characterized by low ability to bind to plasma and tissue proteins. 
Metabolized drugs badly penetrate through biological membranes and are 
not reabsorbed by kidneys and intestine.  
Drug biotransformation occurs mainly due to hepatic microsomes. 
Some metabolic changes take place in the intestine, lungs, skin, and 
plasma. Only some drugs are excreted from the body in unchanged form.   
There are two main types of drug biotransformation: 
– metabolic transformation;  
– and conjugation.            
Metabolic transformation is the chemical change of the substance due 
to oxidation, reduction, or hydrolysis.  
Oxidation is one of the most common ways of drug inactivation. 
Oxidation occurs in the liver with participation of microsomal enzymes – 
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oxidases. The main representative of oxidases is cytochrome P450. Due to 
oxidation, the hydrogen atoms are cleaved from the side chains of drug 
molecules. NADP (nicotinamide adenine dinucleotide phosphate) and 
oxygen participate in oxidation.  
Reduction is the rarer drug metabolism. Such enzymes as nitro- and 
azoreductases and some others participate in this reaction. Reduction is 
typical for steroid hormones and their analogues. Such drugs as 
chloramphenicol, nitrazepam, chloralhydrate, and some others also undergo 
metabolism by way of reduction.  
Hydrolysis is the way for inactivation of ethers and amides. Due to 
hydrolysis, the ether or amide bond is destroyed. This reaction takes place 
in the presence of water. Enzymes which catalyze hydrolysis (esterases) are 
characterized by substrate specificity. Sometimes, the hydrolysis of initially 
inactive form of drug results in formation of a metabolite with certain 
pharmacological activity. That is, the part of modern angiotensin-
converting-enzyme inhibitors is prodrugs which are transformed into 
pharmacologically active agents due to hydrolysis (enalapril is transformed 
into enalaprilate, fosinopril – into fosinoprilate, etc.).   
Conjugation is a reaction of accession of hydrophilic endogenous 
metabolite to the drug molecule. Previously, endogenous metabolite is 
activated by formation of macroergic bond at the expense of ATP. Typical 
reactions of conjugation are the drug binding to the residues of acetic or 
glucuronic acids, glutathione, sulfates, methyl residue, etc. Conjugation can 
be the only way of drug biotransformation or can occur after previous 
metabolic transformation. As a rule, drugs lose the biological activity due 
to metabolic transformation and conjugation. The drug inactivation is 
significantly slowed down in patients with hepatic pathology (acute or 
chronic hepatitis, cirrhosis, etc.). It results in prolongation of drug action 
and overdose.  
Some drugs inhibit the activity of microsomal hepatic enzymes 
(chloramphenicol, phenylbutazone, etc.) or other enzymes (cholinesterase 
inhibitors, MAO (monoamine oxidase) inhibitors, etc.). It causes the 
prolongation of action for drugs which are metabolized by means of these 
enzymes. At the same time, there are drugs which stimulate the synthesis of 
microsomal enzymes: phenobarbital, ethanol, diazepam, carbamazepine, 
rifampicin, etc.  
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Drug Excretion 
 
Drugs and their metabolites are excreted from the body by different 
ways: together with urine, feces, bile, mother milk, expired air; secreted by 
sweat, bronchial, and sebaceous glands, etc.  
The kidneys play a major role in the drug excretion. The drug 
excretion depends on the processes of filtration, reabsorption, and 
secretion. Such substances as water, glucose, amino acids, proteins with 
molecular weight up to 60 000, and some other substances are filtered in 
the glomerulus of the kidney nephron. Drug molecules that bind to plasma 
proteins are not filtered. The filtration speed depends on intensity of renal 
blood flow. In pathological states with reduced renal blood flow (shock, 
glomerulonephritis, etc.), filtration is significantly reduced.   
Active drug secretion occurs in the proximal convoluted tubules of 
nephrons. Secretion through tubular epithelium into the primary urine takes 
place by means of special transporters with the use of energy. Both free 
fraction of the drug and fraction associated with proteins may undergo the 
secretion.  
Reabsorption of drugs occurs in distal convoluted tubules. Because 
drug reabsorption occurs due to passive diffusion through lipid membranes 
of the epithelial cells, the non-dissociated lipophilic molecules of weak 
acids or bases and neutral substances are reabsorbed better. Reabsorption 
depends on pH of urine. Thus, weak acids (barbiturates, benzodiazepines, 
and sulfonamides) poorly dissociate and are easily reabsorbed in blood if 
pH of urine is acidic. On the contrary, molecules of weak bases (morphine, 
atropine, quinine, etc.) dissociate much in the acidic environment and, 
therefore, are poorly reabsorbed and easily excreted from the body.   
Regulation of the urinary pH may be used for treatment of patients 
with drug overdose and poisoning. Thus, alkalization of urine by means of 
sodium hydrocarbonate creates the favorable condition for the acceleration 
of weak acid elimination. And, vice versa, acidification of the urine 
increases alkaloid excretion because alkaloids are weak bases.  
It is necessary to notice that excretion of drugs and their metabolites is 
significantly slowed down in patients with renal failure. The drugs which 
undergo mainly hepatic inactivation are preferable for treatment of such 
patients.    
Drugs, which are poorly absorbed in gastrointestinal tract, are excreted 
with feces. Such drugs are used mainly for influence upon intestinal 
microflora or as laxative agents. 
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Some drugs (tetracyclines, penicillins, etc.) are excreted with bile into 
small intestine, where they undergo either the excretion with feces or 
secondary intestinal reabsorption (so-called enterohepatic recirculation).  
Volatile substances are excreted from the body through lungs. This 
process occurs due to passive diffusion and depends on frequency and 
depth of respiration.  
Some drugs are excreted with secrets of exocrine glands (sweat, 
salivary, gastric, etc.).  
Some alkaloids are secreted into the stomach cavity, where they 
undergo the secondary absorption in the blood (e. g., morphine). Therefore, 
multiple gastric lavages are necessary in treatment of patients poisoned by 
such alkaloids.  
The drug excretion with mother milk (anticoagulants, tranquilizers, 
cytostatic agents, etc.) is a danger to a child.  
The process of clearing the organism from the drug is called 
elimination. For estimation of elimination the value of “half-life of 
elimination” or “plasma half-life” (T1/2) is used. Half-life of elimination is 
the time during which the drug plasma concentration is decreased 2 times 
from its maximum concentration.  
It is necessary to notice that an increase of a drug dose results in the 
lower rate of drug elimination, therefore, the drug’s plasma half-life 
increases.   
Besides, the term “clearance” is used for quantitative characteristic of 
the rate of drug elimination. Drug clearance is defined as the fixed volume 
of fluid (containing the drug) cleared of drug per unit of time (e. g., ml/min, 
L/h). There are general, renal, and hepatic clearances.  
 
Drug Pharmacodynamics  
 
Types of  Drug Action  
 
Some drugs can act at the place of their application. Such type of drug 
action is called local action. Such medicinal forms as pastes, ointments, and 
compresses act locally. But pure local action is very seldom because some 
amount of drug is absorbed through skin and mucosa into the blood.  
Action of the drug after its absorption into the blood is called 
resorptive action.  
Both in local and in resorptive action, the drug can influence the 
substrate directly (direct action), or indirectly – through another organ or 
system (indirect action).  
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Reflex action is an example of indirect action when the changes of 
activity of neural centres or internal organs develop due to the drug 
influence upon some receptors. Thus, the use of mustard plasters, irritating 
skin receptors, results in relaxation of vessels in some tissues and in 
improvement of their trophism.  
The drug action can be nonspecific (general) or specific (selective). 
Drugs with nonspecific action influence the functions of many organs and 
tissues, e. g., adaptogens are characterized by nonspecific action. The drugs 
with specific action influence the function of certain organ or tissue. For 
example, aerosol of salbutamol influences the bronchial smooth muscles 
and is used for treatment of bronchial asthma. Because the pure selective 
action is practically impossible, the term “selective action” is commonly 
replaced by the term “predominant action”.  
There are main and secondary actions of drugs. The main action is a 
drug action which provides therapeutic effect. For instance, cardiotonic 
action of cardiac glycosides upon the heart provides their curative effect in 
treatment of patients with chronic and acute heart failure. Simultaneously, 
cardiac glycosides improve renal blood flow. It is an example of secondary 
action of cardiac glycosides. 
Depending on the strength of the bond between the drug and receptor, 
there are reversible and irreversible actions. In case of reversible action, the 
function of the target organ (tissue, enzyme, etc.) is restored after a certain 
period. Reversible action is typical for cholinesterase inhibitors with 
reversible action (proserin, etc.). Drugs with irreversible action exhibit the 
stable effect when the function of the target organ is restored during long 
time or is never restored. Irreversible action is typical for organic 
phosphorus compounds, blocking acetylcholinesterase in cholinergic 
synapses.  
The pharmacological effect develops due to interaction of a drug with 
certain receptors. Receptors are macromolecules which can interact with 
the drug with the following change in the cellular activity. There are many 
different receptors: cholinergic, adrenergic, dopaminergic, serotoninergic, 
and other receptors.  
The ability of the drug to bind to the receptor, which determines the 
formation of the “drug-receptor” complex, is called affinity.    
A drug is called an agonist  (mimetic)  if its interaction with 
receptors results in certain biological effects. As a rule, these biological 
effects are stimulating. If the drug produces a maximal effect due to 
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interaction with the receptor, this drug is called a full  agonist . A drug 
producing a partial effect is called a partial  agonist .  
A drug is called an antagonist  (blockering drug)  if its interaction 
with receptors does not result in changes which are typical for stimulation 
of these receptors.  
A drug influencing upon one subtype of receptors as an agonist and 
upon another subtype as an antagonist is called an agonist -antagonist . 
For example, nalorphine is an agonist of - and -opioid receptors and an 
antagonist of -receptors.  
 
Principles of  Drug Dosing  
 
 The drug action depends on the dose. A dose is the quantity of the 
drug which is taken by a patient. A quantity of the drug for the one intake is 
called the single dose. A quantity of the drug which is taken by patient 
during a day is called the daily dose. A course dose is the quantity of the 
drug which is needed for the full course of treatment.  
The minimal drug quantity which causes the development of the 
minimal therapeutic effect, is called a minimal therapeutic dose. However, 
the minimal therapeutic doses are seldom used in medicine. Usually, 
clinicians are guided by mean therapeutic doses. A mean therapeutic dose 
is the drug quantity which causes the development of the optimal 
therapeutic effect in most patients. Sometimes, the highest therapeutic dose 
is prescribed. A highest therapeutic dose is the greatest quantity of a drug, 
the intake of which does not cause the development of toxic effects. After 
the range of therapeutic doses, there is the range of toxic doses which is 
replaced by the range of lethal doses. Accordingly, the minimal, mean, and 
highest doses are distinguished in each dose range.  
The maximum therapeutic doses (both single and daily) of strongly-
acting and poisonous drugs are given in the State Pharmacopoeia of 
Ukraine. Recommended mean therapeutic doses for adults and children are 
the benchmarks in clinicians’ work. During the treatment, a clinician 
corrects the prescribed doses in dependence on the severity of the patient’s 
condition, dynamics of change in symptoms, and patient’s sensitivity.  
In cases when it is necessary to create the high drug concentration in 
the human organism, the first dose of the prescribed drug may be higher 
than the subsequent doses. This dose is called a loading dose. The 
subsequent doses which are used for continuation of treatment are called 
maintenance doses .  
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Besides curative doses, the preventive doses  are widely used in 
medicine in cases when it is necessary to prescribe some drugs for 
prevention of certain diseases.  
The term “breadth of therapeutic action” is closely connected with the 
term “dose”. The breadth of therapeutic action is the range from the 
minimal therapeutic dose to the maximal therapeutic dose inclusive. The 
broader is therapeutic action, the greater is safety of the drug that provides 
for clinician the higher ability to choose the optimal therapeutic dose for a 
patient.  
Also, the term “therapeutic index” is used to define the drug safety. 
Therapeutic index is the ratio of mean lethal dose (LD50) to mean 
therapeutic dose (ED50) in animal studies: 
 
Therapeutic index = LD50 : ED50, 
 
where LD50 is a dose that causes the death of 50 % of experimental 
animals and ED50 is a dose causing the pharmacological effect in 50 % of 
animals. The larger the therapeutic index, the safer the drug is.  
A physician should always remember the Arndt–Schulz rule 
formulated by Hugo Paul Friedrich Schulz and Rudolf Arndt. It states that 
for every substance, small doses stimulate, mean doses inhibit, and large 
doses kill. That is, small doses stimulate the functions of vital elements, 
mean doses increase them, high doses inhibit the functions, and excessive 
doses paralyze them.  
 
Phenomena Occurring due to Repeated Drug 
Administration 
          
 The repeated drug administration can result in both the increase and 
the decrease of the drug effect. An increase in effectiveness of the drug is 
the result of drug ability to accumulate in the body. This phenomenon is 
called cumulation.  
There are both material  and functional cumulation . Material 
cumulation is the accumulation of drug itself in the body. It is determined 
by the delay in drug biotransformation and its slow excretion. A possibility 
of cumulation arises when the drug binds to some substrates and undergoes 
slow metabolism. Cumulation can cause intoxication. The high degree of 
cumulation is typical for cardiac glycosides, indirect anticoagulants, 
hypnotic drugs, etc.  
Functional cumulation is the accumulation of drug effects. A 
prominent example of functional cumulation is a phenomenon of 
58 
 
alcoholism. In alcoholism, the pathological psychical changes due to 
alcohol abuse, gradually increase up to the development of the acute 
alcoholic psychosis (delirium tremens). Ethyl alcohol itself does not 
accumulate in the body due to repeated drinking, because it undergoes fast 
metabolism and excretion.  
For prevention of drug cumulation, the close control of the dynamics 
of functional changes in the body and the drug dosage regime correlation 
are necessary.  
Tolerance is another phenomenon which can develop due to 
repeated drug intake. Tolerance is the gradual reduction of drug efficacy 
due to repeated intake. The following tolerance causes are possible: 
reduction of drug absorption, decrease of receptor sensitivity to the drug, 
activation of additional metabolic ways instead of those blocked by the 
drug, acceleration of drug biotransformation (due to induction of 
microsomal enzymes), rate increase of drug excretion from the body, 
amplification of homeostatic regulatory mechanisms, etc. If tolerance has 
developed, the increase of drug dose is necessary for achievement of initial 
drug effect. Also, it is possible to replace used drug by other medications. 
But it is necessary to notice, that cross-tolerance is also possible. In this 
case, tolerance extends to other drugs with similar chemical structure or 
mechanism of action.  
Tachyphylaxis  is a special kind of tolerance. It is a very fast 
tolerance (sometimes after a simple drug intake). As a rule, tachyphylaxis 
develops owing to substrate exhaustion. For example, repeated ephedrine 
administration causes less elevation in blood pressure if drug is 
administered repeatedly, with interval 10–30 minutes. It is due to reduction 
of noradrenaline storage in adrenergic synapses.    
In case of sudden discontinuation of drug administration, the 
withdrawal  (or discontinuation) syndrome can develop. There are two 
types of the withdrawal syndrome. The first type is typical for a long-term 
use of hormonal agents. Its essence is in the inhibition of appropriate 
endocrine glands. Particularly, this type of the withdrawal syndrome is 
typical for glucocorticoids (prednisolone, dexamethasone, etc.). According 
to the negative feedback, a therapy with glucocorticoids results in the 
adrenal gland atrophy and reduction of endogenous glucocorticoid 
synthesis. After cessation of glucocorticoid therapy, the restoration of 
adrenal gland activity lasts from several months to a year or more. 
Therefore, sudden glucocorticoid therapy discontinuation is accompanied 
by acute adrenal insufficiency with shock-like symptoms. An 
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administration of hormonal drugs is necessary for elimination of these 
symptoms. To prevent the discontinuation syndrome, the glucocorticoid 
removal should be slow, with gradual reduction of the dose and frequency 
of drug administration.  
The second type of the withdrawal syndrome develops when the 
sudden cessation of the drug intake is accompanied by the development of 
the rebound syndrome. The essence of this phenomenon lies in the fact that 
cessation of the drug intake is accompanied by disinhibition of the 
regulatory processes which were inhibited by the drug. A 
hypercompensation with acute aggravation of the main disease develops in 
this case. To prevent the rebound syndrome, the phasing out of the drug is 
used when both the dose and the frequency of the drug administration are 
gradually decreased. 
Some drugs cause the development of the drug dependence due to 
repeated intake. There are psychical and physical drug dependences. 
Psychical drug dependence is manifested by changes in the patient’s mind 
with the following desire to take the drug repeatedly. Psychical dependence 
develops due to the use of psychosedative drugs which create the feeling of 
mental comfort, sedation, relaxation, fast and easy way to fall asleep, and 
imaginary elimination of life conflicts. A rejection of such drugs is 
accompanied by discomfort, psychical tension, fear, anxiety, uncertainty, 
etc. A desire to get rid of these feelings makes an addicted person to take 
drugs again and again. Furthermore, the taken dose should be constantly 
increased owing to the development of tolerance.  
Psychical dependence in people develops also to drugs with 
stimulating action (amphetamine, sydnocarbum, caffeine, etc.). These drugs 
cause feeling of tidal forces, activity, euphoria, overestimation of their own 
capabilities, etc. A desire to keep this condition makes people take 
psychostimulants. A cessation of such drug use is accompanied by 
depression, mood decline, reduction of capacity to work, etc. Such 
dependence is called toxicomania.  
Physical drug dependence develops due to metabolic restructuring in 
the organism under the influence of certain drug. That is to say, such drug 
became essential for function of some organs and systems. The physical 
dependence is more severe substance dependence. It develops due to the 
use of opioid analgesics (morphine, promedolum, heroin, etc.), hypnotic 
drugs, and some other drug groups.  
In persons with physical dependence, a cessation of drug intake causes 
severe conditions with functional disturbances of different organs and 
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systems (convulsions, loss of consciousness, abdominal pain, nausea, 
vomiting, respiratory depression, etc.) and even death in patients. A 
complex of these symptoms is called a withdrawal syndrome or abstinence. 
Addiction consequences are well known to everybody: the development of 
drug trafficking, personality destruction, spreading of AIDS, hepatitis, etc.  
 
Combined Drug Use  
 
With an aim to reach the best therapeutic result, the combination of 
several drugs is commonly used in medicine to influence different links of 
pathological process. But it is necessary to notice that such combined 
therapy can cause various complications. According to statistics, the 
quantity of pharmacotherapeutic complications increases proportionally to 
the amount of the used drugs. To avoid possible complications, a clinician 
should know peculiarities of drug interactions.  
Drug interactions can change both pharmacokinetics and 
pharmacodynamics of one another. There is the following classification of 
drug interactions:  
1. Pharmacological interaction. 
1.1. Pharmacokinetic interaction. 
1.2. Pharmacodynamic interaction.  
1.3. Physico-chemical interaction in the body. 
2. Pharmaceutical interaction.       
Pharmacokinetic interaction develops during the use of two or more 
drugs. Drugs can influence one another at the stages of absorption, 
biotransformation, transport, deposition, and excretion from the body.  
Thus, intake of absorbents (active carbon) or covering agents 
(Almagel) worsens the absorption of other drugs.  
If taken drugs interact with plasma proteins, one drug can replace 
another in the binding to proteins that results in an elevation of the free 
fraction of the second agent. It can cause toxic effects. 
Medications can interact at the biotransformation step. Thus, a use of 
drugs stimulating activity of hepatic microsomal enzymes (phenobarbital, 
etc.) can minimize the efficacy of other drugs due to activation of their 
biotransformation. 
In case of pharmacodynamic type, the drugs interact on the level of 
receptors. Unidirectional effect of two or more drugs is called synergism. 
There are two main types of synergism: summation and potentiation. In 
case of summation, the final effect of both drugs is equal to the sum of their 
individual effects (additive effect, by analogy with arithmetic: 2 + 4 = 6). 
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When final effect of two or several drugs is more than arithmetic sum of 
their individual effects, such type of synergism is called potentiation 
(supra-additive effect: 2 + 4 → 10). Potentiation is more profitable type of 
synergism. Also, it is a possible variant when the final effect is less than 
arithmetic sum of individual effects of drugs, but more than individual 
effects of every single drug. It is the so-called infra-additive effect  
(2 + 4 → 5). 
Synergism is widely used in therapy to achieve the necessary effect 
by enabling the dose of each of the combined drugs to decrease. 
Unfortunately, synergism is evident not only for therapeutic effects but also 
for toxic effects.  
Drug interaction can be accompanied by reduction of their efficacy. 
This phenomenon is called antagonism. Like synergism, there are direct 
and indirect types of antagonism. If two antagonizing drugs influence the 
same substrate, such antagonism is called direct (e. g., adrenomimetics and 
adrenoblockering drugs). If one drug inhibits the effect of another but these 
drugs influence the different substrates, their antagonism is indirect  
(e. g., the influence of adrenomimetics and cholinomimetics upon the 
heart).  
Besides, there is a phenomenon of synergo-antagonism, when some 
effects of simultaneously used drugs are increased, but other effects are 
reduced.   
Chemical and physicochemical interactions of drugs are possible in 
human organism. Thus, charged negatively molecules of heparin interact 
with positively charged molecules of protamine sulfate. 
Antagonism is widely used in medicine for reduction of drug side 
effects and for treatment of acute poisonings. In such cases we say about 
antidotes. 
Although a combined use of drugs is widely used in medicine, an 
advantage should be given for monotherapy (treatment by one drug) 
because side effects of a simple drug are more easily predictable and 
controllable.  
Pharmaceutical interaction is possible during processes of drug 
manufacturing and storing, or due to mixing drugs in one syringe. For 
example, the mixed in a syringe dibazolum with papaverine reduce the 
effects one of another. A base for pharmaceutical incompatibility of drugs 
is their chemical and physical properties.    
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Main Types of  Pharmacological Therapy  
 
Etiotropic therapy is an ideal type of pharmacotherapy because 
suggests the influence upon the disease cause. An example of etiotropic 
therapy is the antibiotic use for treatment of infections. But it is necessary 
to notice that there is the limited list of drugs which affect the disease 
cause. 
A main direction of modern pharmacotherapy is the use of drugs 
influencing upon basic (possibly the initial) mechanisms of disease 
pathogenesis. It is the so-called pathogenetic therapy. A substitutive 
therapy is the species of pathogenetic pharmacotherapy when certain drugs 
are prescribed for deficit compensation of corresponding metabolites, 
enzymes, hormones, vitamins, etc.  
Symptomatic therapy is the use of drugs which reduce or eliminate 
certain disease symptoms (e. g., pain). Although symptomatic therapy does 
not result in the recovery, this type of pharmacotherapy is very important 
and useful (e. g., the use of analgesics in traumas).   
Preventive therapy is also important because it is used to prevent 
certain disease. Thus, antiviral drugs are used with the purpose of 
preventing epidemics, antiplatelets are used after myocardial infarction 
with the purpose to prevent platelets aggregation, etc. Preventive therapy is 
the therapy of future.  
 
Factors Influencing Drug Effects  
 
Age value. Mean and highest therapeutic doses are prescribed to 
adults aged from 18 to 60 years. As a rule, a size, weight, and other 
individual peculiarities of a person are not considered. For patients with 
low stature and for exhausted patients, the doses are decreased. Sometimes, 
the drug dosage is performed for 1 kg of the patient’s weight or for the unit 
of the body surface area. 
Pediatric pharmacology studies the peculiarities of drug action upon 
the child’s body. The less is the child’s age, less perfect are his neuronal 
and humoral regulatory mechanisms, systems of drug inactivation, 
immunity, etc. Such organism peculiarities influence the health, growth, 
and development of the child.  
Perinatal pharmacology is the special section of pediatric 
pharmacology. Perinatal pharmacology studies the drug influence upon the 
fetus from 24 weeks up to labor and upon the newborn up to 4 weeks. The 
fetus and newborns are especially sensitive to drug action. It is due to the 
following peculiarities of their organism: low activity of enzymes, which 
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metabolize the drugs, or absence of these enzymes, reduced excretory renal 
function, increased permeability of the blood-brain barrier, and 
underdeveloped central nervous system. Microsomal enzyme system of the 
liver is formed in the newborn up to the end of the second week, but the full 
development is reached only up to the end of pubescence. Thus, 
chloramphenicol, antibiotic drug, is very toxic for newborns and can cause 
their death because their liver lacks the enzymes which are essential for 
inactivation of this agent.  
State Pharmacopoeia contains the highest simple and daily doses of 
poisoning and powerful drugs that are prescribed to children of different 
age. Dose calculation for drugs which are absent in Pharmacopoeia is 
fulfilled according to the following rule: 1/20 part of the adult’s dosage is 
taken for each year of the child’s age. It is necessary to notice that such 
calculations are very approximate because some children, in their weight 
and stature, may lag in development at 1–2 years of age. 
Geriatric pharmacology studies the reaction peculiarities of old and 
senile patients to the medications. As a rule, such patients have not only age 
changes but also several chronic diseases. In such patients, absorption and 
excretion of drug slows down owing to worsened blood supply of 
gastrointestinal tract and kidneys. Hepatic drug biotransformation is 
slowed; the level of blood proteins is reduced. The body water is decreased, 
and the fat tissue volume is increased with age. In old age, the adaptive 
reserves of human organism are sharply reduced; the carbohydrate 
assimilation is impaired; and the risk of thrombosis, hypoxia, and acidosis 
is increased. Age-related changes in vascular wall result in the decreased 
blood flow: cerebral and coronary blood supply is especially reduced. 
Therefore, for patients after 60 years of age, the doses of most drugs should 
be decreased by 1/3–1/2 of the adult treatment dose. Even with these 
amendments, the drug toxicity in elderly patients significantly higher than 
in middle-aged people. Therefore, if it is possible, herbal medicines and 
other safe drugs should be used for treatment of elderly patients.  
Patient status. Different diseases significantly influence the 
sensitivity to drugs and their efficacy. Renal and hepatic diseases can cause 
the retardation of active drug elimination from the organism that increases 
the complication risks.  For their prevention, it is necessary to know the 
main ways of drug inactivation. Thus, in patients with renal insufficiency, 
the use of drugs which are inactivated in liver is preferable; in patients with 
hepatic diseases, preference is given to drugs which are excreted mainly in 
unchanged form through the kidneys. A frequency of drug complications 
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and intoxications is higher in dehydrated, exhausted and hyposthenic 
patients. Sometimes, the sensitivity to drugs is changed owing to certain 
pathology. Thus, hyperthyreosis is accompanied by the increased 
sensitivity of myocardium to catecholamines. Also, human organism 
sensitivity to drugs changes during pregnancy, menopause, etc.  
Gender value. Gender-linked differences in pharmacological 
response have been investigated insufficiently. In comparison with a male 
organism, female organism is more sensitive to some substances and drugs 
(nicotine, alcohol, strychnine, hormonal agents, psychotropic drugs, etc.). 
But, sensitivity of female organism to cardiovascular drugs is less than that 
of the male organism. Males need higher doses of analgesics for 
postoperative pain relief. Often, pharmacotherapy in women should be 
stopped during menses and for several following days.  
Value of genetic factors. Pharmacogenetics studies the hereditary 
influence on the reactivity of human organism to drugs and other 
xenobiotics. It is known that some toxic effects of drugs are caused by 
blockage or absence of certain genes responsible for synthesis of some 
enzymes metabolizing xenobiotics. Thus, duration of dithylinum action 
sharply increases (up to 6–8 hours instead of 5–7 minutes) due to hereditary 
insufficiency of plasma pseudocholinesterase (butyrylcholinesterase). 
Erythrocyte glucose-6-phosphate dehydrogenase deficiency is widely 
spread in regions where population suffer from malaria for many centuries. 
This enzyme deficiency causes erythrocyte hemolysis after intake of certain 
drugs (acetylsalicylic acid, paracetamol, chloramphenicol, amidopyrine, 
sulfonamides, nitrofurans, etc.). Such abnormal individual response to a 
drug due to a genetic anomaly is called drug idiosyncrasy. It develops on 
the first administration of the drug, even in small doses. As a rule, 
idiosyncrasy manifests by sharp and turbulent development. Idiosyncrasy 
can be identified by collecting family history and survey information of the 
patient’s tolerability of drugs in the past.  When prescribing new drugs, it is 
necessary to control the reaction on the first administration of the drug 
(especially in childhood).  
Value of daily rhythms. A value of daily rhythms has an undoubted 
importance for the physiological state of the organism. In the waking state, 
the activity of nervous and endocrine systems is significantly higher than 
during the sleep. It is reflected in the susceptibility of the organism to 
different drugs. Chronopharmacology studies the influence of daily  
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rhythms on the organism. Chronopharmacology is divided into 
chronopharmacokinetics and chronopharmacodynamics.  
It is proved that the maximum effect of drugs is observed during the 
period of the maximum human activity, that is, in the daytime. Thus, 
maximum analgesic effect of morphine is produced at the beginning of the 
second half of the day. In the morning and in the night, the morphine activity 
is significantly less. During angina attacks, nitroglycerin efficacy is 
significantly higher in the morning than during the second half of the day. 
The drug toxicity also changes in dependence of the day time. Absorption, 
biotransformation, and other pharmacological peculiarities of drugs can 
change during the day. It is known, that antimycotic agent griseofulvin is 
absorbed better at noon. Absorption of lithium carbonate is significantly 
higher in the daytime than during the night. One should remember that the 
drug pharmacological effects produced by drugs at certain times of the day 
can depend on certain pathological states of the organism. Besides the daily 
rhythms, there are seasonal rhythms – physiological functions of the 
organism which also influence the drug activity. 
 
Main and Side Drug Effects  
 
The drug action which provides the development of necessary 
pharmacological effect (blood pressure reduction, pain relief, fewer 
reduction, etc.) is called main action. However, besides the main effects, all 
drugs exhibit side effects which are undesirable for the organism. Side effects 
develop in the range of therapeutic drug doses. Thus, a hypnotic agent chloral 
hydrate significantly irritates the mucous membranes when used in 
therapeutic doses. Side effects may be primary and secondary. Primary side 
effects arise as a direct result of the drug influence on a certain substrate. 
That is, nausea and vomiting induced by ether inhalation develop due to 
irritative action of ether on gastric mucosa. Secondary side effects develop 
indirectly. Thus, severe destructive pneumonia can develop due to aspiration 
of vomit into the respiratory tract during ether narcosis.  
Side effects have different levels of severity and different  
degrees of undesirable influence upon organs and systems.  
Allergic reactions are among the undesirable side effects. Drugs can 
serve as allergens (antigens). According to clinical manifestations, there are 
allergic reactions of immediate and delayed types. Both types depend on 
sensitization of the organism and changes of cellular and humoral immunity. 
Idiosyncrasy is also one of clinical manifestations of drug side effects.  
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Undesirable effects which arise in the range of toxic doses are called 
toxic effects. The main cause of toxic effects is drug overdose.  
Different medications can exhibit an undesirable influence on the fetus. 
Embryotoxic effect  develops during first 12 weeks after fertilization and, 
as a rule, results in the fetus death. Embryotoxic effect is typical for nicotine, 
fluor-containing drugs, hormonal drugs (estrogens, progestins, 
desoxycorticosterone acetate, somatotropin, etc.), barbituric acid derivatives, 
antimetabolites, etc.  
Teratogenic action can develop due to the drug influence on the 
fetus from the end of the 4
th
 week up to the end of the 10
th
 week. Teratogenic 
action is manifested by disturbances of tissue differentiation that results in 
the development of the newborn abnormalities (malformations). For 
example, intake of hypnotic agent thalidomide by European pregnant women 
has resulted in the birth of more than 5 000 children with phocomelia 
(malformation of the limbs), gastrointestinal and genitourinary tract 
disorders, etc.  
Fetotoxic effect  is the result of undesirable effects of the drug on the 
fetus during the later stages of pregnancy. Herewith, a quality of fetus 
reaction is virtually identical to the reaction of an adult and can cause the 
development of severe pathology or death of either a fetus or a newborn. 
It is necessary to notice that drugs can influence the fetus even on the 
step of progenesis by affecting the reproduction and trophism of male and 
female sex cells and by causing the chromosomal aberrations or gene 
mutations. Such drug ability to cause the stable damages of cells and their 
genetic apparatus which is accompanied by genotype change in the child is 
called mutagenic action. Thereby, it is necessary to stop taking any drugs 
at least 6 months before the planned pregnancy.  
Cancerogenic action  is the substance ability to cause the 
development of malignant tumors. Cancerogenic action of drugs can occur in 
people of any age.   
Besides mentioned disturbances, the so-called non-physiological 
deviations from the norm are possible due to a drug undesirable action  
(e. g., level elevation of uric acid, bilirubin, metabolic acidosis, etc.). It 
provides the conditions for the development of certain diseases.     
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General Principles of Treatment  
of Acute Poisoning   
 
According to statistics, acute poisonings are about 40 % of general 
amount of emergency cases in clinics. Urgent care in intensive care unit was 
necessary for 25 % of them. Mortality from acute poisonings is about 4 %. 
Maximum cases of poisonings (accidental poisoning) occur in children 
aged from 1 to 4 years.  Among adults, there are both accidental and 
deliberate (suicidal) poisonings. Moreover, suicidal poisonings are 
common among young people aged from 16 to 20 years and among elderly. 
The poisonings caused by alcohol, medicines (hypnotic drugs, 
antihypertensive drugs, etc.), and household chemicals (insecticides, dyes, 
gasoline, kerosene, antifreeze, etc.) are dominant. During summer, the 
poisonings caused by such plants as belladonna, herb Paris (Crow’s eye), 
jimsonweed, and mushrooms (especially, by Amanita phalloides) are 
common. The incidents of substance dependence are widespread among 
teenagers inhaling insecticides (Chlorophos [Metrifonate], Carbophos 
[Malathion], etc.), gasoline, kerosene, etc. It is commonly accompanied by 
severe poisonings with fatalities. It is necessary to notice that poisons 
containing toluene cause the condition which is like action of hallucinogen 
LSD (lysergic acid diethylamide). Such substances can cause psychical 
dependence with fast personality degradation.  
There are acute and chronic poisonings. The chronic poisonings 
develop due to repeated intake of small doses of toxic substances and are 
characterized by slow progressive development of symptoms. Most of 
professional diseases caused by toxic substances are chronic poisonings.  
Acute poisonings are characterized by sharp onset and fast 
development (from several hours to several days). In some cases, such 
poisonings result in the death of a patient. Patients with hyperacute 
poisonings are isolated when symptoms increase extremely rapidly with the 
fast death of the patient. For example, a person dies in 15 minutes after 
parathion intake on an empty stomach.  
A treatment of acute poisonings includes the following measures:  
– poison elimination from the body; 
– poison inactivation;  
– symptomatic therapy (maintenance of organism functions).  
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Elimination of  Poison from the Body 
 
Elimination of Unabsorbed Poison 
 
After the skin contact with poison drops, it is necessary to rinse it 
from the skin with warm water and soap. There are specific antidotes 
which neutralize the poison or interfere with its influence upon the skin. If 
poison gets on the conjunctiva or cornea of the eye, it is necessary to rinse 
them with warm normal saline, milk, or water during 10–15 minutes. After 
this, 0.5–1 % dicain (tetracaine hydrochloride) solution is applied into the 
conjunctival sack. If phosphorus organic compounds get in the eyes, they 
should be rinsed with 3 % sodium hydrocarbonate solution.  
In cases when solutions of acids or alkalis get in the eye, the washing 
of the eye by acidic or alkaline solutions is contraindicated due to 
possibility of eye tissue damage. Such patients should be taken to the 
ophthalmologist. 
In case of snake bite, the cold is applied topically during 6–8 hours. 
Circulatory procaine blockage is fulfilled above the bite.  
Gastric lavage or induced vomiting is used for the poison elimination 
from the stomach. 5–10 % sodium chloride solution is used (2–4 teaspoon 
of sodium chloride dissolved in a glass of water) for inducing vomiting. 
This solution irritates the gastric mucosa accompanied by spasm of pyloric 
sphincter and the movement delay of poison into intestine. It results in the 
reduction of poison absorption. Ipecacuanha syrup may be prescribed for 
children. This syrup induces the vomiting in 5–20 minutes after intake. 
Also, apomorphine may be administered subcutaneously or intramuscularly 
to adults or children over 5 years of age. Simultaneously, ephedrine is 
administered intramuscularly to prevent hypotension.  
Inducing vomiting is contraindicated in the following cases: 
– in unconscious patients (vomit can get into the respiratory ways and 
provoke its obstruction or aspiration pneumonia, because such patients 
have the relaxed epiglottis); 
– in patients poisoned by gasoline, kerosene, turpentine, acids, alkalis, 
phenol, and other substances which irritate mucous membranes (during 
vomiting the drops of these substances can get into respiratory tract and 
cause its damage and pneumonia that can result in the death of the patient).   
In other cases, gastric lavage should be fulfilled even after vomiting. 
Gastric lavage is fulfilled several times with interval 3–4 hours until 
complete purification of stomach from poison. To prevent body 
hypothermia, the warm water or solutions are used for gastric lavage. The 
use of normal saline, Rheopolyglucin, or potassium permanganate for 
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gastric lavage is preferable. If necessary, active carbon or other adsorbents 
may be added to the mentioned solutions. Also, milk or egg protein 
solution (12 egg whites in 1 litre of boiled water) may be used. But the use 
of milk is contraindicated in poisonings caused by lipid-soluble substances, 
because butterfat facilitates the poison absorption, relaxes pyloric sphincter, 
and promotes the poison transition into the intestine.  
Some poisons can be secreted from the blood into the stomach, with 
the following repeated absorption in the blood. It provides the high 
concentration of poison in the blood during long time. In such cases, gastric 
lavage is fulfilled 3–4 times and more for 2 days (e. g., morphine and 
noxyron poisonings). After gastric lavage, it is necessary to prescribe active 
carbon or any other absorbent which sorbs the poison residue.  
In cases of lipid-soluble poisoning, vaseline oil should be administered 
(3 ml per 1 kg of the patient’s weight) before gastric lavage. Also, saline 
laxative drug is prescribed, and the intestine lavage is fulfilled. Saline 
laxatives (magnesium sulfate or sodium sulfate) clean both small and large 
intestines. Vaseline oil dissolves lipid soluble poisons (kerosene, 
turpentine, gasoline, etc.) but does not promote their absorption.   
Also, the siphon enemas are used for elimination of poisons from 
intestine. For siphon enema, 8–10 litres of water is used.  
 
Elimination of  Poison from Blood 
 
Before elimination of poison from the blood, it is necessary to provide 
a patient with fresh air and administration of analeptics (caffeine, 
aethymizole), or carbogen inspiration. In poisonings caused by irritative 
substances for prevention of pulmonary edema, a patient should avoid 
doing sharp movements. Such patients should be warmed and receive 
inhaled oxygen. For moistening, oxygen is passed through the water in 
Bobrov’s apparatus. The anti-foaming agents (ethyl alcohol or 
antifomsilanum) are administered to the patient when the symptoms of 
pulmonary edema develop. After that, measures to eliminate poison from 
the blood are carried out: forced diuresis, hemodialysis, hemosorption, 
blood replacement, etc.   
Forced diuresis  is used for elimination of water-soluble poisons 
and their metabolites from the blood. It is possible if poisons are badly bind 
to proteins and lipids in the blood.  
The technique of forced diuresis depends on poisoning severity. In 
mild poisoning, a patient receives a large volume of drinking water and 
furosemide perorally. The patient should drink the necessary water volume 
70 
 
during 8–12 hours. The volume of drinking water should be at least of daily 
water demand. In case of average poisoning, drugs which can bind 
poisoning are administered intravenously (Neohemodesum, Polyglucinum, 
Reopolyglucinum, etc.). In case of acid poisoning (barbiturates, acetic acid, 
salicylic acid derivatives, etc.), 2–4 % solution of sodium hydrocarbonate is 
also administered intravenously. After that, 10 % glucose solution with 
potassium chloride is administered intravenously. In severe cases of 
poisoning, Neohemodesum, Reopolyglucinum, and sodium hydrocarbonate 
solution are administered for 1 hour. After this, osmotic diuretics 
(mannitol) or loop diuretics (furosemide) are administered. A volume of 
fluids administered intravenously should be equal to the volume of excreted 
urine. In case of super-severe (terminal) poisoning, initially, it is necessary 
to restore the breathing and the blood circulation. After that, forced diuresis 
is carried out. 
Forced diuresis is contraindicated in patients with acute and chronic 
cardiovascular failure and patients with disturbances of excretory renal 
function. Forced diuresis efficacy is reduced in patients over 50 years of age. 
Blood substi tution is effective when a volume of transfused blood 
is 1.5–2 times more than a volume of patient’s blood. To prevent 
hypocalcemia, 10 ml of 10 % calcium chloride solution is added to each 
500 ml of citrated blood. Blood substitution is effective if it is carried out 
during the first hours of poisoning. As a rule, this measure is ineffective if 
carried out 8–29 hours after poisoning.  
Peritoneal dialysis  is based on the ability to transport poison from 
the organism into peritoneal fluid which is in the abdominal cavity. For 
peritoneal dialysis, Ringer solution is used together with added glucose and 
5 % albumin solution. Sodium hydrocarbonate solution is added in cases of 
poisoning by acidic compounds. Administered into abdominal cavity, the 
solution is left for 45–60 minutes. After that, the solution is evacuated with 
registration of both input and evacuated volumes. Antibiotics are added to 
the fluid to prevent infection. 
Hemodialysis  is used for cases of poisoning by substances which do 
not bind to plasma proteins and in development of acute renal failure. The 
earlier you start hemodialysis, the better is a chance for success. 
Hemoperfusion is a method of filtering the blood when the blood 
passes through a column with absorbtive properties aiming at removing 
specific toxic substances from the blood. The adsorbent substances most 
commonly used in hemoperfusion are resins and activated carbon. 
Hemoperfusion is an extracorporal form of treatment because the blood is 
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pumped through a device outside the patient’s body. By means of 
hemoperfusion, not only the poisons that do not bind to plasma proteins, 
but also other poisons may be eliminated from the body.     
 
Inactivation of  Toxic Substance  
 
When the toxic substance is known, antidotes are used in the treatment 
of poisoning. Antidotes are drugs which are used in specific treatment of 
poisoning. There are 3 groups of antidotes:  
– antidotes which bind poison and prevent the absorption of poison by 
their presence;  
– antidotes which accelerate the poison biotransformation;  
– antidotes which are pharmacological antagonists. 
   
Antidotes Binding to the Poison and Facil itating Its 
Excretion from the Body  
 
     Unithiol  is a representative of this group. This drug binds heavy 
metals (copper, zinc, bismuth, gold, nickel, chromium, etc.), arsenic, and 
cardiac glycosides. Formed complexes are easily soluble in water, and 
therefore quickly excreted through the kidneys. It is necessary to notice that 
coordination complexes of unithiol with such metals as iron, silver, lead, 
and cadmium are unstable and undergo fast hydrolysis. Therefore, in cases 
of poisoning by these metals, unithiol is not used. Unithiol is administered 
intramuscularly, sometimes orally, or in inhalations. Complexes of unithiol 
with metals undergo dissociation in acidic environment that can cause 
damage of renal tissues. To prevent that, sodium hydrocarbonate is used 
after unithiol administration. Side effects of unithiol are dyspepsia, 
headache, and burning mouth syndrome. Convulsions can develop due to 
unithiol overdose.  
Succimer  binds heavy metals, arsenic, and cardiac glycosides. The 
drug is taken orally, administered intramuscularly, or used for inhalations. 
In severe poisoning, 3–4 ml of 5 % succimer solution is administered 
intramuscularly.  
Edetate Calcium Disodium (in Ukraine – Tetacinum-calcium) 
is a chelating agent which interacts with many metals: lead, iron, zinc, 
copper, chromium, uranium, manganese, vanadium, cesium, etc. Most 
commonly, Tetacinum-calcium is used in treatment of acute and chronic 
lead poisoning. The drug is administered intramuscularly, taken orally, or 
applied locally. For peroral intake, Tetacinum-calcium is prescribed only 
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after poison elimination from the stomach because its complexes with 
metals can be easily absorbed. Long-time use of Tetacinum-calcium can 
result in iron deficiency and hypochromic anemia. This drug is 
contraindicated in renal failure and hepatic disturbances.  
Penicil lamin  is a derivative of penicillin. Penicillamin is used for 
treatment of copper and lead poisoning.  
Pentacinum  is a drug which is used for elimination of radioactive 
lead, cesium, zinc, tritium, and decomposition products of uranium. 
Pentacinum is administered intravenously slowly. 
Methylene blue  transforms about 10 % of hemoglobin into 
methemoglobin. The drug is used for treatment of cases with poisoning by 
cyanides, naphthalene, hydrogen sulfide, sulfonamides, etc. Cyanides bind 
to methemoglobin forming nontoxic metcyanohemoglobin that is 
accompanied by restoration of tissue respiration. Also, glucose promotes 
the inactivation of cyanides.   
 
Antidotes Accelerating Biotransformation of  Poison  
 
Sodium thiosulfate  is used for treatment of acute cyanide 
poisoning. The drug reacts with cyanides to produce nontoxic metabolites 
which are excreted with the urine.  
Ethyl  alcohol  (Ethanol)  is used for treatment of methanol 
poisoning. Ethanol interacts with alcohol dehydrogenase and prevents the 
formation of formaldehyde and formic acid that cause metabolic acidosis. 
Also, ethanol prevents blindness which is caused by methanol.   
 
Antidotes –  Pharmacological Antagonists  
 
Atropine  is used for treatment of cases with poisoning by  
M-cholinomimetics and cholinesterase inhibitors. Naloxone  and 
naltrexone  are antagonists of opiod receptors and are used for treatment 
of opioid analgesic poisoning (morphine, heroin, etc.). As a rule, antidotes, 
pharmacological antagonists, interact with the same receptors as poisons. 
Thus, creation of specific antibodies against substances, which are the most 
common cause of poisoning, is promising. The sooner the antidotes are 
administered, the better is the therapy result. In the already developed 
pathology of tissues, organs, and systems, the efficacy of antidote therapy 
is reduced. Especially low efficacy of antidotes is in the treatment of 
patients in terminal stages of poisoning.   
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Symptomatic Therapy of  Acute Poisonings  
 
Symptomatic therapy has especially important meaning in treatment of 
poisonings caused by substances which have no specific antidotes. First, it 
is necessary to maintain vital functions of the organism – blood circulation 
and respiration.   
In inhibitory breathing, it is necessary to clean the mouth and pharynx 
from the contents. After that, the mechanical ventilation is carried out. If 
necessary, cough reflex may be provoked. For that, the inserted through the 
nose catheter is used for irritation of the epiglottis. A 2 % sodium chloride 
solution or a 3 % sodium hydrocarbonate solution are inhaled for reduction 
of sputum viscosity. Trypsine or acetylcysteine are inhaled in the presence 
of purulent sputum. Antispasmodic agents are added to inhaled solutions.  
Centrally acting analeptics are used only in cases of moderate 
inhibition of central nervous system.  
An elimination of hypoxia and pulmonary edema is the primary task in 
patients with acute heart failure. Thereto, the fluid pumping from the lungs 
is fulfilled. Also, antifoam agents are administered (ethyl alcohol or 
antifomsilan). In Bobrov’s apparatus, oxygen is passed through the water 
with ethanol added (10 ml of 30–40 % ethanol). Antifomsilan is used as 
aerosol or administered (5–8 drops) into the respiratory ways. In the case of 
progressive hypoxia, the artificial respiration is used. Ganglion blocking 
drugs are used for decreasing preload and afterload of the heart. 
Simultaneously, furosemide is administered. It increases diuresis and 
reduces the circulating blood volume that results in decreasing preload. It is 
necessary to notice that osmotic diuretics are contraindicated in such cases. 
Also, cardiac glycosides are administered to a patient. Albumin is used for 
restriction of fluid transudation into the alveoli. Prednisolone, calcium 
gluconate, and antagonists of H1-histamine receptors (e. g., dimedrolum) 
are used to reduce vascular permeability.  
In cases of acute vascular failure, the therapy is directed to the cause 
of intoxication. If poison is unknown, the treatment of acute vascular 
insufficiency is carried out in the following sequence. Prednisolone is 
administered first, and then plasma or macromolecular plasma-substituting 
agents are administered. These measures normalize the blood pressure and 
increase the urine excretion. If hypotension persists, the vasoconstrictors 
are administered: noradrenaline, mesatonum (phenylephrine), or 
angiotensinamide. In cases of circulatory centralization, ganglion blocking 
drugs or dopamine are administered. Ephedrine and adrenaline are 
contraindicated at poisoning caused by gasoline, kerosene, and turpentine 
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because these drugs can provoke cardiac arrhythmias. If, despite all 
measures fulfilled, the blood pressure remains low, the administration of 
noradrenaline or mesatonum is continued on the background of 
corticosteroids and ganglionic blocking drugs. Simultaneously, sodium 
hydrocarbonate and trisaminum are administered for elimination of 
acidosis. Glucose, insulin, and vitamins are administered for metabolism 
normalization.  
Diazepam, sodium oxibutirate, or barbituric acid derivatives are 
administered in case of hypoxic convulsions. It is necessary to remember 
that barbiturates are dangerous due to their ability to cause the respiratory 
inhibition.   
In case when marked hypoxia results in brain edema, furosemide, 
glucocorticoids (prednisolone, dexamethasone), ascorbic acid, and 
phenobarbital are administered. 
Hyperthermia can develop due to hypoxia or poison influence upon 
the thermoregulatory centre. Organism cooling may be carried out by 
means of the cold which is applied upon the head and regions of large 
vessels. Also, antipyretic drugs are administered intramuscularly or 
intravenously together with dibazolum or benzohexonium (for the increase 
of heat emission). In severe cases, dimedrolum or diprazine are 
administered. 
An acute hepatic failure commonly develops due to the toxic influence 
of chlorine-containing substances, tetracyclines, phosphorus organic 
compounds, poison of Amanita phalloides, etc. In such cases, a 20–40 % 
glucose solution is administered together with insulin and vitamin B 
complex.  
Acute renal failure occurs in poisoning by heavy metals, formalin, 
arsenic, Amanita phalloides, hypnotic drugs, etc. In such cases after 
antidotes administration, the drugs for elimination of water-salt 
disturbances (plasma, glucose with insulin, isotonic sodium chloride 
solution), and diuretics (furosemide, mannitol) are administered. Gastric 
lavage and saline laxative drugs are used for elimination of excessive 
potassium in patients with anuria. In case of aggravation of the patient’s 
condition, hemodialysis is carried out.   
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Step 1. Tasks for Self-Control  
General Pharmacology  
 
1. Drug A has been prescribed to a patient. In several days, the action of 
the drug has significantly decreased, and the increased dose of the drug is 
necessary for achievement of initial effect. What is the name of this 
phenomenon? 
A. Idiosyncrasy.  
B. Tachyphylaxis. 
C. Tolerance. 
D. Drug dependence (drug addiction). 
E. Cumulation. 
2. Drug A, which decreases the blood clotting, has been prescribed to a 
patient with thrombosis of veins. After several days the signs of overdose 
have developed in patient. The level of drug A in blood significantly 
exceeded the top border of therapeutic concentration. What is the name of 
this phenomenon? 
A. Antagonism.  
B. Cumulation. 
C. Tachyphylaxis. 
D. Tolerance. 
E. Potentiation. 
3. Substance A increases the tone of smooth muscles of intestine. This 
effect is not observed in presence of substance B.  But the tone of intestine 
is increased if concentration of substance A is enhanced 10 times and 
concentration of substance B is not changed. What is this type of drugs 
interaction called? 
A. Non-equilibrium antagonism. 
B. Indirect antagonism. 
C. Equilibrium antagonism. 
D. Potentiation. 
E. Synergism. 
4. The biological activity of xenobiotics in human organism is 
decreased due to reactions of: 
A. Hydration. 
B. Amination. 
C. Carboxylation. 
D. Dehydration. 
E. Hydroxylation. 
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5. The synthesis of ATP in cells is blockaded in pharmacological 
experiment. What type of drugs transport through the bio membranes will 
undergo the greatest changes? 
A. Filtration. 
B. Passive diffusion. 
C. Osmosis. 
D. Active transport. 
E. Simplified diffusion. 
6. A man, 36-year-old, with craniocerebral trauma has diminished 
breath sounds, thready pulse, reflexes are absent. What route of 
administration of pyracetam is the most appropriate in this case? 
A. Inhalation. 
B. Subcutaneous. 
C. Intravenous. 
D. Peroral. 
E. Rectal. 
7. A man abused drug A during a long time. After the interruption of 
this drug use, the abstinence has developed in this patient. But the signs of 
abstinence are eliminated after the use of drug B. This phenomenon is an 
example of:  
A. Psychic dependence. 
B. Potentiation. 
C. Tolerance. 
D. Physical dependence. 
E. Cross-dependence. 
8. For the passive diffusion of medicinal substance through the 
biological membranes the following is typical: 
A. Moving of molecules according to the concentration gradient. 
B. Possibility of competition of two substances for one transport 
mechanism. 
C. Presence of protein carrier in membranes. 
D. Presence of external source of energy. 
E. Moving of molecules through membranes by means of their kinetic 
energy.  
9. What property of medicinal substances promotes their cumulation?  
A. High degree of dissociation. 
B. High degree of biotransformation. 
C. High solubility in lipids. 
D. Low degree of binding with proteins. 
E. High degree of binding with proteins. 
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10. Amebiasis was diagnosed in a patient, who had appealed to the 
doctor. Doctor prescribed tetracycline to this patient. What type of action 
was used in this case? 
A. Irreversible action. 
B. Direct action. 
C. Etiotropic action. 
D. Reflex action. 
E. Main action. 
11. It is necessary to introduce the drug into an organism in a definite 
period for creation of effective concentration of the drug in the organism. 
Point out the pharmacological parameter which should be considered at a 
choice of drugs introduction rhythm.   
A. Constant of elimination. 
B. Breadth of therapeutic action.  
C. Coefficient of diffusion in intestine. 
D. Period of half-life.  
E. Degree of binding with proteins. 
12. The tranquilizer diazepam in average therapeutic doses was 
prescribed to a patient with disturbing-imaginary state. But due to the 
genetically determinant enzymopathy the action of the drug was so strong, 
that the marked hypnotic effect was showed in the patient. What is such 
atypical reaction to a drug called?   
A. Dependence. 
B. Idiosyncrasy. 
C. Allergy. 
D. Tachyphylaxis. 
E. Tolerance. 
13. What is the name of the psychic and physical disturbances in 
narcomaniac, which develop due to interruption of narcotic intake?   
A. Abstinence. 
B. Idiosyncrasy. 
C. Tachyphylaxis. 
D. Euphoria. 
E. Tolerance. 
14. The recommended route of drugs administration to a comatose 
patient is: 
A. Rectal. 
B. Intravenous. 
C. Inhalation. 
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D. Peroral. 
E. Subcutaneous. 
15. A woman intakes tranquilizers in the second part of pregnancy. The 
delivery develops in time, but the child was born with different anomalies 
of development (labium leporium, polydactyly). What is such drug action 
called? 
A. Carcinogenic action. 
B. Mutagenic action. 
C. Embryotoxic action. 
D. Fetotoxic action. 
E. Teratogenic action. 
16. Several injections of ephedrine hydrochloride had been given in 
short period of time to a patient with acute dropping of blood pressure. But 
the reaction of vessel to the last introduction was much lower, than to 
previous injections. What is the cause of this phenomenon?    
A. Ricochet syndrome. 
B. Idiosyncrasy. 
C. Tolerance. 
D. Cumulation. 
E. Tachyphylaxis. 
17. The significant psychic, neurologic, and somatic disturbances 
develop in an addict after the cessation of narcotic action. What is the name 
of this phenomenon? 
A. Tolerance. 
B. Physical dependence. 
C. Abstinence. 
D. Sensitization. 
E. Cumulation. 
18. A pregnant woman had taken high doses of retinol during the first 
trimester of pregnancy. This caused hypervitaminosis. The pregnancy 
developed normally, but the newborn had the anomalies of development. 
What is such negative drug action called? 
A. Carcinogenic. 
B. Teratogenic. 
C. Embryotoxic. 
D. Fetotoxic. 
E. Mutagenic. 
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19. Some drug in tablets was prescribed to a patient with hypertensive 
disease. What factor does not have the influence upon absorption of the 
drug from intestine? 
A. Activity of microsomal hepatic enzymes.  
B. Intake of other drugs. 
C. Food intake. 
D. Solubility of the drug in water or in lipids. 
E. Acidity of stomach juice. 
20. Digitoxin was prescribed to a patient with chronic heart failure. 
After several weeks of treatment, the following symptoms of glycoside 
intoxication had developed in the patient: bradycardia, nausea, 
extrasystoles. But the dose did not exceed the average therapeutics and the 
term of treatment course did not terminate. What is this phenomenon 
called? 
A. Idiosyncrasy. 
B. Material cumulation. 
C. Functional cumulation. 
D. Tolerance. 
E. Tachyphylaxis. 
21. A doctor has prescribed diclofenac-sodium and prednisolone to  
a patient with serious polyarthritis. The doctor considers, that in case of 
simultaneous introduction of non-steroid anti-inflammatory drugs and 
glucocorticoids their action will significantly increase because the drugs 
have different mechanisms of action. What is such type of drugs interaction 
called? 
A. Pharmacokynetical interaction. 
B. Direct synergism. 
C. Physicochemical interaction. 
D. Pharmaceutical interaction. 
E. Indirect synergism. 
22. It is known that the substance has significant hydrophilic properties. 
What pharmacological peculiarity is typical for this substance? 
A. Ability to freely penetrate the blood-brain barrier. 
B. High bioavailability. 
C. Rapid renal elimination. 
D. Biotransformation in liver. 
E. Ability to penetrate cells. 
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23. During an experiment the acetylsalicylic acid was introduced in 
different parts of gastrointestinal tract. In what part of GI-tract is this drug 
absorbed with the maximal speed?  
A. Stomach. 
B. Large intestine.   
C. Oral cavity. 
D. Duodenum. 
E. Small intestine. 
24. The following type of reaction should be expected in case of 
prescribing drugs to a pregnant woman: 
A. Mutagenic. 
B. Teratogenic. 
C. Embryotoxic. 
D. Fetotoxic. 
E. All from above. 
25. Indicate the properties of a drug which depend on the time of drugs’ 
introduction. 
A. Speed of drug absorption. 
B. Toxicity. 
C. Qualitative activity. 
D. Quantitative activity. 
E. All from above. 
26. A doctor has introduced the caffeine intramuscularly to a patient 
with alcohol intoxication. What is the principle which is the base of 
expediency for such treatment? 
A. Summation. 
B. Physiological antagonism. 
C. Synergism. 
D. Potentiation. 
E. Competitive antagonism. 
27. The metabolism of drugs in fetus is significantly slower than in 
adult organism. This feature of fetus pharmacokinetics is due to: 
A. Insufficiency of tissue receptors. 
B. Significant permeability of blood-tissue interfaces. 
C. Significant volume of extracellular fluid. 
D. Capacity of skin to absorb and excrete the drugs. 
E. Functional insufficiency of enzymes or their absence. 
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28. The influence of some adverse factors, such as drugs, before 
pregnancy increases the possibility of birth of the child with genetic 
abnormalities. What is this action called? 
A. Carcinogenic. 
B. Embryotoxic. 
C. Teratogenic. 
D. Mutagenic.  
E. Fetotoxic. 
29. It is known that in persons with genetically determined 
insufficiency of glucoso-6-phosphate dehydrogenase of erythrocytes the 
prescription of some antimalarial drugs can cause the hemolysis of 
erythrocytes. What is this atypical reaction upon drugs called? 
A. Idiosyncrasy. 
B. Tolerance. 
C. Allergy. 
D. Sensitization. 
E. Tachyphylaxis. 
30. The drug A with significant solubility in lipids was prescribed to 
a patient. What is the main mechanism of its absorption?     
A. Interaction with transport proteins.   
B. Filtration. 
C. Passive diffusion. 
D. Active transport. 
E. Pinocytosis. 
31. During operation the anaesthesiologist used the nitric oxide as 
general anaesthetic. This drug has significant lipophilic properties. What is 
the mechanism of this drug penetration through biological membranes? 
A. Pinocytosis. 
B. Active transport. 
C. Simplified diffusion. 
D. Filtration. 
E. Passive diffusion. 
32. Benzylpenicillin sodium is injected to a patient with pneumonia in 
a dose of 500 000 units of action 6 times daily. After another injection there 
arose fever, spasms, and then the patient lost consciousness. What has 
happened to the patient? 
A. Medicines tolerance. 
B. Idiosyncrasy. 
C. Anaphylactic shock. 
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D. Tachyphylaxis. 
E. Cumulation. 
33. A victim was delivered to an emergency station by an ambulance 
with the following diagnosis: displaced fracture of the middle one-third of 
the hip. With the purpose of bone fragments reposition 10 ml of 2 % 
dithylinum solution was injected to the patient intravenously. In 
consequence of that a long-lasting apnea and muscle relaxation developed. 
What enzyme deficiency causes such side effect? 
A. Pseudocholinesterase.  
B. N-acetyltransferase. 
C. Acetylcholinesterase. 
D. Glucose-6-phosphate dehydrogenase. 
E. Methemoglobin reductase. 
34. A medicine A was prescribed to a patient. In a few days the drug 
effect has considerably decreased and to get the initial effect it was 
necessary to increase the dose. What is this phenomenon called? 
A. Idiosyncrasy. 
B. Tachyphylaxis. 
C. Drug dependence. 
D. Tolerance.  
E. Cumulation. 
35. During an operative intervention with the use of muscle relaxants 
breath disorder appeared. Injection of proserinum led to improvement. 
What is such drug interaction called? 
A. Cumulation. 
B. Antagonism.  
C. Synergism. 
D. Incompatibility. 
E. Tachyphylaxis. 
36. A patient suffering from epilepsy has been continuously receiving 
0.2 g dose of phenobarbital daily. Recently, the attacks became more 
frequent, dysphoria was observed. Which process became the cause of the 
deterioration of the patient’s status? 
A. Glycolysis inhibition. 
B. Liver monooxygenase system enzymes inhibition. 
C. Lipolysis activation. 
D. Gluconeogenesis activation. 
E.  Liver monooxygenase system enzymes induction. 
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37. In the postoperative period promedol was injected continuously to a 
patient. Withdrawal of the drug caused serious mental and somatic 
disturbances. What is this phenomenon called? 
A. Output syndrome. 
B. Idiosyncrasy. 
C. Abstinence syndrome.  
D. Tachyphylaxis. 
E. Steal syndrome. 
38. A man, 36-year-old, with a craniocerebral trauma has diminished 
breath sounds, thready pulse, reflexes are absent. What route of pyracetam 
administration is the most appropriate in this case? 
A. Inhalation. 
B. Subcutaneous. 
C. Peroral. 
D. Rectal. 
E. Intravenous.  
39. Ambulance has been called to a 22-year-old man for the reason of 
bronchial asthma attack. What route of salbutamol introduction is the most 
appropriate in this case? 
A. Sublingual. 
B. Inhalation.  
C. Intramuscular. 
D. Intravenous. 
E. Subcutaneous. 
40. Angina pectoris attack happened to a man, 48-year-old. A doctor 
prescribed him a pill of nitroglycerine sublingually. Why has the doctor 
chosen a sublingual method of medicine administration? 
A. Effect develops faster.  
B. Only because it damaged the liver. 
C. Drug elimination by gastric juice. 
D. Low intestinal absorption. 
E. It is activated by saliva. 
41. Ambulance has been called to a 22-year-old man because of 
asthmatic status. What route of adrenaline hydrochloride administration is 
the most appropriate in this case? 
A. Sublingual. 
B. Inhalation. 
C. Intramuscular. 
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D. Subcutaneous. 
E. Intravenous.  
42. Intramuscular injection of benzylpenicillin sodium was made to a 
man, 28-year-old, because of a shoulder phlegmon. After that the man had 
tachycardia, thready pulse and arterial pressure decreased to 80/60 mm Hg. 
What kind of pharmacological reaction has developed? 
A. Peripheral effect. 
B. Anaphylactic shock.  
C. Central effect. 
D. Reflex effect. 
E. Potentiation. 
43. Phenobarbital was prescribed to a man, 56-year-old, suffering from 
insomnia. The sleep rhythm has been normalized. But gradually, for 
2 months, the effect of the drug had decreased, and insomnia arose. What 
reason has caused the reduction of the hypnotic effect? 
A. Tachyphylaxis. 
B. Low solubility. 
C. Bad absorption in the stomach. 
D. Tolerance.  
E. Accumulation in lipids. 
44. During the fetal period metabolism of medications is considerably 
slower than in adult age. The specified feature of a fetus pharmacokinetics 
is primarily caused by the following: 
A. “Maturation” of receptors in organs at different terms. 
B. High permeability of blood-tissue interfaces. 
C. Significant volume of extracellular liquid. 
D. Ability for absorption and release of water-soluble drugs by skin. 
E. Functional imperfection of most enzymes, their absence. 
45. It is known that people with insufficiency of glucose-6-phosphate 
dehydrogenase of red blood cells, caused genetically, may develop 
hemolysis of these cells as a reaction to some antimalarial medications 
prescription. What is such atypical reaction to medications called? 
A. Tolerance. 
B. Idiosyncrasy.  
C. Sensitization. 
D. Allergy. 
E. Tachyphylaxis. 
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46. How can be explained the fact that for tuberculosis treatment an 
isoniazid dose is being selected individually with obligatory control of 
contents of the medication in urine after its first intake? 
A. Development of hemolytic anemia. 
B. Hyperglycemia after the drug intake. 
C. Genetically caused speed of acetylation of the drug.  
D. Development of renal insufficiency. 
E. Irritative effect of the drug. 
47. A patient with hypertension has been taking an antihypertensive 
medication for a long time, but suddenly he stopped the intake. After that 
the patient’s status worsened, the hypertensive crisis developed. What kind 
of collateral action has developed? 
A. Withdrawal syndrome.  
B. Dependence. 
C. Cumulation. 
D. Tolerance. 
E. Sensitization. 
48. An out-patient with chronic cardiac insufficiency has been taking 
digoxin in therapeutic doses during several months. At a certain stage of 
treatment overdose symptoms appeared. What phenomenon underlies the 
development of such complication? 
A. Tachyphylaxis. 
B. Drug habituation. 
C. Sensitization. 
D. Functional cumulation. 
E. Material cumulation.  
49. At a stomatologist, a patient developed an attack of bronchospasm 
which was cured with 5 % ephedrine hydrochloride solution injection. In 
20 minutes the attack repeated. An additional injection of ephedrine had no 
effect due to tachyphylaxis. What mechanism underlies this phenomenon? 
A. Induction of microsomal enzymes of the liver. 
B. Exhaustion of noradrenaline depot in presynaptic endings. 
C. Inhibition of adrenoreceptors. 
D. Activation of adrenoreceptors. 
E. Material cumulation of the drug. 
50. A patient with atypical reaction developing in the result of drug 
administration is delivered to intensive care unit. Indicate the name of 
increased sensitivity and atypical reaction to the drug. 
A. Idiosyncrasy. 
B. Summation. 
C. Tolerance. 
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D. Dependence. 
E. Cumulation. 
51. A patient with morphinism is delivered to narcological unit. In the 
result of examination, a doctor indicated the decrease of morphine action. 
What is the phenomenon of drug action weakening in the result of repeated 
drug administration called?  
A. Summation. 
B. Material cumulation. 
C. Functional cumulation. 
D. Antagonism. 
E. Tolerance (accustoming). 
52. What medicinal form provides the fastest and most complete 
absorption of a drug in gastrointestinal tract? 
A. Granules. 
B. Tablets. 
C. Capsules. 
D. Dragee. 
E. Solutions for internal use. 
 
           
87 
 
DRUGS INFLUENCING PERIPHERAL NERVOUS 
SYSTEM 
 
Drugs Influencing Afferent Innervation  
 
Drugs influencing afferent innervation are classified as follows: 
1. Drugs reducing the sensitivity of nervous endings and interrupting 
the conductibility of afferent nerves: 
– local anaesthetics; 
– astringent drugs; 
– enveloping agents (demulcents); 
– adsorbing drugs. 
2. Drugs stimulating the endings of afferent nerves: 
– irritative drugs; 
– emetic drugs; 
– laxative drugs; 
– expectorants; 
– amarines. 
 
Local Anaesthetics  
 
On the locus of applying, local anaesthetics block the sensitivity of 
afferent nerve endings and impulse conduction in nervous fibers. It results 
in the loss of pain sensitivity. High concentrations of local anaesthetics also 
suppress temperature sensitivity and other kinds of sensitivity. In the last 
turn, reaction to touch and pressure is suppressed. 
The history of local anaesthetics began in 1859, when Niman and 
Vekler singled out alkaloid cocaine from South American coca plant. 
Chemically, local anaesthetics are esters of aromathic acids (benzoic, 
para-aminobenzoic, etc.) or substituted amides. Molecules of local 
anaesthetic consist of aromathic nucleus connected by means of ester or 
amide bond with amino alkyl group. Aromatic nucleus is lipophilic part of 
molecule that provides drug ability to penetrate through the cell membrane. 
Intermediate chain, containing ester or amide bond, provides the stability of 
drug and duration of its effect. Thus, anaesthtics, bond fast enough with 
ester, are hydrolyzed by plasma esterases. Amino acid residue determines 
the molecule ability to form the salt with acids and consequently the drug 
ability to dissolve in water.  
Local anaesthetics (except benzocaine) are manufactured as salts of 
hydrochloric acid. Anaesthesia develops only after the salt hydrolysis with 
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base release. Hydrolysis occurs at pH = 7.35–7.4. In acidic environment (in 
inflammation) hydrosysis does not occur, therefore, local anaesthetics are 
ineffective. 
Mechanism of action of local anaesthetics is associated with the block 
of potential-dependent sodium channels that inhibit the formation of action 
potential and its propagation. Lipid-soluble molecules of local anaesthetic 
penetrate through the membrane of a nervous fiber and block sodium 
channels from the inside. Wherein, molecules of local anaesthetic 
competitively replace calcium participating in regulation of membrane 
permeability for sodium. It causes inhibition of calcium-dependent 
phospholipases and ATPase with the following reduction of concentration 
of fatty acids and phospholipid lyso-forms, that results in the change of 
structure and function of sodium channels. Local anaesthetics block not 
only permeability for sodium and calcium, but also potassium permeability. 
There are several types of local anaesthesia: terminal (superficial), 
conduction (regional), infiltration, spinal anaesthesia, etc.  
For terminal anaesthesia, preparation of local anaesthetic is applied on 
mucosa, burn, or wound that provides the loss of pain sensitivity. 
Superficial anaesthesia is widely used to treat burns and wounds, in 
ophthalmology, urology, otorhinolaryngology, etc.  
Conduction anaesthesia develops due to blockage of a large nervous 
fiber by local anaesthetic. A loss of pain sensitivity develops in the area 
which is innervated by this nerve. Regional anaesthesia is frequently used 
in stomatological, surgical, and therapeutic practice. 
Infiltration anaesthesia is a result of injectional saturation of tissues by 
anaesthetic solution. It is widely used in surgical practice. 
For spinal anaesthesia, local anaesthetic solution is administered into 
subarachnoidal space that causes the block of impulse transduction through 
sensitive spines of the spinal cord. Spinal anaesthesia is used in operations 
of lower extremities and pelvic organs. 
Local anaesthetics differ among themselves by efficacy, duration of 
action, ability to penetrate through mucous membranes, and toxicity. There 
are drugs of choice for each type of local anaesthesia. 
Local anaesthetics are classified as follows: 
1. Drugs for superficial anaesthesia: cocaine, dicaine 
(tetracaine),  anaesthesine  (benzocaine),  and pyromecaine  
(bumecaine) . 
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2. Drugs which are used mainly for infiltration and conduction 
anaesthesia: novocaine (procaine),  trimecaine, bupivacaine,  
ultracaine (articaine) . 
3. Drugs which are used for all types of local anaesthesia: l idocaine 
(xylocaine) . 
 
The requirements for local anaesthetics are the following: 
– high eficacy and selectivity of action; 
– lack of negative influence upon surrounding tissues; 
– short latent period; 
– duration of action corresponding to a certain operation. 
It is also desirable, that a drug constricts vessels or, at least, does not 
cause vasodilation.  
Resorptive effects of local anaesthetics are quite diverse. These effects 
are marked in case of intravenous administration of local anaesthetic or due 
to absorption of a large drug amount into systemic bloodstreem. Thus, slow 
intravenous novocaine administration is accompanied by gradually 
developing feeling of loss of your own weight, analgesia, CNS depression, 
novocaine-induced sleep, and narcosis. Most significant inhibition is 
observed in polysynaptic neuronal pathways of spinal cord, ascending part 
of reticular formation, and cortex. 
Together with central effects, changes in activity of peripheral organs 
develop. Novocaine inhibits vegetative ganglia that results in 
antispasmodic effect and lowering of the blood pressure. The drug 
suppresses impulse transduction through the conductive system of the 
heart, reduces the heart rate, and exhibits antiarrhythmic action. 
The described effects, to a greater or lesser extent, are typical for all 
local anaesthetics. Bupivacaine has more marked cardiotoxic action. 
According to the chemical structure, local anaesthetics are classified as 
follows: 
1. Derivatives of ethers of benzoic acid and amino alcohols: cocaine . 
2. Derivatives of ethers of para-aminobenzoic acid: novocaine  
(procaine) ,  dicaine  (tetracaine),  and anaesthesine  
(benzocaine) .  
3. Substituted amides of acetanilide: l idocaine, trimecaine,  
pyromecaine (bumecaine),  bupivacaine ,  and ultracaine  
(articaine).  
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Comparative characteristics of local anaesthetic drugs are given in the 
table 4. 
 
Table 4 – Comparative characteristics of local anaesthetics 
 
 
Drug Activity  Toxicity 
terminal 
anaesthesia 
infiltration 
anaesthesia 
conduction 
anaesthesia 
Novocaine 0.1* 1 1 1 
Dicaine 10 – – 20 
Trimecaine 0.4 2–3 2.5–3.5 1.3–1.4 
Lidocaine 0.6 3–4 2.5–3.5 1.5–2 
Ultracaine 0.5 3–5 3–5 1 
  
* high concentration (more than 10–20 %) of novocaine causes corneal 
anaesthesia, but damages epithelium 
 
 
Derivatives of Ethers of Benzoic Acid and Amino Alcohols  
 
Cocaine  was first anaesthetic used in medicine. Presently, its use is 
stopped due to high toxicity and ability to cause drug dependence. Most 
commonly, cocaine was used in ophthalmology. Besides the marked 
anaesthetic effect (which lasts up to 1 hour), cocaine constricts vessels of 
the sclera and dilates the pupil. Intraocular pressure is reduced. These 
effects develop due to indirect adrenomimetic action of cocaine. Long-term 
use of cocaine leads to epithelial cleavage of cornea and its ulceration. In 
resorptive action, cocaine stimulates central nervous system. The following 
symptoms develop: loss of feeling of hunger and tiredness, psychomotor 
excitement, and euphoria. Cocaine stimulates respiratory, vasomotor, and 
emetic centres of medulla oblongata. Cocaine can provoke convulsions. 
Also, cocaine causes tachycardia and hypertension. If cocaine dose is very 
high, stimulation of central nervous system is replesed by its inhibition. 
Death occurs due to depression of vital centres of medulla oblongata 
(primarily, respiratory centre). In cocaine overdose, diazepam or barbituric 
acid derivatives (thiopental sodium, hexenal) are administered for reduction 
of excessive excitation of CNS and adrenergic antagonists – for 
normalization of heart rate and blood pressure. Artificial respiration is used 
in patients with respiratory depression. 
Chronic cocaine intake leads to drug dependence – cocainism. 
Psychical, but no physical, dependence develops in cocaine-dependent 
patients. In this case, sudden cessation of cocaine intake results in severe 
psychical state including dysphoria, depression, drowsiness, fatigue, and 
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increased craving for cocaine. Tolerance to cocaine manifestes 
insignificantly or does not develop.  
 
Derivatives of Ethers of Para-Aminobenzoic Acid  
 
Dicaine (tetracaine)  is local anaesthetic used only for topical 
anaesthesia. The drug is 10 times more potent anaesthetic than cocaine, but 
its toxicity is 2–5 times more. Dicaine does not cause mydriasis and does 
not influence intraocular pressure. Dicaine dilates vessels therefore its 
combination with adrenaline is expedient. At terminal anaesthesia, the drug 
is easily absorbed through mucous membranes and can cause toxic effects 
and patient’s death due to overdose. Therefore, dosage of dicaine should be 
strictly observed.  
Anaesthesine (benzocaine)  is poorly soluble in water; therefore, 
it is used in the following medicinal forms: powders for external 
application, ointments, pastes (anaesthesia of wounds or skin ulcers, itchy 
skin, etc.), rectal suppositories (hemorrhoids and perianal fissures), and 
tablets or powders for oral intake (stomach pain and kinetosis).  
Novocaine (procaine)  is used for infiltration and conduction 
anaesthesia. Duration of infiltration anaesthesia induced by novocaine is 
0.5–1 hour. The drug is low toxic. Novocaine is hydrolyzed mainly by 
butyrylcholinesterase and excreted by kidneys in conjugated form with 
glycine or glucuronic acid. Novocaine is seldom used for terminal 
anaesthesia because poorly penetrates through mucous membranes. The 
drug does not influence vascular tone or insignificantly relaxes vessels. 
Therefore, it is used with the added adrenaline solution. In this case, 
duration of novocaine-induced anaesthesia increases to 1.5–2 hours. The 
main metabolites of novocaine are diethylaminoethanol and para-
aminobenzoic acid. It is necessary to notice, that para-aminobenzoic acid is 
competitive antagonist of sulfonamides.  
 
Substi tuted Amides of  Acetanil ide 
 
Lidocaine  is used for terminal, infiltration, epidural, subarachnoidal, 
and other types of anaesthesia. The anaesthetic activity of lidocaine is 
2.5 times more than novocaine activity. Duration of lidocaine anaesthesia is 
2–4 hours. Lidocaine toxicity is equal or slightly higher than toxicity of 
novocaine. The drug does not have irritative action. Combination of 
lidocaine with epinephrine solution prolongs duration of anaesthesia and 
reduces lidocaine toxicity. Symptoms of lidocaine overdose are similar as 
overdose of novocaine. Lidocaine is not derivative of para-aminobenzoic 
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acid and is not competitive antagonist of sulfonamides. Lidocaine (or 
trimecaine) may be used in patients intolerant to para-aminobenzoic acid. 
Besides, lidocaine is the drug of choice for urgent care at ventricular 
extrasystoles. 
Trimecaine  activity is 2–3 times higher than activity of novocaine, 
but at the same time trimecaine is more toxic agent. The duration of 
anaesthesia caused by trimecaine is about 2–4 hours. The drug is used for 
conduction and infiltration anaesthesia. The resorptive action of trimecaine 
is manifested by sedative, hypnotic, antiarrhythmic, and anticonvulsant 
effects. The use of trimecaine for infiltration and conduction anaesthesia is 
not accompanied by disorders of cardiovascular system and respiration. 
Trimecaine overdose can provoke the convulsions. 
Bupivacaine hydrochloride (Marcaine)  is highly active local 
anaesthetic with long duration of action. The drug is used for conduction 
and infiltration anaesthesia. Effect develops in 5–10 minutes and lasts up to 
7–14 hours (sometimes, up to 24 hours and more). Overdose of Marcaine 
can cause convulsions and suppression of cardiac activity. 
Ultracaine (articaine)  is drug with fast onset of effect and long 
duration of action. It is used for infiltration, conduction, subarachnoidal, 
and lumbar anaesthesia. Toxicity of ultracaine is low. In stomatological 
practice, ultracaine is used in combination with epinephrine. The side 
effects of ultracaine are headache, allergic reaction, and double vision. 
Combination of local anaesthetics with hypnotic drugs, general 
anaesthetics, neuroleptics, and opioid analgesics leads to the increase of 
anaesthesia. Stimulants of the central nervous system reduce the effect of 
local anaesthetics. 
 
Astringent Drugs 
 
Astringent drugs coagulate the proteins on the surface of mucous 
membranes, wounds, and ulcers. Coagulated proteins create the protective 
film on the damaged surface and protect it from the action of the damaging 
factors and, also, prevent the absorption of toxins in the blood. Under the 
influence of astringent drugs, mucosal surface, which commonly has folded 
structure, is reduced – “contracted” – and small vessels mechanically 
constrict. Tanning effect develops due to dehydration of submucosal 
protein layer, its compaction, and the decrease of membrane permeability. 
These changes result in the reduction of inflammation.  
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Astringent drugs are classified as follows:  
1. Inorganic astringent drugs: bismuth subnitrate , zinc 
sulphate, alumen, si lver nitrate ,  etc.  
2. Organic astringent drugs: tannin, tannalbine; tinctures, extracts, 
infusions or decoctions of oak bark,  chamomile f lowers , Salvia 
leaves, Hypericum grass ,  aplicata alder , cherry and blueberry 
fruits ,  etc.  
Inorganic astringent drugs interact with proteins and form albuminates. 
Depending on concentration and type of the metal, the following effects 
can develop on the place of drug application: astringent, irritative, or 
cauterizing. These effects are based on the ability of salts to interact with 
tissue proteins with the formation of albuminates. The interation with only 
superficial layers of skin and mucosa is accompanied by formation of dense 
albuminates preventing the penetration of ions into the deep layers of 
tissues. In this case, the astringent effect develops. In case of loose 
albuminate formation, metal ions penetrate the deep layers of tissues that 
results in cauterizing effect on the tissue, accompanied by tissue damage 
(necrosis). Prof. O. Schmiedeberg made up a list of metals based on 
albuminate density:    
Pb, Al, ... Fe, Cu, Zn, ... Ag, Hg. 
Metals which are in the left part of this list have mainly astringent and 
low irritative actions. Metals which are in the right part of the 
Schmiedeberg’s list have cauterizing action and significant antibacterial 
effect. Metals which are in the middle part of the list can exhibit all these 
actions in dependence on their concentration.  
Lately, inorganic astringent drugs are used reletively seldom. 
Organic astringent drugs form with proteins insoluble albuminates. 
Therefore, their action is restricted by superficial coagulation and does not 
spread to more deeply located tissues.     
Tannin  is gallic acid derived from oak apples (Gallae turcicae) – 
growths on the shoots of the Little Asian oak. Tannin is used in solutions 
and ointments. Tannalbine  is protein compound of tannin that is used in 
the treatment for inflammatory diseases of gastrointestinal tracts.   
Oak bark, chamomile f lowers , Salvia leaves, Hypericum 
grass,  aplicata alder ,  cherry and blueberry fruits  and parts of 
other plants contain significant amount of tannic compounds which provide 
astringent effect of their galenic preparations (infusions, decoctions, etc.). 
Therapeutic applications for astringent drugs are the following: 
– acute inflammatory diseases of gastrointestinal tract: gastritis, 
enteritis, enterocolitis, and stomatitis; 
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– ulcer disease of stomach and duodenum, chronic gastritis and 
duodenitis; 
– acute bronchitis, laringitis, and tracheitis; 
– conjunctivitis; 
– uretritis; 
– burns, ulcers, traumas of skin and soft tissues; 
– acute poisoning by alkaloids and heavy metal salts (0.5 % tannin 
solution).  
 
Enveloping Agents (Demulcents)  
 
Enveloping agents create colloid solutions in water and provide 
protection of tissues and endings of sensitive nerves. Starch sl ime  and 
slime of  f lax seeds  are most commonly used demulcents. Besides 
protective action, these drugs exhibit anti-inflammatory and analgesic 
effects. Enveloping drugs are used to treat the inflammatory diseases of 
gastrointestinal tract. They are prescribed for oral intake or in enemas. 
Also, enveloping drugs are used in the treatment for poisoning by acids, 
alkalies, and other aggressive substances (phenol, solution of bleaching 
powder, etc.). In this case, enveloping agents protect damaged mucosal 
surface by colloid film, absorb molecules of irritant, exhibit antiemetic and 
antidiarrheal effects. 
 
Adsorbing Drugs 
 
Adsorbing drugs are small-pounded biologically inactive powders with 
high surface activity that are able to adsorb poisons and irritative agents. 
Adsorbing drugs are activated carbon (activated charcoal ),  talc 
(magnesium sil icate),  white clay (kaolin),  magnesium oxide ,  
zinc oxide, enterosgel ,  polyphepan,  etc.   
Activated cabon  is used to treat acute poisoning. The drug adsorbs 
the poison, reduces its absorption by intestine, and decreases the irritation 
of intestinal mucous membrane. At poisoning, water suspension of 20–30 g 
of activated carbon is taken orally or used for gastric lavage. A dose of  
1–3 g of activated carbon is taken orally 3–4 times a day to treat flatulence. 
Other adsorbing drugs are used in the treatment for different poisoning 
and intestinal diseases accompanied by putrefaction and flatulence. 
Polyphepan  also exhibits cholesterol-lowering effect due to reduction of 
its intestinal absorption. It is necessary to notice, that prolonged adsorbent 
intake leads to reduction of amount of vitamins, lipids, proteins and other 
vital-essential substances in the body. 
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Powders, ointments or pastes containing adsorbting agents (talc, 
magnesium oxide, and zinc oxide) are commonly used to treat damaged 
humid skin surface. 
Besides, there are special sorbents used for hemosorption (elimination 
of toxins from the blood), lymphosorption, plasmosorption, etc. Presently, 
many resins with high cation- and anion-exchange capacity are used for 
hemosorption. This blood purification method is used in the treatment of 
some autoimmunic diseases and allows removing antigen-antibody 
complexes and complements from the blood.  
 
Irritative Drugs 
 
Irritative drugs excite the endings of sensory nerves and cause reflex 
and local changes which improve blood supply and trophicity of tissues. 
The group of irritative drugs includes such agents as sinapisms 
(mustard plasters),  turpentine, camphor, ammonia solution ,  etc.  
Mustard plasters  are one of the most popular irritative drugs. For 
preparation of mustard plasters, fat-free mustard seed powder is applied on 
the sheet of thick paper. Before the use, sinapisms should be moistening 
with warm water (not more 40
 °
C). Mustard contains glycoside sinigrin and 
enzyme myrosinase. At temperature about 40 
°
C, activated myrosinase 
cleaves sinigrin with formation of allyl isothiocyanate – mustard etheric oil 
with irritative activity. It is necessary to notice, that hot water (more than 
40 
°
C) intactivates myrosinase, therefore mustard plasters moistened by hot 
water lack irritative activity. Sinapisms are used in the treatment for 
respiratory diseases, angina pectoris, neuralgia, and sore muscles (myalgia). 
Mustard plasters are applied on the site of skin that receives sensory 
innervation from the same segment of spinal cord as diseased organ. 
Inflammatory focus in diseased organ is source of painful irritations which 
permanently enter the corresponding segment of spinal cord and from  
there – to the central nervous system. It leads to the formation of 
pathological dominant focus in the CNS. Mustard plaster irritates 
corresponding part of skin with formation of new flow of nerve impulses to 
CNS. It creates the new dominant focus of excitation that results in 
inhibition of pathological focus. Due to such mechanism, painful sensations 
are significantly reduced. An irritation of the corresponding parts of skin is 
accompanied by vasodilation and improving the blood supply both in the 
irritated skin and in the corresponding inner organ. It favours the reduction 
of inflammation. Thus, the use of irritative agents leads to analgesic and 
trophic effects. 
Turpentine  is obtained by distilling galipot from pine trees. The 
main active substance of turpentine is lipid-soluble α-pinene that easily 
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penetrates through epidermis and irritates the sensory nerve endings. 
Turpentine is used in the treatment for neuralgia, myalgia, and arthralgia. 
Menthol  is etheric oil of peppermint. Applied on the skin or mucous 
membranes menthol causes the feeling of cold due to irritation of cold 
receptors. It results in vasoconstriction and reduction of pain at the site of 
the menthol application. But, the tone of vessels and smooth muscles of 
inner organs can decrease due to the reflex mechanism. Menthol (in form of 
drops, inhalations, or anointments) is used in the treatment for 
inflammatory diseases of upper respiratory tract. Also, menthol is a 
component of such drugs as validol and corvalol which are used 
sublingually or orally to treat heartache due to mild attack of angina 
pectoris and spasm of bile ducts. To treat rhinitis, neuralgia, myalgia, 
arthralgia, migraine, and skin diseases with itch, 1–2 % menthol oil 
solution is used. 
Ammonia solution  has marked irritative properties. Inhalation of 
wapors of ammonia solution leads to the irritation of sensory nerves of 
apper respiratory tract and to the reflex stimulation of respiratory centre. 
This effect is used to treat syncope. To reduce alcohol intoxication, 5–10 
drops of ammonia solution per ½ glass of water is used orally. Also, 
ammonia solution is used to disinfect surgeon hands. 
Some drugs acting on the gastrointestinal tract (amarines, emetic and 
laxative drugs) and expectorants also have reflex action. Their 
characteristics are given in the corresponding chapters.   
 
Table 5 – Drugs for prescription 
 
 
Drug name  
(Latin) 
Single dose and route  
of administration 
Drug product 
1 2 3 
Anaesthesinum Orally 0.3 g;  
 
rectally 0.05–0.1 g;  
on the skin 5–10 % 
ointment 
Powder; 
tablets 0.3 g;  
suppositories 0.05 or 0.1 g; 
5 % ointment   
Novocainum For infiltration anaesthesia – 
0.25–0.5 % solution;  
for conduction anaesthesia – 
1–2 % solution;  
for terminal anaesthesia – 
10–20 % solution and 5– 
10 % ointment;  
rectally 0.1 g 
Ampoules 0.25 % and 
0.5 % solution – 1, 2, 5, 10 
and 20 ml; 1 % and 2 % 
solution – 1, 2, 5, and 10 ml;  
vials 200 or 400 ml of  
0.25 % or 0.5 % solution;  
suppositories 0.1 g;  
5 % and 10 % ointments 
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Continuation of the table 5 
1 2 3 
Trimecainum For infiltration anaesthesia – 
0.125 %, 0.25 % or 0.5 % 
solution;  
for conduction anaesthesia –  
1–2 % solution;  
for terminal anaesthesia –  
2–5 % solution;  
for epidural anaesthesia –  
1–2 % solution;  
for spinal anaesthesia –  
5 % solution 
Ampoules 10 ml of 0.25 % 
solution; 2, 5, or 10 ml of 
0.5 % or  
1 % solution; 1, 2, 5, or  
10 ml of 2 % solution;  
1 or 2 ml of 5 % solution 
Lidocainum  For infiltration anaesthesia –
0.25 % or 0.5 % solution;  
for conduction anaesthesia – 
0.5–2 % solution;  
for terminal anaesthesia –  
1–5 % solution 
Ampoules 10 or 20 ml of 
1 % solution; 2 or 10 ml of 
2 % solution; 2 ml of 10 % 
solution 
 
Tanninum For oral, nasal, pharyngeal 
rinsing, and throat gargling – 
1–2 % water or glyceric 
solutions;  
for application on injured 
surfaces – 3–10 % solution 
or ointment;  
for gastric lavage – 0.5 % 
solution  
There are no made forms at 
the plant. Pharmacist 
prepares these forms  
(the prescriptions can be 
written in short or full 
forms) 
Bismuthi subnitras Orally – 0.25–0.5 g;  
on the skin – 5–10 % 
ointment and aspersion  
Powder; tablets 0.25 or 0.5 g; 
10 % ointment 
Carbo activatus Orally – 1–2 g to treat 
meteorism;  
20–30 g to treat poisonings 
Powder;  
tablets 0.25 or 0.5 g  
Mentholum  For applying on the skin –  
0.5–2 % alcoholic solution, 
1 % ointment;  
sublingually 2–3 drops of  
5 % alcoholic solution (on a 
slice of sugar) 
1, 2 or 5 % alcoholic 
solution;  
1 % ointment 
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Step 1. Tasks for Self -Control  
Drugs Affecting the Afferent Innervation  
 
1. The patient had received the trauma of an eye due to the hits of the 
metal shavings. The patient has oedema of the eye, significant hyperemia, 
and acute pain. The removal of an intraocular foreign body is possible only 
with local anaesthesia. Choose the drug for local anaesthesia in this case. 
A. Benzocaine (anaesthesine). 
B. Cocaine. 
C. Procaine (novocaine). 
D. Trimecaine. 
E. Tetracaine (dicaine). 
2. An unconscious patient was delivered to the hospital. The doctor 
gave him the smell of the ammonia solution to bring him to consciousness. 
What is the type of action, which provides the pharmacological effect of 
this drug? 
A. Etiotropic action. 
B. Resorptive action. 
C. Reflex action. 
D. Local action. 
E. Selective action. 
3. The conduction anaesthesia was given to a patient before tooth 
extraction. In several minutes after this, the oedema and hyperemia 
developed around the injection site; the general weakness and hypotension 
developed in a patient. Determine the described complication. 
A. Allergic reaction. 
B. Idiosyncrasy. 
C. Tolerance. 
D. Tachyphylaxis. 
E. Drug dependence. 
4. These drugs cause the coagulation of mucous proteins, condense the 
superficial surface of mucous membranes, and display anti-inflammatory 
action. What is this group of drugs? 
A. Adsorbing drugs. 
B. Local anaesthetics. 
C. Irritative drugs. 
D. Astringent drugs. 
E. Covering drugs. 
5. This drug has low solubility in water; therefore, it is used for 
terminal anaesthesia in ointments, pastas, powders, candles. Also, it is 
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prescribed in powders for internal use at stomach pain and vomiting. 
Indicate this drug. 
A. Lidocaine. 
B. Procaine (novocaine). 
C. Benzocaine (anaesthesine). 
D. Tetracaine (dicaine). 
E. Trimecaine. 
6. A patient has heart pain for some time, which is not connected with 
physical activity. Call the irritative substance which narrows the vessels of 
mucous in local use and causes reflex expansion of coronary vessels. 
A. Sinapisms. 
B. Ammonia solution. 
C. Turpentine oil. 
D. Camphor. 
E. Menthol. 
7. Combine operator had received the eye trauma during crop harvest. 
What local anaesthetic should be used for removal of foreign body from the 
eye? 
A. Sovcaine. 
B. Tetracaine (dicaine). 
C. Procaine (novocaine). 
D. Lidocaine. 
E. Trimecaine. 
8. A doctor made the sensitivity test to novocaine in a patient before the 
infiltration anaesthesia. The test is positive. What drug should be used for 
infiltration anaesthesia to this patient? 
A. Cocaine. 
B. Novocainamide. 
C. Dicaine. 
D. Anaesthesine. 
E. Lidocaine. 
9. A patient with abscess of a shoulder was delivered to the surgery 
department. During examination a doctor has found out ventricular 
extrasystoles. What type of anaesthesia is most expedient in this patient? 
A. General anaesthesia with ketamine. 
B. Local anaesthesia with lidocaine. 
C. Spinal anaesthesia with sovcaine. 
D. General anaesthesia with hexenalum. 
E. General anaesthesia with ether pro narcosis. 
10. A patient with acute attack of appendicitis was delivered to a 
surgery unit. An anaesthesiologist suggested local anaesthesia for 
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operation. But during examination it became clear that the patient had the 
frequent allergic reaction upon the drugs. Choose the drug which can be 
used for local anaesthesia in this case. 
A. Novocaine. 
B. Anaesthesine. 
C. Dicaine. 
D. Lidocaine.  
E. Cocaine. 
11. The terminal anaesthesia develops in the result of drug’s influence 
upon the following element of skin and mucous membranes: 
A. Derma. 
B. Sensitive nervous ending. 
C. Epidermis. 
D. Hypodermic fatty tissue. 
E. Capillaries wall. 
12. A patient is in need of the paranefral blockade according to 
Vishnevsky. What concentration of novocaine solution is used in this case? 
A. 4–5 %. 
B. 0.5–1 %. 
C. 1–2 %. 
D. 2–4 %. 
E. 0.125–0.5 %. 
13. A patient with high sensitivity to sulfonamides had appealed to the 
ophthalmic department with trauma of an eye. What drug should be used 
for anaesthesia of conjunctiva in this case? 
A. Anaesthesine. 
B. Novocaine. 
C. Lidocaine. 
D. Trimecaine. 
E. Dicaine. 
14. Point out the drug from a group of local anaesthetics which is not 
desirable to prescribe simultaneously with sulfonamides. 
A. Ultracaine. 
B. Novocaine. 
C. Anaesthesine. 
D. Lidocaine. 
E. Trimecaine. 
15. A doctor has prescribed an ointment “Efcamonum” to a patient. 
This ointment is an irritative drug according to the mechanism of action. 
Indicate the case in which “Efcamonum” is contraindicated. 
A. Neuritis. 
B. Neuralgia. 
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C. Pain in a joint.  
D. Skin injury. 
E. Myalgia. 
16. The action of novocaine is decreased in areas of inflammation 
because the disturbance of hydrolysis of novocaine salt and release of 
active basic substance develop. What is the cause of this phenomenon? 
A. Inhibition of oxidative phosphorylation. 
B. Local tissue alkalosis. 
C. Inhibition of carbonic anhydrase. 
D. Activation of succinate dehydrogenase. 
E. Local tissue acidosis. 
17. A third year student during the practice should put the sinapisms on 
the back of a patient. For this purpose, he has moistened the sinapisms with 
very hot water (the temperature is more than 60 
°
C). In 30 minutes the 
student has found out that the skin of the patient has not reddened in the 
place of applied sinapisms. What is the cause of this phenomenon? 
A. Hot water causes activation of MAO. 
B. Hot water causes inactivation of mirosine. 
C. Hot water causes inactivation of cholinesterase. 
D. Hot water causes activation of mirosine. 
E. Hot water causes inactivation of MAO. 
18. A 25-year-old woman with red and itchy eczematoid dermatitis 
visits your office. She had a dental procedure one day earlier with 
administration of local anaesthetic. There are no other data, although she 
indicated that she had a history of allergic reactions. Which of the 
following drugs is most likely involved? 
A. Procaine. 
B. Cocaine. 
C. Bupivacaine. 
D. Lidocaine. 
E. Etidocaine. 
19. A patient with an abscess was admitted to a surgical department for 
operative treatment. During additional examination the ventricular 
premature beats were detected. What drug is the most expedient for 
anaesthesia in this case? 
A. Ketamine. 
B. Halothane (fluothane). 
C. Hexenal. 
D. Diethyl ether. 
E. Lidocaine.  
 
102 
 
Drugs Influencing Efferent Innervation 
 
Cholinergic Drugs  
  
Cholinomimetic Drugs  
 
The nervous system is divided into two branches: the central nervous 
system (brain and spinal cord) and peripheral nervous system. Peripheral 
nervous system is divided into the afferent (or sensory) part and efferent 
part. The neurons of afferent part bring information from the periphery to 
the central nervous system. The efferent neurons carry information from the 
central nervous system to the peripheral tissues. Efferent division includes 
autonomic system and somatic neurons.  
The autonomic nervous system carries impulses from the central 
nervous system to the inner organs by way of two neuron types. The first 
neuron is called a preganglionic  neuron. Its cell body is located within 
the central nervous system. Preganglionic neuron makes a synaptic contact 
in ganglion. The ganglion works as transmitting station between the 
preganglionic neuron and the second nerve cell called a postganglionic  
neuron. The endings of postganglionic neurons contact with cells of inner 
organs. The somatic nervous system travels directly to skeletal muscles 
without the mediation of ganglia. The somatic nervous system is under 
voluntary control, whereas the autonomic system is an involuntary one.  
Autonomic nervous system is divided into the sympathetic  and 
parasympathetic  parts. The preganglionic neurons of the sympathetic 
nervous system have their cell bodies within the thoracic and lumbar 
regions of the spinal cord – the thoracolumbar division . The 
preganglionic neurons of the parasympathetic part have their cell bodies in 
the brainstem and in the sacral region of the spinal cord – the 
craniosacral  division . The cranial part of the parasympathetic nervous 
system innervates the head, neck, thorax, and abdomen (the stomach, part 
of intestine and pancreas). The cranial parasympathetic nerves leave the 
central nervous system in the oculomotor, facial, glosopharyngeal and 
vagal cranial nerves. Approximately 75 % of the parasympathetic fibers are 
contained within the vagus nerve. The sacral division of the 
parasympathetic nervous system innervates the remainder of the intestine 
and the pelvic viscera.  
The sympathetic ganglia form two chains of 22 segmentally arranged 
ganglia, which are located laterally to the vertebral column. Because the 
sympathetic ganglia are located close to the vertebral column, their 
preganglionic fibers, as a rule, are short. But postganglionic fibers are long 
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since they arise in vertebral ganglia and must travel to the innervated 
effector cells. In contrast, the parasympathetic ganglia are located very 
close to (or within) the organs innervated by the parasympathetic 
postganglionic neurons. As a rule, all inner organs receive both the 
sympathetic and parasympathetic innervation. Sympathetic and 
parasympathetic systems work in opposition one to another. 
Communications between nerve cells as well as between nerve cells 
and effector organs occur due to the release of the specific chemical 
substances by nerve terminals. These substances are called 
neurotransmitters  (mediators) . The neurotransmitters rapidly diffuse 
across the synaptic cleft (synapse) between nerve endings and bind with 
specific receptors on the membrane of postsynaptic cell.  
There are two main mediators of autonomic nervous system. They are 
acetylcholine and noradrenaline (norepinephrine) .  
The neurotransmission in the peripheral nervous system occurs in 
three major sites: 
– synapses of both parasympathetic and sympathetic ganglia; 
– parasympathetic and sympathetic postganglionic neuroeffector 
junctions;  
– the endplates of skeletal muscles.  
Acetylcholine is released in these sites except of most sympathetic 
neuroeffector synapses. Neurons which release acetylcholine are called 
cholinergic  neurons.  
Norepinephrine is released in most of sympathetic postganglionic 
neuroeffector synapses. Neurons which release norepinephrine are called 
adrenergic  neurons.  
It is necessary to notice, that some sympathetic postganglionic neurons 
are cholinergic. Thus, sympathetic postganglionic neurons innervating the 
sweat glands and some blood vessels in skeletal muscle release 
acetylcholine. But anatomically they are sympathetic neurons.  
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Figure 1 – The scheme of efferent innervation 
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Although most tissues receive dual innervation, some effector organs, 
such as the adrenal medulla, kidneys, pilomotor muscles, and sweat glands 
are innervated only by sympathetic system. Blood pressure is also 
controlled mainly by sympathetic nervous system.  
Adrenal medulla, like the sympathetic ganglia, receives preganglionic 
fibers of the sympathetic system. The adrenal medulla cells (chromaffin 
cells) are homologous with sympathetic postganglionic neurons. Therefore, 
adrenal medulla may be considered as a modified sympathetic ganglion. 
The adrenal medulla secretes two hormones. The main medullary hormone 
is adrenaline. Second is noradrenaline that is also the primary mediator of 
sympathetic postganglionic neurons. General activation of the sympathetic 
system due to stress, fear, or anxiety is accompanied by increased secretion 
of adrenal medullary hormones. The CNS regulates the secretory activity of 
the adrenal medulla. 
The activity of autonomic nervous system may be changed by means 
of different medicines. Drugs affecting the autonomic nervous system are 
divided into two groups corresponding to the type of neuron involved in 
their mechanism of action. There are cholinergic and adrenergic drugs. The 
cholinergic drugs act on the receptors that are activated by acetylcholine. 
The adrenergic drugs act on receptors that are stimulated by 
norepinephrine.  
Drugs which influence parasympathetic nervous system are divided 
into cholinomimetic drugs (they excite cholinergic receptors) and 
cholinoblockering drugs (they bind with cholinergic receptors and prevent 
its excitation).  
The main localization sites of cholinergic synapses are: 
– both sympathetic and parasympasetic ganglia; 
– inner organs near the endings of the parasympathetic postganglionic 
fibers; 
– medullary substance of the adrenal glands; 
– skeletal muscles; 
– carotid glomeruli; 
– vessels of skeletal muscles; 
– central nervous system. 
Structure of cholinergic synapse is the following. As well as all other 
synapses, cholinergic synapse consists of presynaptic membrane, synaptic 
cleft, and postsynaptic membrane containing cholinergic receptors.  
Transmission of nervous impulses in cholinergic synapse involves the 
following processes.  
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Acetylcholine synthesis. Acetylcholine is synthesized from choline 
and acetyl CoA in the cytosol of preganglionic neuron’s endings. Synthesis 
of acetylcholine is catalyzed by choline acetyltransferase: 
 
CH3-CoA + HOCH2-CH2N(CH3)3 
choline acetyltransferase→ CH3-COOCH2CH2N(CH3)3. 
 
Acetylcholine storage. The acetylcholine is packaged into the vesicles 
by means of active transport. Synthesized acetylcholine is distributed in 
three pools: 
– associated pool that is unsuitable for immediate mobilization;  
– weakly-associated pool released during work; 
– “hot” pool that is able immediately to be released into synaptic cleft. 
Acetylcholine release. Presynaptic membrane contains about 200–
300 diffusion channels for acetylcholine. Incoming nervous impulse leads 
to the release of calcium ions that cause the acetylcholine release from the 
vesiculs into the synapse.    
Acetylcholine interaction with cholinoceptors. Released acetylcholine 
diffuses across the synaptic space and binds to postsynaptic receptors on 
the target cell. This binding is possible due to physic-chemical affinity of 
acetylcholine to cholinoceptor. Interaction of acetylcholine with cholinergic 
receptors results in certain biological response in the cell.  
Nowadays, pure forms of cholinergic receptors are isolated from the 
cellular membrane. It was found that these receptors are not homogeneous 
and characterized by certain conformational differences. These differences 
are insignificant for acetylcholine binding, but they are important for 
interanction between receptors and different pharmacological agents.  
Some cholinoceptors are selectively activated by muscarine 
(poisonous alkaloid of fly-agaric) and blocked by atropine (belladonna 
alkaloid). These receptors are called muscarinergic cholinoceptors or  
M-cholinoceptors. Another type of cholinergic receptors is selectively 
activated by small doses of nicotine and blocked by its high doses. These 
receptors are called nicotinergic cholinoceptors or N-cholinoceptors 
(H. Dale and S. Anichkov). In more detail, the characteristicas of different 
types of cholinoceptors are given below.          
Acetylcholine inactivation. After the interaction with cholinoceptors, 
acetylcholine is destroyed by the “acetylcholinesterase” enzyme. This 
enzyme cleaves acetylcholine to choline and acetate: 
 
CH3-COOCH2CH2N(CH3)3 
acetylcholinesterase→ CH3-COOH + HOCH2-CH2N(CH3)3. 
 
 Acetylcholinesterase accelerates the hydrolysis of acetylcholine in 
millions of times. Fast acetylcholine hydrolysis leads to lowering of the 
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mediator concentration and a rapid dissociation of the mediator from its 
receptors. Choline undergoes the reuptake by the nerve terminals, where it 
is used for the further acetylcholine synthesis.  
M-cholinoceptor is the complex receptor system that contains  
the following elements: 
– superficial part of receptor that recognizes the mediator; 
– G-protein that is located on the inner surface of cell membrane; 
– enzyme (adenylyl cyclase or phosphorylase C) or ionic channel.     
 
1
2
3
4
 
 
Figure 2 – M-cholinoceptor model (according to V. Vinogradov) 
 
1 – superficial part of receptor that recognizes acetylcholine; it consists of 
sites of long polypeptide chain which protrude above the membrane surface and 
permeate it, like a serpentine, 7 times;     
2 – G-protein; there are Gi-proteins inhibiting adenylyl cyclase, Gs-proteins 
stimulating adenylyl cyclase, Gq activating phospholipase C, Go opening ionic 
channel, and other G-proteins;     
3 – membrane enzyme or ionic channel; 
4 – cell membrane 
 
Transmission of signal through M-cholinoceptor to intracellular 
effectors (enzymes) are carried out in several steps: 
– acetylcholine interacts with superficial part of receptor; 
– receptor activates G-protein; 
– G-protein changes functional activity of membrane enzyme or ionic 
channel.    
 Five subtypes of M-cholinoceptors are known presently: M1-, M2-, 
M3-, M4-, and M5-cholinoceptors. These subtypes of muscarinic receptors 
are heterogeneously distributed in the human body. 
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Table 6 – Predominant localization and functional role of different subtypes 
of М-cholinoceptors 
 
 
Cholinoceptor 
subtype 
Localization Effect of activation 
М1-cholinoceptors 
(located outside of 
the synapse)  
Membranes of the cells of 
both parasympathetic and 
sympathetic ganglia (receptors 
with modulating function)  
Slow depolarization of 
ganglionic neurons 
Endothelial cells of vessels, 
mainly in skeletal muscles, 
skin, subcutaneous tissue 
Secretion of endothelial 
relaxing factor and 
vasodilation  
Postsynaptic  
М2-cholinoceptors 
 
Endings of postganglionic 
parasympathetic neurons in 
the heart  
Automatism reduction 
(bradycardia), slow down 
of conduction, decrease of 
atrial contractility 
Presynaptic  
М2-cholinoceptors  
Presynaptic membrane of the 
endings of parasympathetic 
and sympathetic nerves 
  
Deceleration of the 
mediator release (acetyl-
choline and noradrenaline)   
Postsynaptic  
М3-cholinoceptors  
The endings of postganglionic 
parasympathetic nerves in the 
smooth muscles of urinary 
tract, gastrointestinal tract, 
bronchi, and eye  
Contraction 
 
 
The endings of postganglionic 
parasympathetic nerves in the 
exocrine glands (salivary, 
nasopharyngeal, bronchial, 
stomach, and intestine glands) 
Elevation of secretion 
 
 
 
The endings of postganglionic 
sympathetic nerves in the 
sweat glands  
Elevation of secretion 
 
 
М1-, М2-, М3-, М4-, 
М5-cholinoceptors 
Central nervous system 
(cortex, subcortical structures, 
reticular formation, etc.)  
Different effects 
 
M3- and M1-cholinoceptors are coupled with Gq-proteins. Their 
excitation by acetylcholine leads to activation of phospholipase C and the 
release of intracellular calcium. 
Activation of M2-receptors through Gi-proteins inhibits adenylyl 
cyclase and simultaneously activates potassium channels through  
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Go-proteins. Increased potassium outward current from the cells 
hyperpolarizes the cellular membrane and decreases excitability of cells. 
The inhibition of adenylyl cyclase decreases cellular cAMP (cyclic 
adenosine monophosphate) level.  
Activation of presynaptic M2-cholinoceptors inhibits the following 
release of acetylcholine into the synaptic cleft.  
N-cholinoceptor consists of 5 polypeptide subunits (two -, -, γ- and 
δ-subunits) located surrounding a sodium channel.     
 
 
 
 
Figure 3 – N-cholinoceptor model (according to J. Kistler, R. M. Stroud) 
 
For understanding the mechanism coupling N-cholinoceptor activation 
with cellular function, it is necessary to remember that external surface of 
membrane at rest is charged positively, but internal surface is charged 
negatively. This charge is due to difference in distribution of cations: 
intracellular potassium concentration is higher than its concentration in the 
environment surrounding the cell. Vice versa, sodium concentration is 
higher in the environment surrounding the cell. Sodium ions drag the 
anions which are accumulated near internal surface of membrane and cause 
its negative charge.  
Acetylcholine binds with two α-subunits that leads to opening of 
sodium channel. Inward sodium current causes the membrane 
depolarization and the occurrence of action potential. In skeletal muscles, 
an action potential causes the activation of Ca
2+
-channels that is 
accompanied by the increase of cytoplasmic calcium concentration and the 
following muscular contraction.  
It is necessary to notice, that nicotinic receptors of vegetative ganglia 
differ from those of the neuromuscular junction. Thus, ganglionic receptors 
are selectively blocked by benzohexonium, whereas cholinergic receptors 
in skeletal muscles are selectively blocked by tubocurarine. Ganglionic 
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receptors are called Nn-cholinoceptors, but the neuromuscular junction 
receptors – Nm-cholinoceptors.  
Drugs which affect the impulse transmission in the cholinergic 
synapses are called cholinergic drugs. They are divided into the 
cholinomimetic (agents stimulating the cholinoceptors or leading to their 
excitation) and the cholinolytic drugs (agents blocking the cholinoceptors). 
Each of these groups is classified into subgroups depending on the 
influence upon the different types of cholinoceptors. 
 
Classification of Cholinergic Drugs  
 
I. Cholinomimetic drugs. 
1. M-, N-cholinomimetic drugs with direct action: acetylcholine 
and carbacholine . 
2. M-cholinomimetic drugs with direct action: pilocarpine and 
aceclidine . 
3. N-cholinomimetic drugs with direct action: nicotine, lobeline, 
and cyti tonum .  
4. Indirectly acting M-, N-cholinomimetic drugs or cholinesterase 
inhibitors: galantamine, physostigmine, proserinum 
(neostigmine),  pyridostigmine , oxazylum (ambenonium),  
dist igmine, and armin . 
II. Anticholinergic drugs. 
1. M-cholinolytic drugs: atropine sulfate ,  scopolamine ,  
platyphyll in, metacinum, ipratropium bromide , pirenzepine,  
homatropine,  and tropicamide .  
2. N-cholinolytic drugs.   
2.1. Nn-cholinolytic drugs (ganglion blocking drugs):  
benzohexonium, pentaminum, hygronium, arfonade,  
piri lenum, and pachycarpine . 
2.2. Nm-cholinolytic drugs (peripheral myorelaxants): tubocurarine,  
pipecuronium, pancuronium, dithylinum, and dioxonium .  
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M-, N-Cholinomimetics with Direct Action  
 
M-, N-cholinimetic drugs with direct action are acetylchil ine  and 
carbacholine .   
Acetylcholine  is a quaternary ammonium compound that cannot 
penetrate membranes. Acetylcholine excites both M- and N-cholinoceptors. 
In case of oral intake, acetylcholine is destroyed before absorption in the 
blood. Subcutaneously administered acetylcholine is quickly hydrolyzed in 
the blood. Therefore, resorptive action of acetylcholine is observed only 
after its intravenous administration. In this case, the excitation of  
M-choliceptors is predominant.  
The following effects of M-cholinoceptors stimulation are observed.  
Heart. Activation of M2-receptors by acetylcholine increases the 
potassium permeability and reduces cAMP levels, that results in the 
deceleration of depolarization and reduction of the excitability of sinoatrial 
and atrioventricular nodes. It results in marked bradycardia and a 
deceleration of atrioventricular conduction. Very high doses of 
acetylcholine, as other M-chlolinergic agonists, can cause lethal 
bradycardia and atrioventricular blockage.  
Vascular tone and blood pressure. Due to stimulation of  
M-cholinoceptors of vascular endothelial cells, acetylcholine causes 
vasodilatation and reduces the blood pressure. M-cholinoceptors excitation 
stimulates the synthesis and release of nitric oxide by the endothelial cells. 
Nitric oxide diffuses to vascular smooth muscle cells and activates guanylyl 
cyclase that leads to the increase of cGMP (cyclic guanosine 
monophosphate) synthesis and relaxation of vascular smooth muscles. It is 
necessary to notice, that the the resistance vessels are not innervated by 
cholinergic neurons, and the physiological role of the endothelial  
M-cholinoceptors is unknown. But, activation of these receptors by directly 
acting M-cholinomimetic drugs leads to marked hypotension.  
Exocrine glands. Owing to excitation of M3-cholinoceptors, 
acetylcholine increases secretion of all exocrine glands: salivary, sweat, 
lacrimal, nasopharyngeal, bronchial, gastric, etc.  
Smooth muscles. Acetylcholine increases the bronchial tone, stimulates 
motility and tone of stomach, intestine, gallbladder, bile ducts, and bladder. 
Eye. Acetylcholine causes contraction of the iris sphincter and ciliary 
muscles. Contraction of the iris sphincter muscle leads to the decrease of 
the pupil diameter (miosis). The intraocular pressure is lowered because the 
pupil sphincter contraction provides opening of the spaces of the iris angle 
(Fontana’s spaces). Due to this, the outflow of the aqueous humour from 
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the anterior chamber of the eye into the venous sinus of the sclera  
(the Schlemm channel) is increased. Contraction of the ciliary muscle 
reduces the tension of the suspensory ligaments stretching and flattening 
the lens. It results in the increase of the lens curvature. The lens focuses for 
near vision. This phenomenon is called the spasm of accommodation.   
The sensitivity of N-cholinoceptors to acetylcholine is significantly 
less, than sensitivity of M-cholinoceptors. Therefore, the effects of their 
excitation are observed against the background of the preliminary 
administration of M-cholinergic antagonist (e. g., atropine). In this case, 
intravenous acetylcholine administration results in the elevation of blood 
pressure. It is due to stimulation of N-cholinoceptors of sympathetic 
ganglia and chromaffinic cells of adrenal medulla releasing adrenaline. 
Partly, this effect is also the result of excitation of N-cholinoceptors of 
carotid bodies that provides the increase of tone vasomotor centre. Marked 
respiratory stimulation, observed after intravenous acetylcholine 
administration, is also due to the stimulation of N-cholinoceptors of carotid 
bodies. Besides, acetylcholine increases the vasopressin release by 
posterior pituitary and improves the neuromuscular transmission in skeletal 
muscles. 
Acetylcholine is rapidly hydrolyzed by cholinesterase. Subcutaneously 
administered acetylcholine acts 5–15 min. Acetylcholine practically does 
not have therapeutic value. Sometimes, it is used for the cardiac arrest 
during operations with artificial circulation or administered intravenously 
in the treatment for frostbite of the extremities.  
 
Carbacholine (Carbachol)  is synthetic ester of choline and 
carbamic acid. Its duration of action is 1–1.5 hours. Because the drug 
excites both M- and N-cholinergic receptors, its effects are like the effects 
of acetylcholine. Ocular films or eye drops with carbacholine is used to 
treat the open-angle glaucoma which is resistant to pilocarpine.  
  
Cholinesterase Inhibitors  
 
Cholinesterase inhibitors bind and inhibit the activity of both 
acetylcholinesterase and butyrylcholinesterase (plasma cholinesterase, or 
pseudocholinesterase).  
These drugs are classified as follows: 
1. Cholinesterase inhibitors of reversible action: galantamine,  
physostigmine, proserinum (neostigmine),  pyridostigmine ,  
oxazylum (ambenonium),  and distigmine.  
2. Cholinesterase inhibitors of irreversible action: armin .  
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Also, numerous phosphorus organic compounds as insecticides 
(carbophos, chlorophos, dichlophos, etc.) and warfare agents (sarin, soman, 
etc.) are irreversible inhibitors of cholinesterase. 
The drugs of reversible action reversibly inactivate the enzyme due to 
formation of the unstable bond with it. The irreversibly-acting drugs 
covalently bond to cholinesterase; therefore, the inhibition of enzyme has 
the irreversible character. It is necessary to notice, that this covalent bond is 
slowly hydrolyzed by water (about 20 days).  
Acetylcholinesterase is membrane bound enzyme located both pre- 
and postsynaptically in the cholinergic nerve endings. Cholinesterase 
molecule has two centres interacting with acetylcholine: the anionic centre 
and the esterase centre. The anionic centre binds to the positively charged 
quaternary ammonium group of acetylcholine. The esterase centre binds to 
carbon of carbonyl group of acetylcholine. This interaction leads to 
hydrolysis of acetylcholine. Acetylcholine hydrolysis lasts about 
150 microseconds. It is one of the fastest enzymatic reactions that is known 
nowadays.  
Cholinesterase inhibitors can bind ether anionic centre (edrophonium) 
or esterase centre (most phosphorus organic compounds). Some drugs bind 
to both centres (proserinum). The enzyme inhibition leads to accumulation 
of acetylcholine in synapses. It results in the excitation of both M- and  
N-cholinoceptors. But at resorptive action of cholinesterase inhibitors, first, 
the effects of activation of M-cholinoceptors are observed: 
– miosis; 
– increased salivation;  
– increase of bronchial tone; 
– bradycardia that is replaced by tachycardia; 
– increase of intestinal motility and tone; 
– hypotension that is replaced by elevation of blood pressure; 
– stimulation of uterine contraction; 
– increase of bladder tone.  
In some cases, effects of cholinesterase inhibitors differ from effects of 
M-cholinomimetics: tachycardia is observed after bradycardia and lowering 
of blood pressure is replaced by the pressor effect. It is due to the later 
acetylcholine activation of N-cholinergic receptors of sympathetic ganglia 
and adrenal medulla. Acetylcholine accumulation near Nm-cholinoceptors 
of skeletal muscles leads to facilitation of neuromuscular transmission. It is 
necessary to notice, that high doses of cholinesterase inhibitors cause 
muscle twitching replaced by blockage of neuromuscular transmission. 
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Presently, there are evidences that together with the blockage of 
enzyme, cholinesterase inhibitors (e. g., proserinum) are able directly to 
bind and excite the cholinergic receptors. The direct activation of 
cholinergic receptors plays a secondary role in action of cholinesterase 
inhibitors. 
Physostigmine  is an alkaloid of plants and a tertiary amine that 
penetrates in the central nervous system. The drug acts about 2–4 hours. 
Eye drops of physostigmine are used to treat glaucoma. Physostigmine is 
also used to treat the overdoses of M-chlolinergic antagonists (atropine, 
scopolamine, etc.). The drug is used to treat Alzheimer’s disease1), 
craniocerebral traumas, cerebral hemorrhages, and residual effects after 
poliomyelitis. It should be noticed that physostigmine can produce cardiac 
arrhythmias and other serious toxic effects which restrict its clinical use.   
Galantamine  is alkaloid of Woronow’s snowdrop. It is tertiary 
amine that penetrates central nervous system. Therapeutic indications of 
galantamine are like physostigmine. But galantamine is not used in the 
glaucoma treatment due to its irritative action that causes conjunctival 
oedema.  
At  the therapy of the damages of central nervous system (traumas, 
strokes, poliomyelitis, etc.), physostigmine and galantamine are prescribed 
after liquidation of the acute symptoms; when residual disturbances are 
persisting due to stable inhibition in CNS. Cholinesterase inhibitors 
stabilize acetylcholine concentration, and synaptic transmission is 
improved; that diminishes the residual symptoms. 
Proserinum  is a synthetic polar compound and, therefore, does not 
penetrate in the central nervous system. Its stimulative effect on skeletal 
muscles is greater than that of physostigmine. The duration of action of 
proserinum is 2–4 hours.  
The duration of action of pyridostigmine  is longer than that of 
proserinum. 
Except the treatment of central nervous system, there are the following 
therapeutic indications for cholinesterase inhibitors: 
1. Glaucoma. Cholinesterase inhibitors are applied topically in forms 
of eye drops or eye ointment. The use of 0.25–1 % physostigmine solution 
causes the marked reduction of intraocular pressure. It is commonly used to 
treat acute glaucoma in cases when pilocarpine is ineffective. Proserinum 
                                                          
1)
 Alzheimer’s disease or senile dementia is a slowly developing neurodegenerative 
disease that is characterized by the memory loss and cognitive dysfunction. 
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(0.5 % solution) and armin (0.01 % solution) are also used in the treatment 
of glaucoma. As mentioned above, galantamine is not used for this purpose.  
2. Postsurgical atony of intestine and bladder. As a rule, 0.25–0.3 ml 
0.5 % proserinum solution is injected subcutaneously every 30–60 minutes 
up to the occurrence of peristalsis. If patient’s condition allows, proserinum 
may be taken orally 2–3 times a day. If long-time treatment is necessary, 
pyridostigmine is preferable. It is administered intramuscularly or taken 
orally 1–3 times a day.   
3. Residual muscular relaxation after the use of non-depolarizing 
myorelaxants (e. g., tubocurarine). The drug of choice is proserinum.  
4. Peripheral paralysis of skeletal muscles and myasthenia gravis. 
Cholinesterase inhibitors poorly penetrating in the central nervous system 
are preferable in these cases: proserinum, pyridostigmine, and distigmine. 
The therapeutic regimen is selected individually.       
Side effects of these drugs are hypersalivation, flushing, decreased 
blood pressure, nausea, abdominal pain, diarrhea, bronchospasm, and 
bradycardia.  
Cholinesterase inhibitors are contraindicated in bronchial asthma, 
organic heart diseases with disorders of conduction, and pregnancy.  
Acute poisoning by irreversibly-acting cholinesterase inhibitors is 
frequent because organophosphorus compounds are widely used as 
agricultural and household insecticides. Many of these substances are 
extremely toxic and were developed by the military as nerve agents. Acute 
poisoning is manifested by the following symptoms: gastrointestinal 
distress (hypersalivation, nausea, vomiting, and diarrhea), bronchospasm 
and increased bronchial secretion, bradycardia that is replaced by 
tachycardia, AV-block, hypotension, miosis, sweating, and disturbances of 
skeletal muscles function (successive incoordination, muscle cramps, 
weakness, fasciculation, and paralysis). The symptoms of central nervous 
system damage include agitation, dizziness, convulsions, and mental 
confusion. Death usually results from paralysis of skeletal muscles required 
for respiration, or owing to the cardiac arrest. Depending on the severity of 
poisoning, death occurs in several minutes or hours (up to a day). The 
urgent care includes the atropine administration, elimination of poison from 
the organism, and symptomatic therapy.  
In 1951, it was found that covalent bond between organophosphorus 
compound and cholinesterase is slow hydrolysed by water. Substances, 
which contain oxime group (-N=N-OH) in molecules, accelerate this 
reaction. Drugs with such action are called cholinesterase reactivators. The 
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mechanism of restoration of enzyme activity is based on the reactivator 
ability to bind to organophosphorus residue and to cleave it from 
cholinesterase. But, “poisoned” enzyme quickly is “aging” and lost the 
ability to be reactivated. Therefore, the administration of reactivator should 
be as early as possible. There are the following reactivators of 
cholinesterase: dipyroxime (trimedoxime bromide), isonitrosine, and 
alloxime. These drugs are administered parenterally.  
 
M-Cholinomimetic Drugs  
 
An ancestor of M-cholinomimetics is muscarine. But it does not have 
practical use in medicine and is used for toxicological investigations only. 
M-cholinomimetic drugs are pilocarpine  and aceclidine . The 
mechanism of action of these drugs is associated with direct stimulation of 
all sybtypes of M-cholinoceptors: M1, M2, and M3. As mentioned above, 
M-cholinoceptors are in cellular membranes near postganglionic 
parasympathetic nerves: 
– in all inner organs receiving parasympathetic innervation; 
– in the salivary glands and smooth muscles of vessels receiving 
sympathetic but cholinergic innervation;  
– in the central nervous system (reticular formation, new cortex, 
limbic system, hippocampus, etc.). 
Because M-cholinoceptors belong to effector cells, the activity of 
direct M-cholinomimetics persists and even became higher due to 
denervation or degeneration of the nerve.  
Effects of M-cholinomimetics are very similar to effects of 
cholinesterase inhibitors and M,N-cholinomimetics. 
Because the cardial branches of vagus mainly innervate sinoatrial and 
atrioventricular nodes of heart (ventricles are not innervated by 
parasympathetic innervation), the action of M-cholinomimetics is directed 
upon the function of these nodes. The excitation of M2-cholinoceptors of 
sinoatrial node leads to bradycardia. Due to that, cardiac output and blood 
pressure are reduced. Intravenous administration of M-cholinomimetics can 
result in sudden cardiac arrest. Owing to this, intravenous administration of 
M-cholinomimetics is not practiced. 
Excitation of M2-cholinergic receptors of conductive system by  
M-cholinomimetics also results in slow down of conduction. This 
phenomenon is most marked in the atrioventriculalar node.  
M-cholinomimetics can provoke atrioventricular blockages of different 
degrees. 
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M-cholinomimetics reduce blood pressure due to: 
– reduction of heart work; 
– excitation of M-cholinergic receptors in vessels of skeletal muscles 
(these receptors are innervated by sympathetic cholinergic nervous fibers); 
– excitation of M-cholinoceptors of sweat glands which are also 
innervated by sympathetic cholinergic fibers.  
Sweat glands secrete proteolytic enzyme kallikrein that synthesizes 
bradykinin. Bradykinin causes the dilation of arterioles and capillaries of 
skin and subcutaneous tissue that promotes the hypotension. 
Other effects of M-cholinomimetics include miosis, lowering of the 
intraocular pressure, the spasm of accommodation, the increase of smooth 
muscle tone (bronchi, gastrointestinal tract, biliferous and urinary tracts, 
and uterus), hypersecretion of bronchial, digestive, and lacrimal glands.    
The pilocarpine  is alkaloid derived from the leaves of tropical plant 
Pilocarpus jaborandi. Pilocarpine is characterized by more marked 
influence upon exocrine gland secretion than upon the tone of smooth 
muscules. After pilocarpine injection, sweat glands secrete during  
3–4 hours about 3 litres of sweat. General loss of liquids by human body is 
about 5–6 litres. It results in serious dehydration. Therefore, resorptive 
effects of pilocarpine are not used in medicine. But, pilocarpine is widely 
used in the treatment for glaucoma. Pilocarpine is the drug of choice in the 
emergency lowering of intraocular pressure in glaucomatous crisis. 
Pilocarpine is used as 1–5 % eye drops (duration of action – 4–8 hours),  
1–5 % eye ointment, eye membranules on the polymer base that slowly 
dissolve in lacrimal fluid (act to 24 hours), and insoluble membrane 
systems that slowly release pilocarpine (Ocusert). Duration of Ocusert 
action is 5–7 days.  
It is necessary to notice, that pilocarpine can penetrate through the 
blood-brain barrier and affects the central nervous system function. To 
escape the penetration of cholinomimetics into the blood stream after its 
topical application into the eye, the mechanical pressure is applied to the 
lacrimal duct.   
Aceclidine  is synthetic compound. It is used in the treatment of 
glaucoma, postsurgical intestinal and bladder atony. For treatment of 
intestinal and bladder atony, 1–2 ml of 0.2 % aceclidine solution is 
administered subcutaneously. If necessary, administration can be repeated 
2–3 times with intervals 30–60 minutes. Also, aceclidine is sometimes used 
in the treatment for uterine atony and uterine bleeding in the postpartum 
period.  
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In rare cases, when hemodialysis is impossible, pilocarpine may be 
administered to treat acute renal insufficiency. From 10 to 15 mg of 
pilocarpine is administered subcutaneously considering possible side 
effects; 2–3 litres of water, sodium chloride, nitrogen compounds are 
excreted from the body for 2 hours. Undesirable effects may be stopped by 
atropine administration.  
M-cholinomimetics are contraindicated in bronchial asthma, disorders 
of the cardiac conduction, ischemic heart disease, hyperthyroidism, 
Parkinson disease, epilepsy, hyperkynesia, and pregnancy. 
The poisonings by M-cholinomimetics are most commonly caused by 
fly-agaric. The typical symptoms of poisoning are nausea, abdominal 
cramps, diarrhea, salivation, hypotension with reflex tachycardia, cutaneous 
vasodilation, sweating, miosis, spasm of accommodation, macropsia, and 
bronchoconstriction. Agitation and convulsions are also possible. As a rule, 
death occurs due to paralysis of respiratory centre. The urgent aid includes 
gastric lavage and administration of atropine that eliminate all symptoms of 
poisoning. 
 
N-Cholinomimetic  Drugs 
 
Group of N-cholinomimetics includes nicotine, lobeline  and 
cyti tonum .  
These drugs selectively excitate Nn-cholinergic receptors.  
Nn-cholinoceptors are in the carotid bodies, adrenal medulla, vegetative 
ganglia, and central nervous system.    
Nicotine  is the alkaloid of the plant tobacco (Nicotiana tabacum and 
Nicotiana rustica). As a rule, a cigarette contains 6–8 mg of nicotine. About 
60 mg of nicotine results in the acute lethal poisoning. More than 60 % of 
nicotine inhaled while smoking is absorbed into the blood. Nicotine has no 
therapeutic value. It has only toxicological significance. Nicotine is one of 
the most widely used stimulants of the central nervous system. Chronic 
nicotine consumption results in abuse. Except nicotine, cigarette smoke 
contains carbon monoxide, phenol, and toxic tars. Therefore, chronic 
smoking results in the serious risk of cardiovascular disease, various 
cancers, and diseases of the gastrointestinal tract (ulcers, gastritis).   
The peripheral effects of nicotine are complex.  
Low doses of nicotine stimulate Nn-cholinoceptors of both 
parasympathetic and sympathetic ganglia. Stimulation of sympathetic 
ganglia increases blood pressure and heart rate. Nicotine decreases 
coronary blood flow. Stimulation of parasympathetic ganglia increases the 
motility of gastrointestinal tract. Low doses of nicotine stimulate the central 
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nervous system activity and cause some euphoria. Nicotine stimulates the 
release of dopamine, endogenous opioids and glucocorticoids. The high 
doses of nicotine provide the ganglionic blockade and cause marked 
hypotension. Lethal doses of nicotine paralyse respiratory centre. 
Because nicotine is highly-lipid soluble substance, it easily penetrates 
through the placental barrier and is dangerous for fetus. Also, nicotine is 
secreted in the milk of lactating women.  
Chronic smoking is accompanied by fast development of tolerance to 
the toxic effects of nicotine. Also, chronic consumption of nicotine rapidly 
leads to the drug dependence (abuse). Withdrawal syndrome is manifested 
by such symptoms as irritability, anxiety, restlessness, difficulty in 
concentrating, headaches, and insomnia.  
Lobeline  and cyti tonum  are used in medicinal practice. The 
practical importance of these drugs is their ability to excitate  
Nn-cholinoceptors of the carotid glomeruli that leads to the reflex 
stimulation (through Hering’s nerve which is a branch of glossopharyngeal 
nerve) of the respiratory and vasomotor centres of medulla oblongata.   
These drugs are analeptics of reflex action and used as breathing 
stimulants. Their intravenous administration leads to potent but short effect 
(2–5 min). The respiratory centre depression caused by CNS-depressants 
(barbiturates, morphin, etc.) results in the loss of its sensitivity to CO2. In 
such conditions, the reflex stimuli from the vascular chemoreceptors have 
predominant influence upon respiratory centre. Thus, keeping the reflex 
excitability of respiratory centre allows to use N-cholinomimetics for 
restoration of breathing.  
It should be noticed that in case of intravenous administration, 
minimal doses of N-cholinomimetic stimulate respiratory centre. At the 
same time, subcutaneous or intramuscular administration of the drug needs 
doses that are 10–20 times more. It leads to accumulation of a drug into the 
central nervous system and occurrence of different side effects: vomiting, 
convulsions, activation of vagal centre resulting in cardiac arrest, etc. 
Therefore, lobeline and cytitonum are administered only intravenously in 
minimal doses. 
An excitation of Nn-cholinergic receptors of sympathetic ganglia, 
adrenal medulla, carotid bodies, and posterior pituitary results in short-time 
elevation of blood pressure. It is necessary to remember that overdose of  
N-cholinomimetics results in blockage of correspondent receptors: effect of 
breathing stimulation disappears, and hypotension develops.  
N-cholinomimetics are ineffective against the background of action of 
ganglionic blocking drugs. 
Lobeline and cytitonum are used to restore breathing in patients 
poisoned by barbiturates, opioid analgesics, carbone monoxide, etc. Also, 
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these drugs are used to restore breathing in cases of its inhibition due to 
operations, drowning, and traumas. About 0.2–0.5 ml of 1 % lobeline 
solution or 0.5 ml of cytitonum is slowly administered intravenously. If it is 
necessary, cytitonum may be administered repeatedly in 10–20 minutes.  
It should be noticed that artificial ventilation is more reliable and 
effective than the use of respiratory analeptics.  
Besides, N-cholinomimetics are used to stop smoking. The drugs are 
prescribed according to the therapeutic scheme with gradual dose 
reduction. The course of treatment lasts 20–25 days. The following drugs 
are used: tablets “Tabex”  containing cytosine, and tablets “Lobesil”  
containing lobeline; anabasine in peroral or sublingual tablets, buccal 
plates, or chewing gum “Gamibazin” . Anabasine is an alkaloid 
contained in the tree tobacco.  
 
 Table 7 – Drugs for prescription 
 
 
Drug name 
(Latin) 
Single dose and route 
of administration 
Drug product 
Proserinum Orally 0.01–0.015 g; 
subcutaneously 0.0005 g; 
 
in the eye: 1–2 drops  
Tablets 0.015g; 
ampoules 1 ml of 0.05 % 
solution; 
0.5 % ophthalmic solution 
 
Galanthamini 
hydrobromidum 
Subcutaneously 0.0025–
0.005 g 
Ampoules 1 ml of 0.1, 0.25, 
0.5 or 1 % solution 
Pilocarpini 
hydrochloridum 
In the eye: 1–2 drops of 
ophthalmic solution or 
ophthalmic ointment 
1 or 2 % ophthalmic solution 
in vials 5 or 10 ml; 
1 or 2 % ophthalmic 
ointment 
Aceclidinum In the eye: 2–5 % ophthalmic 
solution (1–2 drops) or 3–
5 % ophthalmic ointment; 
subcutaneously 0.002 g 
2–5 % ophthalmic solution; 
3 and 5 % ophthalmic 
ointment; 
ampoules 1 or 2 ml of 0.2 % 
solution 
Carbacholinum In the eye: 1–2 drops of 0.5–
1 % ophthalmic solution 
0.5 or 1 % ophthalmic 
solution in vials 5 or 10 ml 
Dipiroximum Subcutaneously, 
intramuscularly or 
intravenously 0.15–0.3 g 
Ampoules 1 ml of 15 % 
solution 
Lobelini 
hydrochloridum 
Intravenously slowly 0.005 g  Ampoules 1 ml of 1 % 
solution 
Cytitonum Intravenously slowly 0.5 ml  Ampoules 1 ml 
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Step 1. Tasks for Self -Control  
Cholinomimetic Drugs  
 
1. During operation the anaesthesiologist has overdosed tubocurarine 
chloride to a patient. Proserinum has been prescribed. What is the base of 
proserinum action in this case? 
A. Blockade of adrenoceptors. 
B. Increase of cholinesterase activity.  
C. Blockade of presynaptic membrane. 
D. Inhibition of cholinesterase activity. 
E. Stimulation of M-cholinoceptors. 
2. A patient is delivered into a hospital with complaints of dizziness, 
decrease of vision acuteness, nausea, hypersalivation, and abdominal 
cramps. The diagnosis is poisoning with organophosphorus compounds. 
What drugs should be included in the complex therapy? 
A. Glucose and bemegride. 
B. Atropine sulfate and dipyroxime. 
C. Thiosulfate sodium and bemegride. 
D. EDTA. 
E. Naloxone and bemegride.  
3. A patient with complaints of dry mouth and skin, vision 
disturbances, mydriasis, and tachycardia has been delivered into hospital. 
The doctor has put the diagnosis of poisoning with Belladonna’s alkaloids. 
What drug should be prescribed? 
A. Dipyroxime. 
B. Aceclidine. 
C. Pilocarpine. 
D. Armine. 
E. Neostigmine (proserinum). 
4. Residual phenomena are observed in a child after poliomyelitis. 
What drug should be prescribed in this case? 
A. Pyrroxane. 
B. Pentamine (azamethonium). 
C. Galantamine. 
D. Dimecoline. 
E. Atropine sulfate. 
5. A victim treated the plants with insecticides without personal 
protective equipment. After some time, he developed the following 
symptoms: hypersalivation, sweating, diarrhea, miosis, and pain in the 
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abdomen. The drug, which has caused this poisoning, is included to the 
group of: 
A. Organic chloride compounds. 
B. N-cholinomimetics. 
C. Cuprum salts. 
D. Nitrates. 
E. Cholinesterase inhibitors. 
6. After instilling eye drops the miosis and short-sightedness has 
developed in a patient with glaucoma. The intraocular pressure has 
decreased. What group of drugs can cause such effect? 
A. Ganglioblockers. 
B. M-cholinoblockers. 
C. -Adrenomimetics. 
D. N-cholinomimetics. 
E. M-cholinomimetics. 
7. Paresis of intestine has developed in a patient after surgery. What 
drug from the group of cholinesterase inhibitors should be prescribed to 
this patient? 
A. Acetylcholine. 
B. Carbacholine. 
C. Neostigmine (proserinum). 
D. Aceclidine. 
E. Pilocarpine. 
8. A 5-year-old child has been delivered to emergency department 
with the following symptoms: marked psychomotor excitation, delirium, 
hallucinations, hoarse voice, dilatation of pupils, hyperemia of the skin, 
tachycardia, tachypnea. These symptoms were developed after the child 
had used the berries of Belladonna. What group of drugs should be 
prescribed for treatment of the child?  
A. Cholinesterase regenerators. 
B. N-cholinomimetics. 
C. M-cholinomimetics. 
D. Cholinesterase inhibitors. 
E. N-cholinoblockers. 
9. The disturbances of breathing had developed in a patient during 
operation with the use of peripheral myorelaxants. The administration of 
proserinum improves the patient’s condition. What is such interaction of 
drugs called? 
A. Antagonism. 
B. Cumulation. 
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C. Synergism.  
D. Incompatibility. 
E. Tachyphylaxis.   
10. A 4-year-old boy was delivered to a toxicological department with 
poisoning by berries of Belladonna. What drug should be prescribed to the 
boy in this condition? 
A. Platyphylline. 
B. Aceclidine. 
C. Lobeline. 
D. Cytitonum. 
E. Galantamine. 
11. The peristaltic of intestine was not restored in a patient after 
resection of stomach. What drug should be prescribed to the patient for 
stimulation of GI-tract function? 
A. Succinylcholine (dithylinum). 
B. Platyphylline. 
C. Neostigmine (proserinum). 
D. Cyclodol. 
E. Atropine. 
12. A patient with complaints of weakness and disturbances of gait 
came to the doctor. The doctor has diagnosed myasthenia and prescribed to 
the patient the injection of proserinum. What is the mechanism of 
proserinum action? 
A. Inhibition of cholinesterase. 
B. Activation of acetylcholine synthesis. 
C. Direct stimulation of cholinoceptors. 
D. Stimulation of metabolic processes. 
E. Inhibition of brake processes. 
13. A 40-year-old male was delivered to a toxicological department 
with poisoning by insecticides. What cholinesterase regenerator drug 
should be prescribed to the patient? 
A. Atropine. 
B. Platyphylline. 
C. Scopolamine. 
D. Amizylum. 
E. Dipyroxime. 
14. What drug, which can cause miosis, will keep the action in  
an animal with denervation of smooth muscles of the eye? 
A. Reserpine. 
B. Galantamine. 
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C. Proserinum. 
D. Pilocarpine. 
E. Prazosin. 
15. A female received injections of galantamine for restoration of CNS 
functions after the ischemic stroke. The condition of the patient has 
significantly improved. What is the mechanism of this drug action? 
A. Blockade of monoamine oxidase. 
B. Blockade of cholinesterase. 
C. Blockade of cholinoceptors. 
D. Blockade of catechol-ortho-methyltransferase. 
E. Blockade of dopamine hydroxylase. 
16. A 65-year-old male is accepted in a neurological department with 
the post-stroke syndrome. What drug should be prescribed for acceleration 
of this patient’s recovery? 
A. Aceclidine. 
B. Galantamine hydrobromide. 
C. Ipratropium bromide. 
D. Dipyroxime. 
E. Isonitrosine. 
17. Drug A was prescribed to a patient with myasthenia and caused the 
improving of muscles activity. But several side effects had developed 
gradually: hypersalivation, sweating, diarrhea, nausea. What drug was used 
for treatment of the patient? 
A. Armine. 
B. Metamizole (analginum). 
C. Strychnine. 
D. Caffeine. 
E. Neostigmine (proserinum). 
18. A physician has prescribed eye drops with proserinum to a patient 
for decreasing intraocular pressure. What is the mechanism of proserinum 
action? 
A. Blockade of phospholipase.  
B. Blockade of cyclooxygenase.  
C. Blockade of lipoxygenase. 
D. Blockade of phosphodiesterase. 
E. Blockade of cholinesterase. 
19. The victim was delivered to an emergency department with 
complaints of dryness in the mouth, photophobia, and disturbances of 
vision. Hyperemia, dryness of skin, and tachycardia are observed. The 
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diagnosis is the poisoning with alkaloids of Belladonna. What drug should 
be prescribed? 
A. Dipyroxime. 
B. Proserinum. 
C. Diazepam. 
D. Pilocarpine. 
E. Armine. 
20. The atony of intestine has developed in a patient on the 3
rd
 day 
after the resection of the stomach. What drug should be used? 
A. Proserinum.  
B. Pirilenum. 
C. Atropine sulfate. 
D. Hexamethonium (benzohexonium). 
E. “No-spa” (drotaverine). 
21. A 2-year-old child has had a drink of eye drops from the first-aid 
set. The child has significant sweating and hypersalivation, difficult 
breathing, and cough. The pupils are narrowed, and bradycardia is 
observed. The peristaltic of intestine is increased. The blood pressure is 
low. What drug has caused poisoning? 
A. Sulfacetamide (sulfacylum-sodium). 
B. Propranolol (anaprilinum). 
C. Pilocarpine hydrochloride. 
D. Atropine. 
E. Platyphylline. 
22. A patient was delivered to an emergency department with such 
symptoms: miosis, hypersalivation, sweating, vomiting, diarrhea, and 
spasm of bronchi. The diagnosis of poisoning with organophosphorus 
substances was ascertained. What drugs should be included in the complex 
therapy?  
A. Panangin and unithiol. 
B. Thiosulfate sodium and bemegride. 
C. Nalorphine hydrochloride and bemegride. 
D. Atropine sulfate and dipyroxime. 
E. Glucose and bemegride. 
23. Analeptic of reflective type from the H-cholinomimetics group 
was given to the patient for restoration of breathing after poisoning with 
carbon monoxide. What medicine was prescribed to the patient? 
A. Atropine sulfate. 
B. Lobeline hydrochloride.  
C. Phenylephrine (mesatonum). 
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D. Adrenaline hydrochloride. 
E. Pentaminum. 
24. A 50-year-old male farm worker has been brought to the 
emergency room. He was found confused in the orchard and since then has 
remained unconscious. His heart rate is 45 and his blood pressure is 80/40 
mm Hg. He is sweating and salivating profusely. Which of the following 
should be prescribed? 
A. Pentaminum. 
B. Proserinum. 
C. Physostigmine. 
D. Noradrenaline. 
E. Atropine. 
25. A child has residual phenomena after poliomyelitis. What drug is 
to be prescribed? 
A. Pyroxanum. 
B. Galantamine hydrobromide.  
C. Pentaminum. 
D. Dimecoline. 
E. Atropine sulfate. 
26. An injection of galantamine hydrobromide was made to a woman, 
63-year-old, after the ischemic stroke. Condition of the patient has 
considerably improved. What is the mechanism of this medication effect? 
A. Inhibition of monoamine oxidase. 
B. Inhibition of cholinergic receptors. 
C. Inhibition of catechol-o-methyltransferase. 
D. Inhibition of dopamine-hydroxylase. 
E. Inhibition of acetylcholinesterase.  
27. It is necessary to prescribe a medication to a patient with glaucoma 
diagnosis. Which anticholinesterase drug (tertiary amine) isn’t used in 
ophthalmologic practice due to its irritative influence on the eye 
conjunctiva? 
A. Armine. 
B. Galantamine hydrobromide.  
C. Pyridostigmine bromide. 
D. Armin. 
E. Proserinum. 
28. A patient with myasthenia was prescribed a drug which improved 
muscle performance. But several defects have been revealed gradually: 
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intensive salivation, transpiration, diarrhea, nausea. What drug was used for 
treatment? 
A. Armine. 
B. Analginum. 
C. Strychnine nitrate. 
D. Caffeine sodium benzoate. 
E. Proserinum.  
29. A 25-year-old man appeals to a neurologist with complaints of 
weakness in legs and gait disorder. The doctor diagnoses myasthenia and 
prescribes to the patient an injection of proserinum. What is the typical 
action of this drug? 
A. Activation of acetylcholine synthesis. 
B. Prevention of acetylcholine destruction. 
C. Direct cholinomimetic. 
D. Stimulation of metabolic processes. 
E. Ganglion blocking. 
30. A child poisoned with mushrooms, namely fly agarics, has been 
taken to a toxicological department. What drug should be primarily used 
for emergency? 
A. Dipiroxime. 
B. Papaverine hydrochloride. 
C. Unithiol. 
D. Sodium thiosulfate. 
E. Atropine sulfate.  
31. A child, 2-years-old, has drunk eye drops from the domestic first-
aid kit. The child’s condition is poor, accompanied by transpiration and 
salivation, asthmatic breathing, cough, sharply miotic pupils, muffled heart 
sounds, bradycardia, low arterial pressure, intensive intestinal peristalsis, 
diarrhea. What is the drug which has caused the poisoning? 
A. Sulfacyl sodium. 
B. Propranolol. 
C. Pilocarpine hydrochloride. 
D. Atropine sulfate. 
E. Platyphylline hydrotartrate. 
32. A victim sprayed the plants with an insecticidal solution without 
personal protection equipment. After a while salivation, transpiration, tears 
secretion, pain in the stomach, and diarrhea began. Examination revealed 
miosis. What group does the substance, which has caused such symptoms, 
belong to? 
A. Organic compounds of chlorine. 
B. N-cholinomimetics. 
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C. Copper salt. 
D. Organic compounds of phosphorus. 
E. Nitrates. 
33. Having used eye drops, a patient with glaucoma has developed 
miosis and myopia, intraocular pressure has decreased. What group of 
drugs causes such effect? 
A. M-cholinomimetics.  
B. Ganglionic blockers. 
C. M-cholinergic blockers. 
D. -Adrenergic blockers. 
E. N-cholinomimetics. 
34. An 18-year-old unconscious patient was delivered to an urgent unit 
with the signs of dry skin and widened pupils. It is known, that the patient 
has poisoned with berries of Belladonna which contain M-cholinoblocker 
atropine.  What drug should be prescribed to the patient? 
A. Platyphylline. 
B. Proserinum. 
C. Adrenaline. 
D. Pilocarpine. 
E. Propranolol (anaprilinum). 
35. A victim with acute poisoning by fly-agaric was delivered to an 
urgent department. What drug should be prescribed to him? 
A. Omeprazole. 
B. Dithylinum. 
C. Diazolinum. 
D. Furacilinum. 
E. Atropine sulfate. 
36. The agent which decreases intraocular pressure is prescribed to 
a patient with glaucoma. Indicate this agent. 
A. Proserinum. 
B. Penicillin. 
C. Noradrenaline. 
D. Phenazepam.  
E. Analginum. 
37. Paralysis of bladder muscles has developed in a patient owing to 
surgery.  What group of drugs should be prescribed to this patient? 
A. Antianginal drugs. 
B. Diuretics. 
C. Antibiotics. 
D. Adrenoblockers. 
E. Cholinesterase inhibitors. 
129 
 
M - C h o l i n o b l o c k i n g  D r u g s   
( M u s c a r i n i c  A n t a g o n i s t s )  
 
These agents selectively block M-cholinergic receptors and prevent 
the acethylcholine action. M-cholinoblocking drugs are classified as 
follows: 
1. Alkaloids: atropine , extract and t incture of Belladonna , 
scopolamine , and platyphyll in . 
2. Synthetic agents: metacinium , ipratropium bromide  
(Atrovent), pirenzepine  (Gastrocepine ), homatropine , and 
tropicamide . 
Natural muscarinic antagonists are used for millennia as medicines and 
cosmetics. For example, inhabitants of Ancient India used Mandrake root 
containing scopolamine for analgesia during operation.  
Besides scopolamine, atropine (hyoscyamine) and platyphyllin are 
alkaloids of natural origin. Atropine is contained in the plant Atropa 
belladonna (deadly nightshade) and in Datura Stramonium (jimsonweed or 
thorn apple). Platyphyllin is alkaloid of plants of genus Senecio. 
All drugs, except pirenzepine block all subfamilies of  
M-cholinoceptors (M1, M2, M3, M4, and M5). Pirenzepine is selective  
M1-cholinergic antagonist.  
Ancestor of M-cholinergic antagonists is atropine . It is racemic 
mixture of d-hyoscyamine (dextrorotatory isomer) and l-hyoscyamine 
(laevorotatory isomer). The l-isomer of atropine is significantly more 
potent pharmacological agent than d-isomer. The peripheral effects 
predominantly occur due to the action of l-isomer. Effects of atropine in the 
central nervous system are the result of d-isomer action.  
Atropine interacts with anionic site of M-cholinergic receptor. A very 
high distance between nitrogen atom and ester bond in atropine molecule 
interfere the binding of atropine to esterase site of receptor. Due to this, the 
interaction between acetylcholine and receptor becomes impossible. The 
affinity of atropine to M-cholinergic receptors is 1 000 times more than 
acetylcholine affinity. A molecule of atropine prevents the stimulation of 
4 receptors by acetylcholine. Therefore, the antagonism between atropine 
and acetylcholine has one-way character.  
When low doses of atropine are administered, the short-term phase of 
stimulation of postsynaptic M-cholinergic receptors precedes the phase of 
their blockade. This short-term excitation develops owing to the blockade 
of the presynaptic M2-cholinergic receptors that leads to the increase of 
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acetylcholine release into the synaptic cleft. Thus, administration of a low 
dose of atropine often results in initial short-time bradycardia.   
Atropine in therapeutic doses does not affect N-cholinoceptors. Their 
blockage is possible only due to the administration of high doses of 
atropine.      
The following effects are observed after administration of therapeutic 
doses of atropine.  
Сardiovascular system. The sinoatrial node is very sensitive to the 
action of M-cholinergic antagonists and atropine administration results in 
tachycardia. But, as mentioned above, the low dose of atropine can cause 
the initial bradycardia due to initial blockage of presynaptic  
M2-cholinoceptors. The degree of tachycardia depends on the atropine dose 
and initial vagal tone. Children and old patients commonly have the natural 
high heart rate, therefore they do not exhibit appreciable tachycardia due to 
administration of muscarinic antagonists. Most marked tachycardia is 
observed in age group from 17 to 22 years.  
Also, atropine significantly facilitates the conduction through 
atrioventricular node and reduces the PR interval of the ECG. Atropine 
improves coronary circulation, but it does not compensate the sharply 
increased oxygen demand of the heart.  
Respiratory system. Administration of antimuscarinic agents causes 
the bronchodilation and reduces the secretion of bronchial glands owing to 
the blockage of M3-cholinergic receptors. It is necessary to note, that  
M-blockers are more effective in bronchospasm that is caused by 
cholinesterase inhibitors or directly-acting M-cholinomimetics. In treatment 
of bronchial asthma, the therapeutic effect of antimuscarinic agents is less 
than effect of adrenomimetics. 
M-cholinoblockering drugs are commonly used before the 
administration of inhalant anesthetics to reduce the accumulation of 
secretions in the trachea and the possibility of laryngospasm.   
Gastrointestinal tract. The muscarinic antagonists exhibit the 
antispasmodic action upon the gastrointestinal tract. Both tone and motility 
of gastrointestinal tract are decreased. The gastric emptying time is 
prolonged, and intestinal transit time is lengthened. Therefore, atropine is 
contraindicated in patients with tendency to intestinal paresis and with 
paralytic ileus. M-cholinergic antagonists also decrease the tone of the 
gallbladder and sphincters of bile ducts. It results in the increase of bile 
discharge into intestine. Muscarinic antagonists significantly reduce the 
salivary secretion (dry mouth). Gastric secretion is decreased in less degree. 
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Basal secretion is blocked more effectively than that stimulated by food, 
nicotine, or alcohol. M-cholinergic antagonists insignificantly reduce the 
pancreatic and intestinal secretions because these processes are mainly 
under hormonal control then under vagal influence.       
Urogenital tract. M-cholinergic antagonists relax the smooth muscles 
of the urinary tract and bladder wall and slow voiding. This action is useful 
in the treatment of spastic conditions of urinary tract which can be induced 
by inflammation, urolithiasis, and surgery. But M-cholinergic antagonists 
can increase the urinary retention in patients with prostatic hyperplasia. 
Also, these drugs decrease the tone of uterus neck, but have no significant 
effect on the uterus.  
Sweat glands. M-cholinergic antagonists suppress the sweating due to 
the blockage of M3-cholinergic receptors of sweat glands receving 
sympathetic cholinergic innervation. In adults, only large doses of atropine 
cause the increase of body temperature. But in infants and children even 
mean therapeutic doses may cause the so-called “atropine fever”.  
Eye. The effects of M-cholinergic antagonists in the eye are opposite 
to effects of muscarinic agonists. Antimuscarinic drugs block the  
M-cholinergic receptors of the iris sphincter muscle and cause the 
mydriasis. The blockage of M-cholinergic receptors of ciliary muscle 
results in cycloplegia (paralysis of accommodation). Curvature of lens is 
reduced, and eye cannot focus for near vision. Owing to mydriasis and 
cycloplegia, the outflow of the aqueous humor from the anterior chamber is 
worsened. It can provoke the elevation of intraocular pressure. 
Central nervous system. The therapeutic doses of atropine exhibit 
insignificant stimulative effect in the central nervous system. High doses of 
atropine markedly stimulate the brain cortex and cause the motor and 
verbal agitation. Central effects of scopolamine significantly differ from the 
effects of atropine. Therapeutic doses of scopolamine produce the sedation, 
drowsiness, inhibition of extrapyramidal system, and affect the impulse 
transmission from the pyramidal passways to the motoneurons of spinal 
cord.  Scopolamine reduces the tremor in patients with Parkinson’s disease. 
Also, scopolamine prevents or eliminates the vestibular disturbances that 
developed after operation on the inner ear or in patients with kinetosis 
(motion sickness). 
M-cholinoblockers differ in their degree of influence upon different 
inner organs. Atrovent, metacinium, and atropine cause most marked 
bronchodilation. Platyphyllin and scopolamine have less influence upon the 
tone of smooth muscles of bronchi. The antispasmodic action upon the 
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smooth muscles of intestine, biliferous and urinary tracts is more marked in 
scopolamine, atropine, and metacinium than in platyphyllin. But, 
additionally to M-choliblocking action, platyphyllin has direct 
antispasmodic action. Also, platyphyllin blocks the ganglia and suppresses 
the vasomotor centre. The action of scopolamine upon the eye and glands’ 
secretion is more potent than action of atropine. But duration of 
scopolamine’s effects is less. Atropine has the longest effects upon the eye.  
Metacinium is synthetic agent containing tertiary atom of nitrogen. 
Therefore, metacinium acts only upon peripheral M-cholinergic receptors.  
Ipratropium bromide is polar water-soluble synthetic agent used only 
as inhalations in patients with bronchial asthma.  
Pirenzepine (Gastrozepin) is used in the treatment of peptic ulcers. 
This drug reduces gastric secretion of hydrochloric acid and decreases the 
smooth muscle spasm. 
Synthetic agent homatropine is used only in ophthalmology.  
The muscarinic antagonists with predominantly blocking action upon 
central M-cholinergic receptors (such as amizyl, benztropine mesylate) also 
are used in medical practice.  
There are the following indications for the use of M-cholinolytics:  
1. Atropine, metacinium, and scopolamine are used as preanesthetic 
agents (for so-called premedication). An administration of these agents 
prior to inhalant anesthetics decreases the accumulation of secretions in the 
trachea, reduces the possibility of laryngospasm, and prevents reflexive 
heart arrest. 
2. M-blockering drugs (atropine, metacinium, ipratropium, and 
tiotropium) are used to treat bronchial asthma and chronic obstructive 
pulmonary disease (a condition that occurs with higher frequency in older 
patients, particularly chronic smokers).  
3. Atropine and Belladonna-containing drugs are used to treat 
bradiarrhythmias owing to disturbances of atrioventricular conduction or in 
marked sinus bradycardia, including arising in initial stage of myocardial 
infarction.  
4. Atropine, plathyphyllin, metacinium, and Belladonna-containing 
drugs (such as tincture or extract of Belladonna) are used to treat spasms of 
smooth muscles of intestine, urinary and biliferous tracts. These agents are 
administered parenterally in the treatment for urinary or biliary colics. 
Antimuscarinic agents are also used in patients with diarrhea (especially in 
traveler’s diarrhea).  
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5. Nowadays, non-selective M-cholinergic antagonists are rarely used 
in the treatment for hyperacid gastritis and ulcer disease of stomach and 
duodenum. Selective M1-antagonist pirenzepine (orally or parenterally) is 
preferable in the therapy of these diseases.  
6. Scopolamine and central antimuscarinic agents (such as amizyl and 
metamizyl) are used in Parkinson’s disease.  
7. Scopolamine is one of the oldest agents used to treat motion 
sickness. It can be administered in injections, taken orally (tablets 
“Aeron”), or applied to the skin in the form of transdermal patch. The 
longest action is typical for a patch – from 48 to 72 hours.  
8. M-cholinergic antagonists are widely used in ophthalmology with 
diagnostic and therapeutic aims: to examine eye fundus, select spectacles, 
to treat iridocyclitis and eye trauma. At inflammation of iris, the local use 
of M-cholinergic antagonists prevents the adhesion of the iris with lens 
capsule. The duration of eye effects of atropine lasts up to 7–10 days. 
Effects of scopolamine last from 3 to 7 days; eye effects of homatropine – 
1–3 days; the action of tropicamide is about 6 hours.  
9. Atropine is used in medical emergency for treatment of patients 
poisoned by cholinesterase inhibitors or muscarine. 
10. Central M-cholinergic antagonists (metamizyl) reduce the intensity 
of brain oedema in patients with cranial traumas. The positive effect of 
metamizyl is observed also in children with motor disordes arising due to 
birth injures.   
Treatment with M-blockering agents directed at the certain organ 
frequently induces undesirable effects in other organs. Thus, administration 
of antimuscarinic agents can result in dry mouth, cycloplegia, mydriasis, 
increase of intraocular pressure, tachycardia, obstipation, and urinary 
retention.  
Muscarinic antagonists are contraindicated in patients with glaucoma, 
severe heart lesions (danger of myocardial exhaustion owing to 
tachycardia), prostatic hyperplasia, dismenorrhea, ulcerative gingivitis, and 
stomatitis.  
Poisoning by M-cholinergic antagonists is occurred as a result of 
attempted suicide, inadvertent eating of Belladonna’s berries by children, or 
due to attempts to induce hallucinations. The initial symptoms arise in  
2–3 hours after poisoning and include the dry mouth, mydriasis, 
tachycardia, and hot and dry skin. After that, the central symptoms occur: 
motor and verbal agitation, hallucinations, seizures, and delirium. The body 
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temperature is rising. It should be noticed that children, especially infants, 
are very sensitive to the hyperthermic effect of atropine. 
The lethal dose of atropine for adults is 150–200 mg (but sometimes 
administration of over 400 mg has been followed by recovery). In children, 
10–15 mg of administered atropine can result in the death.  
Poisoning by atropine is generally treated symptomatically: gastric 
lavage with absorbents, administration of saline laxative drugs, intravenous 
plasma-substitutive drugs, and temperature control with cooling blankets. 
Diazepam is used to cessate marked psychomotor agitation. β-adrenergic 
antagonists (propranolol) are used to reduce tachycardia. Parenteral 
administration of proserinum (neostigmine) partly relieves the peripheral 
effects of M-blockers. The prognosis is favorable if a child remains alive 
during 36–48 hours.  
 
Table 8 – Drugs for prescription 
 
 
Drug name 
(Latin) 
Single dose and route  
of administration 
Drug product 
1 2 3 
Atropini sulfas Orally 0.00025–0.0005 g  
1–3 times a day; 
subcutaneously or 
intramuscularly 0.00025–
0.0005 g 1–2 times a day; 
intravenously 0.00025–
0.0005 g; 
in the eye: 1 % ointment or  
1–2 drops of 0.5–1 % 
solution (once a day) 
Tablets 0.0005 g; 
 
ampoules 1 ml of 0.1 % 
solution; 
 
 
 
0.5 % or 1 % solution of eye 
drops;  
1 % eye ointment 
Extractum 
Belladonnae 
siccum 
Orally 0.02–0.04 g 2–3 times 
a day; 
rectally 0.02–0.04 g 1–2 
times a day 
Powders for internal use; 
 
suppositories 0.02 or 0.04 g 
Scopolamini 
hydrobromidum 
Orally or subcutaneously 
0.00025 g; 
 
in the eye: 1–2 drops of 
0.25 % solution 1–2 times  
a day 
 
Powders for internal use; 
ampoules 1 ml of 0.05 % 
solution; 
0.25 % ophthalmic solution  
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Continuation of the table 8 
1 2 3 
Platyphyllini 
hydrotartras 
Orally 0.003–0.005 g 2–3 
times a day; 
subcutaneously 0.002–0.004 
g 1–2 times a day; 
in the eye: 1–2 drops of  
1–2 % solution 
Tablets 0.005 g; 
 
ampoules 1 ml of 0.2 % 
solution; 
1 % or 2 % solution of eye 
drops  
Methacinum Orally 0.002–0.004 g 2–3 
times a day; 
subcutaneously, 
intramuscularly or 
intravenously 0.0005–0.001 
g 1–2 times a day 
Tablets 0.002 g; 
 
ampoules 1 ml of  0.1 % 
solution 
Aeronum Orally 1–2 tablets prior or 
during travel (for treatment 
or prevention of motion 
sickness) 
Tablets containing 
scopolamine 0.0001 g of and 
0.0004 g of hyoscyamine (10 
tablets in packing)  
 
Step 1. Tasks for Self -Control  
M-Cholinoblocking Drugs  (Muscarinic Antagonists)  
 
1. Laryngospasm and hypersalivation have developed in a patient after 
introduction of thiopental sodium for initial anaesthesia. The previous 
introduction of what drug can prevent the development of these side 
effects? 
A. Epinephrine hydrochloride. 
B. Proserinum. 
C. Alloxime. 
D. Pirroxane. 
E. Atropine sulfate. 
2. A patient was delivered to an emergency department with poisoning 
by mushrooms, among which fly-agaric has casually appeared. The 
injection of atropine sulfate was prescribed to the patient as well as the 
gastric lavage, active carbon, saline laxative drugs, and infusion therapy. 
Name a type of interaction between the atropine and muscarine.   
A. Physicochemical antagonism. 
B. Direct functional one-way antagonism. 
C. Indirect functional antagonism. 
D. Intermediary antagonism. 
E. Chemical antagonism. 
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3. Nausea, vomiting, diarrhea, and twitching of skeletal muscles 
developed in a patient with myasthenia after administration of proserinum. 
What drug can eliminate these symptoms?  
A. Phenylephrine (mesatonum). 
B. Physostigmine. 
C. Atropine. 
D. Pyridostigmine bromide. 
E. Isoprenaline (isadrinum). 
4. As a rule, the attacks of bronchial asthma develop in a patient at 
night, and are accompanied by bradycardia, spastic pain of intestine, and 
diarrhea. What group of drugs can eliminate these symptoms? 
A. Sympatholytics. 
B. N-cholinoblockers and blockers of H2-histamine receptors. 
C. M-cholinoblockers. 
D. -Adrenoblockers. 
E. -Adrenoblockers. 
5. It is necessary to expand the pupils for examination of the eye 
fundus. Call the drug, which is used for this purpose in a clinic.  
A. Acetylcholine. 
B. Atropine. 
C. Pilocarpine. 
D. Mesatonum. 
E. Adrenaline. 
6. The drugs of this group are used to decrease salivary glands 
secretion, prevention of laryngospasm, nausea, and bradycardia. Call this 
group. 
A. Cholinesterase regenerators. 
B. Myorelaxants. 
C. M-cholinomimetics. 
D. Inhibitors of cholinesterase. 
E. M-cholinoblockers. 
7. Bronchospasm has developed in a worker owing to the careless use 
of organophosphorus substances. What broncholytic should be used in this 
situation? 
A. Ephedrine. 
B. Atropine. 
C. Berotec (fenoterol). 
D. Aminophylline (euphyllinum). 
E. Adrenaline. 
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8. Atropine is used as antidote in case of poisoning with fly-agaric 
mushrooms. What is the mechanism of atropine action, which causes the 
elimination of toxic effects of muscarine? 
A. Competition for the same receptors. 
B. Enzymatic. 
C. Physico-chemical. 
D. Anti-enzymatic. 
E. Metabolic. 
9. A 48-year-old male was delivered to a urologic department with 
symptoms of renal colic. Choose a drug which is the most rational in this 
case. 
A. Fentanyl. 
B. Atropine. 
C. Morphine. 
D. Metamizole (analginum). 
E. Trimeperidine (promedol). 
10. The decrease of salivation and expansion of pupils are developed in 
an experimental animal after introduction of a drug X. After the following 
intravenous administration of acetylcholine, the heart rate has not changed. 
Call the drug X. 
A. Atropine. 
B. Salbutamol. 
C. Adrenaline. 
D. Propranolol (anaprilinum).  
E. Proserinum. 
11. A female with glaucoma asked the pharmacist with the request to 
give her out the eye drops with atropine sulfate. But the pharmacist has 
explained her that this drug is contraindicated to her. Why atropine is 
contraindicated at glaucoma? 
A. It oppresses eye reflexes. 
B. It causes the increase of intraocular pressure. 
C. It causes the paralysis of accommodation. 
D. It causes the expansion of pupils. 
E. It reduces the acuteness of vision. 
12. A patient was delivered to the hospital with the following 
symptoms: dizziness, thirst, impairment of swallowing, bad vision of near 
subjects. The patient has tachypnoea, dilated pupils, and excitement. The 
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blood pressure is 110/70 mm Hg, heart rate is 110 per 1 minute. These 
symptoms testify the overdose of: 
A. Caffeine. 
B. Morphine. 
C. Ephedrine. 
D. Atropine. 
E. Aminazine (chlorpromazine). 
13. Mydriasis and paralysis of accommodation have developed in 
a patient after instilling into eyes the solution of a drug X. Call the group, to 
which the drug X is referred. 
A. -Adrenomimetics. 
B. M-cholinomimetics. 
C. Cholinesterase inhibitors. 
D. -Adrenomimetics. 
E. M-cholinoblockers. 
14. A patient, who receives the treatment concerning bronchial asthma, 
also suffers from glaucoma. The drugs of which group are not 
recommended to this patient for treatment of asthma? 
A. Adrenoblockers. 
B. Adrenomimetics. 
C. M-cholinoblockers. 
D. Miotropic spasmolytics. 
E. Glucocorticoids. 
15. Atropine sulfate was prescribed to a patient for interruption of 
intestine colic. What disease is the contraindication for administration of 
atropine? 
A. Dizziness. 
B. Glaucoma. 
C. Bronchial asthma. 
D. Node tachycardia. 
E. Hypotension. 
16. A 6-year-old child was delivered to a hospital with markedly 
expressed symptoms of psychomotor excitement, impairment of 
swallowing, and hoarse voice. The skin is dry and hot. The pupils are 
dilated. Tachycardia is observed. The doctor established, that the child had 
taken some berries of dark-violet colour. What substance is the cause of 
poisoning? 
A. Metacinium. 
B. Pirenzepine. 
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C. Pilocarpine. 
D. Platyphylline. 
E. Atropine. 
17. It is necessary to prescribe M-cholinoblocker for a patient who 
suffers from ulcer disease of stomach (with hyperacidic syndrome) and 
glaucoma. What drug may be prescribed to this patient? 
A. Metacinium. 
B. Homatropine. 
C. Adiphenine (spasmolytinum).  
D. Atropine. 
E. Scopolamine. 
18. The increase of heart rate, mydriasis, and significant dryness of 
mucous membranes have developed in a patient after introduction of 
atropine. What drug should be prescribed to the patient for reduction of 
these symptoms? 
A. Strophanthin. 
B. Metacinium. 
C. Proserinum. 
D. Salbutamol. 
E. Ephedrine hydrochloride. 
19. A 40-year-old male was delivered to the hospital with acute attack 
of hepatic colic, which is accompanied by sharp pain. What drug should be 
introduced first? 
A. Morphine.  
B. Codeine. 
C. Metamizole (analginum).  
D. Pentazocine. 
E. Atropine. 
20. A patient with complaints of dryness in the mouth, photophobia, 
and vision disorders was admitted to the reception-room. Skin is hyperemic 
and dry, pupils are dilated, tachycardia. Poisoning with Belladonna 
alkaloids was diagnosed at further examination. What drug should be 
prescribed? 
A. Dipyroxime. 
B. Proserinum.  
C. Pilocarpine. 
D. Armine. 
E. Diazepam. 
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21. Pirenzepine was prescribed to a woman for stomach ulcer 
treatment. What pharmacological group can this medication be referred to? 
A. Local anaesthetics. 
B. Acetylcholinesterase reactivators. 
C. -Adrenergic blockers. 
D. Selective 1-adrenergic blockers. 
E. Selective M1-cholinergic antagonists.  
22. A doctor has been appealed to by a man who was preliminary 
examined by an ophthalmologist. The patient complains of thirst and bad 
vision of close subjects. Objectively he demonstrates tachypnoea, mydriatic 
pupils, general excitation, garrulity, though the speech is obscure. Arterial 
pressure is 110/70, pulse is 110 per minute. The overdose of which drug 
can cause these symptoms? 
A. Caffeine sodium benzoate. 
B. Atropine sulfate.  
C. Morphine hydrochloride. 
D. Ephedrine hydrochloride. 
E. Aminazine. 
23. Sharp pain in the eye area of a patient has developed after the use of 
atropine in eye drops during examination of the eye fundus. From 
anamnesis it became clear that the patient suffered from the mild form of 
glaucoma. Why atropine is contraindicative at glaucoma? 
A. Atropine oppresses eye reflexes. 
B. Atropine causes paralysis of accommodation. 
C. Atropine narrows pupils. 
D. Atropine increases intraocular pressure. 
E. Atropine affects vision. 
24. The victim with acute poisoning by fly-agaric was delivered to an 
urgent department. What drug should be prescribed to him? 
A. Atropine sulfate. 
B. Omeprazole. 
C. Dithylinum. 
D. Diazolinum. 
E. Furacilinum. 
25. Proserinum has been administered to a patient suffering from 
myasthenia. After its administration the patient has got nausea, diarrhea, 
twitch of tongue and skeletal muscles. What drug would help to eliminate 
the intoxication? 
A. Physostigmine. 
B. Mesatonum. 
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C. Pyridostigmine bromide. 
D. Isadrinum. 
E. Atropine sulfate. 
26. A patient with drug intoxication is presented with the dryness of 
oral mucous membrane and mydriatic pupils. Such action of this drug is 
associated with the following effect: 
A. Blockage of adrenoceptors. 
B. Blockage of muscarinergic receptors. 
C. Stimulation of nicotinergic receptors. 
D. Stimulation of adrenoceptors. 
E. Stimulation of muscarinergic receptors. 
 
N-Cholinoblocking Drugs 
 
N-cholinoblockers are divided into two main groups depending on the 
subfamily of N-cholinergic receptors blocked by these agents: ganglionic 
blockers (ganglioplegic drugs) and peripheral myorelaxants. Also, there 
exists a group of both M- and N-cholinoblockers.  
 
Ganglionic Blockers (Ganglioplegic  Drugs) 
 
Ganglionic blocking agents interact and competitively block the  
Nn-cholinergic receptors of sympathetic and parasympathetic ganglia, 
adrenal medulla, and carotid bodies. The lipophilic agents penetrate 
through the blood-brain barrier and block the centrally located  
Nn-cholinoceptors.  
The ganglionic blockers are classified depending on the duration of 
action: 
1. Drugs with short action (duration of action is 15–26 minutes):  
– arfonade (trimethaphan); 
– hygronium (trepirium). 
2. Drugs with intermediate duration of action: 
– benzohexonium (hexamethonium)  (duration of action is  
2–4 hours); 
– pentaminum (azamethonium)  (duration of action is 1–2 hours); 
– pachycarpine  (duration of action is 6–8 hours). 
3. Drugs with long action (duration of action is 8–12 hours): 
– pirilenum (pempidine) . 
 
Only two drugs of this group, pachycarpine and pirilenum, have the 
tertiary atom of nitrogen in their molecules and can penetrate the brain. All 
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other ganglionic blockers are quaternary ammonium compounds and have 
no central effects.      
A blockade of both sympathetic and parasympathetic ganglia leads to 
condition that is called “pharmacological denervation” of inner organs. In 
this situation, the initial neuronal control of the activity of inner organs is 
significantly decreased or lost.   
Especially essential changes are observed in activity of the cardio-
vascular system. The ganglionic blockers markedly decrease the blood 
pressure. The vessels extend, because the entering of vessel-narrowing 
reflexes through sympathetic ganglia is blocked by the drug. It should be 
noticed that the dilation of arterioles and small arteries is more expressed 
than dilation of the venules. The blood is accumulated in a lower part of the 
trunk. Blood-filling of a small circle of circulation and pressure in it are 
decreased. Both preload and afterload upon the left ventricle are decreased 
due to the reduction of blood venous return and peripheral vascular 
resistance. Ganglionic blockers have no direct depressive influence upon 
myocardium. The cardio-vascular reflexes, including pathological (for 
example, in myocardial infarction, surgical trauma), are blocked. In patients 
with hemorrhage, the inhibition of compensatory reflexes can cause the 
dangerous drop of blood pressure. The decrease of systolic blood pressure 
lower than 80–70 mm Hg leads to hypoxia of the brain and heart. The 
blockade of Nn-cholinoceptors of adrenal medulla results in the reduction 
of adrenaline secretion. It also promotes hypotension and weakening of 
compensatory vascular reflexes.  
A blockade of both sympathetic and parasympathetic ganglia causes 
the decrease of gastrointestinal secretion and motility. This property of 
ganglionic blockers can be used in the treatment for ulcer disease of 
stomach and duodenum. But a possibility of dangerous hypotension 
significantly restricts their use for this purpose. On the other hand, during 
long-time treatment of hypertension by ganglionic blockers, the blockade 
of parasympathetic ganglia of intestine can lead to the serious constipations 
that poorly respond to the therapy.         
Some ganglionic blockers (e. g., pachycarpine) stimulate the uterine 
contraction activity due to the blockade of inferior mesenteric ganglion and 
direct action upon uterus. Also, ganglionic blockers stimulate the posterior 
pituitary and sensitize the myometrium to action of oxytocin and folliculin. 
Therefore, pachycarpine may be used to stimulate the parturition. 
The serious complication of ganglionic blockers is expressed 
hypotension. These drugs inhibit the vascular reflexes regulating the blood 
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redistribution at changes of body position. It is a result of blockage of both 
sympathetic ganglia and adrenal medulla. Blood is accumulated in vessels 
of lower part of the body. An acute dropping of cerebral circulation owing 
to the change of body position (from horizontal to vertical) can result in 
orthostatic collapse. For prevention of collapse, a patient should lay during 
2 hours after administration of ganglionic blocker. Prolonged hypotension 
can result in serious complications, such as appearance of locus of brain 
necrosis, myocardial infarction, thrombosis of coronary, cerebral, and 
retinal vessels, and kidney failure.        
The symptoms of overdose of ganglionic blockers are rather 
characteristic: frequent thread-like pulse, low blood pressure, mydriatic 
pupils that do not react to the light, warm and dry skin, and dizziness.  
The collapse requires urgent care directed to restoration of the blood 
pressure. It is significant, that under ganglionic blockade vascular smooth 
muscles retain the ability to react upon the vasoconstrictive agents acting 
lower than ganglia. Moreover, in this case, the sensitivity of vessel walls to 
such vasoconstrictors is increased. Therefore, in case of overdose of 
ganglionic blockers, adrenomimetic agent (noradrenaline, mesatonum, or 
ephedrine) is administered intravenously. If intravenous administration is 
impossible, mesatonum or ephedrine is administered intramuscularly every 
1–1.5 hours until stabilization of blood pressure.  
There are the following therapeutic indications for ganglionic 
blockers: 
1. Controlled hypotension. The agents with short duration of action 
(arfonade and hygronium) are preferable for this purpose. Controlled 
hypotension is the temporally decrease of blood pressure (to 70–80 mmHg) 
which is widely used in surgical practice. Controlled hypotension together 
with elevation of the operated body area creates the favorable conditions 
for surgeon work and decreases the bleeding. Controlled hypotension is 
used during extensive and traumatic surgical operations on the brain, pelvic 
organs, vessels, etc. Ganglion blocker is administered intravenously drop-
by-drop monitoring the blood pressure. 
2. Acute edema of the brain or lungs. Hygronium, arfonade, 
benzohexonium, or pentaminum are administered intravenously monitoring 
the blood pressure. 
3. Urgent care for patients with hypertensive crisis (pentaminum or 
benzohexonium is administered intravenously or intramuscularly).   
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4. Treatment of severe forms of hypertensive disease. It should be 
noticed that presently ganglionic blockers are rarely used for this aim. 
Sometimes, pirilenum is prescribed for inpatients. 
5. Treatment of obliterating endarteritis and Raynaud’s disease.  
6. Pharmacological management of ulcer disease of stomach and 
duodenum (but nowadays ganglionic blockers are not used almost for this 
aim). 
7. Very seldom, pachycarpine is used to stimulate parturition.        
Ganglionic blockers are contraindicated for patients with diseases at 
which the significant drop of blood pressure can provoke the dangerous 
complications: 
– hypotension of different origin; 
– ischemic stroke; 
– coronary insufficiency; 
– disturbances of renal or hepatic function; 
– atherosclerosis; 
– glaucoma.  
 
Peripheral Myorelaxants  
 
Peripheral myorelaxants selectively block postsynaptic Nm-cholinergic 
receptors of skeletal muscles (including respiratory) that leads to muscular 
relaxation. 
An ancestor of this group is the poison “curare” – a mixture of extracts 
from different kinds of South American plant Strychnos. 
Skeletal muscles of a human body are characterized by different 
sensitivity to myorelaxant action. The majority of agents block, first and 
foremost, neuromuscular synapses of the face and neck; after that – 
extremities and trunk. The respiratory muscles are more resistant to 
myorelaxantaction. The last thing, paralysis of diaphragm occurs which 
leads to the stop of breathing. 
The wide use of myorelaxants in surgical practice began in 1942, 
when Canadian anesthesiologists Griffith and Johnson proved the 
possibility of big surgical operations under the light anaesthesia on the 
background of myorelaxation caused by curare. Nowadays, the meaning of 
myorelaxants in anesthesiology is extremely great. 
Chemically, all myorelaxants are quaternary ammonium compounds 
and do not penetrate through the blood-brain barrier. 
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Depending on the mechanism of action, myorelaxants are classified as 
follows: 
1. Nondepolarizing myorelaxants (duration of action is 20– 
50 minutes): 
– tubocurarine; 
– pipecuronium; 
– pancuronium; 
– alcuronium; 
– atracurium;  
– vecuronium. 
2. Depolarizing myorelaxants (duration of action is 5–10 minutes): 
– dithylinum  (suxamethonium). 
3. Mixed-action myorelaxants:  
– dioxonium  (duration of action is 20–40 minutes).  
     
Nondepolarizing Myorelaxants  
 
These agents compete with acetylcholine for binding with  
Nm-cholinergic receptors and prevent the neurotransmitter action. Owing to 
this, the depolarization becomes impossible. The chemical structure of non-
depolarizing myorelaxants significantly differs from the structure of 
acetylcholine. The large molecules of non-depolarizing agents relatively 
weakly bind to Nm-cholinergic receptors and do not penetrate inside of 
muscular fibers. The binding of these molecules with cholinergic receptors 
is reversible. When a concentration of acetylcholine in synapses is 
increased (e. g., in inhibition of cholinesterase by proserinum), the mediator 
displaces the molecules of myorelaxant from receptors. This results in 
restoration of neuromuscular transmission. 
Nondepolarizing myorelaxants act 20–50 minutes. A repeated 
administration of nondepolarizing myorelaxants prolongs the duration of  
a drug action due to cumulation. These agents are used at long-time 
surgical operations and in the treatment for tetanus. The administration of 
myorelaxants causes the complete relaxation of skeletal muscles that 
provides the favorable conditions for surgeon’s work and prevents the 
motor reaction to the surgery trauma. Thus, myorelaxant administration 
allows to perform surgical operation under the light anaesthesia that allows 
to avoid the complications of deep narcosis.    
Myorelaxant administration is especially indicated if the disturbances 
of breathing are very probable during operation (e. g., intrathoracic 
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surgery). In this case, myorelaxants create the necessary conditions for 
artificial ventilation.  
It should be noticed that the selectivity of competitive myorelaxants to 
Nm-cholinergic receptors is relative. At fast drug administration or at 
administration of a large dose, these agents can cause the temporary 
blockade of Nn-cholinergic receptors of parasympathetic and sympathetic 
ganglia, adrenal medulla, and chemoreceptors of vessels. It can cause the 
decrease of blood pressure. Also, tubocurarine and, to a lesser extent, 
atracurium, can produce hypotension due to systemic histamine release. 
Myorelaxants do not directly suppress the myocardium and practically do 
not influence the central nervous system. Non-depolarizing myorelaxants 
have no direct effect on bronchial smooth muscle, but tubocurarine and 
mivacurium can cause bronchoconstriction due to the stimulation of 
histamine release.      
The action of non-depolarizing myorelaxants can be stopped by 
administration of proserinum (so-called “decurarisation”). For this purpose, 
3–4 ml of 0.05 % proserinum solution is administered intravenously against 
the background of the preliminary intravenous administration of 0.5–1 ml 
of 0.1 % atropine solution. The pre-blockade of M-cholinergic receptors by 
atropine prevents the side effects of proserinum arising in the result of 
indirect stimulation of M-cholinoceptors. 
The nondepolarizing myorelaxants are partly metabolized in the liver 
and excreted through the kidneys. Therefore, the duration of action of non-
depolarizing agents depends on functional activity of these organs. The 
repeated administration of non-depolarizing myorelaxants can result in 
cumulation. 
Presently, such nondepolarizing agent as atracurium  (Tracrium)  
is widely used. Atracurium is partly transformed in inactive metabolites in 
the blood plasma. Therefore, its action does not depend on the liver and 
kidney condition. Atracurium does not cumulate in the human body. The 
action of the drug is stable and easily stopped by proserinum 
administration. Atracurium practically does not cause any side effects. 
 
Depolarizing Myorelaxants  
 
  These agents are structurally like acetylcholine. The molecule of 
dithylinum  (succinylcholine , suxamethonium) consists of two 
molecules of acetylcholine connected by ether binding. Dithylinum excites 
Nm-cholinergic receptors and causes the depolarization of postsynaptic 
membranes. This depolarization is observed as muscular fibrillation. Unlike 
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acetylcholine, dithylinum is not hydrolyzed by acetylcholinesterase. 
Hydrolysis of dithylinum is carried out by butyrylcholinesterase. Due to the 
low speed of hydrolysis, the drug interaction with receptors lasts several 
minutes. It leads to the stable excitation of a cell membrane and its reaction 
upon nervous stimuli becomes impossible. Therefore, dithylinum-induced 
relaxation of skeletal muscles develops after the phase of muscular 
fibrillation.  
The phase of depolarizing blockade caused by dithylinum lasts 3–
10 minutes. If the duration of a surgical operation is longer, dithylinum is 
administered repeatedly. As a result of administration of large doses of 
relaxant (1 g of dithylinum and more) and in patients with myasthenia 
gravis, after a short restoration of nervous-muscular transmission, the 
development of the second phase of blockade is possible. The mechanism 
of this phase isn’t completely known. This second phase of blockade 
develops gradually, can last several hours and leads to the muscular 
weakness and hypoventilation in postsurgical period. Unlike depolarizing 
phase, this second phase is cessated by proserinum.   
The depolarizing agents don’t penetrate through the blood-brain 
barrier. Unlike non-depolarizing myorelaxants, depolarizing agents don’t 
suppress neurotransmission through the vegetative ganglia. Moreover, 
sometimes administration of dithylinum can cause the short-term 
cholinomimetic effects.  
Dithylinum can cause cardiac arrhythmias owing to the release of 
potassium from the skeletal muscles into the blood. Also, dithylinum can 
cause the temporary increase of intraoccular pressure. Muscle pain 
developed due to initial muscular fibrillation is a typical side effect of 
dithylinum.  
There are the following indications for сlinical use of skeletal muscle 
relaxants: 
1. The relaxation of glottis, muscles of pharynx, and muscles of neck 
before the tracheal intubation (dithylinum). 
2. The relaxation of skeletal muscles of a patient during surgical 
operations under the general anaesthesia. It is the main purpose of the use 
of non-depolarizing myorelaxants (tubocurarine, atracurium, etc.) and 
dithylinum (bolus or drop-by-drop intravenous administration).  
3. Myorelaxants are administered to the patients with respiratory 
failure who need the artificial ventilation: patients poisoned by hypnotics, 
tranquilizers, or convulsive poisons (strychnine); patients with serious 
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craniocerebral traumas, insults, brain edema, meningitis, hypoxic coma, 
etc. The drugs with long action are used for this purpose.  
4. The elimination of convulsions in a patient with tetanus, when the 
administration of other anticonvulsive agents (such as diazepam) is 
ineffective. In severe cases, the myorelaxation of a patient is supported 
from 2–3 to 7–10 days.     
5. The reposition of bone fragments and reduction of joint 
dislocations. 
 
M- and N-cholinoblockers  
 
The group of M- and N-cholinoblockers is represented by such drugs 
as aprofene,  spasmolytinum (diphenyltropine),  and fenpiverinium 
bromide . These agents block both M- and N-cholinergic receptors. It 
should be noticed that the ability of these drugs to block  
M-cholinergic receptors is less than ability of M-cholinolytics, and  
N-cholinolytic activity is less than activity of ganglionic blockers. 
Additionally, M- and N-cholinergic antagonists have the moderate 
antispasmodic activity. The following effects of these agents are used 
practically: antispasmodic action, ability to decrease the gastric secretion, 
and ability to dilate the blood vessels. 
The indications for use of M- and N-cholinergic antagonists are as 
follows: 
1. Spasms of smooth muscles of inner organs: spastic colitis, 
pylorospasm, biliary and renal colics.     
2. Ulcer disease of stomach and duodenum (drugs are used seldom). 
3. The obliterating endarteritis, Raynaud’s disease, spasm of coronary 
and cerebral vessels. At these diseases, the most effective drug is aprofene.  
M- and N-cholinoblockers are taken orally 2–4 times a day. Aprofene 
is also administered subcutaneously and intramuscularly.  
Fenpiverinium bromide is commonly used together with pitophenone 
hydrochloride (papaverine-like agent) and analginum (metamizole): 
combined drugs “Baralginum”, “Maxigan”, “Spasmalgonum”, etc.  
An administration of M- and N-cholinoblockers is accompanied by 
dizziness, headache, dryness of mouth, hypotension, vision disturbances 
and other side effects. These drugs are contraindicated in patients with 
glaucoma.  
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Table 9 – Drugs for prescription 
 
 
Drug name 
(Latin) 
Single dose and route  
of administration 
Drug product 
Benzohexonium Orally 0.1–0.2 g 3–6 times 
a day; 
subcutaneously or 
intramuscularly 0.025 g  
1–2 times a day 
Tablets 0.1 g; 
 
ampoules 1 ml of 2.5 % 
solution 
Pirilenum Orally 0.0025–0.005 g  
2–5 times a day 
Tablets 0.005 g 
Pentaminum Intramuscularly 0.05–0.1 g 
2–3 times a day; 
intravenously slowly  
0.01–0.025 g (before the 
administration, a single dose 
is mixed with 20 ml of sterile 
isotonic sodium chloride 
solution or glucose solution) 
Ampoules 1 or 2 ml of 5 % 
solution 
Hygronium Intravenously drop-by-drop 
0.04–0.08 g (as 0.1 % 
solution) 
Ampoules or vials containing 
0.1 g of powder for injection 
Tubocurarini 
chloridum 
Intravenously  
0.0004–0.0005 g/kg 
Ampoules 1 ml of 1.5 % 
solution 
Dithylinum Intravenously  
0.0015–0.002 g/kg 
Ampoules 5 or 10 ml of 2 % 
solution 
 
Step 1.  Tasks for Self -Control  
N-Cholinoblocking Drugs  
 
1. The breathing does not restore more than 30 minutes after 
introduction of suxamethonium (dithylinum) to a patient for performing 
a short operation. What is the aid for this patient?   
A. Forced diuresis.   
B. Hemodialysis. 
C. Hemosorption. 
D. Blood transfusion.  
E. Peritoneal dialysis. 
2. A patient with fracture of the bottom jaw was delivered to the 
hospital. The myorelaxant was introduced to him for performing 
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an operation. The short-term twitching of face muscles was observed after 
the drug introduction. What drug was introduced to the patient? 
A. Mellictinum. 
B. Tubocurarine chloride. 
C. Pipecuronium.  
D. Diazepam. 
E. Suxamethonium (dithylinum). 
3. The symptoms of overdose of dithylinum have appeared in a patient 
during operation. What measure can decrease these symptoms?  
A. N-cholinoblockers. 
B. Introduction of cholinesterase inhibitors. 
C. Blood transfusion. 
D. Ganglion blockers. 
E. M-cholinoblockers. 
4. The stopping of breathing had developed in a 42-year-old woman 
after operation on a kidney with the use of dithylinum. Choose the drug 
which can restore the muscles tone.  
A. Blood plasma. 
B. Galantamine. 
C. Proserinum. 
D. Strychnine nitrate. 
E. Caffeine. 
5. The curare-like drugs (myorelaxants) are used in clinic for 
decreasing or stopping impulse transmission from motor nerve endings to 
muscular cells. What is the mechanism of action of these drugs? 
A. Decrease of mediator releasing in a synaptic cleft. 
B. Blockade of Ca
2+
 moving through channels of postsynaptic 
membrane. 
C. Inhibition of Na
+
, K
+
-ATPase activity. 
D. Inhibition of acetylcholinesterase. 
E. Blockade of N-cholinoceptors of postsynaptic membrane. 
6. The breathing of a patient is not restored after ending of operation 
with reposition of a fractured bone of the hip. What drug should be 
introduced to the patient for elimination of relaxation? 
A. Aceclidine. 
B. Platyphylline. 
C. Proserinum. 
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D. Cyclodol. 
E. Atropine. 
7. A patient with dislocation of a glenohumeral joint was delivered to 
a hospital. For relaxation of skeletal muscles, the doctor introduced 
dithylinum to him. In the norm this drug acts during 5–7 minutes. But in 
this patient the drug action lasted for 8 hours. What is probable cause of 
this phenomenon? 
A. Potentiation of effect by another drug. 
B. Decrease of microsomal enzymes activity. 
C. Decrease of drug excretion. 
D. Material cumulation. 
E. Hereditary insufficiency of blood cholinesterase.  
8. It is necessary to prescribe the myorelaxation short-acting drug to 
a patient for reposition of the fractured bone of the hip. Choose the drug. 
A. Mellictinum. 
B. Arduan. 
C. Tubocurarine. 
D. Suxamethonium (dithylinum). 
E. Decametonium. 
9. The operation with the use of tubocurarine was performed to 
a patient with abdominal wound. In the end of operation after restoration of 
breathing, the doctor has administered gentamycin to the patient. But 
unexpectedly the breathing stopped, and skeletal muscles relaxed. What 
effect is the base of this phenomenon? 
A. Sensitization. 
B. Potentiation. 
C. Cumulation. 
D. Tolerance. 
E. Antagonism. 
10. The relaxation of skeletal muscles and inhibition of breathing have 
lasted more than 2 hours in a patient in the result of introduction of 
dithylinum. Indicate the enzyme, insufficiency of which in plasma is the 
cause of this phenomenon. 
A. Glutathione peroxidase. 
B. Butyrylcholinesterase. 
C. Catalase. 
D. Acetylcholinesterase. 
E. Glucose-6-phosphate dehydrogenase. 
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11. The introduction of dithylinum to a patient with dislocation of a 
glenohumeral joint has caused the apnea. The doctor introduced proserinum 
to the patient, but breathing is not restored. What substance should be 
introduced to this patient? 
A. Atropine. 
B. Galantamine. 
C. Dipyroxime. 
D. Isonitrosine. 
E. Blood. 
12. Myorelaxant was introduced to a patient for relaxation of skeletal 
muscles before repositioning of the bone fracture. This introduction caused 
the respiratory arrest. After the introduction of fresh blood, the breathing 
has restored. Call the myorelaxant, which was introduced to the patient. 
A. Pancuronium. 
B. Dithylinum. 
C. Diplacinum. 
D. Tubocurarine chloride. 
E. Pipecuronium. 
13. The signs of tubocurarine overdose have arisen in a patient after 
operation. What drug group should be introduced to the patient for 
elimination of overdose? 
A. N-cholinoblockers. 
B. Ganglion blockers. 
C. Adrenomimetics. 
D. Cholinesterase inhibitors. 
E. M-cholinoblockers. 
14. Dithylinum (Lystenon) was introduced for tracheal intubation. 
After the end of operation the breathing did not restore. What enzyme 
insufficiency is the cause of this phenomenon? 
A. K, Na-ANPase. 
B. Butyrylcholinesterase. 
C. Succinate dehydrogenase.   
D. Carbonic anhydrase. 
E. N-acetyltransferase. 
15. Tubocurarine was introduced to a patient for operation of  
the stomach resection. What drug should be introduced for restoration of 
breathing? 
A. Proserinum. 
B. Benzohexonium. 
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C. Dithylinum. 
D. Cytitonum. 
E. Aethymizole. 
16. A patient with a fracture of an average part of the femur with 
displacement was delivered to traumatologic department. For reposition of 
the bone, 10 ml of 2 % dithylinum solution was introduced intravenously to 
the patient. Due to this, the long apnea and myorelaxation have developed. 
What enzyme insufficiency is the cause of this phenomenon? 
A. N-acetyltransferase. 
B. Transferase. 
C. Butyrylcholinesterase. 
D. Glucose-6-phosphate dehydrogenase. 
E. Methemoglobin reductase. 
17. After a short-term operative intervention with the use of 
dithylinum, for over 30 minutes a patient was noticed to have respiratory 
depression, previous muscle tone didn’t restore. What assistance is 
necessary to render to the patient? 
A. Peritoneal dialysis. 
B. Blood or plasma transfusion.  
C. Hemodialysis. 
D. Hemosorption. 
E. Forced diuresis. 
18. Before an operative intervention a dithylinum solution was injected 
to a patient and intubation was performed. After the operative intervention 
self-breathing didn’t restore. What enzyme insufficiency in the organism of 
the patient predetermines such prolonged effect of the muscle relaxant? 
A. Na
+
, K
+
-ATP-ase. 
B. Succinate dehydrogenase. 
C. Carbonic anhydrase. 
D. N-acetyltranspherase. 
E. Pseudocholinesterase. 
19. Tubocurarine chloride was applied to a patient under combined 
narcosis as a muscle relaxant while performing the resection of the 
stomach. What antagonist should be injected to the patient to restore 
spontaneous breathing? 
A. Benzohexonium. 
B. Dithylinum. 
C. Cytitonum. 
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D. Proserinum. 
E. Aethymizole. 
20. To a patient with femoral bone fracture with the purpose of 
reduction of the tone of cross-striated muscles with reposition of bone 
fragments it is necessary to prescribe muscle relaxant of a short-term 
action. What drug is expedient for prescribing to the patient? 
A. Mellictinum. 
B. Dithylinum.  
C. Arduan. 
D. Tubocurarine chloride. 
E. Pirilenum. 
21. During an operative intervention with additional use of hygronium 
the patient’s arterial pressure has sharply decreased. What groups of drugs 
can normalize arterial pressure in the given situation? 
A. N-cholinomimetics. 
B. -Adrenergic blockers. 
C. Ganglionic blockers. 
D. M-cholinoblockers. 
E. -Adrenomimetics.  
22. Symptoms of dithylinum overdose appeared during an operative 
intervention. What actions will be expedient to reduce the phenomenon of 
overdose? 
A. Transfusion of blood or plasma.  
B. Introduction of N-cholinergic antagonist. 
C. Introduction of anticholinesterase drugs. 
D. Introduction of ganglionic blockers. 
E. Introduction of M-cholinergic antagonist. 
23. For the abatement or termination of excitation transmission from 
the nervous ending to a muscular fiber the curare-like substances – muscle 
relaxants – are clinically used. What is the mechanism of action of this 
pharmacological group? 
A. Reduction of mediator elimination into the synaptic cleft. 
B. Blockade of calcium ions passing through the channels of the 
presynaptic membrane. 
C. Inhibition of Na
+
, K
+
-pumps activity. 
D. Depression of acetylcholinesterase. 
E. Blockade of postsynaptic membrane N-cholinergic receptors of the 
myoneural junction.  
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24. A 45-year-old female is delivered to an urgent unit. It is necessary 
to perform trachea intubation. What drug should be used in this case? 
A. Gentamycin. 
B. Nitroglycerin. 
C. Dithylinum. 
D. Metronidazole. 
E. Atropine sulfate. 
25. A patient with a limb fracture must be administered depolarizing 
drug from the myorelaxant group for a short-time surgery. What drug is it? 
A. Cytitonum. 
B. Dithylinum. 
C. Pentamine. 
D. Tubocurarine chloride. 
E. Atropine sulfate. 
 
Adrenergic Drugs  
 
The adrenergic drugs bind to adrenergic receptors that are in 
postsynaptic membrane of effector cells near the endings of postganglionic 
sympathetic neurons. Adrenergic receptors are also found in a presynaptic 
membrane of adrenergic nerve endings. Also, adrenergic receptors are in 
the central nervous system. 
 A mediator of adrenergic neurons is noradrenaline (norepinephrine). 
Adrenaline (epinephrine) is produced by cells of adrenal medulla and 
released directly in the blood. Thus, adrenaline is hormone. Sometimes, 
dopamine plays the mediator role in adrenergic neurons. These three 
catecholamines are similar not only by chemical structure, but also by 
pharmacological effects.  
Neurotransmission in adrenergic synapses involves five steps: the 
synthesis of norepinephrine, its storage, release, binding to correspondent 
receptors, and removal from the synaptic cleft. 
A starting material for catecholamine synthesis is tyrosine. Tyrosine is 
transported into the axoplasm of the adrenergic neuron and hydroxylated to 
dihydroxyphenylalanine (DOPA) by tyrosine hydroxylase. DOPA is 
decarboxylated to dopamine. Dopamine is transported into synaptic 
vesicles where it is hydroxylated to norepinephrine. In the adrenal medulla, 
norepinephrine is mainly transformed to epinephrine that is stored in 
chromaffin cells. Due to stimulation, adrenal medulla releases about 85 % 
of epinephrine and 15 % of norepinephrine in the blood.  
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In adrenergic synapses, about 80 % of synthesized norepinephrine is 
deposited in vesicles by means of binding with specific protein and ATP. 
Certain amount of noradrenaline persists as a cytoplasmic pool that is fastly 
released at the action of nervous stimuli. 
Released norepinephrine diffuses across the synaptic space and binds 
to either postsynaptic receptors on the effector cell or presynaptic receptors 
on the nerve ending. The stimulation of adrenergic receptors by 
noradrenaline activates the formation of intracellurar second messengers 
that changes the cell activity.  
Released noradrenaline may diffuse out of the synapse; undergoes 
metabolism by catechol O-methyltransferase (COMT) in the synaptic 
space; or undergoes reuptake by the neuronal endings with the following 
deposition in the vesicles. Part of norepinephrine is oxidized by 
monoamine oxidase (MAO) present in neuronal mitochondria. 
 
 
 
 
Figure 4 – The structure of adrenergic synapse 
 
 
Adrenergic receptors are divided into - and -adrenoceptors.  
-Adrenoceptors are divided into 1- and 2-adrenoceptors. In turn, 
1-adrenoceptors are divided into 1A, 1B, and 1D-receptors; and  
2-adrenoceptors are divided into 2A, 2B, and 2C-receptors.  These 
subtypes are located heterogeneously within the body. For example, the 
prostate is rich in α1A-receptors, but vascular smooth muscles contain 
mainly α1B-receptors.  
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1-Adrenoceptors are located on a postsynaptic membrane of the 
effector organs within the synapse. 2-Adrenoceptors are located both on 
presynaptic and on postsynaptic membranes. It should be noticed that 
postsynaptic α2-adrenergic receptors are located outside of the synapse. In 
vessels, they are in the inner layer that is not innervated. Obviously, these 
receptors are mainly activated by adrenaline circulating in the blood.  
1-Adrenoceptors are mainly activated by noradrenaline. The stimulation 
of presynaptic 2-adrenoceptors leads to the reduction of the noradrenaline 
release (so-called negative feedback).  
The excitation of all kinds of 1-adrenoceptors leads (through  
Gq-proteins) to activation of phospholipase C and elevation of intracellular 
level of inositol triphosphate and diacylglycerol that promotes output of 
calcium from the intracellular depot and activation of corresponding protein 
kinases with the following contraction of smooth muscles.   
The excitation of all kinds of 2-adrenoceptors results in the decrease 
of adenylyl cyclase activity (through Gi-proteins) and reduction of 
intracellular cAMP level. It leads to inhibition of activity of cAMP-
dependent protein kinases. It is possible, that some effects of excitation of 
2-receptors (e. g., deceleration of mediator release from presynaptic 
endings) develop due to the activation of potassium channels with the 
following potassium outflow, hyperpolarization of membrane, and decrease 
of activity of calcium channels.  
Depending on the affinity for adrenergic agonists and antagonists,  
-adrenoceptors are divided into 1-, 2- and 3-adrenoceptors.  
1-adrenergic receptors are located on a postsynaptic membrane within the 
synapses. 2-adrenoceptors are located both on postsynaptic and on 
presynaptic membranes. Moreover, postsynaptic 2-adrenoceptors are 
located outside of the synapses and excited mainly by adrenaline 
circulating in the blood. Presynaptic 2-adrenoceptors regulate the positive 
feedback: their excitation increases the noradrenaline release into synaptic 
cleft. The recently opened 3-adrenoceptors are in the fat tissue, in the 
smooth muscles of gastrointestinal tract and gallbladder, and in the heart. 
The function of 3-adrenoceptors in smooth muscles is unknown. 
Stimulation of 3-adrenoceptors in the fat tissue leads to activation of 
lipolysis and thermogenesis.     
1-Adrenoceptors have approximately equal affinity for epinephrine 
and norepinephrine, whereas 2-adrenoceptors have a significantly higher 
affinity to epinephrine. -Adrenoreceptors activate the adenylyl cyclase 
that leads to the elevation of cAMP level in the cell. It is accompanied by 
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activation of cAMP-dependent protein kinases and changes of metabolism 
and functional activity of the cells. Thus, activation of β1-adrenoceptors in 
the heart promotes the calcium entrance into the cardiomyocites and 
activates all functions of the heart. Activation of 2-adrenoceptors in the 
smooth muscles causes their relaxation.    
 As mentioned above, inner organs and tissues are characterized by 
unequal density of different types and subtypes of adrenergic receptors. 
Thus, vasculature of skeletal muscles contains both 1- and  
2-adrenoceptors, but the density of 2-adrenoceptors is significantly 
higher. The heart contains predominantly 1-adrenoceptors. The 
vasculature of skin and abdominal viscera contains predominantly  
1-adrenergic receptors. The smooth muscles of bronchi contain mainly  
2-adrenoceptors. The gastrointestinal tract contains both - and  
-adrenoceptors.  
 
Table 10 – Predominant localization and effects of excitation of adrenergic 
receptors 
 
Inner organ or tissue 
(predominant type  
of adrenergic receptors) 
Effect of stimulation  
of adrenergic receptors  
1 2 
Medula oblongata (2) Reduction of blood pressure and heart rate 
Heart: sinus node, 
atrioventricular node, and 
cardiomyocytes of atria and 
ventricles (1) 
Positive chronotropic action (accelerated heart 
rate). 
Positive dromotropic action (increased 
conductibility). 
Increase of contractility of atria and ventricles 
Blood vessels: 
– skin and mucosa, abdominal 
viscera, renal (); 
– skeletal muscles, lungs, brain, 
liver, coronary (2) 
 
Constriction. 
 
Dilation  
Bronchial muscles (2) Relaxation 
Gastrointestinal tract: 
– smooth muscles (2; 2); 
 
– sphincters () 
 
Decreased motility and tone of gastrointestinal 
tract. 
Contraction 
Pancreas (2; 2) Inhibiting of insulin release (2); stimulation of 
insulin release (2) 
Sex organ, male () Ejaculation 
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Continuation of the table 10 
1 2 
Bladder: 
– trigone (); 
– detrusor () 
 
Contraction. 
Relaxation 
Radial muscle of iris (1) Contraction (mydriasis) 
Epithelium of ciliary body of eye 
(1) 
Increase of aqueous humour secretion  
Salivary glands () Thick, viscous secretion 
Adipocytes (2; 3) Inhibition of lipolysis (2); stimulation of 
lipolysis (3) 
Liver (1 and 2) Glycogenolysis, neoglucogenesis, inhibition of 
glycogen synthase 
Uterus (1; 2) Stimulation of uterine contraction (1); 
inhibition of uterine contraction (2) 
Platelet (2) Stimulation of platelet aggregation 
 
Adrenergic drugs are divided into 2 groups: drugs which excite or lead 
to excitement of adrenoceptors (adrenomimetic drugs or adrenergic 
agonists) and drugs which block or diminish the excitement of 
adrenoceptors (antiadrenergic drugs or adrenergic antagonists). 
I. Adrenergic agonists.    
1. Adrenomimetic drugs of direct action. 
1.1. - and -adrenomimetics: adrenaline  (epinephrine) and 
noradrenaline  (norepinephrine). 
1.2. α-Adrenomimetics: 
– 1-adrenomimetics: mesatonum  (phenylephrine) and 
midodrine; 
– α2-adrenomimetics: naphthyzinum  (naphazoline ), 
halazolinum  (xylometazoline), and oxymetazoline. 
1.3. β-adrenomimetics: 
– 1,2-adrenomimetics: isadrinum (isoprenaline) and 
orciprenaline; 
– β1-adrenomimetics: dobutamine  (Dobutrex, Inotrex); 
– β2-adrenomimetics: salbutamol , fenoterol ,  terbutaline, and  
formoterol. 
2. Sympathomimetics or - and -adrenomimetics of indirect action: 
ephedrine and phenamine. 
II. Antiadrenergic drugs (adrenergic antagonists). 
1. Adrenoblockers. 
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1.1. α,β-adrenoblockers: labetalol, proxodol, and carvedilol. 
1.2. α-adrenoblockers:  
– α1,2-adrenoblockers: phentolamine (regit ine), tropaphenum, 
and pirroxane; 
– α1-adrenoblockers: prazosin (minipress), terazosin, and 
doxazosin (cardura); 
1.3. β-adrenoblockers:  
– β1,2-adrenoblockers: anapril inum (propranolol), nadolol, 
sotalol, oxprenolol, and pindolol; 
–  β1-adrenoblockers: metoprolol, talinolol, atenolol, nebivolol, 
and acebutalol.  
2. Sympatholytics: reserpine, octadinum (guanethidine), and 
ornidum (bretylium tosilate). 
 
- and  -Adrenomimetics of Direct Action 
 
This group includes adrenaline (epinephrine) and noradrenaline 
(norepinephrine).   
 
Adrenaline (epinephrine)  
Epinephrine directly interacts with both - and -adrenoceptors, but 
when a drug is given in therapeutic doses, the -adrenoceptors are more 
sensitive to adrenaline. Depending on the degree of sensitivity to 
adrenaline, adrenoceptors are in the following sequence: β2, β1, α2, and α1.  
Adrenaline exhibits the most expressive influence upon the cardio-
vascular system. An excitation of β1-receptors of the heart is accompanied 
by the following effects:   
1. Tachycardia.  It is a result of excitation of β1-receptors of sinoatrial 
node that leads to the increased automatism.   
2. Facilitation of atrioventricular conduction arises due to excitation of 
β1-receptors of atrioventricular node.  
3. Increase of myocardium contractility. The main mechanism of this 
effect is associated with adrenaline influence upon metabolism of 
carbohydrates, lipids, and calcium ions in the myocardium. Thus, 
adrenaline, through β1-adrenergic receptors coupled with Gs-proteins, 
stimulates adenylyl cyclase and promotes cAMP synthesis in 
cardiomyocytes. It leads to activation of lipase (hydrolysis of lipids), 
phosphorylase (hydrolysis of glucogen), and promotes the elevation of 
intracellular concentration of calcium ions. It leads to the increase of stroke 
volume of the heart and cardiac output. But, increased metabolism of lipids 
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and glycogen results in elevation of oxygen consumption by myocardium 
that can provoke the hypoxia of cardiac muscle in patients with 
pathological changes in coronary vessels. At disturbances of metabolism, 
the exhaustion of myocardium with the following heart failure develops. 
Therefore, epinephrine is not used in the treatment of heart failure. Vice 
versa, epinephrine is contraindicated at diseases of the heart and coronary 
vessels.  
There is evidence, that heart can selectively absorb epinephrine from 
the blood. In the heart, epinephrine binds with proteins that protect it from 
degradation. An increase of sympathetic tone (psychical and emotional 
excitation) leads to the release of this epinephrine that adversely affects 
metabolism in the myocardium. This fact has high meaning in the 
development of myocardial infarction.     
The influence of epinephrine upon vascular system is 
complex. Epinephrine constricts arterioles in the skin, mucous membranes, 
and viscera owing to the excitation of α1- and α2-adrenoceptors. Renal 
blood flow is also decreased. But excitation of β2-adrenergic receptors by 
epinephrine causes the vasodilation in the liver and in the skeletal muscles.  
At low doses of epinephrine, excitation of -adrenergic receptors with 
vasodilatation predominates, whereas high doses of epinephrine initially 
influence -adrenergic receptors with the following vasoconstriction. At 
the average therapeutic doses of epinephrine, the summary effect is the 
increase of systolic blood pressure and the moderate reduction of diastolic 
blood pressure. Depending on an administered dose the average blood 
pressure increases, decreases or remains without changes.  
Adrenaline is unsuitable for treating the acute hypotension due to its 
negative influence upon the heart, weak influence upon diastolic blood 
pressure, and disorders of blood supply in some tissues and organs. As 
pressor agent, adrenaline may be used only in exceptional cases if other 
drugs increasing blood pressure are absent. An ability of adrenaline to 
constrict blood vessels is used by anaesthesiologists. Adrenaline is added to 
solutions of local anaesthetics. Such combination slows down the 
absorption of local anesthetic into the blood, prolongs the anaesthesia, 
decreases the toxicity of local anaesthetic, and decreases the bleeding from 
operative area.  
Adrenaline stimulates the spleen contraction owing to excitation of  
α-adrenergic receptors.  
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Epinephrine increases the tone of gastrointestinal sphincters and slows 
down peristaltics of stomach and intestine. These effects do not have 
practical meaning.     
Adrenaline causes bronchodilation due to excitation of 2-adrenergic 
receptors of bronchial smooth muscles. Broncholytic action of adrenaline is 
higher than the same effect of atropine-like drugs. Adrenaline relieves all 
known allergic-induced bronchoconstriction (including anaphylactic shock) 
and acute attacks of bronchial asthma.  
The radial muscle of the iris (m. dilatator pupillae) contains  
α1-adrenoceptors. Epinephrine causes dilation of the pupil (mydriasis) by 
contracting the radial muscle. This effect is not accompanied by elevation 
of intraocular pressure because adrenaline causes the local vasoconstriction 
that reduces the production of aqueous humour. Thereby, 2 % adrenaline 
solution is sometimes used to treat glaucoma.    
Uterine muscle contains both α- and β2-adrenoceptors, excitation of 
which respectively causes either contraction or relaxation of the uterus. 
This adrenaline’s effect depends on the endocrine balance. Stimulation of 
β2-receptors is predominant during the last stage of pregnancy and during 
parturition; therefore, epinephrine relaxes the uterine muscle. 
The detrusor muscle of the bladder body contains β2-adrenoceptors 
and adrenaline relaxes it. On the other hand, the trigone and sphincter of 
bladder, containing α1-adrenergic receptors, are contracted by epinephrine. 
This action inhibits the voiding.  
Therapeutic doses of epinephrine mildly stimulate the central nervous 
system, excitate the centre of thermoregulation, and stimulate the secretion 
of adrenal cortex. 
Adrenaline increases the glucagon release, stimulates glycogenolysis, 
and decreases the insulin release that leads to hyperglycemia. Excitation of 
β3-receptors by epinephrine results in stimulation of lipolysis. The levels of 
free fatty acids, glucose, and lactic acid in the blood are increased.  
Excitation of β3-adrenoceptors located in the membranes of the mast 
cells (labrocytes) leads to a decrease of histamine release from these cells. 
Epinephrine increases the working capacity of the skeletal muscles, 
especially on the background of the fatigue. The drug reduces the influence 
of kurare-like agents upon skeletal muscles. These effects are associated 
with the sensitization of skeletal muscles to acetylcholine. Besides, an 
increased carbohydrate metabolism in skeletal muscles, improved blood 
circulation, acceleration of carbohydrate metabolism and synthesis of ATP 
are also important.        
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Epinephrine has a rapid onset but short duration of action because 
COMT and MAO rapidly metabolize the drug. At subcutaneous 
administration, the duration of epinephrine action is about 30 minutes.  
Epinephrine is widely used in urgent care. The drug is used to treat 
allergic reactions of immediate type: urticaria, angioneurotic edema, serum 
sickness. Epinephrine is the drug of choice to treat anaphylactic shock.  
To treat the acute bronchoconstriction, epinephrine is administered 
intramuscularly or subcutaneously.  
As mentioned above, 2 % epinephrine solution is used topically to 
reduce intraocular pressure in patients with open-angle glaucoma or for 
mydriasis.  
Weak solutions of epinephrine are used topically to stop capillary 
bleeding (e. g., nosebleed). Epinephrine is added to local anaesthetic 
solutions (most commonly one part of epinephrine to 100 000 or 
200 000 parts of anaesthetic solution).  
The drug is used to treat hypoglycemic coma caused by insulin 
overdose.  
Adrenaline is used in the treatment for cardiac arrhythmias associated 
with conductivity disturbances.  
Epinephrine is administered intracardialy in the case of cardiac arrest. 
In this case, 0.3–0.5 ml of 0.1 % adrenaline solution is mixed with 10 ml of 
solution of sodium chloride or glucose and administered into the cavity of 
the left ventricle. Right after adrenaline administration, heart massage is 
performed.     
Very seldom, adrenaline is used to elevate the low blood pressure.  
Side effects of epinephrine are anxiety, headache, tremor, cerebral 
hemorrhage, cardiac arrhythmias, etc.  
 
Norepinephrine  (noradrenaline) 
 
Noradrenaline directly stimulates α1-, α2-, and β1- types of adrenergic 
receptors. It is necessary to notice that -adrenoceptors are more sensitive 
to noradrenaline.   
 The main effect of norepinephrine is the expressed but short-time 
increase of peripheral vascular resistance. Both systolic and diastolic blood 
pressure increases. Stimulation of baroreceptors due to hypertension 
induces the reflex increase of vagal activity that leads to bradycardia. But 
this reflex does not eliminate the positive inotropic effect of the 
norepinephrine. As a result, the cardiac output is practically not changed or 
even reduced, and stroke volume is increased.  
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It should be noticed that preliminary administration of atropine 
prevents the reflex bradycardia and in this case administration of 
noradrenaline results in tachycardia.  
Noradrenaline acts several minutes because COMT and MAO rapidly 
inactivate it. Subcutaneously administered noradrenaline causes the local 
vascular spasm and, therefore, it is badly absorbed and can cause tissue 
necrosis. Therefore, subcutaneous or intramuscular norepinephrine 
administration is not permissible. Norepinephrine is administered 
intravenously drop-by-drop (to that end, 2–4 ml of noradrenaline solution is 
diluted in 1 litre of 5 % glucose solution).  
Norepinephrine is used to combat acute hypotension (e. g., 
hypotension arising at the spinal anaesthesia, operations, traumas). But 
norepinephrine is not used in cases of hypotension developed due to most 
types of shock (e. g., hemorrhagic and cardiogenic shock which are 
accompanied by hypovolemia). In cases of shock, marked sympathetic 
activity is already present, and perfusion of organs, such as kidneys, may be 
worsened due to norepinephrine administration. In this case,  
α-adrenoblockers are administered after compensation of hypovolemia.  
The side-effects of norepinephrine develop seldom and include the 
reflexive sinus bradycardia, respiratory disturbances, headache, and tissue 
necrosis in the site of norepinephrine injection. 
 
Sympathomimetics  
 
Sympathomimetics or indirectly-acting adrenomimetics include 
ephedrine  and phenamine.  
Mechanism of sympathomimetic action is associated with the 
following: 
– these drugs induce release of the mobile pool of noradrenaline into 
the synaptic cleft; 
– sympathomimetics slow down the mediator reuptake by the nervous 
endings; 
– sympathomimetics decrease the MAO activity; 
– these drugs are weak direct agonists of postsynaptic - and  
-adrenergic receptors.  
A repeated administration of sympathomimetics with a short-time 
interval (10–30 min) leads to the fast weakening of their effects (so-called 
tahyphylaxis). It is associated with the decrease of norepinephrine storage 
in vesicles.  
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Ephedrine  is alkaloid of the plant Ephedra. The drug has a long 
duration of action. The main effects of ephedrine are like those of 
epinephrine, but less apparent. Ephedrine increases the blood pressure, 
accelerates the heart rate, produces bronchodilation, inhibits the intestinal 
motility, and causes mydriasis. The drug penetrates the central nervous 
system and produces its stimulation. Ephedrine increases alertness, 
decreases fatigue, and prevents sleep. Also, ephedrine increases the tone of 
skeletal muscles and causes hyperglycemia.  
Ephedrine is used in bronchial asthma treatment both to prevent 
asthma attacks (powders, tablets, and rectal suppositories) and to stop them 
(subcutaneous or intravenous injections). To treat arterial hypotension, 
ephedrine is administered subcutaneously, intramuscularly, intravenously, 
or taken orally. In cases of intramuscular administration, the blood pressure 
increases during 40–60 minutes. Ephedrine is used topically to treat rhinitis 
and synusitis. The drug is used in the treatment for myasthenia gravis. 
Central stimulative effects of ephedrine are used to treat narcolepsy and 
poisoning by hypnotic drugs. The drug ability to improve the 
atrioventricular conduction is used in the treatment for atrioventricular 
blockage. Ophthalmic drops with ephedrine are used for mydriasis.   
 
-Adrenomimetics  
 
-Adrenomimetics are the drugs which selectively stimulate  
-adrenergic receptors. This group includes α1-adrenomimetics 
mesatonum  (phenylephrine) and midodrine  and α2-adrenomimetics 
naphthyzinum (naphazoline) and halazolinum (xylometazoline). 
Mesatonum  stimulates 1-adrenoceptors of the postsynaptic 
membranes. It is a synthetic adrenergic drug that is less potent than 
noradrenaline but acts longer (40–60 minutes). Mesatonum is administered 
subcutaneously, intramuscularly, intravenously, and taken orally. Drug is 
vasoconstrictor that raises both systolic and diastolic blood pressure.  
Mesatonum does not directly influence the heart but induces reflex 
bradycardia owing to the stimulation of baroreceptors in aortic arch and the 
following activation of nervus vagus. Mesatonum is often used topically on 
the nasal mucous membranes at rhinits and in ophthalmic solutions for 
mydriasis and at open-angle glaucoma. It is used to treat arterial 
hypotension and for prolongation of local anesthetics’ action. Besides, 
mesatonum is used in the treatment for supraventricular tachycardia. It is 
also used to treat hypotension during halothane anaesthesia. Large doses of 
mesatonum can cause hypertensive headache.  
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Naphthyzinum  and halazolinum  selectively stimulate  
2-adrenergic receptors. Both drugs have longer vasoconstrictive effect 
than mesatonum. These drugs are used locally as nasal decongestant in 
symptomatic treatment for rhinitis. The drugs cause local irritative effect.   
 
 -Adrenomimetics  
 
-Adrenomimetics are drugs which directly stimulate -adrenergic 
receptors. β-Adrenomimetics are classified as follows: 
– 1,2-adrenomimetics: isadrinum (isoprenaline) and orciprenaline; 
– β1-adrenomimetics: dobutamine  (dobutrex,  inotrex); 
– β2-adrenomimetics: salbutamol, fenoterol  (Partusisten), 
terbutaline, and formoterol. 
 Isadrinum  stimulates both 1- and 2-receptors and acts upon the 
heart, smooth muscles, and metabolism. Stimulation of 1-adrenoceptors 
increases the heart rate, myocardial contractility, excitability, automatism 
and conduction. Cardiac output is increased. Isadrinum increases systolic 
pressure but lowers diastolic pressure due to the stimulation of  
2-adrenergic receptors of blood vessels and the following vasodilation.  
Stimulation of 2-adrenoceptors of smooth muscles results in 
bronchodilation and reduction of the uterine tone. Isadrinum also stimulates 
glycogenolisis, lipolysis and gluconeogenesis. Isadrinum is used to 
eliminate the acute attacks of bronchial asthma. Duration of its 
bronchodilating effect is about 1 hour. The drug is also used in the 
treatment for atrioventricular blockade.  
The side-effects of isadrinum are tachycardia, tremor, and headache. 
Isadrinum is contraindicated in ischemic heart disease, thyrotoxicosis, 
artherial hypertension, and diabetes mellitus.  
2-adrenomimetics (salbutamol, fenoterol, terbutaline, 
formoterol) selectively stimulate 2-adrenoceptors that results in 
bronchodilation. Also, these drugs decrease the uterine tone and weaken the 
partirition hyperactivity. This effect is called tocolytic action. Selective  
2-adrenomimetics are used to treat bronchial asthma and bronchospasm 
associated with bronchitis and emphysema. These drugs are also used to 
reduce uterine contractions in premature parturition (Partusisten). The 
drugs are administered orally, parenterally or in inhalation. The duration of 
action of these drugs is about 6–8 hours. Side effects include nervousness, 
tremor, tachycardia, palpitations, headache, nausea, vomiting, and 
sweating. The frequency of these side effects is minimized when the drugs 
are given in inhalations.  
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Dobutamine  selectively stimulates 1-adrenergic receptors. The drug 
increases cardiac output owing to positive inotropic action. The drug has 
low influence upon the heart rate and, therefore, does not significantly 
increase myocardium oxygen demand. The drug is used in the treatment for 
acute heart failure. It should be noticed that dobutamine is used with 
caution in atrial fibrillation because it improves atrioventricular conduction.  
 
Table 11 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and mode  
of administration 
Drug product 
Adrenalini 
hydrochloridum 
Subcutaneously or 
intramuscularly 0.0003–
0.00075 g; 
in the eye: 1–2 drops of 1–2 % 
solution  
Ampoules 1 ml of 0.1 % 
solution; 
 
1 % or 2 % ophthalmic 
solution  
Noradrenalini 
hydrotartras 
Intravenously drop-by-drop 
0.004–0.008 g in 1 litre of 5 % 
glucose solution 
Ampoules 1 ml of 0.2 % 
solution 
Ephedrini 
hydrochloridum 
Orally, subcutaneously, 
intramuscularly, and 
intravenously 0.025 g 2–3 
times a day 
Tablets 0.025 g; 
ampoules 1 ml of 5 % solution 
Mesatonum Orally 0.01–0.025 g 2–3 times 
a day; 
subcutaneously or 
intramuscularly 0.003–0.005 g 
1–2 times daily; 
intravenously 0.001–0.003 g 
with 40 ml of sterile isotonic 
NaCl solution; 
in the eye: 1–2 drops of 1–2 % 
solution 
Powders for internal use; 
 
ampoules 1 ml of 1 % 
solution; 
 
 
 
 
vials 5 ml of 2.5 % ophthalmic 
solution  
Naphthyzinum Into the nose 1–2 drops of 
0.05–0.1 % solution 3 times 
a day 
Vials 10 ml of 0.05 or 0.1 % 
solution 
Isadrinum Sublingually 0.005 g; 
for inhalation: 1–2 inhalations 
of 0.5–1 % solution   
Tablets 0.005 g; 
vials 25 ml or 100 ml of 0.5 % 
or 1 % solution  
Salbutamol Orally 0.002 g 3 times a day; 
for inhalation: 1–2 inhalations 
3 times daily 
Tablets 0.002 g; 
aerosol 10 ml  
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Step 1. Tasks for Self -Control  
Adrenomimetic Drugs and Sympathomimetics  
 
1. The acute attack of bronchial asthma had developed in a patient who 
also suffered from angina pectoris.  What broncholytic should be used in 
this case? 
A. Salbutamol. 
B. Atropine sulfate. 
C. Adrenaline hydrochloride. 
D. Isoprenaline (isadrinum). 
E. Aminophylline (euphyllinum). 
2. The blood pressure had dropped in a patient receiving the halothane 
(phthorotanum) narcosis. What drug can be used for correction of 
hypotension? 
A. Adrenaline. 
B. Noradrenaline.  
C. Mesatonum (phenylephrine). 
D. Ephedrine. 
E. Dopamine. 
3. A drug stimulates adrenoreceptors. It is used at collapse, shock 
(except cardiogenic and haemorrhagic), heart arrest, hypoglycemic coma. It 
is a drug of choice at anaphylactic shock. What is this drug called? 
A. Noradrenaline (norepinephrine). 
B. Ephedrine. 
C. Isadrinum (isoprenaline).  
D. Adrenaline (epinephrine). 
E. Naphthyzinum (naphazoline). 
4. The frequent instillation of indirect adrenomimetic into the nose at 
rhinitis leads to a gradual decrease of vasoconstriction. What is the name of 
this phenomenon? 
A. Idiosyncrasy. 
B. Allergy. 
C. Cumulation. 
D. Teratogenic action. 
E. Tachyphylaxis. 
5. Indicate the drug which was introduced to a patient for interruption 
of bronchospasm having caused tachycardia and increase of blood pressure. 
A. Platyphylline. 
B. Isadrinum (isoprenaline). 
C. Proserinum. 
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D. Salbutamol. 
E. Ventolin. 
6. Acute bronchospasm developed in a woman who also suffered from 
hypertonic disease. Prescribe the drug for interruption of acute attack of 
asthma for this woman. 
A. Ephedrine. 
B. Adrenaline. 
C. Euphyllinum. 
D. Salbutamol. 
E. Isadrinum. 
7. A patient with acute rhinitis injects drops of naphthyzinum 
(naphazoline) solution into the nose. Having felt improvment of condition, 
the patient sped up the injecting every 15–20 minutes. But the improvment 
does not develop. What is the cause of this phenomenon? 
A. Tachyphylaxis. 
B. Cumulation. 
C. Drug dependence. 
D. Potentiation. 
E. Sensitization. 
8. A patient has acute attack of bronchial asthma. The use of which 
drug is the physiologically substantiated for elimination of bronchospasm? 
A. Obsidan. 
B. Inderal. 
C. Adrenaline. 
D. Phentolamine. 
E. All answers are not correct. 
9. What group has the mechanism of action, which is connected with 
accumulation of cAMP in the cells? 
A. Antineoplastic antibiotics. 
B. Analgesics. 
C. Organic nitrates. 
D. Sulfonamides. 
E. β-Adrenomimetics. 
10. This drug is a selective agonist of β-adrenoceptors, introduced 
orally and in inhalation, does not influence the heart activity. It is used for 
interruption and prevention of bronchospasms. Call this drug. 
A. Adrenaline hydrochloride. 
B. Asthmopent
®
 (orciprenaline). 
C. Salbutamol. 
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D. Ephedrine hydrochloride. 
E. Isadrinum (isoprenaline). 
11. A patient with rhinitis injected drops of ephedrine solution into the 
nose. The oedema of mucous membranes has decreased. But in the result of 
frequent repeated introduction of solution the effect of the drug has 
decreased up to the complete disappearance. What is the cause of this 
phenomenon? 
A. Introduction of a drug by wrong route. 
B. Tachyphylaxis. 
C. Individual tolerance to a drug. 
D. Adverse effect of a drug. 
E. Sensitization to a drug. 
12. A doctor has introduced to a patient the drug X for interruption of 
an acute asthma attack. In the result of this introduction tachycardia and 
increasing of blood pressure have developed. Call the drug X. 
A. Ventolin. 
B. Euphyllinum. 
C. Isadrinum (isoprenaline). 
D. Platyphylline. 
E. Proserinum. 
13. Prescribe to a patient with hypertensive disease the drug for 
prevention of acute attack of bronchial asthma. 
A. Proserinum. 
B. Salbutamol. 
C. Adrenaline. 
D. Mesatonum (phenylephrine). 
E. Ephedrine. 
14. Point out the adrenomimetic which in therapeutic doses causes the 
increase of systemic blood pressure, mydriasis, and tachycardia. 
A. Salbutamol.  
B. Noradrenaline (norepinephrine). 
C. Mesatonum (phenylephrine). 
D. Isadrinum (isoprenaline). 
E. Adrenaline (epinephrine). 
15. In the result of long-term using of fenoterol as broncholytic, its 
therapeutic activity has gradually decreased. What is the cause of tolerance 
developing? 
A. The increase of drug elimination. 
B. The increase of drug interaction with plasma albumins. 
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C. The decrease of β-adrenoceptors sensitivity. 
D. The decrease of Gs-proteins amount. 
E. The worsening of drug absorption. 
16. A patient with bronchial asthma after introduction of tablet of some 
drug under the tongue has felt the accelerated heart rate. Point out the drug 
the patient has accepted. 
A. Drotaverine (No-spa). 
B. Isadrinum. 
C. Salbutamol. 
D. Papaverine. 
E. Benzohexonium (hexamethonium). 
17. A patient made the inhalation of some drug for interruption of acute 
attack of bronchospasm. The injection of this drug is also used in obstetrics 
for prevention of premature labour. Call this drug.  
A. Euphyllinum. 
B. Isadrinum. 
C. Adrenaline. 
D. Ephedrine. 
E. Fenoterol. 
18. A 45-year-old male suffers from bronchial asthma. The doctor has 
prescribed to him the drug in tablets, which improved the condition of the 
patient. But in some days the man began to complain of insomnia and 
increased blood pressure. What drug was prescribed to the patient? 
A. Papaverine. 
B. Metacinum. 
C. Salbutamol. 
D. Ephedrine. 
E. Isadrinum. 
19. Indicate the drug which is selective adrenomimetic and is used for 
short-term treatment of heart failure. 
A. Adrenaline. 
B. Dobutamine. 
C. Proserinum. 
D. Anaprilinum (propranolol). 
E. Mesatonum. 
20. A patient with hypotension had felt the worsening of condition 
(dizziness, weakness, and shaky gait) and accepted several tablets of 
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ephedrine in the short intervals of time. But some improvement the patient 
felt only after the first tablet. What is the cause of this phenomenon? 
A. Cumulation. 
B. Idiosyncrasy. 
C. Tolerance. 
D. Sensitization. 
E. Tachyphylaxis. 
21. The asthmatic status has developed in a patient. The doctor has 
prescribed intravenous introduction of adrenaline hydrochloride for 
elimination of bronchoconstriction. But its introduction has caused the 
worsening of condition (the increase of cyanosis, and hypoxia). What 
pathological mechanism is the cause of this phenomenon? 
A. The increase of leukotrienes synthesis. 
B. The increase of histamine releasing.   
C. The decrease of sensitivity of α-adrenoceptors to adrenaline. 
D. The increase of sensitivity of β2-adrenoceptors to adrenaline. 
E. The decrease of sensitivity of β2-adrenoceptors to adrenaline in 
hypoxia condition. 
22. A patient with acute rhinitis frequently injected 5 % ephedrine 
solution into nose. The efficacy of the drug sharply decreased and on the 3
rd
 
day completely disappeared. What is the cause of this phenomenon 
(tachyphylaxis)? 
A. The infringement of mediator releasing from depot. 
B. The progressive decrease of noradrenaline storage in sympathetic 
nerves. 
C. The increase of reuptake of mediator. 
D. The infringement of mediator synthesis in sympathetic fibers. 
E. The blockade of adrenoceptors. 
23. The adrenaline action is directed to the activation of enzymes group 
with the purpose of receiving energy. The main enzyme of this group is: 
A. Phosphorylase. 
B. Phosphatase. 
C. Phosphofructokinase. 
D. Phosphokinase. 
E. Phosphomutase. 
24. The inhalation drug was prescribed to a patient with bronchial 
asthma, which also suffered from angina pectoris. During the following 
inhalation the patient felt worsening of condition (tachycardia, pain in the 
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heart area with irradiation in the left shoulder). Choose the drug which can 
cause such adverse effects. 
A. Naphthyzinum. 
B. Cromolyn sodium. 
C. Fenoterol. 
D. Isadrinum. 
E. Euphyllinum. 
25. A 13-year-old girl with the history of asthma complained of cough, 
dyspnea, and wheezing. Her symptoms became so severe that her parents 
brought her to the emergency room. Physical examination revealed 
diaphoresis, dyspnea, tachycardia, and tachypnoea. Her respiratory rate was 
42/min, pulse rate was 110 beats per minute, and blood pressure was 
130/70 mm Hg. Choose from the following list the most appropriate drug 
to reverse the bronchoconstriction rapidly: 
A. Cromolyn sodium. 
B. Salbutamol.  
C. Ipratropium. 
D. Methylprednisolone. 
E. Beclomethasone. 
26. Spasm of smooth muscle of bronchi developed in a patient. The use 
of activators of what membrane cytoreceptors is physiologically valid to 
decrease the attack? 
A.  -Adrenoreceptors. 
B. -Adrenoreceptors. 
C. - and -adrenoreceptors. 
D. M-cholinoreceptors. 
E. H-cholinorceptors. 
27. A patient with bronchial asthma had been taking tablets which 
caused insomnia, headache, and increased blood pressure. What drug can 
cause such complication? 
A. Chromolyn sodium. 
B. Isadrinum. 
C. Euphyllinum. 
D. Adrenaline. 
E. Ephedrine.  
28. An emergency doctor was called to a 40-year-old patient with 
bronchial asthma, who had an attack of bronchospasm with manifestations 
of angina pectoris. What drug is the most effective for the acute care? 
A. Platyphylline hydrotartrate.  
B. Salbutamol.  
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C. Ephedrine hydrochloride. 
D. Adrenaline hydrochloride. 
E. Atropine sulfate. 
29. A patient came to a doctor complaining of health state 
deterioration. While waiting he had an attack of bronchial asthma. Drugs of 
what group are expedient for the first aid? 
A. -Adrenoreceptor agonists.  
B. -Adrenergic blockers. 
C. N-cholinominetics. 
D. M-cholinominetics. 
E. Sympatholytics. 
30. During an operative intervention with additional use of hygronium 
the patient’s arterial pressure has sharply decreased. What groups of drugs 
can normalize the arterial pressure in the given situation? 
A. N-cholinomimetics. 
B. -Adrenergic blockers. 
C. Ganglionic blockers. 
D. -Adrenomimetics.  
E. M-cholinoblockers. 
31. A 63-year-old man was admitted to an emergency hospital in 
a collaptoid state. In order to cure hypotension, the doctor chose 
noradrenaline hydrotartrate. What is the mechanism of the hypertensive 
action of this drug? 
A. Inhibition of M-cholinoreceptors. 
B. Activation of 1-adrenoceptors.  
C. Activation of serotoninergic receptors. 
D. Activation of -adrenoceptors. 
E. Activation of dopamine receptors. 
32. Some therapeutic agent has the following characteristics: synthetic 
catecholamine, stimulates 1- and 2-adrenoceptors, activates the work of 
the heart, determines the increase of heart rate. But it can lead to the 
suppression of birth activity and to the decrease of arterial pressure. It is a 
pharmacological antagonist of propranolol. What is this drug? 
A. Cytitonum. 
B. Carbacholine. 
C. Aceclidine. 
D. Pilocarpine hydrochloride. 
E. Isadrinum.  
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33. With a diagnostic purpose (pupils dilation for the inspection of the 
eye ground) an ophthalmologist used 1 % solution of mesatonum. 
Mydriasis, brought on by the drug, is the result of: 
A. Activation of M-cholinoreceptors. 
B. Activation of 2-adrenoreceptors. 
C. Activation of 1-adrenoreceptors.  
D. Blockade of 1-adrenoreceptors. 
E. Activation of 1-adrenoreceptors. 
34. A patient in the condition of acute circulatory collapse resulting 
from severe poisoning with unknown substance has been admitted to the 
hospital. What drug should be used for the acute care? 
A. Propranolol. 
B. Mesatonum.  
C. Naphthyzinum. 
D. Isadrinum. 
E. Salbutamol. 
35. A 42-year-old patient has bronchial asthma. To relieve the attacks 
of bronchospasm a doctor has prescribed salbutamol. What is its medicinal 
effect? 
A. Stimulation of 1-adrenoreceptors. 
B. Stimulation of 2-adrenoreceptors. 
C. Blockade of 2-adrenoreceptors. 
D. Stimulation of 2-adrenoreceptors. 
E. Stimulation of 1-adrenoreceptors. 
36. A patient has anaphylactic shock. From which of adrenoreceptor 
agonists is it possible to accept the maximal therapeutic effect? 
A. Alupent. 
B. Mesatonum. 
C. Ephedrine hydrochloride. 
D. Noradrenaline hydrotartrate. 
E. Adrenaline hydrochloride.  
37. A patient has a collaptoid state because of the peripheral vessels 
tone decrease. What drug is the most effective in this situation? 
A. Prazosin. 
B. Proserinum. 
C. Mesatonum.  
D. Isadrinum. 
E. Clophelinum.  
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38. A patient visiting a traumatologist had acute arterial hypotension. 
Which of the drugs stimulating adrenergic innervation would you suggest 
for normalization of arterial pressure? 
A. Xylometazoline. 
B. Prazosin. 
C. Naphthyzinum. 
D. Doxazosin. 
E. Mesatonum.  
39. During the tooth extraction a patient had bleeding. The dentist 
imposed a tampon with a medicine, and the bleeding decreased. What drug 
was used by the doctor? 
A. Cromolyn sodium. 
B. Isadrinum. 
C. Adrenaline hydrochloride.  
D. Naphthyzinum. 
E. Octadinum. 
40. The broncholytic which stimulates the 2-adrenergic receptors is 
prescribed to a patient with obstructive bronchitis. Indicate this drug. 
A. Prednisolone. 
B. Salbutamol. 
C. Cromolyn sodium. 
D. Euphyllinum. 
E. Metacinum. 
41. The anaphylactic shock has developed in a patient during local 
anaesthesia concerning tooth extraction. Choose the drug for interruption of 
this condition.  
A. Atropine sulfate. 
B. Euphyllinum. 
C. Cordiaminum. 
D. Dimedrol. 
E. Adrenaline hydrochloride. 
42. The acute vessels insufficiency has developed in a 58-year-old 
patient in the result of overdosing of vessels-widening drug. What drug 
should be used for elimination of this condition? 
A. Noradrenaline. 
B. Caffeine.   
C. Euphyllinum. 
D. Dopamine. 
E. Cordiaminum. 
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43. In experiments on live sections of a liver, the substance addition to 
medium solution has caused increasing of secretion of glucose. This 
substance effect is reduced by anaprilinum. What substance is it?  
A. Adrenaline. 
B. Dobutamine.  
C. Isadrinum. 
D. Fenoterol. 
E. Mesatonum. 
44. A female with hypoglycaemic coma is delivered to an urgent 
department. What drug should be prescribed to this patient? 
A. Clophelinum. 
B. Pilocarpine hydrochloride. 
C. Aminazine. 
D. Adrenaline hydrochloride. 
E. Biseptol. 
45. The broncholytic drug is prescribed to a patient for prevention of 
bronchial asthma attacks. What drug is prescribed? 
A. Anaprilinum. 
B. Noradrenaline.  
C. Metronidazole. 
D. Salbutamol. 
E. Proserinum. 
46. The bitten by a bee patient with the signs of anaphylactic shock is 
delivered to an emergency room. What drug should be introduced to the 
patient?  
A. Ranitidine. 
B. Isoniazid. 
C. Adrenaline hydrochloride. 
D. Clotrimazole. 
E. Sulfadimethoxine. 
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Antiadrenergic Agents  
 
Drugs which block adrenergic receptors are called adrenoblockers or 
adrenergic antagonists. These agents prevent or eliminate the corresponding 
effects of adrenomimetics owing to the blockade of certain types of 
adrenergic receptors. 
According to two families of adrenergic receptors, adrenergic 
antagonists are classified into -adrenergic antagonists (-adrenoblocking 
drugs), -adrenergic antagonists (-adrenoblocking drugs), and  
, -adrenergic antagonists (,-adrenoblocking drugs). Also, there is a 
group of sympatholytics. 
 
Classification of adrenergic antagonists  
1. α-Adrenoblocking drugs:  
a) α1,2-adrenoblocking drugs: phentolamine (regit ine), 
tropaphenum, and pirroxane; 
b) α1-adrenoblocking drugs: prazosin (minipress), terazosin, 
and doxazosin (cardura); 
c) α2-adrenoblocking drugs: yohimbine. 
2. β-Adrenoblocking drugs:  
a) β1,2-adrenoblocking drugs: anapril inum (propranolol ), 
nadolol, sotalol, oxprenolol, and pindolol; 
b) β1-adrenoblocking drugs: metoprolol ,  talinolol ,  atenolol ,  
nebivolol ,  and acebutalol .  
3. α, β-Adrenoblocking drugs: labetalol, proxodol, and 
carvedilol. 
4. Sympatholytics: reserpine, octadinum (guanethidine), and 
ornidum (bretylium tosilate). 
 
-Adrenoblocking Drugs 
 
The drugs of this group compete with catecholamines for binding with 
-adrenergic receptors in tissues. These agents more readily prevent or 
eliminate the -adrenergic effects of adrenaline than those of 
noradrenaline. The α-adrenergic antagonists reverse the effects of 
adrenaline mediated by excitation of -adrenergic receptors. Thus, the 
vasoconstrictive action of adrenaline is interrupted, but vasodilation caused 
by stimulation of β-receptors is not blocked. Therefore, the systemic blood 
pressure decreases due to the epinephrine administration on the background 
of preliminary administration of α-adrenoblocking agent. This phenomenon 
is called “epinephrine reversal”. 
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Phentolamine (regit ine)  competitively blocks both 1- and  
2-adrenergic receptors. Intravenously administered phentolamine causes 
short-time hypotension (10–15 minutes). The blood flow in vessels of skin, 
mucosa, and partly in vessels of skeletal muscles is increased. The vascular 
effects of phentolamine are used in the treatment for obliterating 
endarteritis and Raynaud’s disease and disorders associated with them (shin 
ulcers, atrophic rhinitis, and degenerative retinal changes). Also, 
phentolamine is used to treat acute heart failure, hypertensive crisis, and 
pheochromocytoma. Pheochromocytoma is a hormonal active tumor of 
adrenal medulla which produces and releases adrenaline into the blood, and 
less – noradrenaline. This disease is characterized by periodical attacks of 
tachycardia and hypertensive crisis. -Adrenoblockers are the active drugs 
for treatment and diagnostics of pheochromocytoma because adrenaline 
(but not noradrenaline) plays the leading role in genesis of this disease.  
-Adrenoblockers are also used to reduce vascular spasm at traumatic 
shock. This pathology is accompanied by the stable activation of 
sympathetic nervous system that leads to the marked vasoconstriction. In 
this situation, the administration of -adrenoblockers prevents ischemia of 
tissues, acidosis, and focal necrosis.    
The indications for therapeutic use of tropaphenum  and pirroxane  
are identical with those of phentolamine. There are evidences that 
tropaphenum decreases platelet aggregation and viscosity of arterial and 
venous blood.   
Except peripheral adrenergic receptors, pirroxane  also blocks the 
central ones. Therefore, it is also used in treatment for hypertension with 
diencephalic pathology. Pirroxane diminishes psychical tension and anxiety 
and prevents the vomiting of vestibular origin (at motion sickness and 
Meniere’s syndrome). Also, pirroxane is used to reduce manifestations of 
withdrawal syndrome that developed in addicts owing to the termination of 
administration of morphine and ethyl alcohol.   
After parenteral administration of -adrenoblockers, a patient should 
lie for 2–3 hours to prevent postural hypotension.   
The overdose of adrenoblockers leads to orthostatic collapse, 
tachycardia, disorders of the heart rhythm, increased myocardial oxygen 
demand, nausea, increased secretion of exocrine glands, and diarrhea.   
Interest to -adrenoblockers has grown in relation to synthesis of 
drugs that selectively act upon 1-adrenergic receptors (prazosin, 
terazosin, doxazosin, nicergoline). These drugs don’t cause marked 
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tachicardia and increase of myocardium oxygen consumption because 
agents don’t affect the negative feedback associated with the blockage of 
presynaptic 2-adrenoceptors. Therefore, the vasodilator effect of  
1-adrenergic antagonists is stable in a long-term use. 
1-Adrenoblockers exhibit mainly indirect action upon the heart.  
These drugs decrease the afterload upon the left ventricle due to the dilation 
of peripheral vessels and reduction of peripheral resistance. The blood 
pressure in pulmonary circulation is reduced. The preload (venous blood 
return) is also slightly decreased. These changes provide the decrease of the 
heart work and oxygen consumption of myocardium. Thus, 1-adrenergic 
antagonists facilitate the heart work and are used in the treatment for 
chronic heart failure. Many therapists consider 1-adrenoblockers as 
alternative to cardiac glycosides because they are safer.  
Duration of action of Prazosin is 6–8 hours in case of oral intake. 
Also, the drug exhibits antiatherosclerotic action. Prazosin is used to 
interrupt hypertensive crisis, to treat pulmonary hypertension, hypertensive 
disease, and disorders of peripheral blood circulation. 
Nicergoline is used in the treatment for cerebrovascular 
insufficiency.  
Terazosin and doxazosin selectively block α1A-adrenergic 
receptors. These drugs are used to treat arterial hypertension and prostate 
adenoma. The blockage of α1A-adrenoceptors relaxes the smooth muscles of 
prostate, bladder neck, and prostatic part of the urinary tract that improves 
the urination. 
Yohimbine selectively blocks α2-adrenergic receptors. The drug 
easily penetrates the central nervous system and exhibits antidepressive and 
psychistimulative effects. Yohimbine stimulates the sexual potency in men. 
The drug is manufactured in tablets and is used to treat the erectile 
dysfunction.   
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 -Adrenergic Antagonists  
 
-Adrenergic antagonists (-adrenoblockers) are drugs which 
selectively bind with -adrenergic receptors of the heart, vessels, bronchi, 
uterus, and other organs and prevent their excitation by catecholamines.  
Depending on the selectivity to certain types of -adrenergic receptors, 
-adrenergic antagonists are classified as follows:  
1) β1- and 2-adrenoblockers (non-selective -adrenoblockers): 
anapril inum (propranolol ), nadolol, sotalol, oxprenolol, 
pindolol; 
2) β1-adrenoblockers (cardioselective -adrenoblocklers): 
metoprolol, talinolol, atenolol, nebivolol, acebutalol.  
Due to blockage of β1-adrenergic receptors in the heart, the heart rate 
and impulse conduction are decelerated, and the force of heart contraction 
is decreased.  
The action of β-adrenoblockers upon the blood pressure is complex.  
β-Adrenoblockers decrease the renin secretion owing to blockage of  
1-adrenergic receptors which are located in the cell membranes of 
juxtaglomerular apparatus. It leads to the reduction of production of 
angiotensin II and aldosterone with the following lowering blood pressure. 
The decrease of cardiac output also provides the hypotensive effect. Non-
selective β-adrenergic antagonists block presynaptic β2-adrenoceptors that 
leads to the decrease of noradrenaline release that also promotes the 
lowering of blood pressure. Lipophilic β-adrenergic antagonists exhibit the 
additional mechanism of antihypertensive action that is associated with the 
blockage of β-adrenoceptors in the central nervous system. 
-Adrenoblockers also cause the decrease of intraoccular pressure 
because blockage of 1-adrenergic receptors suppresses the production of 
aqueous humour by the ciliary body.  
The blockage of 2-adrenergic receptors of smooth muscles is 
manifested by the increase of bronchial, uterine, and vascular tone.  
-Adrenoblockers antagonize metabolic effects of catecholamines. 
Under their influence, the catabolism of lipids and glycogen is suppressed, 
the body temperature is lowered, the level of Ca
2+
 ions in cardiomyocytes 
and in skeletal muscles is decreased, but the intracellular calcium 
concentration in smooth muscles is increased.  
Nowadays, -adrenergic antagonists play the significant role in the 
treatment of ischemic heart disease, myocardial infarction, 
tachyarrhythmias, and hypertensive disease.   
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The -adrenoblockers are characterized by some specific properties, 
which influence the peculiarities of their clinical use.  
1. Selective or non-selective -adrenoblockering activity. The agents 
with selective action upon 1-adrenergic receptors (such as metoprolol, 
talinolol, atenolol, etc.) are most valuable for cardiology. The parallel 
blockage of 2-adrenoceptors as a rule is undesirable and can cause such 
complications as reduction of coronary blood flow, impairment of blood 
flow in extremities, and spasm of bronchi.       
2. Intrinsic sympathomimetic activity. It is the ability of drugs to show 
the moderate and stable -adrenomimetic activity along with the ability to 
block the excessive influence of catecholamines upon the heart.  Such 
drugs (pindolol, acebutalol, etc.) have less apparent ability to provoke the 
left ventricular insufficiency due to the loss of adaptive tonic function of 
sympathetic nervous system.  
3. Membrano-stabilizing activity (propranolol, pindolol, metoprolol, 
etc.). This effect is a result of the blockade of sodium channels. It is like the 
action of local anesthetics. Membrano-stabilizing action of  
-adrenoblockers is manifested in the conductive system of the heart and 
neurons.  
Thus, the ability to block β1-adrenergic receptors is the main property 
of β-adrenergic antagonists. It leads to reduction of sympathoadrenal 
control of the heart functions manifested by prevention or elimination of 
tachycardia, lowering of elevated oxygen demand of the heart, and 
reduction of neurogenic disorders of the heart rate. The heart contractility 
also decreases but in less degree. In patients with masked insufficiency of 
left ventricle, it can provoke a heart failure due to physical activity.  
β-Adrenoblockers protect the heart from the influence of stress and 
negative emotions. These drugs also eliminate the active influence of 
sympathetic innervation upon the speed of impulse conduction in the 
conductive system, especially through the atrioventricular node.  
β-Adrenoblockers increase the possibility of conduction blockages. Drugs 
with intrinsic sympathomimetic activity are less dangerous in this respect. 
There are the following indications for clinical use of  
β -adrenoblockers: 
1. Cardiac tachyarrhythmias including those requiring urgent care. 
2. Angina pectoris. Selective β1-adrenergic antagonists are more 
valuable in the treatment for ischemic heart disease, especially in patients 
who have bronchial asthma or spasm of peripheral vessels in anamnesis.   
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3. Group of β-adrenergic antagonists is one of the basic groups for 
treatment of hypertensive disease.   
4. Treatment of hyperthyroidism. β-Adrenoblockers eliminate the 
peripheral manifestations of hyperthyroidism, such as tachycardia, 
increased cardiac output, and muscle tremors.  
5. β-Adrenergic antagonists (timolol, betaxolol, etc.) are used topically 
to reduce intraocular pressure in patients with glaucoma.  
6. Lipophilic β-blockers are used to treat neurosis and migraine.  At 
migraine, the blockade of cerebrovascular β-receptors reduces the 
vasodilation and pain. 
7. Propranolol is used to reduce uterine bleeding at parturition and in 
postoperative period.  
Side effects of β-adrenoceptor antagonists are bradycardia, 
conduction disturbances, arterial hypotension, heart failure, 
bronchoconstriction, worsening of lipid spectrum (drugs increase the level 
of atherogenic lipoproteins), central nervous system suppression, 
hypoglycemia, vasospasm of limbs, and dyspeptic disorders. 
Sudden interruption of β-adrenoceptor antagonist intake after a long-
time therapy can result in return syndrome that manifests by hypertensive 
crisis, angina attacks, and tachyarrhythmias. Phasing out of the drug with 
the use of another scheme of treatment is the simplest and safest way of 
preventing the return syndrome.   
 
α- and β-Adrenoblockers  
 
Labetalol  (Trandate)  simultaneously blocks α1-, β1-, and  
β2-adrenergic receptors. The ratio of β- to α-activity is about 3:1 when 
labetalol is administered orally and about 7:1 if the drug is administered 
intravenously. The blocking ability of labetalol is significantly less than 
those of phentolamine and propranolol (2–7 times, but according to some 
data – 5–18 times). Due to the blockage of vascular α1-adrenoceptors, 
labetalol reduces the blood pressure and after-load upon the heart 
accompanied by insignificant changes of the heart rate and cardiac output 
because the drug also blocks β1-adrenoceptors of the heart. 
Antihypertensive effect of labetalol is mainly determinated by its 
influence upon the vessels and is gradually developed. Labetalol is used 
both to treat hypertensive disease and to interrupt hypertensive crisis. Also, 
labetalol is used in the treatment for pheochromocytoma and moderately 
severe heart failure. The drug can provoke postural hypotension.   
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Sympatholytics  
 
Sympatholytics are drugs with presynaptic action which affect the 
synthesis, release, and deposition of noradrenaline. These drugs eliminate 
the effects of excitation of sympathetic nerves, but do not prevent the 
effects of exogenous adrenaline and noradrenaline. It should be noticed that 
these drugs cause sympathetic blockage at the presynaptic level. The most 
important part of their pharmacodynamics is their influence upon the 
cardiovascular system. Sympatholytics exhibit antihypertensive effect that 
is the base for their clinical use in the treatment for hypertensive disease. 
This group includes reserpine, octadinum  (guanethidine ), and 
ornidum  (bretylium).       
Reserpine  is a plant alkaloid derived from rauwolfia. This drug 
blocks the deposition of noradrenaline into the vesicles of adrenergic nerve 
endings that leads to mediator inactivation by MAO. On the other hand, 
reserpine stimulates the noradrenaline release by presynaptic membrane. It 
can cause the initial adrenomimetic effect which is, however, weakly 
expressed. Besides, reserpine inhibits the synthesis of noradrenaline.  
Thus, reserpine exhausts the mediator depot that leads to reduction of 
adrenergic influence upon inner organs. It should be noticed that adrenergic 
function is reduced when the depot of noradrenaline is decreased by 2/3 
that needs some time. Therefore, sympatholytic action of reserpine begins 
to develop only in several hours. Maximal effect develops in 3–4 days after 
the start of drug intake. After termination of the drug intake, its effects 
persist for many days, because partial recovery of mediator level occurs in 
about a week and full recovery of mediator depot develops in 2–3 weeks.   
Reserpine easily penetrates the central nervous system and exhibits its 
action in adrenergic and serotoninergic synapses. The drug exhibits 
sedative and weak antipsychotic effects due to which it is also included to 
the group of neuroleptics.    
Reserpine is used to treat hypertensive disease, mainly its initial form 
and cases of moderate severity. Also, the drug is seldom used in the 
treatment of tachyarrhythmias.  
Side effects of reserpine are associated with predominat influence of 
cholinergic innervation: bradycardia, elevation of secretion and motility of 
gastrointestinal tract (diarrhea, gastritis), nasal congestion, drowsiness, 
weakness, depression, pain in the area of a parotid gland, and decreased 
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libido in men. Reserpine increases the possibility of breast cancer in 
women. 
Octadinum (guanethidine) reduces the depot of noradrenaline 
owing to the stimulation of mediator release by presynaptic membrane, 
lowering of mediator redeposition, and inhibition of noradrenaline 
synthesis. But the main part of octadinum action is blockage of 
noradrenaline reuptake by presynaptic nervous endings that leads to 
inactivation of mediator by COMT. The first administration of octadinum 
can result in short-time sympathomimetic effects (elevation of blood 
pressure and tachycardia) which is replaced by the following inhibition of 
sympathetic activity. Octadinum does not penetrate in the central nervous 
system and lacks the central effects.  
Octadinum is used to treat hypertensive disease of moderate severity 
and severe its forms. Due to possibility of orthostatic collapse, octadinum is 
used mainly to treat inpatients. Sometimes, octadinum is used in the 
treatment of glaucoma. Side effects of octadinum are identical to side 
effects of reserpine. Besides, octadinum can cause orthostatic collapse. 
Ornidum blocks the noradrenaline release without influence upon 
mediator depot. Its use is accompanied by different side effects, besides its 
hypotensive effect is characterized by fast development of tolerance. 
Therefore, ornidum is not used in treatment of hypertensive disease. The 
drug is used as reserve agent to treat ventricular tachyarrhythmias.   
Sympatholytics are contraindicated at severe organic cardiovascular 
diseases, marked renal failure, and ulcer disease of stomach and duodenum. 
Octadinum is not recommended for pheochromocytoma.   
 
Table 12 – Drugs for prescription 
 
 
Drug name 
(Latin) 
Single dose and route  
of administration 
Drug product 
1 2 3 
Phentolamini 
hydrochloridum 
Orally 0.05 g 3–5 times  
a day 
Tablets 0.025 g 
Tropaphenum Subcutaneously or 
intramuscularly 0.01–0.02 g 
1–3 times a day;  
intravenously 0.01 g 
Ampoules 0.02 g of powder 
for injection (before 
administration the powder of 
1 ampoule is dissolved in 1–2 
ml of sterile water)  
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Continuation of the table 12 
1 2 3 
Prazosinum Orally, 0.0005–0.002 g  
3–4 times a day 
Tablets 0.001; 0.002 or 0.005 
g 
Anaprilinum Orally 0.01–0.04 g  
3–4 times a day; 
intravenously slowly 0.001 g 
Tablets 0.01 or 0.04 g; 
 
ampoules 1 or 5 ml of 0.1 % 
solution 
Metoprololum Orally 0.05–0.1 g  
2–4 times a day; 
intravenously slowly 0.005–
0.015 g  
Tablets 0.05 or 0.1 g 
 
ampoules 5 ml of 1 % 
solution 
Talinololum Orally 0.05–0.1 g 3 times a 
day 
Dragee 0.05 g 
Octadinum Orally 0.025–0.05 g once a 
day 
Tablets 0.025 g 
Reserpinum Orally 0.00005–0.0001 g 1–3 
times a day 
Tablets 0.0001 or  
0.00025 g 
 
Step 1. Tasks for Self -Control  
Antiadrenergic Drugs 
 
1. A doctor prescribed the antihypertensive drug to a patient, who 
suffers from hypertensive disease and obstructive bronchitis. After some 
time, asthma attacks have arisen in the patient and expressed bradycardia 
has developed. In ECG the signs of AV blockade were observed. Choose 
the drug for which these adverse effects are most common. 
A. Reserpine. 
B. Clophelinum (clonidine).  
C. Talinolol (Cordanum). 
D. Verapamil. 
E. Anaprilinum (propranolol). 
2. A doctor prescribed the antihypertensive drug to a patient, who 
suffers from hypertensive disease and obstructive bronchitis. After some 
time, asthma attacks have arisen in the patient. What is the cause of this 
adverse effect? 
A. Stimulation of bronchial 1-adrenoceptors. 
B. Blockade of bronchial 1-adrenoceptors. 
C. Blockade of bronchial 2-adrenoceptors. 
D. Stimulation of bronchial 2-adrenoceptors. 
E. Blockade of bronchial 2-adrenoceptors. 
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3. A patient suffering from bronchial asthma is staying in the hospital. 
Hypertonic disease is diagnosed as accompanying disease. Indicate the 
drug, which is contraindicated to this patient. 
A. Ephedrine hydrochloride. 
B. Anaprilinum (propranolol). 
C. Papaverine hydrochloride. 
D. Atropine sulfate. 
E. Salbutamol. 
4. A patient with pheochromocytoma suffers from increased blood 
pressure which develops at hypertensive crisis. What drug group is useful 
in this case? 
A. -Adrenoblockers. 
B. Blockers of Ca
2+
 channels. 
C. -Adrenoblockers. 
D. Ganglion blockers. 
E. Sympatholytics. 
5. Rapid and significant decrease of blood pressure is the main way of 
interruption of hypertensive crisis. The injection of which group of 
antiadrenergic drugs is used for this purpose? 
A. -Adrenoblockers. 
B. Non-selective -adrenoblockers. 
C. Cardioselective -adrenoblockers. 
D. Sympatholytics. 
E. All answers are incorrect. 
6. Bronchospasm has developed in a patient with angina pectoris after 
taking antihypertensive drug. What drug was taken by the patient? 
A. Dipyridamole. 
B. Nitroglycerin. 
C. Sustac forte. 
D. Nifedipine. 
E. Propranolol (anaprilinum). 
7. A doctor has prescribed propranolol to a 36-year-old female with 
ischaemic heart disease. But having found out the presence of 
accompanying disease, the doctor replaced propranolol by atenolol. What 
disease is the cause of this replacement?  
A. Cholecystitis. 
B. Arterial hypertension. 
C. Bronchial asthma. 
D. Ulcer disease of duodenum. 
E. Myasthenia. 
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8. A 60-year-old female suffers from toxic goiter and complains of a 
tachycardia. What drug should be prescribed for normalization of cardiac 
rhythm? 
A. Pentamine. 
B. Isadrinum (isoproterenol). 
C. Salbutamol. 
D. Anaprilinum (propranolol). 
E. Adrenaline (epinephrine). 
9. A patient with diabetes mellitus has taken the dose of long-acting 
insulin in the morning but did not take food. After some time, the patient 
has got the following signs: weakness, headache, dizziness, trembling, and 
convulsions. What drug should be introduced for interruption of 
hypoglycemia?  
A. Hydrocortisone. 
B. Triamcinolone. 
C. Adrenaline. 
D. Noradrenaline. 
E. Prednisolone. 
10. A patient with ischemic heart disease did not inform the doctor, that 
he had attacks of bronchospasm. The doctor prescribed the drug A to him. 
After that the attacks of angina pectoris became rare, but attacks of 
bronchospasm became more often. Point out the drug, which was 
prescribed to the patient.  
A. Nitrosorbide. 
B. Atenolol. 
C. Anaprilinum (propranolol). 
D. Verapamil. 
E. Diltiazem. 
11. Broncho-obstructive syndrome (deterioration of breathing, cough) 
has developed in a patient during the treatment of сiliary arrhythmia. 
Indicate the antiarrhythmic drug which can cause such complication. 
A. Novocainamidum (procainamide). 
B. Ajmalin. 
C. Nifedipine. 
D. Verapamil. 
E. Anaprilinum (propranolol). 
12. A doctor has prescribed anaprilinum to a patient who suffers from 
hypertensive disease. In two weeks from the start of treatment the patient 
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began to complain of asthma feeling and deterioration of breathing. Explain 
the possible cause of this complication and doctor’s tactics in this case.  
A. Allergic reaction. To cancel anaprilinum and prescribe  
H1-histaminoblockers. 
B. Blockade of β1-adrenoceptors. To prescribe selective β2-adrenoblocker. 
C. Myotropic bronchospastic action. To prescribe euphyllinum 
(aminophylline). 
D. Excitation of M-cholinoceptors. To prescribe atropine.  
E. Blockade of β2-adrenoceptors. To prescribe selective  
β1-adrenoblocker. 
13. A 50-year-old female suffers from hypertensive disease and ulcer 
disease of stomach with increased production of hydrochloric acid. Indicate 
the drug which is contraindicated to this patient for treatment of 
hypertensive disease. 
A. Nifedipine (phenygidine). 
B. Dibazol. 
C. Spironolactone. 
D. Reserpine. 
E. Furosemide. 
14. A 50-year-old patient suffers from ischemic heart disease, сiliary 
arrhythmia, and cardiosclerosis. Choose the drug which is necessary to 
prescribe to this patient.  
A. Potassium chloride. 
B. Metoprolol. 
C. Acetylsalicylic acid.  
D. Digoxin. 
E. Strophanthin. 
15. A patient who suffers from hypertensive disease of the  
I stage, took the drug A in tablets. In several weeks he began feeling pain in 
stomach, nausea, apathy, sleepiness. What drug is the cause of these 
adverse effects? 
A. Reserpine. 
B. Captopril. 
C. Chlorothiazide (dichlothiazidum). 
D. Octadinum. 
E. Phenygidine. 
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16. It is necessary to prescribe antiarrhythmic drug to a patient who 
suffers from сiliary arrhythmia and bronchial asthma. Indicate 
antiarrhythmic drug which is contraindicated to this patient. 
A. Novocainamidum (procainamide). 
B. Ajmalin. 
C. Verapamil. 
D. Nifedipine. 
E. Anaprilinum (propranolol). 
17. Anaprilinum therapy caused a positive effect in the dynamic of the 
disease of a 44-year-old woman suffering from stenocardia. What is the 
main mechanism of the effect of this drug? 
A. Decrease of oxidative exchange in myocardium due to enzyme 
blockade of Krebs cycle. 
B. Increased oxygen supply to the myocardium. 
C. Decreased power inputs of myocardium due to reduced loading. 
D. Decreased need in increasing of oxygen supply to the myocardium. 
E. Blockade of -adrenoceptors and decrease of myocardial 
requirements to the oxygen.  
18. Propranolol has been prescribed to a 36-year-old female patient 
suffering from ischemic heart disease. But the doctor decided to replace 
this drug by atenolol due to concomitant disease. What disease was found 
by the doctor? 
A. Cholecystitis. 
B. Bronchial asthma.  
C. Arterial hypertension. 
D. Duodenal ulcer. 
E. Myasthenia. 
19. A 60-year-old woman, suffering from toxic goiter, complains of 
constant palpitation. What drug should be prescribed for normalization of 
heart rate? 
A. Pentamine. 
B. Isadrinum. 
C. Propranolol.  
D. Salbutamol. 
E. Adrenaline hydrochloride. 
20. For the treatment of angina a selective 1-adrenergic blocker, which 
has no internal sympathomimetic activity, was prescribed. It is known that 
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the drug is lipophilic, has average duration of action and is produced in 
tablets and ampoules. What is this drug? 
A. Metoprolol.  
B. Propranolol.  
C. Talinolol. 
D. Benzohexonium. 
E. Drotaverine. 
21. Therapy with propranolol has positively affected the course of the 
disease of a 44-year-old woman with angina pectoris. What is the 
mechanism of antianginal action of this drug? 
A. Decrease of the need for oxygen and increase of the coming of 
oxygen into the myocardium. 
B. Decrease of the oxidative exchange in the myocardium due to the 
inhibition of the enzymes of Krebs cycle. 
C. Decrease of myocardium energy consumption due to the decrease of 
load. 
D. Increase of oxygen coming into the myocardium.  
E. Inhibition of 1-adrenoceptors and decrease of the need of the 
myocardium for oxygen. 
22. A patient suffering from ischemic heart disease did not inform the 
doctor about the attacks of bronchospasm he sometimes had, the doctor 
prescribed a drug, the intake of which made the attacks of angina pectoris 
less frequent, but the attacks of bronchospasm became more frequent. What 
drug has been prescribed? 
A. Propranolol.  
B. Diltiazem. 
C. Verapamil. 
D. Nitrosorbide. 
E. Nitroglycerin. 
23. For the treatment of ischemic heart disease a patient has been given 
-adrenoreceptor antagonist. After a while he had a cough and 
bronchospasm. Which of the drugs has such evident side action? 
A. Metoprolol. 
B. Talinolol. 
C. Atenolol. 
D. Propranolol.  
E. Nifedipine. 
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24. Bronchoconstriction has developed in a hypertensive patient after 
an intake of a drug. What drug causes bronchoconstriction? 
A. Isosorbide mononitrate. 
B. Nitroglycerin. 
C. Corglycon. 
D. Propranolol. 
E. Amiodarone. 
25. Antihypertensive agent has decreased the blood pressure during 
first several days of treatment owing to reducing the minute heart volume. 
In four weeks of using, the minute heart volume restored to an initial level 
but the blood pressure remained low. Indicate the drug which is used in this 
case.  
A. Losartan. 
B. Prazosin. 
C. Anaprilinum. 
D. Methyldopa.  
E. Octadinum. 
26. Drag A is prescribed to a patient with ischemic heart disease for 
prevention of angina attacks. Indicate this drug. 
A. Metoprolol. 
B. Furosemide. 
C. Atropine sulfate. 
D. Morphine. 
E. Oxytocin. 
27. A patient with hypertensive disease is delivered to a cardiologic 
department. The doctor prescribed him the hypotensive drug which blocks 
both 1- and 2-adrenoceptors. Indicate this drug. 
A. Indomethacin. 
B. Proserinum. 
C. Celecoxib. 
D. Prednisolone. 
E. Anaprilinum. 
28. A patient with coronary artery disease was admitted to the 
cardiological department. For stenocardia prevention a drug from the group 
of β-adrenoceptor blockers was administered. What drug is it? 
A. Atropine sulfate. 
B. Morphine hydrochloride. 
C. Metoprolol. 
D. Oxytocin. 
E. Furosemide. 
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DRUGS INFLUENCING CENTRAL NERVOUS 
SYSTEM 
 
General Anaesthetics  
 
General anaesthetics induce reversible physiological state which is 
characterized by analgesia, loss of consciousness and all types of 
sensitivity, inhibition of reflexes, and skeletal muscle relaxation.  
General anaesthetics vary in their chemical and physical 
characteristics and in their usual routes of administration.  
General anaesthetics are classified as follows:  
1. Inhalational general anaesthetics. 
1.1. Volatile liquids: diethyl  ether , halothane  (f luothane),  
enflurane, and isoflurane. 
1.2. Gases: nitrous oxide (N2O). 
2. Intravenous anaesthetics. 
2.1. Drugs with short duration of action: propanidid (sombrevin) 
and ketamine (ketalar).  
2.2. Drugs with intermediate duration of action: barbituric acid 
derivatives thiopental sodium and hexenalum (hexobarbital ); 
2.3. Drugs with long duration of action: sodium oxybutyrate  
(oxybate sodium).  
The phenomenon of general anaesthesia was discovered in 1846, when 
Morton showed the use of ether as a general anaesthetic. In a year, several 
Russian scientists (F. I. Inozemtsev, N. I. Pirogov, N. L. Vancetti, and 
V. A. Karavaev) practically simultaneously fulfilled surgical operations 
under ether anaesthesia. Many other general anaesthetics have been derived 
later and are available for use nowadays. 
 
Mechanism of Action  
All effects of general anaesthetics are associated with the inhibition of 
synaptic impulces transmission on the different levels of the central 
nervous system: cerebral cortex, diencephalon, midbrain, spinal cord, etc. 
There are different theories which explain the mechanisms of action of 
general anaesthetics: coagulative, proteinic, lipoid, absorption, 
thermodinamic theory, etc. But none of them can explain the mechanism of 
action of all general anaesthetics at the neuronal level. It should be noticed 
that mechanisms of anaesthetic effect can significantly differ for different 
drugs due to their different chemical structure.  
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General anaesthetics are built in the neuronal membranes and change 
their structure and function of sodium and calcium channels. The following 
reduction of intracellular sodium results in reduction of neuronal 
excitability. Reduction of intracellular calcium concentration affects the 
release of mediators by presynaptic membranes. Due to this, the activity of 
adrenergic transmission in the central nervous system decreases with 
simultaneous activation of GABA-ergic and opioidergic activity. Besides, 
general anaesthetics inhibit dopaminergic, cholinergic, and serotoninergic 
transmission in the central nervous system.  
There are general anaesthetics which exhibit anaesthetic activity due to 
interaction with certain receptors. Thus, derivatives of barbituric acid bind 
to barbiturate receptors which are the part of benzodiazepine-barbiturate-
GABA receptor complex. It results in an increase of sensitivity of  
GABAA-receptors to GABA with the following opening of chlorine 
channels and hyperpolarization of neuronal membrane. Ketamine is 
antagonist of N-methyl-D-aspartic acid (NMDA) receptors. At the same 
time, the action mechanism of diethyl ether, nitrous oxide, halothane and 
other inhalational anaesthetics is not associated with specific influence 
upon the certain receptors. Anaesthetic effects of these drugs result from 
their interaction with neuronal membranes in the central nervous system. 
Independently from the mechanism of action, the final result of action of all 
drugs is inhibition of synaptic transmission of excitement in the central 
nervous system. 
The state of general anaesthesia is divided into the following stages: 
I – Stage of analgesia. 
II – Stage of excitement. 
III – Stage of surgical anaesthesia which is divided into 4 levels: 
– 1st level – superficial anaesthesia; 
– 2nd level – light anaesthesia;  
– 3rd level – deep anaesthesia;  
– 4th level – super-deep anaesthesia.  
IV – Stage of respiratory paralysis (overdose). 
It is the general scheme of anaesthesia, but it can differ for different 
drugs.   
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Inhalational Anaesthetics  
 
The inhalational anaesthetics are divided into two groups depending 
on their physical properties: gases (nitrous oxide and cyclopropane) and 
volarile liquids (diethyl ether, halothane, etc.).  
Inhalational anaesthetics require the special anaesthesia machine for 
their dosage. At inspiration, anaesthetics are absorbed in the blood from the 
lungs and distributed into the different tissues. The higher drug 
concentration increases in the blood and tissues, the faster general 
anaesthesia develops. This process depends on concentration of a drug in 
the inhaled air, frequency and depth of respiration, solubility of anaesthetic 
in the blood and other factors. 
There are certain requirements to general anaesthetics: 
– drugs should not irritate mucous membranes; 
– anaesthesia should develop quickly and without stage of excitement;  
– anaesthesia should be easily manageable; 
– anaesthetic should not cause toxic and side effects; 
– period of recovery should be short, without afteraction; 
– anaesthetic should be fire-safe.   
   Diethyl ether  is volatile liquid with irritative properties. High 
activity and relatively low toxicity of diethyl ether allow to achieve the 
necessary depth of anaesthesia and relaxation of skeletal muscles at 
sufficient oxygen concentration in inhaled air. Ether anaesthesia is easily 
manageable.    
The ether anaesthesia is characterized by all well expressed stages of 
anaesthesia.  
The stage of analgesia lasts for 1–3 minutes. This stage begins with the 
start of anaesthetic inhalation and lasts to the loss of consciousness. It is 
manifested by loss of pain sensitivity with partial preservation of other 
types of sensitivity and consciousness. But after anaesthesia, a patient 
develops amnesia on events taking place during this period.  
The stage of excitement lasts 10–20 minutes. This stage is the result of 
the reduction of inhibitory control of cortical centres over the subcortical 
centres of brain (“riot” of subcortex). The manifestations of this stage are 
motor and verbal agitation, loss of consciousness, increased muscular 
activity, nonstable blood pressure, tachypnoea, and hyperventilation. Due 
to irritative activity of ether, cough, laryngeal spasm, hypersecretion of 
salivary and bronchial gland, nausea, and vomiting can occur. Apnea and  
a sudden cardiac arrest can develop owing to irritation of upper respiratory 
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tract. These effects are prevented by atropine administration. The pupils are 
dilating. 
The stage of surgical anaesthesia is characterized by a loss of 
consciousness and pain sensitivity, inhibited reflexes, regular respiration, 
and stabilization of the blood pressure. Diethyl ether well relaxes the 
skeletal muscles and potentiates the action of curare-like agents. 
At ether overdose, the stage of respiratory paralysis develops. This 
stage is characterized by severe depression of the vital medullary centres 
that leads to progressive decrease of the blood pressure and respiration, and 
cardiac arrest. It is clear, that the deepening of the anaesthesia up to this 
stage is inadmissible. 
Diethyl ether activates the central links of sympathoadrenal system 
that leads to the release of adrenaline from the adrenal medulla. The drug 
inhibits the renal function. But as a rule, renal function normalizes itself in 
post-operative period.    
In case of deep anaesthesia, the acidosis develops. 
Recovery after ether anaesthesia develops gradually (for 30 minutes). 
The full restoration of brain activity needs several hours. An analgesia is 
typical for post-anaesthetic period. Also, vomiting is possible during 
recovery period.  
Diethyl ether has insignificant influence upon cardiovascular system. 
It is due to the direct inhibitory action of ether upon the heart and 
vasculature and simultaneous stimulative action upon sympathoadrenal 
system. 
Hepatotoxicity of diethyl ether is low and is dangerous for patients 
suffering from hepatic diseases. In other patients, ether can cause functional 
hepatic disorders which disappear in 5–7 days after anaesthesia.  
In post-operative period, an elevation of glucose, lactic and pyruvic 
acids, and acidosis are observed.  
Disadvantages of diethyl ether are the marked stage of excitement and 
expressed irritation of mucous membranes of respiratory tract. The last one 
leads to laryngeal and bronchial spasm choking feeling and increased 
bronchial secretion. An irritation of mucous membranes of stomach can 
provoke the vomiting.  
Halothane  has high anaesthetic activity that is 3–4 times higher than 
the activity of diethyl ether. An anaesthesia develops in 3–5 minutes after 
the start of halothane inhalation. The stage of excitement is insignificant or 
absent. Halothane does not irritate mucous membranes, does not stimulate 
bronchial secretion, and does not cause laryngeal spasm. Halothane 
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anaesthesia is easily manageable. After the stop of halothane inhalation, 
patient recovers in 5–10 minutes. As a rule, afteraction is absent. Halothane 
anaesthesia is accompanied by satisfactory muscular relaxation. The drug 
potentiates the effect of curare-like agents. Despite halothane inhibit the 
respiratory centre in certain degree, this effect quickly disappears after 
cessation of halothane inhalation.  
Halothane suppresses the force of cardiac contraction, reduces the 
stroke volume and cardiac output, and lowers the blood pressure. 
Hypotension is a result of direct myotropic antispasmodic action of 
halothane, reduction of cardiac output, and inhibition of vasomotor centre 
and sympathetic ganglia.  
Halothane increases the sensitivity of the heart to adrenaline that can 
cause the arrhythmias and even ventricular fibrillation. Therefore, 
administration of adrenaline, noradrenaline, and ephedrine is 
contraindicated at halothane anaesthesia. If it is necessary to increase the 
blood pressure, mesatone is administered.  
Halothane inhibits salivary, bronchial, and gastrointestinal secretion. 
Dispite the fact that halothane insignificantly influences hepatic function, it 
is contraindicated to patients with hepatic diseases. Halothane slightly 
reduces renal blood circulation and urination. These changes disappear 
after the cessation of anaesthesia. Unlike diethyl ether, halothane is non-
inflammable agent. 
Nitrous oxide  provides almost immediate development of 
anaesthesia. As a rule, the stage of excitement is absent. Nitrous oxide does 
not exhibit irritative action and does not have negative influence upon 
parenchymatous organs. After-anaestitic period is characterized by a very 
fast recovery. Nitrous oxide has low anaesthtic activity and does not cause 
necessary muscular relaxation. For a necessary depth of anaesthesia, the 
high contration of nitrous oxide is necessary in inhaled air (about 95 %). A 
use of such concentration is impossible because it is accompanied by 
expressed hypoxia (concentration of oxygen is only 5 %).  As a rule, the 
mixture, containing 80 % of nitrous oxide and 20 % of oxygen, is used in 
anaesthesiology. Such combination provides an opportunity to achieve the 
initial plane of surgical anaesthesia. To increase the depth of anaesthesia 
and relaxation of skeletal muscles, nitrous oxide is used in combination 
with potent anaesthetics (diethyl ether, halothane, barbituric acid 
derivatives, etc.) and myorelaxants.  
Besides inhalational anaesthesia, nitrous oxide is used to relieve pain 
at myocardial infarction, traumas, parturition, and in postoperative period. 
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The early use of nitrous oxide prevents the shock development in patients 
with severe traumas. It should be noticed that long-time inhalation (more 
than a day) of nitrous oxide can lead to leukopenia, megaloblastic anaemia, 
thrombocytopenia, and neutropenia. 
 
Drugs for Non-Inhalation Anaesthesia  
 
As a rule, drugs for non-inhalation anaesthesia are administered 
parenterally, sometimes – enterally. In comparison with inhalational 
anaesthetics, these drugs have some advantages, because provide high 
speed of anaesthesia development without stage of excitement, do not 
require the special anaesthesia-respiratory apparatus, do not induce 
vomiting, etc.  
Non-inhalation anaesthetics are classified as follows: 
1. Drugs with short duration of action (duration of anaesthesia is about 
15 minutes): propanidid (sombrevin) and ketamine (ketalar) . 
 2. Drugs with intermediate duration of action (20–30 minutes): 
barbituric acid derivatives thiopental sodium and hexenalum 
(hexobarbital) ; 
3. Drugs with long duration of action (60 minutes and more): sodium 
oxybutyrate (oxybate sodium).    
Propanidid  (sombrevin ) is intravenous anaesthetic with ultrashort 
duration of action. After intravenous administration of the drug, anaesthesia 
develops in 20–40 seconds without stage of excitement and lasts 4–8 
minutes. A short duration of action is due to the fast hydrolysis of the drug 
by butyrylcholinesterase (also known as pseudocholinesterase). After 
anaesthesia, the inhibition of central nervous system activity does not 
appear. Before anaesthesia, the hyperventilation of lungs with short-time 
apnoe is possible with the following normalization of breath. Minor 
tachycardia and increase of blood pressure are possible during anaesthesia. 
Propanidid exhibits a local irritative effect that can cause hyperemia and 
pain in the veins. Also, formation of clots is possible. Propanidid is used for 
the induction anaesthesia and for short-term operations.    
Ketamine  (ketalar) is antagonist of NMDA (N-methyl-D-
aspartate) receptors. Ketamine is administered intravenously or 
intramuscularly.  Anaesthesia develops in 30–60 seconds if the drug is 
administered intravenously, and in 2–6 minutes – in case of intramuscular 
administration. The duration of ketamine’s anaesthesia is about 5–
15 minutes (intravenous administration) and 15–30 minutes (intramuscular 
administration).  
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The drug causes the so-called “dissociative anaesthesia” because 
ketamine inhibits some structures of the central nervous system without 
influence upon others. Ketamine does not directly inhibit the functions of 
cortex and brainstem; their changes have a secondary character. 
Dissociative anaesthesia is characterized by amnesia, expressed analgesia, 
slight hypnotic effect, and partial loss of consciousness. The drug does not 
provide muscular relaxation, pharyngeal and cough reflexes are saved. 
Ketamine increases the blood pressure, heart rate, and intracranial pressure. 
Hypersalivation is also possible. Ketamine exhibits the moderate 
broncholytic effect. Ketamine commonly causes hallucinations, 
disorientation, agitation, and vivid dreams during recovery. The drug is 
used for induction anaesthesia or for maintenance of anaesthesia during 
short-term operations or painful procedures (e. g., bronchoscopy, dressing 
of burns, abortions). In combination with tranquilazers or neuroleptics, 
ketamine may be used for long-time anaesthesia.    
Thiopental sodium  administered intravenously causes the fast 
anaesthesia without stage of excitement. Anaesthesia lasts 20–30 minutes. 
The short duration of anaesthesia is the result of the drug redistribution due 
to high solubility of thiopental in lipids. Analgesia is poorly expressed. 
Thiopental sodium is a potent respiratory depressant: both frequency and 
depth of breathing movements are reduced. Thiopental sodium inhibits the 
vasomotor centre and cardiac output and decreases the blood pressure. A 
fast drug administration can lead to collapse. Thiopental sodium exhibits 
the local irritative effect. Thiopental sodium is used for induction 
anaesthesia, for anaesthesia during short operations. Also, thiopental may 
be used to cessate convulsions. 
Pharmacological properties of hexenalum (hexobarbital)  are 
similar to properties of thiopental sodium. But it should be noticed that 
hexenalum has more expressed cardiodepressive effect and provokes 
convulsions more frequently. The indications for use of hexenalum are 
identical to thiopental.    
Sodium oxybutyrate  is GABA derivative. The drug easily 
penetrates the central nervous system. Sodium oxybutirate exhibits 
sedative, hypnotic, antihypoxic, narcotic, and anticonvulsive effects. The 
analgesic action of sodium oxybutyrate is low. The drug causes expressed 
relaxation of skeletal muscles, increases the resistance of brain and heart to 
hypoxia. The anaesthetic effect of sodium oxybutirate is moderate. 
Therefore, for general anaesthesia, the sodium oxybutyrate is administered 
in high doses. The anaesthesia develops without the stage of excitement. At 
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intravenous administration, the stage of surgical anaesthesia develops in 
30–40 minutes; in case of peroral intake – in 40–60 minutes. The 
anaesthesia lasts 1–3 hours.  
The drug administration is accompanied by the minor decrease of 
frequency and simultaneous increase of depth of breathing. The 
bradycardia and insignificant increase of the blood pressure are commonly 
observed. Also, vomiting is possible. 
In combination with active analgesics and other general anaesthetics, 
sodium oxybutyrate is used for introduction and basic anaesthesia, for 
analgesia of parturition, in the treatment for hypoxic brain oedema and 
shock. Also, the drug is used as sedative and hypnotic agent.     
 
Preanesthetic Medication 
 
Preanesthetic medication is the term applied to the use of drugs before 
the administration of general anaesthetics. Preanesthetic drugs are used for 
the following aims: 
– to sedate a patient and reduce fear; 
– to prevent such side effects of general anaesthetics as cardiac arrest, 
vomiting, bronchospasm, hypersalivation, and hypersecretion of bronchial 
glands; 
– to provide rapid onset of anaesthesia without stage of excitement; 
– to decrease pre- and postoperative pain. 
As preanesthetic agents, the following groups and drugs are used: 
opioid analgesics (morphine, etc.), tranquilizers (diazepam, etc),  
M-cholinergic antagonists (atropine and scopolamine), and antiemetic 
agents (metoclopramide, etc.). 
 
Table 13 – Drugs for prescription 
 
 
Drug name 
(Latin) 
Single dose and route  
of administration 
Drug product 
1 2 3 
Propanididum Intravenously 0.005– 
0.01 g/kg 
Ampoules 10 ml of 5 % 
solution 
Hexenalum Intravenously 0.5–0.7 g Vials 1.0 g of powder for 
injection (dissolved before 
administration in 50 ml of 
sterile 0.9 % sodium chloride 
solution) 
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Continuation of the table 13 
1 2 3 
Thiopentalum-
natrium 
Intravenously 0.4–0.5 g  Vials 0.5 g or 1.0 g of 
powder for injection 
(dissolved before 
administration in 50 ml of 
sterile 0.9 % sodium chloride 
solution) 
Natrii oxybutyras Intravenously 0.07– 
0.12 g/kg; 
orally 0.1–0.2 g/kg (for 
general anaesthesia); 
orally 2–3 table spoons 
before bedtime (to treat 
insomnia)  
Ampoules 10 ml of 20 % 
solution; 
vials 400 ml of 5 % syrup 
Ketaminum Intramuscularly 0.006 g/kg or 
intravenously  
0.002 g/kg 
Vials 20 ml of  
5 % solution; 
ampoules 2.5 and 5 ml of 5 % 
solution  
 
Step 1. Tasks for Self -Control  
General Anaesthetics  
 
1. Proserinum in case of systemic administration increases the tone of 
skeletal muscles. Phthorothanum (fluothane, halothane) causes relaxation 
of skeletal muscles and decreases the effects of proserinum. Point out the 
character of interaction with proserinum and phthorothanum.  
A. Noncompetitive antagonism. 
B. Indirect functional antagonism. 
C. Direct functional antagonism. 
D. Competitive antagonism. 
E. Independent antagonism. 
2. An anaesthesiologist has used nitrous oxide as general anaesthetic 
during operation. This drug has significant solubility in lipids. Indicate the 
mechanism of penetration of this drug through biological membranes. 
A. Pinocytosis. 
B. Active transport. 
C. Passive diffusion. 
D. Simplified diffusion. 
E. Filtration. 
202 
 
3. To anaesthetize the manipulation related to the burn surface 
treatment, a drug for short-acting narcosis was intravenously injected to  
a patient. A minute later, blood pressure increased, tachycardia appeared, 
the tone of skeletal muscles increased; reflexes remained. After awakening, 
the patient had disorientation and visual hallucinations. What drug was 
injected to the patient? 
A. Ketamine.  
B. Nitrous oxide. 
C. Sombrevin. 
D. Diethyl ether. 
E. Thiopental sodium. 
4. Proserinum raises skeletal muscle tone when given systematically. 
Halothane induces relaxation of skeletal muscles and reduces proserinum 
effects. What is the nature of proserinum and halothane interaction? 
A. Indirect functional antagonism. 
B. Noncompetitive antagonism. 
C. Independent antagonism. 
D. Competitive antagonism. 
E. Direct functional antagonism. 
5. For initial anaesthesia, an anaesthesiologist administers thiopenthal 
sodium to a patient. Owing to this, hypersalivation and laryngospasm are 
developed in the patient. Which drug can prevent these complications? 
A. Salbutamol.  
B. Adrenaline. 
C. Proserinum. 
D. Atropine. 
E. Ephedrine. 
6. For general anaesthesia, an anaesthesiologist uses a combination of 
inhaled anaesthetic and derivative of barbituric acid. Choose this 
combination.  
A. Droperidol and ether. 
B. Promedol and halothane. 
C. Nitrous oxide and ketamine. 
D. Halothane and fentanyl.  
E. Thiopental sodium and halothane. 
7. Acute hepatitis developed in a patient after surgery with repeated use 
of sorting general anaesthetic. Which anaesthetic drug is used? 
A. Ether. 
B. Halothane (phthorothanum). 
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C. Nitrous oxide. 
D. Thiopental sodium. 
E.  Propanidid. 
8. Anaesthesiologist administers general anaesthetic with prolonged 
phase of excitation to a patient. Which drug is administered? 
A. Oxybutyrate sodium.  
B. Phthorothanum (halothane). 
C. Ether. 
D. Nitrous oxide. 
E. Propanidid. 
9. Progressive drop of blood pressure is developed in a patient under 
the general anaesthesia. Doctor administers the injection of adrenaline to 
him. Owing to this, ventricular fibrillation is developed in the patient. 
Indicate the general anaesthetic which is used for narcosis in this case.  
A. Ketamine. 
B. Nitrous oxide. 
C. Sodium oxybutyrate. 
D. Sodium thiopental. 
E. Phthorothanum.  
 
Hypnotic Drugs 
 
Sleep is an active process developing due to increase of activity of 
brain hypnotic system (lower parts of the cerebral trunk, basal nuclei of the 
forebrain, lateral prethalamic and medial thalamic areas, and caudate 
nucleus). The activity of stimulating the ascending part of the reticular 
formation (rostral part of reticular formation) during sleep is decreased. The 
changes in the balance of mediators that lead to sleep are not completely 
clear.    
Sleep is not a uniform process. It includes 2–4 cycles consisting of 
synchronized or non-REM (REM – rapid eye movement) sleep and 
desynchronized (REM sleep) phases.  
In turn, the synchronized sleep consists of four stages with different 
depths of sleep and EEG (electroencephalogram) characteristics: I stage 
(transition from a state of vivacity to drowsiness), II stage (drowsiness), III 
stage (superficial sleep), and IV stage (deep sleep). A phase of 
synchronized sleep lasts about 1.5 hours. Generally, the phase of 
synchronized sleep constitutes about 75 % of the sleeping time. During this 
phase, metabolism slows down, body temperature reduces, blood pressure 
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decreases, and vagal tone elevates. The deficit of synchronized sleep causes 
the feeling of chronic tiredness, alarm, and decrease of mental performance.  
Desynchronized sleep is characterized by low voltage activity on the 
EEG. This phase is accompanied by quick eye movements and dreams. The 
duration of desynchronized sleep is approximately 25 % of the sleeping 
time. The deficit of desynchronized sleep leads to a significant change of 
psyche and behaviour, and hallucinations.  
Sleep disorders require non-pharmacological or pharmacological 
treatment. Non-pharmacological therapies that are sometimes useful for 
sleep disorders include proper diet and exercises, avoiding stimulants 
before retiring to bed, ensuring a comfortable sleeping environment, and 
retiring at the usual time every night. However, sometimes patients need 
a sedative-hypnotic agent during the limited period.  
Hypnotic drugs are classified as follows:  
1. Barbituric acid derivatives: phenobarbital . 
2. Benzodiazepine derivatives: nitrazepam, nozepam 
(oxazepam), phenazepam, diazepam, lorasepam, f lurazepam, 
temazepam, and triazolam . 
3. GABA derivatives: sodium oxybutyrate  and phenibut .  
4. Aliphatic compounds: chloral hydrate  and bromisoval . 
5. Cyclopyrolone derivatives: zopiclone (Imovane).  
6. Imidazopyridine derivatives: zolpidem (Ivadal).  
7. Ethanolamine derivative: doxylamine  (Donormyl).   
Besides, drugs of other pharmacological groups are used to treat 
insomnia: small doses of neuroleptics, antidepressants with sedative effects, 
sedative drugs and antihistamines.  
It should be noticed that only two drugs – sodium oxybutirate and 
chloral hydrate – induce sleep that is close to the physiological one.    
There are three forms of sleep disorders.  
Neurastenia or overwork can provoke the disturbances of falling 
asleep, especially in young people. To fall asleep, a patient needs several 
hours, after that the deep and long enough sleep develops. For treatmernt of 
this disorder, hypnotic drugs with short or moderate duration of action are 
preferable.  
Significant part of patients suffer from both disturbances of falling 
asleep and, in general, disturbances of depth and duration of sleep. Their 
superficial sleep is characterized by frequent awakenings. A ratio of 
synchronized and desynchronized sleep changes in favor of the latter. Such 
patients need hypnotic drugs with long duration of action.  
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For aged people with atherosclerosis of cerebral vessels, short-time 
sleep (2–5 hours) with disturbances of falling asleep is typical. Hypnotic 
drugs with short action (at the time of nightly awakening) or long-acting 
drugs in the evening are recommended for these patients.   
 
Barbituric Acid Derivatives 
 
Barbiturates bind to barbiturate receptors modulating an activity of 
GABAA-receptors. It leads to the increase of inhibitory inflence of GABA 
in the central nervous system. Besides, barbiturates suppress the action of 
excitatory mediators (glutamic and aspartic acids). Hypnotic effect of 
barbiturates develops due to inhibition of ascending reticular activating 
system of the brainstem. It results in the decrease of the tonic pulses to the 
cortex and development of sleep.  
Barbiturates decrease the latency of sleep onset (time to fall asleep) 
and increase the total duration of sleep. Under barbirurate influence, the 
duration of stages 2 and 3 of synchronized sleep is increased. But drugs 
decrease duration of stages 1 (superficial sleep) and 4 (deep, slow-wave 
sleep) of non-REM sleep. It should be noticed that barbiturates 
significantly decrease duration of desynchronized sleep.  Hypnotic effect 
develops in 30–40 minutes after a drug intake and lasts 6–8 hours.  
Due to such peculiarities of action, barbiturates are prescribed to treat 
sleep disordes with prevalence of desynchronized sleep. Cyclobarbital may 
be prescribed to treat disturbances of falling asleep, because the drug has 
short duration of action (4–6 hours).  
Duration of drug action is determinated by different factors, foremost 
– by microsomal oxidation in the liver. Barbiturates induce microsomal 
enzymes that lead to elevation of speed of their biotransformation at 
repeated intakes.  
Duration of drug action also depends on the speed of its excretion 
from the kidneys, its redistribution in an organism. Material cumulation is 
typical for lipophilic drugs accumulated in the fat tissue. The half-life of 
phenobarbital in humans is 4–5 days. This drug is characterized by the 
most expressed material cumulation. 
The disadvantages of barbiturates are the following: 
1. Narrow therapeutic index: drug doses which 5–10 times exceed 
therapeutic doses cause expressed intoxication symptoms, such as a state of 
general anaesthesia. 
2. Alteration of sleep structure with severe syndrome of “REM 
rebound” after discontinuation of drug intake. “REM rebound” syndrome is 
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characterized by a significant increase of general duration of 
desynchronized sleep. Vegetative and humoral functions of the body, that 
increased during desynchronized sleep, increase the risk of myocardial 
infarction and insult.  
3. Fast development of drug dependence accompanied by severe 
psychical and physical disordes (abstinence syndrome): anxiety, irritability, 
fear, vomiting, sleep disorders, vision disorders, convulsions, postural 
hypotension, etc. The addiction to barbiturates can develop after  
1–3 months of the barbiturate intake. 
4. Tolerance is the result of barbiturates ability to induce the 
microsomal hepatic system. Tolerance develops after 2 weeks of regular 
barbiturate intake. 
5. A phenomenon of after-action (flaccidity, weakness, disturbance of 
psychomotor reactions and attention) is observed even after a single intake 
of long-action barbiturates.  The slower is the drug elimination, the more 
apparent is its after-action.  
Also, small doses of barbiturates (1/2–1/3 of a hypnotic dose) exhibit 
sedative effect. High doses of barbiturates act as anticonvulsants.  
Barbiturate overdose leads to general depression of the central nervous 
system, reduction of pulmonary ventilation, and drop of blood pressure. 
Severe intoxication results in coma. Hypotension is due to the inhibition of 
vasomotor centre in medulla oblongata, drug influence upon the heart and 
sympathetic ganglia, and direct vasodilating action of drugs. Besides, 
barbiturates violate renal function.  
A treatment of poisoning by barbiturates includes the following 
measures:  
1. Increase of barbiturate elimination from the body: gastric lavage, 
forced diuresis (administration of significant volumes of electrolytes 
solutions together with osmotic diuretics or furosemide), administration of 
alkaline solutions (intravenous sodium hydrocarbonate solution), saline 
laxatives, and hemodialysis.    
2. Restoration of pulmonary ventilation and blood circulation.  
3. Administration of antidote. Bemegride is analeptic drug. But, its 
administration is possible only at the light form of poisoning, because at 
severe poisoning the drug can even aggravate the patient’s condition. In 
any cases, an artificial ventilation is the most reliable method to support 
breathing. 
4. Plasma-substitution drugs and noradrenaline are administered at 
collapse.  
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5. At renal failure, hemodialysis is fulfilled.  
It should be noticed that pneumonia is possible at barbiturate 
poisoning.  
Chronic poisoning commonly develops due to the intake of drugs with 
a high ability to cumulation. Chronic poisoning is manifested by 
drowsiness, apathy, weekness, imbalance, indistinct speech, and dizziness. 
Halucinations, psychomotor excitement, convulsions, renal and hepatic 
disfunction, and indigestion are also possible.  
At barbiturate dependence, the dose of the drug is gradually reduced 
up to the full discontinuation of a drug intake. Simultaneously, 
symptomatic treatment and psychotherapy are carried out.   
 
Benzodiazepine Derivatives  
 
Benzodiazepine derivatives exhibit anticonvulsant, hypnotic, 
anxiolytic effects. These drugs are highly effective in patients with 
insomnia due to neurotic disorders. Unlike barbiturates, benzodiazepine 
derivatives change a sleep structure in less degree.  
As hypnotic agents, benzodiazepines with moderate duration of action 
(nitrazepam, lorazepam, nozepam, triazolam, flunitrazepam) and with long 
duration of action (diazepam, chlozepid, fenazepam, flurazepam) are used 
most commonly. 
Hypnotic effect of benzodiazepines is mediated by their influence 
upon limbic system. Benzodiazepine interacts with a specific 
benzodiazepine receptor which is the part of GABAA-chloride channel 
macromolecular complex. This interaction leads to the increase of 
sensitivity of GABAA-receptors to GABA. Activatated GABAA-receptors 
cause the opening of chlorine channel. Chlorine ions enter the cell that 
leads to hyperpolarization of a cellular membrane. It reduces the neuronal 
activity. Besides, benzodiazepines promote the elevation of GABA 
concentration in the brain. This effect develops due to inhibition of  
GABA-transaminase. Along with serotonin and delta-sleep-inducing 
peptide, GABA is responsible for the development of synchronized sleep. 
Benzodiazepines cause the following changes in the sleep structure:  
– the latent period of sleep onset is shortened (time to fall asleep); 
–  the duration of stage 2 of synchronized sleep is increased; 
–  the duration of REM sleep is decreased; 
–  the duration of stage 4 of non-REM sleep is decreased. More rapid 
onset of sleep and prolongation of stage 2 are clinically useful effects.  
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After a drug intake, hypnotic effect develops in 20–30 minutes and 
lasts 6–8 hours (midazolam – 2–4 hours). 
Benzodiazepines are used to treat disorders of falling asleep and other 
forms of insomnia.  These drugs are especially active as hypnotics in 
patients with emotional tension, anxiety, and alarm. Nitrazepam, 
temazepam, and flurasepam are used only as hypnotics. Other 
benzodiazepines are used more widely in medicine.   
The phenomenon of after-action (flaccidity, weakness, disturbance of 
psychomotor reactions and attention) is observed during the next day, 
especially after the intake of long-acting benzodiazepines. Therefore, 
benzodiazepines are not prescribed for persons whose work needs high 
attention.  
Midazolam is preferable at the night awakenings and disorders of 
falling asleep. Also, this drug is prescribed in cases when a long-time 
therapy of insomnia is needed. 
A long-time therapy with benzodiazepines leads to the development of 
tolerance, drug dependence, and rebound syndrome. Ethyl alcohol 
significantly increases the depressive influence of these drugs upon the 
central nervous system that can cause respiratory failure. 
Flumazenil  (Romazicon) is a competitive antagonist of 
benzodiazepine receptors. This drug is used to stop the toxic effects at 
overodse of benzodiazepines.    
 
GABA Derivatives  
 
Sodium oxybutyrate  is a GABA derivative and is known as general 
anaesthetic. This drug also has a hypnotic action. Sodium oxybutyrate 
prolongates the duration of a deep stage of the synchronized sleep without 
significant influence upon the desynchronized sleep. After a drug removal, 
rebound syndrome is mild and significantly less than in barbiturate 
derivatives. Sodium oxybutyrate does not cause the phenomenon of after-
action. As hypnotic agent, sodium oxybutyrate is prescribed in 5 % syrup 
(2–3 table spoons before bedtime). The hypnotic effect develops in 30– 
40 minutes after the drug intake and lasts 6–8 hours.  
Phenibut has low hypnotic activity. The drug is used mainly as “daily” 
tranquilizer. Phenibut does not influence the sleep structure.  
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Aliphatic Compounds 
 
As hypnotic, chloral hydrate is administered as rectal solution together 
with covering substances (because the drug has a marked local irritative 
action). A sleep develops in 30–60 minutes after the drug administration 
and lasts 6–8 hours. Phenomenon of after-action is typical for chloral 
hydrate. Besides, chloral hydrate exhibits hepato-, nephron-, and 
cardiotoxicity. 
Another hypnotic agent – aliphatic compound is bromisoval . Its 
hypnotic effect is low and non-stable.  
Both drugs are seldom used to treat insomnia.   
 
Non-Benzodiazepine Compounds  –  Agonists of  
Benzodiazepine receptors  
 
New hypnotics zopiclone  and zolpidem are non-benzodiazepine 
compounds which exhibit the affinity to benzodiazepine receptors. These 
drugs bind to BZ1 subtype of benzodiazepine receptors that facilitates the 
activation of GABAA-receptors by GABA, opening of chlorine channes, 
and hyperpolarization of a cellular membrane.  
Zopiclone  is a cyclopyrrolone derivative. Besides hypnotic action, 
the drug exhibits sedative, anticonvulsant, anxiolytic, and amnestic actions. 
Also, zopiclone is a central myorelaxant. The drug shortens the time of 
feeling asleep, decreases the quantity of night awakenings, and increases 
the total duration of a sleep. A phenomenon of after-action is absent. 
Zopiclone is not accumulated in the body. A course of treatment by 
zopiclone should not exceed 4 weeks. Its side effects are nausea, vomiting, 
headache, dizziness, allergic reactions, halucinations, discoordination, and 
nightmares. Rebound syndrome is insignificant. 
Zolpidem  is imidazopyridine derivative. The drug selectively 
interacts with BZ1 subtype of benzodiazepine receptors. The drug exhibits 
hypnotic, sedative, anxiolytic, muscular-relaxating, anticonvulsant, and 
amnestic action. Zolpidem is easily absorbed from the gastrointestinal tract. 
Its bioavailability is about 70 %. The 2/3 part of an administered dose is 
excreted through the kidneys and 1/3 – through the intestine. Side effects of 
zolpidem are allergic reactions, hypotension, excitation, halucinations, 
dispepsy, daily drowsiness, and headache.  
Flumazenil is antagonist of zolpidem and zopicline.       
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Ethanolamine Derivatives 
 
Doxylamine  (Donormyl ) is ethanolamine derivative. The drug 
blocks H1-histaminergic and M-cholienrgic receptors. Donormyl exhibits 
hypnotic, sedative, antiallergic, and peripheral M-cholinoblocking activity. 
Donormyl shortens the time of falling asleep, increase the duration of sleep, 
does not violate the sleep structure, and does not exhibit after-action. 
Donormyl is used to treat insomnia, allergic diseases, cough, and colds. Its 
side effects are a dry mouth, constipation, disorders of accommodation, 
difficulty urinating, etc. The drug is contraindicated to persons whose work 
needs high attention.  
      
Ethyl Alcohol  
  
Ethanol is substance with narcotic type of action. Ethyl alcohol causes 
the total depression of the central nervous system. At local application, 
ethanol causes denaturation and dehydration of proteins (including proteins 
of cellular membranes), that is the base of its antiseptic action. This effect 
is used to disinfect skin and surgeon’s hands, and to sterilize instruments.  
It should be noticed that 70 % ethyl alcohol provides maximal 
antibacterial effect at skin disinfection. Higher concentrations of ethanol 
exhibit less expressed antibacterial effect because fast protein denaturation 
on the skin surface prevents ethanol penetration to deep layers of skin. 90–
95 % ethanol is used to sterilize instruments.  
40 % ethanol exhibits local irritative action, whereby is used for 
compresses and rubbing. Also, ethanol is used to preserve the preparations 
of tissues and organs, as solvent and as extractant for preparation of 
tinctures and liquid extracts. 
At oral intake, ethanol increases the secretory activity of the mucous 
membranes of mouth and stomach due to its irritative action. Gastric 
secretion and digestibility of gastric juice depend on ethanol concentration. 
Thus, low concentration of ethanol (to 10 %) stimulates gastric secretion. 
Ethanol concentration, that is higher than 20 %, inhibits production of 
pepsin and reduces digestibility of gastric juice. In case of chronic alcohol 
consumption, it can cause the development of chronic gastritis. 
Ethyl alcohol is absorbed both in stomach and in intestine. 10–20 % 
ethanol is absorbed quickly, but absorption of concentrated ethanol 
solutions is slow and lasts 2–6 hours. Sometimes, concentrated ethanol 
solution causes pylorospasm.  
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Ethyl alcohol easily penetrates through the blood-brain and placentar 
barriers. Children, born by mothers who abuse alcohol, often are mentally 
underdeveloped.  
About 90 % of taken alcohol undergoes hepatic oxidation by alcohol 
dehydrogenase with formation of acetaldehyde. The subsequent 
metabolism of acetaldehyde is very slow. Therefore, accumulation of 
acetaldehyde causes the development of marked intosixation (handover): 
headache, disorders of heart work, etc. Metabolism of ethanol is slowed in 
persons with hepatic diseases.  
Long-time intake of ethyl alcohol leads to expressed psychical 
disorders (delirium tremens).  
Ethyl alcohol has a high energetic value (7 kcal are released at burning 
of 1 g of ethanol). This property is sometimes used in the treatment for 
patients with fever when body proteins are catabolized. Also, ethanol is 
used in the treatment of depleted patients (after operations on 
gastrointestinal tract, at prolonged vomiting, etc.). In such cases, a small 
amount of ethyl alcohol is added to solutions for intravenous infusions. 
Ethanol significantly influences thermoregulation, increasing both 
a heat production and a heat emission.  
Ethanol decreases the vasopressin release by posterior pituitary that 
leads to the increase of diuresis. 
Ethanol exhibits mainly inhibitory influence upon the central nervous 
system. There are four stages of its influence upon CNS: analgesia, 
excitement, general anaesthesia, and agony. Most commonly, alcoholic 
intoxication is manifested by excitation developed due to the reduction of 
inhibitory processes in the central nervous system. It is accompanied by 
loss of critical attitude to own actions and people around. High doses of 
ethanol directly inhibit the brain cortex.   
Narrow therapeutic index and marked stage of excitement do not allow 
to use ethanol as general anaesthetic. But, ethyl alcohol sometimes may be 
used as anti-shock agent owing to its marked analgesic property.  
Ethanol is used in medical practice as follows:  
– antiseptic agent: 95 % ethanol – for disinfection of medical 
instruments and 70 % ethanol – for disinfection of surgeon’s hands and 
skin; 
– for compress – 40 % ethanol; 
– foam-extinguisher for treatment of pulmonary oedema: ethanol is 
used for inhalation, or 20–30 % ethanol in sterile isotonic solution of 
sodium chloride is administered intravenously; 
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– for treatment of methanol’s poisoning (orally 300–400 ml 30 % 
ethanol per day or 5 % ethanol intravenously drop-by-drop in dose which 
equals 1ml per 1 kg of weight of a patient per day). In this case ethanol 
competes with methanol for active centre of enzyme “aldehyde 
dehydrogenase” and lowers toxic effects of methanol.  
Excessive ethanol intake can lead to acute poisoning. The degree of 
ethanol intoxication depends on its blood concentration: concentration  
1–2 g/l causes inebriation, 3–4 g/l – intoxication, and 5–8 g/l – death. Toxic 
doses of ethanol inhibit vital centres of medulla oblongata. Symptoms of 
marked poisoning by ethanol are loss of consciousness, pale skin, 
hypothermia, relaxation of skeletal muscles, reduction of perspiration, 
inhibition of the heart work. Paralysis of respiratory centre leads to death.  
A treatment of acute poisoning by ethanol includes the following 
measures: 
– cleaning of oral cavity and upper respiratory ways; 
– atropine administration for reduction of hypersecretion of salivary 
and bronchial glands; 
– inhaled oxygen;  
– artificial respiration; 
– administration of analeptics (cordiamine, caffeine, etc.); 
– gastric lavage; 
– intravenous administration of sodium hydrocarbonate for correction 
of acid-base balance; 
– administration of antiemetic drugs (metoclopramide, etc.) 
– hemodialysis at severe alcohol poisoning. 
Poisoned patient should be in a heated room because ethanol affects 
thermoregulation.  
Chronic poisoning by ethanol (alcoholism) is characterized by 
significant changes of higher nervous activity, irritability, disorders of sleep 
and digestion, unstable mood, etc. Mental and physical working capacity 
and attention are reduced. Subsequently, alcoholic psychosis and disorders 
of peripheral nervous system are developed. Alcoholism is accompanied by 
severe damages of inner organs: chronic gastritis, heart obesity, cirrhosis of 
the liver, and kidney dystrophy. 
Both medicamental therapy and psychotherapy are used in the 
treatment for alcoholism. Teturam  (disulf iram) is one of the drugs for 
treatment of chronic alcoholism. It is prescribed together with small amount 
of ethyl alcohol. Teturam inhibits aldehyde dehydrogenase that leads to 
accumulation of acetaldehyde in body. Acetaldehyde is highly toxic 
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substance; its accumulation results in the heart pain, fear, headache, 
hypotension, nausea, vomiting, sweating, choking feeling, etc. A treatment 
with teturam promotes the formation of negative conditional reflex to ethyl 
alcohol. The treatment is carried out only for inpatients. Contraindications 
to teturam are cardiovascular, hepatic, renal, and metabolic diseases. Also, 
the drug is contraindicated to patients over 50 years of age. There are 
prolonged teturam-containing preparations (Esperal , Radoter) for 
subcutaneous implantation.  
 
Table 14 – Drugs for prescription 
 
 
Drug name 
(Latin) 
Single dose and mode  
of administration 
Drug product 
Nitrazepamum Orally 0.005–0.01 g (before 
bedtime) 
Tablets 0.005 or 0.01 g 
Phenobarbital Orally 0.1 g (before 
bedtime) 
Tablets 0.05 or 0.1 g 
Aethaminalum-
natrium 
Orally 0.1–0.2 g (before 
bedtime) 
Tablets 0.1 g 
Zolpidem Orally 0.01 g (before 
bedtime) 
Tablets 0.01 g 
Natrii oxybutiras Orally 2–3 table spoons 
(before bedtime) 
Vials 400 ml of 5 % syrup   
Teturamum Orally 0.5 g 1 time a day Tablets 0.25 g 
 
Step 1. Tasks for Self -Control  
Hypnotic Drugs. Ethyl Alcohol  
 
1. A female complains of insomnia after psycho-emotional stress. What 
drug has the advantage for treatment of this patient? 
A. Nitrazepam. 
B. Barbital. 
C. Phenobarbital. 
D. Aethaminal sodium (pentobarbital). 
E. Barbamil. 
2. A patient complains of insomnia due to emotional disturbances. The 
doctor has prescribed him the hypnotic drug with a tranquilizing action. 
What drug has been prescribed to the patient? 
A. Bromisoval. 
B. Nitrazepam. 
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C. Phenobarbital. 
D. Chloral hydrate. 
E. Aethaminal sodium. 
3. An 18-year-old patient complains of insomnia, which is manifested 
as difficulty in getting to sleep. As a result, on the next day the patient feels 
weakness, weariness, and has difficulty in training. The doctor has defined, 
that the insomnia is connected with neurosis. Make the rational choice of 
the hypnotic drug. 
A. Aethaminal sodium. 
B. Nitrazepam. 
C. Bromisoval. 
D. Chloral hydrate. 
E. Phenobarbital. 
4. A 17-year-old woman took an overdose of phenobarbital for the 
suicidal purpose. The urgent doctor made gastric lavage, introduced 
bemegride and sodium hydrocarbonate solution intravenously. For what 
purpose has the doctor introduced the sodium hydrocarbonate?  
A. For wakening effect. 
B. For stimulation of breathing. 
C. For normalization of blood pressure. 
D. For inactivation of phenobarbital. 
E. For increase of kidney excretion of phenobarbital. 
5. A 50-year-old female suffers from insomnia. She has used different 
hypnotic drugs (aethaminal sodium, phenobarbital, and barbamil) during 
3 months. After withdrawal of the drugs the woman became irritable, 
aggressive, the tremor of hands and loss of appetite have appeared. What is 
the complication, which has developed in a woman, called? 
A. Functional cumulation. 
B. Tachyphylaxis. 
C. Physical and psychic dependence. 
D. Sensitization. 
E. Tolerance. 
6. Prescribe to a patient, complaining of insomnia, a modern soporific 
which is an imidazopyridine derivative. It influences benzodiazepine 
receptors in the CNS, does not violate the structure of sleep, does not cause 
dependence, does not change the activity of liver enzymes. What is it? 
A. Phenobarbital. 
B. Chloral hydrate. 
C. Nitrazepam. 
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D. Calcium chloride. 
E. Zolpidem.  
7. The effective hypnotic drug which does not influence the REM sleep 
is prescribed to a patient with sleeping disorders. Choose this drug. 
A. Aminazine. 
B. Phenobarbital. 
C. Oxybate sodium (oxybutyrate sodium). 
D. Zopiclone. 
E. Dimedrol. 
8. A doctor has introduced intramuscularly caffeine to a young patient 
in condition of alcohol intoxication. What is the base of expediency of such 
manipulation?   
A.  Summation of affects. 
B. Physiological antagonism. 
C. Synergism. 
D. Potentiation. 
E. Competitive antagonism. 
9. Disulfiram is widely used in medical practice to prevent alcoholism. 
It inhibits aldehyde dehydrogenase. An increased level of what metabolite 
causes the aversion to alcohol? 
A. Ethanol. 
B. Methanol. 
C. Acetaldehyde.  
D. Propionic aldehyde. 
E. Malonyl aldehyde. 
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Opioid Analgesics  
 
This group includes agents of natural, semisynthetic, and synthetic 
origin which influence central nervous system and exert marked analgesic 
activity. A prolonged use of these drugs leads to the development of 
psychical and physical dependence. All effects of these drugs are due to 
their interaction with opioid receptors. On the base of their interaction with 
opioid receptors, these drugs are classified as follows:  
1. Agonists of opioid receptors: 
1.1. Drugs of natural origin: morphine, codeine, and omnopon. 
1.2. Semisynthetic and synthetic drugs: ethylmorphine 
hydrochloride, meperidine, promedol (trimeperidine), fentanyl, 
piritramide, and tramadol. 
2. Agonists-antagonists and partial agonists of opioid receptors: 
pentazocine, nalorphine, buprenorphine, and butorphanol. 
Opium is a withered milky juice derived from unripe seed pots of 
opium poppy. Opium contains about 20 alkaloids. The main among them is 
morphine; its concentration in opium is about 10–20 %. Morphine was 
obtained in a crystal form in 1806. The chemical synthesis of morphine is 
unprofitable; therefore, nowadays morphine is derived from opium. 
Besides, pharmaceutical industry produces omnopon, which is the 
neogalenical opium drug containing about 50% of morphine.   
On the base of a chemical structure, alkaloids of opium are divided 
into two groups: phenanthrene derivatives (morphine, codeine, thebaine, 
etc.) and isoquinoline derivatives (papaverine, noscapine, etc.). 
Phenanthrene derivatives exhibit the analgesic and antitussive effects and 
cause drug dependence. Isochinoline derivatives exert the antispasmodic 
action. 
Pain is a reaction of the body upon harmful stimuli. Pain is perceived 
by special nociceptors located in the skin, muscles, inner organs, etc. From 
nociceptors, pain impulses are carried out to the dorsal horn of the spinal 
cord, where they are transmitted to an intercalative neuron. From the dorsal 
horn, impulses are carried out to the corresponding arrears of the brain – 
reticular formation, limbic system, thalamus, and hypothalamus. The final 
formation of the pain reaction occurs in the cortex. Activation of the limbic 
system results in a negative emotional reaction upon the pain. Several 
neurotransmitters participate in transduction of pain: dopamine, serotonin, 
substance P, somatostatin, and cholecystokinin. 
In a human organism, the formation of pain reaction is also under 
control of a so-called antinociceptive system. The antinociceptive system 
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includes opioid receptors of the CNS, descending tracts, intercalative 
neurons, and neurons of posterior horns of the spinal cord. The 
antinociceptive system inhibits the pain transmission mainly by means of 
endogenous analgesic peptides (enkephalins, endorphins, dynorphins, etc.). 
These peptides interact with opioid receptors and excite them. Opioid 
receptors are in the areas of brain which participate in pain impulses 
transmission: spinal cord, brainstem, thalamus, hypothalamus, limbic 
system, hypocampus, and brain cortex.  
Opioid receptors are located mainly in presynaptic membranes. Also, 
these receptors are in postsynaptic membranes outside of the synapses. 
There are four main families of opioid receptors: -, -, -, and  
-receptors.        
Functional value of opioid receptors is as follows:    
– 1-receptors inhibit the pain transmission on the supraspinal level; 
increase the tone of smooth muscles; induce miosis, sedation, euphoria, and 
psychical dependence; 
– 2-receptors inhibit respiration and cause physical dependence; 
– -receptors regulate pain transduction, emotions, activity of 
vasomotor centre; 
– -receptors inhibit pain transduction in the spinal cord, cause 
sedation and drug dependence; 
– -receptors cause disphoria, hallucinations, stimulate respiration, 
cardio-vascular system, and smooth muscles of gastrointestinal tract.         
  Excessive pain can aggravate the patient’s state because it changes 
the activity of cardiovascular system, tissue perfusion, respiratory function, 
and immune function. Therefore, pathological states accompanied by 
excessive pain need an administration of analgesics.  
Opioid analgesics interact with opioid receptors. Agonists activate all 
families of opioid receptors. Agonists-antagonists, as a rule, activate - and 
-receptors and block - and -receptors. Antagonists (naloxone and 
naltrexone) block all families of opioid receptors. 
-Receptors are associated with adenylyl cyclase. Interaction of opioid 
agonists with these receptors leads to the decrease of adenylyl cyclase 
activity and to reduction of intracellular concentration of cAMP. It leads to 
the decrease of calcium entry to cells. Simultaneously, activation of opioid 
receptors leads to potassium efflux and hyperpolarization of neuronal 
membrane. The net result of excitation of opioid receptors is a decrease in 
the release of pain mediators and reduction of nociceptive transmission. 
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The following pharmacological effects are typical for opioid 
analgesics.  
Analgesia. An analgesic action of opioid analgesics is realized maily at 
the level of gray matter of midbrain and diencephalon. Besides, opioid 
analgesics inhibit the pain transmission through the gelatinous 
substance of posterior horn of spinal cord, subcortical structures (thalamus, 
hypothalamus, hyppocampus, and amygdala), and brain cortex. Thus, 
analgesic effect is associated by both inhibition of transmission of pain 
impulses in the central nervous system and violation of emotional 
perception of pain.    
Additionally, opioid analgesics induce euphoria (due to excitation of 
--receptors), reduce fear, anxiety, stress, and mental discomfort. Patients 
become inattentive to the painful stimuli, less anxious, and more relaxed. In 
patients who receive opioid analgesic for the first time, marked euphoria 
develops very seldom. But namely a desire to renew euphoria is the cause 
of development of psychical and physical dependence to morphin. It should 
be noticed that such agents as tramadol and pyrithramide cause mild 
euphoria. Agonists-antagonists (pentazocine, butorphanol, etc.) do not 
cause euphoria but exert sedative and hypnotic effects. Unlike agonists, 
drug dependence to these drugs develops slowly and is characterized by  
a mild withdrawal syndrome.       
Sedative and hypnotic effects. Sleep induced by opioid analgesics is 
accompanied by bright pleasant dreams. Morphine-induced sleep is 
superficial and is quickly interrupted by any external stimulus. 
Inhibition of respiratory centre. Opioid analgesics depress respiration 
due to excitation of the 2-receptors of respiratory centre in medulla 
oblongata. At therapeutic doses, the slowing of breathing is compensated 
by its deepening, but in increasing of the dose the reduction of respiratory 
minute volume up to respiration of Cheyne–Stokes is observed. The lethal 
doses of opioid analgesics cause the paralysis of respiratory centre and 
death of a patient. It should be noticed that a decrease of pulmonary 
ventilation is insignificant in conscious patients and critically increases in 
unconscious or sleeping persons.   
Antitussive effect. Morphine significantly depresses the cough centre 
in the medulla oblongata. Less doses of morphine, than those required for 
analgesia, exhibit an antitussive effect. It should be noticed that inhibition 
of the cough centre worsens sputum discharge from respiratory ways.  
Morphine inhibits vomiting centre in 85–90 % of patients. But in 10–
15 % of patients, morphine administration induces nausea and vomiting.  
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Morphine insignificantly suppresses vasomotor centre that leads to the 
short-time mild hypotension.  
A drug inhibits centre of thermoregulation in hypothalamus. 
Morphine increases the tone of vagus nerve. It leads to bradycardia, 
increases tone of smooth muscles (gastrointestinal tract, uterus, bronchi, 
biliary and urinary tracts). Besides, morphine exerts direct spasmodic 
action upon intestine, biliary ducts, and urinary tract. Evacuation of gastric 
contents is slowed down up to 8–12 hours (instead of 2–4 hours). Under the 
morphine influence, the tone of gastrointestinal tract and sphincters is 
increased, but the intestinal motility is decreased. Together with increased 
water absorption, it leads to constipation.  
Morphine increases the vasopressin release by posterior pituitary. It 
stimulates water absorption from the gastrointestinal tract and decreases 
diuresis.    
Morphine increases of bronchial tone and can provoke asthma attacks 
due to the liberation of histamine and increase of parasympathetic tone.  
Morphine causes miosis due to the stimulation of nuclei of oculomotor 
nerve. This symptom has a high diagnostic value in case of morphine 
overdose. 
Morphine improves coronary blood flow and dilates cerebral vessels. 
The intracranial pressure is increased. Therefore, at cranial traumas, the 
administration of morphine is contraindicated.  
Morphine decreases the release of adrenocorticotropin and 
gonadotropins by anterior pituitary.  
Administration of morphine results in hyperglycemia.  
Therapeutic doses of morphine do not inhibit spinal reflexes.   
After intravenous administration, the effect of morphine develops 
immediately and lasts to 2 hours. At subcutaneous administration, the effect 
develops in 15–20 minutes and lasts 4–5 hours. The drug binds with plasma 
proteins. Morphine undergoes biotransformation in the liver. The 
metabolites are excreted by kidneys. Insignificant concentration of 
morphine is excreted by gastrointestinal tract, salivary glands, and 
mammary glands. It should be noticed that morphine is excreted by gastric 
glands into the stomach where it undergoes the secondary absorption. 
Therefore, patients poisoned by morphine need gastric lavage, even if 
poisoning is due to intravenous morphine administration.   
Therapeutic indications for opioid analgesics are as follows: 
1. Intensive pain associated with severe traumas, surgical operations, 
and incurable malignant tumors.  
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2. Premedication, especially in the heart surgery.  
3. Neuroleptanalgesia. Fentanyl is administered together with 
neuroleptic droperidol. Pharmaceutical industry made a combined drug 
“Thalamonal” containing 2.5 mg of droperidol and 0.05 mg of fentanyl in 
1 ml.  
4. Cough threatening to a patient’s life (tuberculosis, tumors, 
penetrating wounds of chest). 
5. Myocardial infarction. Morphine and fentanyl are used most 
commonly.  
6. Biliary and urinary colics and acute pancreatitis. At urinary colic, 
the promedolum (trimeperidine) is a drug of choice. Pentazocine is 
preferable at biliary colics. It should be noticed that opioid analgesic should 
be administered together with antispasmodic agent (atropine, platyphylline, 
papaverine) to cessate such pathological states.    
Opioid analgesics are contraindicated for children under 3 years of age 
and for elderly (because of the danger of breathing suppression).  
Long-time administration of morphine leads to tolerance. In this case, 
the increased doses should be given for achievement of the necessary 
effect.   
Morphine addiction (chronic poisoning by morphine) develops due to 
psychical and physical dependence and tolerance. One of the dependence 
reasons is reduction of synthesis of endogenous enkephalins and 
endorphins due to chronic morphine administration. The sudden 
interruption of morphine administration results in acute deficiency of 
enkephalins and endorphins, the level of which is not compensated by 
exogenous administration of morphine. In this case, the withdrawal 
syndrome or abstinence is developed. The symptoms of withdrawal 
syndrome are aggravation of pain sensitivity, fear, alarm, negative 
emotions, and vegetative disordes (aberrations of the heart rate, 
tachycardia, nausea, and anorexia). The abstinence symptoms reduce after 
the restoration of synthesis of endogenous enkephalins and endorphins.          
An acute poisoning by opioid analgesics develops due to their 
overdose. Main manifestations of acute poisoning are loss of 
consciousness, increase of spinal reflexes, inhibition of breathing, miosis, 
gradual decrease of blood pressure, bradycardia, hypothermia, and anuria. 
In serious cases, coma and breathing of Cheyne–Stokes are observed. The 
treatment of poisoning includes an administration of antagonists (naloxone 
or naltrexon), artificial respiration, oxygenotherapy, warming of a patient, 
atropine sulfate administration, and gastric lavage with 0.05 % sodium 
permanganate solution.  
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Promedol (trimeperidine)  is phenylpiperidine derivative. 
Promedol is 2–4 times less active analgesic than morphine. Its duration of 
action is 3–4 hours. Unlike morphine, promedol is less potent depressant of 
the respiratory centre. Promedol has less spasmodic action upon 
gastrointestinal tract. Unlike morphine, promedol relaxes the smooth 
muscles of bronchi, of uterus neck, and of urinary tract. Promedol is 
characterized by low toxicity in children and pregnant women. This agent 
may be used for analgesia of labor. 
Fentanyl  is phenylpiperidine derivative with short duration of action. 
At intravenous administration, the effect of fentanyl develops in  
2–3 minutes and lasts 30–40 minutes. The analgesic activity of fentanyl is 
100 times more than morphine activity. Fentanyl causes marked inhibition 
of respiration, sinus bradycardia, rigidity of skeletal muscles of the chest 
and extremities. Fentanyl can provoke bronchospasm. Fentanyl is used for 
neuroleptanalgesia, for premedication, for pain relief at myocardial 
infarction. At chronic pain and in postoperative period, fentanyl-containing 
transdermal plasters are used for analgesia. Their duration of action is about 
72 hours.   
Phenylpiperidine derivative pentazocine  is an agonist-antagonist of 
opioid receptors. This drug is characterized by moderate analgesic activity 
(3–6 times less than morphine) and by low suppression of the respiratory 
centre. Pentazocine increases blood pressure and can provoke tachycardia 
owing to stimulation of sympathetic nervous system. Administration of 
pentazocine results in reduction of coronary blood flow. Drug poorly 
penetrates through the placental barrier, therefore, may be used for pain 
relief of labor. Pentazocine may be used in pediatric practice. 
Tramadol  is 5–10 times less active analgesic than morphine. Its 
effect develops quickly and lasts about 9 hours. Therapeutic doses of 
tramadol do not suppress respiration. The drug has mixed (opioid and non-
opioid) mechanism of action. Non-opioid component is associated with 
reduction of neuronal reuptake of serotonin and noradrenaline that reduces 
pain transmission. Tramadol is used to treat moderate and severe pain. The 
drug is taken orally and administered rectally, subcutaneously, 
intramuscularly, and intravenously.     
Phenanthrene derivative buprenorphine  also is agonist-antagonist 
of opioid receptors. Analgesic activity of buprenorphine is 20–60 times 
higher than morphine activity. Its analgesic effect develops slowly. 
Buprenotphine has less influence upon gastrointestinal tract than morphine. 
The drug is taken sublingually or administered parenterally to treat 
moderate and severe pain. Unlike morphine, buprenorphine seldom causes 
the development of drug dependence.    
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Codeine  and ethylmorphine hydrochloride  are used as 
antitussive agents. Both drugs also exert sedative and analgesic effects. 
Ophthalmic solution of ethylmorphine hydrochloride dilates vessels and 
reduces corneal opacity. 
Naloxone  and naltrexone  are pure antagonists of opioid analgesics. 
These drugs are used to treat poisoning by opioid analgesics. Both agents 
block opioid receptors and eliminate the main effects of opioid analgesics. 
The half-life of naloxone is 1 hour. Therefore, the drug should be 
administered repeatedly at opioid overdose. Antagonist activity of 
naltrexone is 3–5 times higher than naloxone activity. Its duration of action 
is 24–72 hours. It is used orally in the treatment of opioid abstinence. 
 
Table 15 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and mode  
of administration 
Drug product 
Morphini 
hydrochloridum 
Orally 0.01 g; 
subcutaneously 0.01 g 
Powders;  
ampoules 1 ml of 1 % 
solution 
Omnoponum Orally 0.01–0.02 g; 
subcutaneously 0.01–0.02 g 
Powders; 
ampoules 1 ml of 1 or 2 % 
solution 
Promedolum Orally 0.025 g; 
subcutaneously 0.01–0.02 g 
Tablets 0.025 g; 
ampoules 1 ml of 1 or 2 % 
solution 
Phentanylum Intramuscularly or 
intravenously 0.00005–
0.0001 g 
Ampoules 2 or 5 ml  
of 0.005 % solution 
Pentazocini lactas Subcutaneously or 
intramuscularly 0.03 g; 
rectally 0.05 g  
Ampoules 1 ml of 3 % 
solution; 
suppositories 0.05 g 
Pentazocini 
hydrochloridum 
Orally 0.05 g Tablets 0.05 g 
Naloxoni 
hydrochloridum 
Subcutaneously, 
intramuscularly or 
intravenously 0.0004–
0.0008 g 
Ampoules 1 or 2 ml  
of 0.04 % solution 
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Step 1. Tasks for Self -Control  
Opioid Analgesics  
 
1. A patient with signs of poisoning by morphine was delivered to  
an emergency department. What drug should be used in this case for gastric 
lavage? 
A. Boric acid. 
B. Sodium hydrocarbonate. 
C. Potassium permanganate. 
D. Nitrofural (furacilinum). 
E. Solution of sodium chloride. 
2. A patient in a postoperative period received promedol 
(trimeperidine). Due to the stop of the drug intake, the serious psychical 
and physical disturbances developed in the patient. What is this 
complication called? 
A. Tolerance. 
B. Idiosyncrasy. 
C. Tachyphylaxis. 
D. Phenomenon of feedback. 
E. Abstinence. 
3. An unconscious patient was delivered to the hospital. The skin is 
cold, pupils are narrow, the breathing is complicated and periodic, blood 
pressure is low, and the bladder is overflowed. What group of drugs is the 
reason of this poisoning? 
A. Neuroleptics.  
B. Opioid analgesics. 
C. Tranquilizers. 
D. Non-opioid analgesics. 
E. M-cholinoblockers. 
4. Acute spastic pain has developed in a patient with urolithiasis. For 
prevention of pain shock the doctor has introduced to the patient atropine 
with opioid analgesic, which does not have spasmogenic action. Call this 
opioid analgesic.  
A. Ethylmorphine hydrochloride. 
B. Promedol (trimeperidine). 
C. Tramadol. 
D. Piritramide. 
E. Morphine hydrochloride. 
5. A doctor prescribed promedol to a patient with nonresectable tumor 
of stomach. After some time, the patient has noted the decrease of analgesic 
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action and duration of the drug action. What is the reason of this 
phenomenon? 
A. Decrease of the drug reabsorption in kidneys.  
B. Tachyphylaxis. 
C. Psychical dependence. 
D. Tolerance. 
E. Cumulation of promedol. 
6. A patient in the unconscious state was admitted to the emergency 
room. Skin is cold, pupils are dilated, breathing is heavy, with cycles of the 
Cheyne – Stokes type, blood pressure is decreased, urinary bladder is 
overloaded. Poisoning with what substance is the most likely? 
A. Narcotic analgesics.  
B. M-cholinergic agonists. 
C. Nonnarcotic analgetics. 
D. Sedatives.  
E. M-cholinergic antagonists. 
7. A 70-year-old man, who suffered from chronic bronchitis, was 
prescribed the antitussive drug codeine. What is the mechanism of 
antitussive effect of this drug? 
A. Competitive action. 
B. Central effect.  
C. Reflex. 
D. Local effect. 
E. Peripheral effect. 
8. A patient was prescribed narcotic analgesic, which is a derivative of 
cyclohexanol, agonist-antagonist of opiate receptors, a little weaker than 
morphine. It does not influence the digestive tract, has some analgesic 
action, and is characteristic of nonnarcotic analgetics; it is not 
recommended for children under 14. What is this drug? 
A. Omnopon. 
B. Promedol. 
C. Morphine hydrochloride. 
D. Tramadol.  
E. Codeine phosphate. 
9. In 2–3 hours after the parenteral introduction of a drug a patient 
became comatose. Cheyne – Stokes respiration was observed, pupils 
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became abruptly miotic, knee reflex was kept. What drug could lead to the 
poisoning? 
A. Phenobarbital. 
B. Morphine.   
C. Diazepam. 
D. Aminazine.  
E. Ethyl alcohol.  
10. An unconscious patient has been taken to a hospital. His skin is 
cold, pupils are miotic, breathing is complicated (Cheyne – Stokes type), 
arterial pressure is low, the urinary bladder is overfilled. The diagnosis is 
poisoning with morphine. What drug is it necessary to give as an antidote? 
A. Sodium thiosulfate. 
B. Bemegride. 
C. Cytitonum. 
D. Naloxone.  
E. Unithiol. 
11. A 35-year-old parturient woman has a pain syndrome connected 
with the delay of the first labor stage. What drug is necessary to be used for 
relieving the pain? 
A. Promedol.  
B. Paracetamol. 
C. Analginum (metamizole). 
D. Morphine.  
E. Codeine.  
12. An emergency team has taken a patient demonstrating drowsiness, 
cyanosis, and infrequent cogged-wheel breathing, sharply miotic pupils to 
a reception ward. Knee reflexes are kept. The traces of injections are 
revealed on his arms. What drug causes poisoning characterized by the 
above-mentioned symptom? 
A. Aminazine. 
B. Morphine.  
C. Atropine.  
D. Proserinum. 
E. Phenobarbital. 
13. A 30-year-old patient after a traffic accident was delivered with 
a hip bones fracture to a hospital. The patient has low arterial pressure, 
weak pulse, and increased pain reaction to the least touch in the place of 
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damage. What is necessary to use to prevent the traumatic shock of this 
patient? 
A. Papaverine.  
B. Paracetamol. 
C. Pentazocine. 
D. Analginum (metamizole). 
E. Morphine.  
14. A 25-year-old woman is hospitalized with signs of acute poisoning 
with morphine. What antidote is necessary to be given to the patient? 
A. Aethymizole. 
B. Unithiol. 
C. Atropine.  
D. Lobeline.  
E. Naloxone.  
15. A patient with morphine poisoning has been delivered to a hospital. 
It is known that in case of acute poisoning with morphine a specific 
antagonist naloxone is used. What factor provides the development of 
antagonistic action? 
A. Decrease of sensitivity of the organism to morphine. 
B. Direct excitation of respiratory centre. 
C. Reflex excitation of respiratory centre. 
D. Sharp acceleration of morphine metabolism. 
E. Competition for binding with opiate receptors. 
16. Morphine hydrochloride solution has been introduced subcutaneously 
to a patient with traumatic shock to provide analgesia. What is the mechanism 
of analgesic effect of this drug? 
A. Inhibition of formation of pain mediators in peripheral tissues. 
B. Interaction with opiate receptors.  
C. Blockade of peripheral sensitive receptors. 
D. Change of pain emotional coloring. 
E. Abnormality of afferent nerves impulses conduction. 
17. A patient suffering from urolithiasis is hospitalized because of 
an attack of renal colic. What emergency drug is to be prescribed in this 
case? 
A. Contrycal. 
B. Promedol.  
C. Analginum. 
D. Paracetamol. 
E. Furosemide. 
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18. For anaesthesia of labor a doctor prescribed an analgesic. What 
analgesic is the most expedient to use in this case? 
A. Paracetamol. 
B. Analginum. 
C. Morphine.  
D. Fentanyl. 
E. Promedol.  
19. A specific antagonist of morphine hydrochloride was prescribed to 
a 15-year-old boy with manifestations of acute poisoning with narcotic 
analgesics. What is this drug? 
A. Bemegride. 
B. Naloxone. 
C. Tetacinum-calcium (edetate calcium disodium). 
D. Pentazocine.  
E. Unithiol. 
20. Prescribe to patient a drug – a synthetic substitute of morphine, 
which has a sedative effect, does not spasm muscles and sphincters of the 
digestive tract, slightly influences the centre of respiration, and reduces the 
tone of uterus neck. 
A. Promedol.  
B. Analginum. 
C. Omnopon. 
D. Fentanyl. 
E. Paracetamol. 
21. An unconscious patient is hospitalized to a resuscitation unit with 
symptoms of acute morphine poisoning: hypothermia, Cheyne – Stokes 
respiration, hypotension, bradycardia, acute miosis. Which of the listed 
drugs will be the most effective in this case? 
A. Caffeine sodium benzoate. 
B. Cordiaminum. 
C. Camphor. 
D. Aethymizole. 
E. Naloxone.  
22. A 26-year-old patient in coma is brought in intensive care unit. The 
temperature is 35 
°
C. The skin is cold. Mucous membranes are cyanotic. 
Sharply miotic pupils are observed. Respiration is oppressed, as of 
Cheyne – Stokes type. What drug is the cause of poisoning? 
A. Anaprilinum. 
B. Proserinum. 
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C. Adrenaline. 
D. Morphine. 
E. Atropine. 
23. A 60-year-old patient suffers from incurable cancer of the lung with 
multiple metastases. Choose the drug for pain relief in this patient.  
A. Paracetamol. 
B. Diclofenac sodium.  
C. Analginum. 
D. Morphine. 
E. Fentanyl. 
24. A 20-year-old patient is delivered to an urgent unit with opium 
poisoning. What the most effective drug should be administered to him? 
A. Potassium permanganate. 
B. Naloxone. 
C. Atropine. 
D. Aethymizole. 
E. Active carbon. 
25. A victim with hip and ribs fractures is delivered to an emergency 
room after the road accident. What drug should be administered to the 
patient for prevention of pain shock? 
A. Tramadol. 
B. Analginum. 
C. Nitric oxide. 
D. Morphine. 
E. Diazepam. 
26. A patient with myocardial infarction is delivered to a resuscitation 
unit. What drug should be administered to the patient for prevention of pain 
shock? 
A. Naloxone. 
B. Morphine.  
C. Analginum. 
D. Paracetamol. 
E. Celecoxib. 
27. A parturient woman is delivered to an obstetrics department. The 
doctor administered an opioid analgesic for pain relief to the woman. 
Indicate this drug.  
A. Diclofenac sodium. 
B. Acetylsalicylic acid. 
C. Promedol. 
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D. Analginum. 
E. Celecoxib. 
28. A patient with a serious trauma is delivered to an emergency room. 
For prevention of pain shock, a doctor administered an opioid analgesic to 
him. Indicate this drug.  
A. Celecoxib. 
B. Morphine.  
C. Paracetamol. 
D. Piroxicam.  
E. Acetylsalicylic acid. 
29. Antagonist of opioid analgesics was administered to a patient with 
significant signs of opioid intoxication. Indicate this drug. 
A. Fentanyl. 
B. Morphine. 
C. Promedol. 
D. Omnopon. 
E. Naloxone. 
30. A patient with morphinism is delivered to a narcological unit. In the 
result of examination, a doctor indicated the decreasing of morphine action. 
Indicate the name of phenomenon of the drug action weakening in the 
result of repeated drug administration.  
A. Summation. 
B. Material cumulation. 
C. Tolerance (accustoming). 
D. Functional cumulation. 
E. Antagonism. 
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Non-Opioid Analgesics  
 
Non-opioid analgesics are drugs which provide analgesic, anti-
inflammatory, and antipyretic effects. Unlike opioid analgesics, these drugs 
don’t cause euphoria and drug dependence.  
Non-opioid analgesics are classified as follows: 
1. Salicylic acid derivatives (salicylates): acetylsalicylic acid  
(aspirin) and sodium salicylate.  
2. Pyrazolone derivatives: analginum (metamizole), 
butadionum (phenylbutazone), and rheumox (azapropazone).  
3. Para-aminophenol derivatives: paracetamol  (acetaminophen). 
4. Indolacetic acid derivatives: indomethacin and sulindac. 
5. Phenylacetic acid derivatives: ortophenum (diclofenac). 
6. Phenylpropionic acid derivatives: ibuprofen, f lurbiprofen, and 
ketoprofen.  
7. Naphthylpropionic acid derivatives: naproxen.  
8. Oxicams: piroxicam and meloxicam.  
9. Anthranilic acid derivatives: mefenamic acid, f lufenamic acid, 
and meclofenamic acid.  
10. Heteroarylacetic acid derivatives: ketorolac.  
11. Sulfonanilides: nimesulide. 
12. Isonicotinic acid derivatives: amizon (enisamium iodide).  
13. Сoxibes: celecoxib and rofecoxib.  
 
The mechanism of action of non-opioid analgesics is associated with 
their ability to block synthesis of prostaglandins by inhibition of enzyme 
cyclooxygenase. It results in development of anti-inflammatory, 
antipyretic, and analgesic effects.  
Analgesic effect of non-opioid analgesics is due to cyclooxygenase 
inhibition that decreases synthesis of prostaglandins. It is known, that 
prostaglandins increase sensitivity of nociceptors to chemical and 
mechanical irritants. The decrease of exudation and oedema in 
inflammatory region lowers mechanical squeezing of nerve fibers and leads 
to pain relief. It should be noticed that central component is also a part of 
analgesic effect of non-opioid analgesics. Analgesia develops in several 
hours after the drug administration. Analgesic activity of non-opioid 
analgesics is 15–100 times less than those of opioids. Non-opioid 
analgesics are effective mainly at pain induced by inflammation. According 
to the degree of analgesic effect, non-opioid analgesics can be arranged as 
follows: diclofenac > indomethacin > analginum (metamizole) > ibuprofen 
> paracetamol > acetylsalicylic acid.  
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Antipyretic effect of non-opioid analgesics is due to inhibition of 
cyclooxygenase in the central nervous system that decreases PGE1 
synthesis in hypothalamus. PGE1 is a potent pyrogen which affects the 
centre of thermoregulation. At fever, non-opioid analgesics decrease body 
temperature by the increase of heat emission in result of the dilation of skin 
blood vessels and increase of perspiration. Antipyretic effect develops in 
several hours after the drug administration. Most marked antipyretic effect 
is typical for derivatives of indolacetic acid and for pyrazolone derivatives. 
It should be noticed that subfebrile temperature is a protective reaction of 
an organism. Subfebrile temperature does not need an intake of non-opioid 
analgesics. 
Anti-inflammatory effect of non-opioid analgesics also is the result of 
cyclooxygenase inhibition that decreases synthesis of prostaglandins, 
prostacyclins, and thromboxanes. Most drugs inhibit both cyclooxygenase-
1 (COX-1) and cyclooxygenase-2 (COX-2). COX-1 (constitutive) is 
constantly present in human cells. This enzyme participates in regulation of 
normal functional activity of body tissues (synthesis of thromboxane A2 by 
thrombocytes, prostacyclin by endothelial cells, prostaglandins by 
gastrointestinal tract and kidneys, etc.). At normal physiological state, only 
insignificant amount of COX-2 (inducible) is present in body tissues. But 
its concentration sharply elevates due to inflammation. COX-2 participates 
in synthesis eicosanoids potentiating the activity of mediators of 
inflammation, as histamine, serotonin, and bradykinin. These bioactive 
substances irritate pain receptors in an inflammation area, affect the activity 
of thermoregulation centre, stimulate cellular proliferation and 
mutagenesis, promote destructive processes. High activity of COX-2 is 
observed in epithelial cancer cells and in atherosclerotic plaques.  
Recently, selective inhibitors of COX-2 have been created: 
meloxicam, nabumetone, nimesulide, celecoxib, etc. These drugs are called 
nonsteroidal anti-inflammatory drugs of II generation.  
Inhibition of COX leads to increased utilization of arachidonic acid 
through lipoxygenase pathway and increased synthesis of leukotrienes 
which promote vasoconstriction and reduce exudation. 
Also, nonsteroidal anti-inflammatory drugs inhibit free-radical 
reactions and activity of oxygen radicals which promote inflammation due 
to alteration of cellular membranes in the inflammation area. Besides, these 
drugs reduce formation of ATP and other macroergic compounds. It is 
significant, that nonsteroidal anti-inflammatory drugs exhibit cytostatic 
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action that inhibit proliferation in an inflammation area and decelerate 
sclerotic process.      
Non-opioid analgesics restrict exudation and proliferation. These 
agents have little influence upon the stage of alteration. Anti-inflammatory 
effect develops in several days after the start of a drug intake. The 
derivatives of pyrazolone (except analginum) have the most marked anti-
inflammatory effect. Significant anti-inflammatory action also is typical for 
high doses of salicylates, for derivatives of phenylacetic acid, and for 
phenylpropionic acid.    
Desensitizing effect develops in several months of a constant intake of 
nonsteroidal anti-inflammatory drugs. This effect is not used in medicine.   
Anti-aggregative effect develops in the result of a decrease of 
thromboxane A2 synthesis. This effect is most prominent in acetylsalicylic 
acid. Therefore, this drug is used for prevention of platelet aggregation and 
thrombosis.  
Anticancerogenic effect is typical only for selective COX-2 inhibitors 
(celecoxib, rofecoxib). This effect is shown concerning epithelial malignant 
tumors.  
Selective COX-2 inhibitors also slow down the progress of 
atherosclerosis (anti-aterogenic effect).  
Non-opioid analgetics inhibit contractile activity of both pregnant and 
nonpregnant uterus.  
The main route of administration of non-opioid analgesics is oral one. 
Drugs should be given after meals. Some agents are also administered 
parenterally: acelysin (salicylic acid derivative) – intramuscularly or 
intravenously; meloxicam – intravenously; diclofenac sodium – 
intramuscularly. 
Non-opioid analgesics are readily absorbed in gastrointestinal tract. 
The maximal concentration in blood is accumulated in 0.5–2 hours after a 
drug intake. The degree of the drug binding with plasma proteins is up to 
80–99 %. Average duration of action is 6–8 hours. As a rule, non-opioid 
analgesics are prescribed 3–4 times a day. The drugs with prolonged action 
(oxicams, sulindac) are prescribed once a day. Non-opioid analgesics 
undergo the biotransformation in the liver. The degree of biotransformation 
is 90–97 %.   
There is a danger of accumulation of toxic metabolites of non-opioid 
analgesics in the body. Thus, at viral infections (especially in children and 
teenagers), accumulation of toxic metabolites of acetylsalicylic acid can 
induce the development of Reye’s syndrome. It is a potentially fatal 
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syndrome that characterized by toxic encephalopathy, acute fat dystrophy 
of the liver, brain, and kidneys. Therefore, acetylsalicylic acid is 
contraindicated to children and teenagers with either chickenpox or 
influenza. Accumulation of paracetamol metabolites leads to hepato- and 
nephrotoxicity that develops in 1–2 days. 
Indications for the use of non-opioid analgesics are as follows:     
1) pain at small and moderate traumas of soft tissues, dislocations, 
sprain or rapture of ligaments, bone and joint bruises, etc.;  
2) postoperative pain. As a rule, drugs are administered parenterally;  
3) headache;  
4) toothache;  
5) myositis, neuralgia, arthralgia, and radiculitis;  
6) pain at a spasm of urinary or biliary tracts (colics), and pancreatitis;  
7) rheumatic diseases; 
8) gout;  
9) fever.  
The following side effects are observed at the therapy with non-opioid 
analgesics: 
1. Nausea, vomiting, epigastral pain, ulcers of stomach, and intestinal 
erosies. These complications are associated with inhibition of prostaglandin 
synthesis in gastric and intestinal mucous membranes. It is known that 
prostaglandins exhibit protective action upon mucous mebranes of 
gastrointestinal tract: reduce secretion of hydrochloric acid, increase 
secretion of mucous and bicarbonate, improve microcirculation, promote 
tissue regeneration. 
2. Aspirin-induced asthma or Fernand-Widal triad is a result of 
predominant transformation of arachidonic acid by lipoxygenase pathway 
and synthesis of leukotrienes. This syndrome is manifested by nasal 
polyposis, rhinitis, asthma attacks, and urticaria.  
3. Edemas are associated with fluid and electrolytes retardation due to 
inhibition of cyclooxygenase in renal tubules. This complication developes 
in 4–5 days after the start of a drug intake. Among non-opioid analgesics, 
butadionum and indomethacin most commonly cause this complication. 
4. Blood dyscrasias are manifested by leucopenia, agranulocytosis, 
thrombocytopenia, and seldom – erhythrocytopenia. Most commonly these 
complications arise due to intake of analginum or pyrasolone derivatives. 
5. Paracetamol can provoke methemoglobinemia in children under  
1-year-old or in persons with genetic predisposition. 
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6. Hemoragic syndrome develops owing to intake of acetylsalicylic 
acid, because this drug exhibits anti-aggregative and anticoagulative 
properties (aspirin affects activation of II, VII, IX, and X clotting factors in 
the liver).   
7. Retinopathy and keratopathy may develop as a result of 
indomethacin deposition in retina and cornea of eyes. 
  
Salicylic Acid Derivat ives (Salicylates)  
 
Salicylic acid derivatives are acetylsalicylic acid, methyl  
salicylate, and sodium salicylate. Acetylsalicylic acid (aspirin) is used 
most commonly among them. Salicylates exert anti-inflammatory, 
analgesic, and antipyretic effects.  
Salicylic acid  exhibits a marked local irritative activity and is used 
in dermatology. High concentrated salicylic acid (10–20 %) causes 
rejection of epidermis and is used for elimination of callus. 1–2 % salicylic 
acid promotes epidermis regeneration (keratoplastic action). Salicylic acid 
inhibits secretion of sweat glands and is used at increased sweating. Also, 
salicylic acid has antibacterial action and is used as antiseptic agent.   
Methyl salicylate  is used as a component of ointments for 
treatment of arthritis, myositis, and exudative pleuritis. 
Sodium salicylate  is used as antirheumatic agent. The drug exhibits 
mild analgesic and antipyretic effects.  
Acetylsalicylic acid  (aspirin) has higher analgesic and 
antipyretic effects than sodium salicylate. Taken orally aspirin begins to be 
absorbed in the stomach. Speed of absorption depends on pH. Thus, change 
of gastric pH to alkaline side leads to deceleration of aspirin absorption. 
Maximal blood concentration of aspirin is observed in 2 hours after the 
drug intake. Aspirin easely penetrates through tissue barriers. About 50–
80 % of an absorbed aspirin binds with plasma proteins. Aspirin undergoes 
hepatic metabolism by conjugation with glucuronic acid or glycin. 
Metabolites are excreted with urine. 
Anti-inflammatory and antirheumatic effects of acetylsalicylic acid is 
associated not only with violation of prostaglandin synthesis. High doses of 
aspirin stimulate secretion of corticotropin and glucocorticoids, that also 
promotes anti-inflammatory effect. Activity of hyaluronidase is inhibited 
resulting in the decrease of vascular permeability, slow-down of leukocyte 
migration, and reduction of oedema. Also, aspirin inhibits proliferation 
owing to violation of conjugation of tissue respiration and phosphorylation. 
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High doses of salicylates stimulate respiration due to direct excitation 
of the respiratory centre and increase of carbonic acid synthesis in tissues. 
The increase of frequency and amplitude of breathing may result in 
respiratory alkalosis.  
Salicylates stimulate bile secretion in a liver. High doses of salicylates 
increase uric acid excretion due to reduction of its reabsorption. This effect 
is used in the treatment for gout. It should be noticed that low doses of 
acetylsalicylic acid suppresse only secretion of uric acid that results in the 
increase of uric acid concentration in the blood. 
Aspirin decreases manifestations of allergic reactions owing to 
inhibition of histamine release and reduction of antibody synthesis, 
including autoantibodies. Also, its anti-inflammatory effect is an important 
at treatment of inflammation of allergic origin, including nephritis, 
rheumatism, and other collagenoses.    
Antiaggregatory effect of acetylsalicylic acid is due to inhibition of 
cyclooxygenase and decrease of thromboxane A2 synthesis. Aspirin also 
decreases the level of prothrombin in blood owing to disorder of vitamin K 
metabolism. Acetylsalicylic acid is widely used to prevent platelets 
aggregation and thrombosis at ischemic heart disease, myocardial 
infarction, and ischemic stroke.  
Acetylsalicylic acid slows down the synthesis of lipids and accelerates 
the catabolism of lipids and carbohydrates. In diabetic patients, aspirin 
decreases the level of glucose in blood. 
Acetylsalicylic acid is used at moderate pain and inflammatory 
processes: myalgia, headache, toothache, dysmenorrhea, gout, fever, etc. 
The most serious side effect of acetylsalicylic acid is ulcerogenic 
action (ability to cause the development of stomach ulcers and gastritis). 
Ulcerogenic action is due to COX-1 inhibition, that leads to the decrease of 
prostaglandin synthesis by mucous membrane of stomach. It is known, that 
prostaglandins inhibit hydrochloric acid secretion, stimulate synthesis of 
mucous, and improve microcirculation in mucous membrane of stomach.  
Besides, the allergic reactions (even anaphylactic shock) and aspirin-
induced asthma are also possible. The intake of aspirin by a pregnant 
woman can cause vascular disorders in lungs of the fetus. Mutagenic effect 
of acetylsalicylic acid is also possible. 
Long-time therapy with aspirin can cause chronic intoxication by 
aspirin – salicylism. Symptoms of salicylism include such disorders as 
ringing in the ears (tinnitus), hearing impairment, vertigo, headache, and 
bronchospasm (especially in asthmatics). 
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At acute poisoning by aspirin the following symptoms are observed: 
tinnitus, nausea, vomiting, stomach pain, impairment of hearing and vision, 
general weakness, anxiety, incoherent speech, etc. Sometimes, 
hallucinations and convulsions are also possible. Salicylate-induced 
stimulation of respiration leads to hyperventilation. Breathing becomes 
deep and frequent (Kussmaul breathing), that can cause respiratory 
alkalosis. Respiratory alkalosis is replaced by metabolic acidosis due to 
inhibition of tricarboxylic acid cycle, accumulatin of organic acids and 
ketone bodies. Toxic doses of aspirin accelerate glycogenolysis and inhibit 
glycogenesis that leads to hyperglycemia and glycosuria. Hypokalemia and 
hyponatremia develop in tissues, body temperature is elevated.  
Treatment includes alkalinization of the urine, forced diuresis, fluid 
replacement, gastric lavage with activated charcoal, hemodialysis, and 
artificial ventilation. It should be noticed that furosemide, as a rule, does 
not promote salicylates excretion, because its diuretic effect is associated 
with increased synthesis of prostaglandins in kidneys. But this synthesis is 
blocked by salicylates. For stimulation of hepatic biotransformation of 
salicylates, 20 % glucose solution is administered intravenously. Diazepam 
is used to stop convulsions. At hypoxia, oxigenotherapy is provided.    
 
Pyrazolone Derivatives  
 
Pyrazolone derivatives are analginum (metamizole), 
butadionum (phenylbutazone), and rheumox (azapropazone). 
Drugs have anti-inflammatory, analgesic, and antipyretic effects. 
Pyrazolone derivatives have mechanism of action similar to salicylates. 
Most expressed blockage of cyclooxygenase is observed in the central 
nervous system; therefore, central mechanism of action plays an important 
role in analgesic effect of pyrazolone derivatives. Besides, these drugs are 
effective at gout and inhibit hemocoagulation.  
Because pyrazolone derivatives can cause agranulocytosis, long-time 
therapy with these drugs needs control of blood. Nowadays, pharmaceutical 
production of pyrazolone derivatives is significantly restricted.   
Butadione  has a high anti-inflammatory effect. The drug is 
administered perorally and is used locally in ointments. In case of oral 
intake, butadione is easily absorbed from gastrointestinal tract. 
Biotransformation of butadione occurs in liver. Metabolites are excreted by 
kidneys. Butadione is accumulated in the body, because its period of the 
half-life is about 1 day.   
237 
 
Butadione is used to treat arthritis, gout, tendovaginitis, rheumatoid 
arthritis, radiculitis, thrombophlebitis, etc. Butadione is highly toxic agent. 
The most common and serious side effect is ulceration of gastrointestinal 
tract. Also, the drug inhibits diuresis and causes edemas. Long-time drug 
intake (during several months) can cause aplastic anemia, leukopenia, and 
agranulocytosis. Sometimes, allergic reactions, neuritis, and 
myocardiodystrophy are possible.    
Anti-inflammatory effect of analginum  is less, than those of 
butadionum. But analginum exhibits marked analgesic and antipyretic 
effects. The drug is administered both perorally and parenterally 
(intramuscularly and intravenously). Indications for use are moderate pain 
at inflammations, postoperative pain, and fever.  
 
Para-Aminophenol Derivatives  
 
Para-aminophenol derivative paracetamol  exhibits analgesic and 
antipyretic effects but lacks anti-inflammatory effect. Paracetamol is 
commonly combined with codeine and salicylates to treat headache, 
migraine, myalgia, neuralgia, and fever. Paracetamol violates synthesis of 
prostaglandins only in the central nervous system. The drug does not 
influence prostaglandin synthesis in peripheral tissues.    
Paracetamol is primarily metabolized by conjugation in the liver and is 
quickly excreted through kidneys.  
Therapeutic doses of paracetamol seldom cause side effects. But the 
drug has narrow therapeutic index. In case of paracetamol overdose, 
metabolism by conjugation becomes saturated, and paracetamol is oxidated 
by the cytochrome P-450 to N-acetyl-p-benzoquinone imine. This 
metabolite conjugates with glutathione and is excreted through kidneys. 
But in situation of gluthatione deficiency, N-acetyl-p-benzoquinone imine 
interacts with cysteinyl sulfhydryl groups of cellular proteins. This 
interaction leads to mitochondrial dysfunction, liver inflammation and 
necrosis. Similar pathological processes occur in kidneys and myocardium. 
The first symptoms of paracetamol overdose (nausea and vomiting) occur 
in 12–24 hours.    
Acetylcysteine is used to treat poisoning by paracetamol. The drug 
should be administered during first 12 hours after poisoning that allows to 
avoid formation of toxic metabolites in the liver. 
Paracetamol is widely used in pediatric practice to treat children under 
12-years-old, because in this age cytochrome P-450 system is insufficiently 
developed and the drug biotransformation occurred owing to conjugation 
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with sulphates without formation of toxic metabolites. It should be noticed 
that maximal daily therapeutic dose of paracetamol is 4 g for adults and 
0.09 mg/kg for children. 
 
Indolacetic Acid Derivatives  
 
Indomethacin and sulindac  are derivatives of indolacetic acid.   
Indomethacin is widely used in medicine. The drug exhibits marked 
anti-inflammatory and antipyretic effects. Analgesic effect is less 
expressed. Indomethacin is taken orally or administered rectally. The drug 
is readily absorbed from gastrointestinal tract. Its maximal concentration in 
the blood is observed in 2 hours after intake. Indomethacin binds with 
plasma proteins in high degree and slowly penetrates the tissues. But the 
drug easily penetrates through placenta. Indomethacin is metabolized in the 
liver. About 5–10 % of unchanged drug is excreted through kidneys. The 
half-life of indomethacin is about 2 days.  
Indomethacin is used to treat gout, collagenoses, rhumatoid arthritis, 
osteoarthritis, inflammatory diseases of kidneys, glomerulonephritis, 
rheumatism, etc. Therapeutic effect develops in dependence on severity of 
disease. At rheumatism, pain is eliminated in several days, but at 
rheumatoid arthritis effect develops in several weeks. Early cancellation of 
the drug intake leads to restoration of disease symptoms.  
Indomethacin is a highly toxic drug. Its side effects are headache, 
vertigo, depressions, hallucinations, dyspeptic disorders (gastral pain, 
nausea, vomiting, diarhea, ulceration of mucosa, and gastritis), vision 
disorders, allergic reactions, and bronchospasms. Indomethacin slows down 
the blood coagulation, violates platelet aggregation, and inhibits 
hemopoiesis. Also, the drug retains water in the body that leads to 
oedemas. Toxic damage of liver and pancreas is also possible. 
Indomethacin is contraindicated for children under 7 years.  
 
Phenylacetic Acid Derivatives  
 
Diclofenac sodium  (Voltaren), and fenclofenac  are derivatives 
of phenylacetic acid.  
Diclofenac sodium  has a high anti-inflammatory activity and long 
duration of action. Also, diclofenac sodium exhibits marked analgesic and 
antipyretic effects. The drug is used to treat inflammations of different 
localization: rheumatism, rheumatoid arthritis, ankylosing spondylitis, 
osteoarthritis, spondyloarthritis, osteoarthritis, gout, etc. This drug is 
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characterized by low toxicity. Side effects are dyspeptic disorders and 
allergic reactions.  
 
Phenylpropionic Acid Derivatives  
 
This group includes such drugs as ibuprofen, naproxen, and 
nabumetone.  
Ibuprofen  exhibits marked anti-inflammatory, antipyretic, and 
analgesic effects. Anti-inflammatory effect of ibuprofen is higher than 
those of salicylates, but less than anti-inflammatory effect of indomethacin. 
Ibuprofen is taken orally in the treatment for rheumatism, rheumatoid 
arthritis, osteoratrosis, ankylosing spondylitis, etc. Its effect is better if the 
drug is prescribed in an initial stage of the disease. Ibuprofen is a drug with 
low toxicity.   The main side effects of ibuprofen are dyspeptic disorders, 
mild hepatotoxicity, and neurotoxicity.  
Naproxen  is most commonly used as antipyretic agent (its efficacy is 
higher than that of aspirin). Also, naproxen is used to treat inflammatory 
diseases, but its anti-inflammatory activity is less than the activity of 
diclofenac sodium.   
 
Anthranil ic Acid Derivatives  
 
Mefenamic, f lufenamic, and meclofenamic acids  are 
representatives of this group. These drugs are characterized by the marked 
antipyretic effect, which is equal to the aspirin efect. Sodium salt of 
mefenamic acid exhibits a marked and long-lasting analgesic effect at 
toothache. These drugs are inductors of interferon and exhibit 
an antiallergic action. Indications for use of anthranilic acid derivatives are 
rheumatism, nonspecific polyarthritis, artralgia, myalgia, headache, 
stomatitis, paradontosis, etc.  
Side effects of anthranilic acid derivatives are like those of other non-
steroid anti-inflammatory drugs. But these drugs seldom cause ulceration of 
gastrointestinal tract. Long-time use of anthranilic acid derivatives leads to 
albuminuria, leukocyteuria, and erythrocyteuria.      
 
Oxicam Derivatives   
 
This group includes such agents as piroxicam, lornoxicam, and 
meloxicam. 
Piroxicam  is taken orally once a day. The maximum drug 
concentration in the blood is observed in 3–5 hours after an oral intake. 
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The degree of drug binding with plasma proteins is very high. The drug has 
long-lasting effect. Its metabolites and insignificant amount of the 
unchanged drug are excreted through kidneys. The half-life of piroxicam is 
75 hours. The drug is used to treat rheumatism, osteoarthritis, ankylosing 
spondylitis, etc. Sometimes, a course of treatment lasts up to 2 years. Side 
effects of piroxicam are dispetic disorders and hemorrhages.  
Meloxicam  is characterized by a significantly higher ability to inhibit 
COX-2 than COX-1. The drug is taken orally or administered rectally. Its 
indications for use are arthrites, arthroses, and other inflammatory diseases. 
Side effects of meloxicam are nausea, vomiting, stomachache, skin rash, 
headache, dizziness, erosions of gastrointestinal tract, hepatotoxicity, etc.  
 
Sulfonanil ides  
 
 Nimesulide  blocks mainly COX-2. The drug exhibits anti-
inflammatory, analgesic, and antipyretic effects. Additionally, nimesulide 
has antioxidant action. Nimesulide is used to treat posttraumatic pain, 
rheumatoid arthritis, toothache, myalgia, osteoartoses, etc. Its negative 
influence upon gastrointestinal tract is low.   
 
Isonicotinic acid derivatives  
 
Amizon  shows anti-inflammatory, antipyretic, analgesic, and 
immunomodulating effects. Anti-inflammatory and antipyretic effects of 
amizon are identical to those of aspirin. Its analgesic effect, in a significant 
degree, is associated with inhibition of the pain impulse transmission 
through a reticular formation. Immunomodulating effect is manifested by 
the increase of both humoral and cellular immunity. Titre of antibodies and 
endogenous interferon in the blood plasma are 3–4 times increased. Also, 
amizon increases the activity of macrophages and T-lymphocytes. Amizon 
is an active peroral inductor of endogenous interferon. 
Amizon does not exhibit ulcerogenic action and has no toxic influence 
upon blood and parenchymatous organs.  
Amizon is used in the treatment and prevention of the following 
diseases: 
– influenca and other respiratory infections, including children who 
are long and often sick; 
– viral and bacterial pneumonias, infectious mononucleosis, and 
tonsillitis; 
– measles, rubella, chicken pox, scarlet fever, parotitis; 
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–  cutaneous-articular form of erysipeloid (infectious disease caused 
by Erysipelotrix rhusiopathiae) and felinosis or cat-scratch disease 
(infectious disease caused by Bartonella henselae);  
– meningitis and meningoencephalitis of viral and bacterial origin, 
chronic brucellosis, and typhoid fever; 
– herpetic and adenoviral infections: keratitis, uveitis, conjunctivitis, 
and keratoconjunctivitis; 
– pain syndrome at osteochondrosis, artralgia, neuralgia, and 
herniation of the intervertebral disc; 
– acute and chronic inflammatory processes in surgical and obstetric-
gynecological practice.  
The intake of amizon together with high doses of ascorbic acid and 
other vitamins-antioxidants is the most advisable.  
For treatment of influenca and other infectious respiratory diseases, 
adults take amizon orally in a dose 0.25–0.5 g (1–2 tablets) after meals  
2–4 times a day during 5–7 days. A preventive dose is 1 tablet daily during  
3–5 days, further – 1 tablet once per 2–3 days during 2–3 weeks.  
Amizon is a drug with low toxicity. Its side effects are insignificant 
oedemas of mucous membranes, allergic reactions, and bitter taste in the 
mouth. 
Amizon is contraindicated at hypersensitivity to iodine. The drug is 
not prescribed to children under 6 years old and to pregnant women during 
the first trimester. 
 
Coxibs  
 
Celecoxib  and rofecoxib  are selective COX-2 inhibitors. Their 
affinity to COX-2 is hundreds of times more than the affinity to COX-1.   
Celecoxib  exhibits anti-inflammatory, analgesic, and antipyretic 
effects, but lacks anti-aggregant action. The drug prevents the development 
of cancer and polyposis of colon and rectum. Celecoxib is taken orally. The 
drug is readily absorbed from gastrointestinal tract. Biotransformation of 
celecoxib is occurred in liver. The drug and its metabolites are excreted 
mainly with bile. Celecoxib is used to treat osteoarthritis, rheumatoid 
arthritis, and other collagenoses. Also, celecoxib is used in the complex 
treatment for familial adenomatous polyposis of the large intestine and for 
prevention of the colorectal cancer. 
Side effects of celecoxib are presented mainly by allergic reactions. 
Gastrointestinal lesions are observed seldom. Sometimes, nephrotoxicity, 
anemia, and inhibition of hepatic function are occurred.  
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Table 16 – Drugs for prescription 
 
Drug name Single dose and mode  
of administration 
Drug product 
Acidum 
acetylsalicylicum 
Orally 0.25–1 g 3–4 times  
a day 
Tablets 0.1; 0.25 or  
0.5 g 
Analginum Orally 0.25–0.5 g  
2–3 times a day; 
intramuscularly or 
intravenously 0.25–0.5 g 
2–3 times a day 
Tablets 0.5 g; 
 
ampoules 1 ml or 2 ml  
of 25 or 50 % solution 
Butadionum Orally 0.1–0.15 g  
2–4 times a day; 
for topical application as 
5 % ointment 
Tablets 0.15 g; 
 
5% ointment 
Diclofenac-
natrium 
Orally 0.025–0.05 g  
1–3 times a day; 
intramuscularly 0.075 g  
once a day 
Coated tablets 0.025 g;  
 
ampoules 3 ml of 2.5 % 
solution 
Paracetamolum Orally 0.2–0.4 g 2–3 times 
a day 
Tablets 0.2 g 
 
Step 1. Tasks for Self-Control  
Non-Opioid Analgesics  
 
1. After the use of acetylsalicylic acid a patient developed epigastric 
pain because of exacerbation of his ulcer. What is the cause of ulcerogenic 
action of this medication? 
A. Stimulation of pepsin secretion. 
B. Spasm of vessels. 
C. Immunosuppressive effect. 
D. Anti-prostaglandin effect.  
E. Cholagogic effect. 
2. Aspirin has anti-inflammatory effect due to inhibition of the 
cyclooxygenase activity. The level of what biological active compounds 
will decrease? 
A. Biogenic amines. 
B. Catecholamines. 
C. Leukotrienes. 
D. Iodothyronines. 
E. Prostaglandins.  
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3. Signs of gastropathy develop in the patient with rheumatoid arthritis 
who was treated with indomethacin. What activity of the drug causes this 
complication? 
A. Antihistamine. 
B. Antiserotonin. 
C. Anticyclooxygenase.  
D. Local irritating. 
E. Antikinine. 
4. A child with hyperthermia has been prescribed a drug, which is an 
active metabolite of phenacetine and has a strong antipyretic action. It can 
be inactivated by conjugation with glutathione. In toxic doses it can 
damage liver cells. Antidotes in case of poisoning are acetylcysteine and 
methionine. What is this drug? 
A. Phenobarbital. 
B. Atropine sulfate. 
C. Paracetamol.  
D. Armin. 
E. Caffeine sodium benzoate. 
5. A patient with a headache was prescribed a drug – a derivative of 
pyrazolone which has analgesic and antipyretic action. It has negative 
influence on haemopoiesis in case of long application. It is forbidden as 
monotherapy in the countries of the Schengen Agreement. What is this 
drug? 
A. Aethymizole. 
B. Analginum.  
C. Paracetamol. 
D. Pyracetam. 
E. Aminazine. 
6. A patient with arthritis of a knee joint also suffers from the gastric 
ulcer. What drug is preferable to relieve pain in the knee joint for this 
patient?  
A. Tramal. 
B. Analginum. 
C. Aspirin. 
D. Promedol. 
E. Celecoxib. 
7. A 25-year-old patient used a non-opioid analgesic from the group of 
aniline derivatives for the toothache relief. What is this drug?   
A. Ibuprofen. 
B. Acetylsalicylic acid. 
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C. Analginum. 
D. Butadionum. 
E. Paracetamol. 
8. The prolonged use of a non-steroid anti-inflammatory drug in  
a patient with arthritis and varicose phlebectasia has caused the thrombosis 
of skin veins. Indicate the drug which can cause this complication.  
A. Celecoxib. 
B. Ibuprofen. 
C. Indomethacin.  
D. Aspirin. 
E. Butadionum. 
9. A patient with fever was delivered to an infectious unit. The non-
opioid analgesic – a derivative of salicylic acid – is prescribed to the 
patient. Indicate this drug.  
A. Acetylsalicylic acid. 
B. Diclofenac sodium. 
C. Analginum. 
D. Ibuprofen. 
E. Paracetamol. 
10. A patient with acute respiratory viral disease and hyperthermia is 
delivered to an infectious unit. What drug should be prescribed for decrease 
of temperature? 
A. Retabolil. 
B. Ambroxol. 
C. Salbutamol. 
D. Adrenaline. 
E. Paracetamol. 
11. For decreasing gastric mucosa damage possibility, the  
non-steroid anti-inflammatory agent – selective inhibitor of COX-2 – is 
prescribed to a patient with rheumatoid arthritis. Indicate this drug. 
A. Ibuprofen. 
B. Analginum. 
C. Acetylsalicylic acid. 
D. Celecoxib. 
E. Butadionum. 
12. Indicate a drug, the therapeutic effects of which are the result of 
prostaglandins synthesis inhibition. 
A. Acetylsalicylic acid. 
B. Morphine. 
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C. Fentanyl. 
D. Carbamazepine. 
E. Lithium salts. 
13. A female consulted in a doctor about pain and limited movements 
in the knee joints. Which of the following non-steroid anti-inflammatory 
drugs should be administered taking into consideration that the patient has 
a history of chronic gastroduodenitis? 
A. Acetylsalicylic acid. 
B. Promedol. 
C. Butadionum. 
D. Diclofenac sodium. 
E. Celecoxib. 
 
Anticonvulsants   
 
Anticonvulsants are drugs which inhibit the function of motor centres 
and are used in the treatment for convulsions of different origin. 
Anticonvulsants are divided into the following groups:  
– drugs for symptomathic treatment of convulsions;  
– antiepileptic drugs; 
– antiparkinsonic drugs. 
 
Drugs for Symptomatic Treatment of Convulsions  
 
There are different causes of convulsions: intoxication by medicines 
(strychnine, corazole, bemegride, novocaine, etc.) or poisons (insecticides, 
phosphorus-organic compounds, etc.), infectious diseases (meningitis, 
influenca, etc.), and others. Convulsions can have clonic or tonic character.  
The following groups of drugs are most commonly used in the 
treatment for convulsive attacks: general anaesthetics, hypnotic drugs, 
tranquilizers, peripheral myorelaxants, and magnesium sulfate. 
Diazepam (sibazon, relanium, seduxen)  is most commonly 
used to eliminate convulsions of different origins. For this purpose, 2 ml of 
0.5 % diazepam solution is administered intramuscularly. Diazepam 
activates GABA-ergic synapses in the central nervous system. The drug 
inhibits convulsive activity in hippocampus, reduces activation of 
pyramidal cells of cortex and neurons of cerebellum. High doses of 
diazepam exhibit myorelaxating action due to inhibition of motoneurons of 
the spinal cord. 
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Derivatives of barbituric acid – thiopental sodium  and hexenal  – 
are also commonly used to cessate convulsions. These drugs are 
administered intravenously, sometimes – intramuscularly or rectally. The 
main mechanism of their action is associated with inhibition of motor 
cortex, hippocampus, afferent pathways, and polysynaptic reflexes of the 
spinal cord. A significant restriction for the use of barbiturates is their 
depressive influence upon the respiratory centre and inhibition of 
vasomotor centre. 
Sometimes, chloral hydrate  is administered rectally as 
anticonvulsant. But its effect develops in 40–60 minutes, therefore, chloral 
hydrate is more commonly used to prevent recurrent seizures. 
Magnesium sulfate  is also used to interrupt convulsions. The drug 
is administered intravenously or intramuscularly. Magnesium ions replace 
calcium ions in the synapses. It leads to dissociation between the excitation 
of presynaptic membrane and mediator release into synaptic cleft in the 
central nervous system, including motor centres of cortex. Impulses 
transmission in polysynaptic neuronal chains, including convulsive foci, is 
violated. It should be noticed that intravenous administration of magnesium 
sulfate should be slow due to the risk of respiratory depression.  
If administration of the drugs mentioned above does not lead to 
cessation of convulsions, inhalation anaesthetic nitrous oxide  may be 
used. In severe cases, peripheral myorelaxants (tubocurarine, etc.) 
together with general anaesthetics are administered; but patients receiving 
such therapy need artificial ventilation.              
      
Antiepileptic  Drugs  
 
Epilepsy is a common neurological disease affecting about 1 % of 
human population. There are several forms of epilepsy; the main among 
them are grand mal epilepsy (tonic-clonic seizures), petit mal epilepsy (or 
absence seizures), and psychomotor epilepsy (partial seizures). 
Grand mal epilepsy occurs in the form of tonic-clonic convulsions 
with loss of consciousness and bite of the tongue. Patient falls down and 
can be injured. Convulsions last several minutes. When convulsions occur, 
breathing stops. After convulsions, relaxation of skeletal muscles occurs, 
falling back of the tongue is possible. Convulsions can occur again in  
a short-time interval. In the future, this episode is expunged from memory. 
As a rule, sleepiness develops after attack of convulsions. 
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Petit mal epilepsy is characterized by a short-time (3–15 secunds) loss 
of consciousness, atony or twitching of some skeletal muscles without 
convulsions. A patient can fall and be injured. Eventually, rapidly 
progressing psychical disorders develop in such patients.  
Psychomotor epilepsy attacks occur against the background of clear 
consciousness. This form of epilepsy is not accompanied by convulsions or 
myoclonus. Vegetative, visual, auditory, or motor disorders suddenly 
develop in a patient. Sometimes, attacks are accompanied by psychical 
disorders, memory impairment, thought disorder, and abnormal behaviour. 
Outwardly, it looks like meaningful and ordered actions (transportation 
trip, etc.). In the future, this episode is completely expunged from memory.   
Epilepsy is due to the damage of brain tissue (neurons and cells of 
neuroglia) in result of a cranial trauma, infectious or inflammatory diseases, 
disorders of cerebral circulation, intoxication, etc. Also, hereditary 
predisposition is essential. In the lesion area, a part of neurons dies. But, 
some viable and pathologically changed neurons are between the dead cells 
and in peripheria of a lesion. These pathologically changed neurons form 
epileptic focus. The damage of neuronal membranes leads to disfunction of 
Na
+
, K
+
-ATPase with the following deceleration of sodium and calcium 
outflow from the cells. The release of excitatory neurotransmitters 
increases.    
According to the chemical structure, antiepileptic drugs are classified 
as follows: 
1) barbituric acid derivatives: phenobarbital, primidone  
(hexamidine),  and benzobarbital  (benzonal );  
2) hydantoins: diphenine (phenytoin);  
3) suxinimides: ethosuximide; 
4) benzodiazepines: clonazepam, diazepam, and nitrazepam; 
5) valproic acid derivatives: sodium valproate;  
6) iminostilbene derivatives: carbamazepine;  
7) GABA derivatives: vigabatrine;  
8) antagonists of excitatory amino acids: lamotrigine.  
There is a classification of antiepileptic drugs according to their 
clinical use:  
1) drugs which are used to treat grand mal epilepsy: phenobarbital, 
diphenine (phenytoin), hexamidine (primidone ), 
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carbamazepine, sodium valproate  (valproic acid), lamotrigine,  
and topiramate.  
2) drugs which are used in the treatment for petit mal epilepsy: 
ethosuximide, sodium valproate, clonazepam, lamotrigine, and 
trimethadione (trimethine).   
3) drugs which are used to treat psychomotor (partial) epilepsy:  
carbamazepine, diphenine (phenytoin), phenobarbital, sodium 
valproate (valproic acid), hexamidine (primidone), 
clonazepam, lamotrigine, topiramate, vigabatrine, gabapentin, 
t iagabine, and chloracon (beclamide).  
Antiepileptic drugs exhibit different mechanisms of action which are 
characterized by the following components:  
1. Restoration of properties of neuronal membranes in the epileptic 
focus by means of keeping resting potential, blockage of sodium channels, 
inhibition of pathological automatism of neurons in epileptic focus. 
Inhibition of activity of mitochondrial NADH-dehydrogenase and reduction 
of cellular energy exchange are also quite important. This mechanism is 
typical for diphenine, carbamazepine, sodium valproate, and 
topiramate. 
2. Reduction of neuronal exitability in epileptic focus owing to 
blockage of calcium channels of T-type: ethosuximide, trimethadione, 
sodium valproate.  
3. Increase of inhibitory control under excitatory impulses in epileptic 
focus by means of GABA-ergic inhibitory mechanism. There are 4 groups 
of drugs which influence GABA-ergic system:  
– drugs improving affinity of GABA to GABAA-receptors 
(benzodiazepines, phenobarbital, and topiramate); 
– drugs which promote GABA synthesis and prevent its inactivation 
(sodium valproate);  
– drugs violating GABA inactivation (vigabatrine); 
– drugs promoting accumulation of GABA by means of inhibition of 
its neuronal uptake (t iagabine).  
4. Influence upon synthesis and release of excitatory amino acids and 
receptor sensitivity to them. This mechanism is typical for lamotrigine and 
topiramate. Lamotrigine breaks down the release of excitatory amino acids 
(e. g., glutamate) from presynaptic nervous endings. Topiramate blocks 
glutamatergic receptors.  
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There are the following main principles of the epilepsy treatment: 
1. Treatment should be started as soon as possible, but not later than 
1 year after appearance of first symptoms of the disease. 
2. Patient treatment starts as monotherapy. It allows to consider drug 
pharmacokinetics better and to diagnose side effects and complication 
early.  
3. Initial dose, prescribed to a patient, is 1/3 of reccomemded 
therapeutic dose. Further, this starting dose is increased by 1/3 every  
5–7 days up to the full therapeutic dose. If a patient poorly tolerates taken 
drugs, a daily dose is divided in 4–6 intakes. If side effects continue to 
increase, the taken drug is replaced by another one. In this case, the dose of 
the first drug is gradually reduced during 3–7 days with simultaneous 
elevation of a dose of another drug. Any violation of the therapeutic 
scheme can provoke epilepsy attack. Sudden discontinuation of a drug 
intake is unacceptable, because it can result in epileptic status and patient’s 
death.  
4. At disappierence of clinical symptoms of epilepsy, continuous 
treatment lasts 3–4 years. After this, doses of drugs are gradually decreased 
up to full discontinuation of intakes. It should be noticed that full cure as a 
rule is impossible. In general, children demonstrate better treatment 
response. 
Phenobarbital  is one of the main antiepileptic drugs for treatment 
of grand mal epilepsy. It is a derivative of barbituric acid. The drug also 
exhibits sedative and hypnotic effects. Its mechanism of action is associated 
with interaction with barbiturate part of benzodiazepine-barbiturate-
GABAA macromolecular receptor complex that leads to the increase of 
GABA affinity to GABAA-receptor. Due to this mechanism, phenobarbital 
inhibits both epileptic focus and propagation of pathological impulses from 
it. At epilepsy, phenobarbital is used in subhypnotic doses. The drug is 
accumulated in the body. Long-time intake of phenobarbital can lead to the 
tolerance and drug dependence.  
Diphenine  is also used to treat grand mal epilepsy. The drug blocks 
sodium entrance in neurons that suppresses generation of pathological 
impulses in epileptic focus and their propagation. Taken orally diphenine is 
readily absorbed from gastrointestinal tract. Biotransformation of the drug 
is occurred in the liver. Diphenine is an inductor of microsomal enzymes. 
The drug is accumulated in the body. Side effects of diphenine are 
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dizziness, hyperthermia, nausea, vomiting, tremor, nystagmus, allergic 
reactions, gingival hyperplasia (occurs in up to 50 % of patients), hirsutism, 
etc.     
Hexamidine (primidone)  is less active anticonvulsant than 
phenobarbital and diphenine; but its toxicity is also less. Drowsiness, 
dizziness, headache, nausea, and ataxia can occur during first days of the 
drug intake. Long-time intake of hexamidine can cause deficiency of folic 
acid. 
Carbamazepine  is used to treat all forms of epilepsy. The drug is 
derivative of dibenzazepine. Its mechanism of action is associated with 
blockage of sodium channels in epileptic focus. Carbamazepine 
significantly reduces activity of Na
+
, K
+
-ATPase and concentration of 
cAMP. Carbamazepine exhibits favorable influence upon psyche. Patients, 
taking carbamazepine, become more sociable; their interest in the word is 
increased, depression and hypochondria are reduced, and mood improves. 
Side effects of carbamazepine are dispepsy, headache, drowsiness, allergic 
reactions, leukopenia, thrombocytopenia, agranulocytosis, and hepatitis. 
Clonazepam  is benzodiazepine derivative. The drug is taken orally. 
Clonazepam is readily absorbed from gastrointestinal tract, easily 
penetrates through the placental barrier and in the mother’s milk. The drug 
exhibits tranquilizing and anticonvulsive effects. Its mechanism of action is 
associated with activation of GABA-ergic receptors in epileptic focus. 
Also, the drug interrupts dissemination of pathological impulses. 
Clonazepam is used to cessate epilepsy attacks in children and adults, to 
treat petit mal epilepsy and myoclonus epilepsy. Side effects of clonazepam 
are ataxia, depression, aggressiveness, increased fatigue, nausea, etc. The 
drug causes psychical and physical dependence. 
Ethosuximide  is a drug of choice to treat petit mal epilepsy. The 
drug is easily absorbed from gastrointestinal tract and readily penetrates 
through the blood-brain barrier and other histohematological barriers. 
Ethosuximide blocks GABA-transferase in the central nervous system that 
leads to accumulation of GABA and reduction of convulsive activity of 
neurons. Besides, ethosuximide blocks calcium channels of T-type. Side 
effects of ethosuximide are gastrointestinal disorders, headache, dizziness, 
agranulocytosis, and violation of renal function.  
Sodium valproate  is used in the treatment for petit mal epilepsy, 
psychomotor seizures, and grand mal epilepsy. The drug has complex 
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mechanism of action. Sodium valproate blocks GABA-transaminase and 
simultaneously activates glutamate dehydrohenase. The last enzyme 
participates in the synthesis of GABA. Besides, sodium valproate blocks 
sodium channels and calcium channels of T-type. The drug improves mood 
of patients, reduces depression and fear. Side effects of sodium valproate 
include nausea, drowsiness, hair loss, etc. 
Lamotrigine  is used in the treatment of different forms of epilepsy. 
Its mechanism of action is associated with reduction of glutamate release 
from presynaptic nervous endings. Also, the drug blocks sodium channels. 
Lamotrigine is completely absorbed from gastrointestinal tract. The drug 
has long duration of action. Its side effects are dizziness, drowsiness, 
ataxia, nausea, allergic reactions, etc.  
 
Drugs for Treatment of Muscular Spasticity  
 
Increased reflectory excitability of segmental apparatus plays an 
important role in the development of muscular spasticity. A state of 
brainstem and interneurons (internuncial or relay neurons) of spinal cord is 
an important for formation of this pathology. Therefore, drugs reducing 
excitability of intercalative neurons and inhibiting spinal reflexes exhibit 
therapeutic effect at muscular spasticity. These drugs are central 
myorelaxants: tolperizosone (Mydocalm), t izanidine (Sirdalud), 
GABA derivative baclofen, and benzodiazepine derivatives 
(clonazepam, diazepam, phenazepam,  etc.).  
Mydocalm influences mainly interneurons of brainstem (descending 
facilitating system). Tizanidine, baclofen, and benzodiazepines inhibit 
reflexes mainly at the level of spinal cord. Drugs eliminate symptoms of 
spasticity. High doses of these drugs decrease the tone of skeletal muscles. 
Unlike peripheral myorelaxants, centrally acting drugs do not cause total 
relaxation of skeletal muscles, weakly inhibit arbitrary movements, and do 
not stop breathing. Mydocalm, tizanidine, and baclofen exhibit moderate 
sedative and hypnotic effects.  
Central myorelaxants are used to treat spasticity of skeletal muscles of 
different origin, intoxication by strychnine, tetanus, operations on limbs 
(reposition of bone fractures and reversal of dislocations), abdominal 
surgery with the use of local anaesthetics, pathologically increased tone of 
skeletal muscles in patients suffering from diseases of the musculoskeletal 
system, neuralgias, and some gynecological diseases.   
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Antiparkinsonic Drugs 
 
Antiparkinsonic drugs are used to treat Parkinson disease, 
symptomatic parkinsonism, and other diseases caused by disbalance of 
mediators of extrapyramidal system.  
At parkinsonism, the concentration of dopamine in extrapyramidal 
system is sharply decreased that results in reduction of its inhibitory 
influence upon cholinergic neurons participating in regulation of activity of 
spinal motor neurons. An increased activity of cholinergic and 
glutamatergic activation influence leads to appearance of rigidity (sharply 
increased muscular tone), tremor, and hypokinesia (stiffness of 
movements). Gait and posture change. Also, psychical and mental disorders 
develop gradually.  
Therapy of parkinsonism is directed to restoration of mediators 
disbalance: activation of dopaminergic neurons and/or inhibition of 
excessive activity of cholinergic and glutamatergic neurons of 
extrapyramidal system. Therefore, antiparkinsonic drugs are classified as 
follows:  
1. Drugs improving dopaminergic activity. 
1.1. Drugs which restore dopamine level: levodopa  and combined 
drugs –  sinemet,  nacom, madopar,  tolcapone.  
1.2. Dopaminergic receptor agonists: bromocriptine, ropinirole.  
1.3. Monoamine oxidase B (MAO-B) inhibitors: selegil ine.  
2. Drugs inhibiting glutamatergic influence: amantadine.  
3. Anticholinergic agents: cyclodol  (trihexyphenidyl), 
biperiden, benzotropine, tropacinum. 
The therapy of parkinsonism is pathogenetic.  
At parkinsonism, dopamine level in basal ganglia is reduced. 
Therefore, drugs which increase its level in the central nervous system are 
used to treat parkinsonism. Dopamine itself is not used as medicine because 
it poorly penetrates through the blood-brain barrier. Instead dopamine, its 
precursor levodopa (dioxyphenylalanine) is used in medicine. Levodopa 
easily penetrates the central nervous system, decarboxylated and 
transformed to dopamine that restores mediator amount and provides 
therapeutic effect of levodopa. 
Levodopa  is taken orally. Bioavailability of levodopa taken orally is 
about 20–30 %. Maximal blood concentration of levodopa is observed in 
2–3 hours after the drug intake. Initial therapeutic effect is observed in  
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a week. Maximal effect develops in a month after the start of therapy. 
There are several pathways of levodopa metabolism in the body: 
decarboxylation, transamination, methylation, and conjugation. It should be 
noticed that speed of levodopa inactivation depends on vitamin B6 
concentration because this vitamin is cofactor of enzyme inactivating 
levodopa.  
Peripheral DOPA-decarboxylase transforms a part of the taken 
levodopa in dopamine that leads to some side effects of the drug: nausea, 
vomiting, disorders of the heart rate, and ortostatic hypotension. For 
reduction of these complications, levodopa is combined with inhibitors of 
peripheral DOPA-decarboxylase which do not penetrate the central nervous 
system. Thus, Nacom  and Sinemet  are combinations of levodopa with 
carbidopa ; Madopar  is a combination of levodopa with another 
inhibitor of peripheral DOPA-decarboxylase – benserazide . Combined 
drugs are not used to treat patients with diseases of endocrine system, liver, 
kidneys, heart, and psychosis. Also, these drugs are contraindicated to treat 
young people under 25 years (bone growth should be completed).  
Bromocriptine  is agonist of dopaminergic receptors. As a rule, this 
drug is used together with levodopa. Another agent of this group – 
ropinirole – stimulates D2- and D3-receptors in neostriatum (corpus 
striatum). Ropinirole is more potent agent than bromocriptine.  
Drugs, reducing dopamine inactivation due to the blockage of  
MAO-B, are used to increase the dopaminergic influence in extrapyramidal 
system. Selegiline (deprenyl) is selective irreversible inhibitor  
of MAO-B.  
Amantadine  inhibits stimulative glutamatergic influence due to 
blockage of NMDA-receptors. Also, amantadine blocks M-cholinergic 
receptors. The drug is absorbed from gastrointestinal tract slower than 
levodopa. Its maximal concentration in blood is observed in 4 hours after 
the drug intake. Non-metabolized amantadine is slowly excreted by 
kidneys. Its half-life is about 15 hours. Also, the drug exhibits antiviral 
activity. 
Central cholinoblockering drugs (cyclodol ,  biperiden,  etc.) exhibit 
antiparkinsonic effect owing to blockage of M-cholinergic receptors in 
membranes of neurons of basal ganglia. 
Antiparkinsonic drugs reduce hypokinesia, muscular rigidity, tremor, 
drooling, and secretion of sweat and sebaceous glands. 
254 
 
These drugs are used to treat Parkinson disease, symptomatic 
parkinsonism, and extrapyramidal disorders caused by neuroleptics.  
Side effects of drugs improving dopaminergic influence include 
dispepsy, horeathetoid hyperkinesis, headache, postural hypotension, and 
disorders of the heart rate.  
Amantadine can cause dispepsy, weakness, headache, and insomnia.  
Side effects of cholinergic antagonists are associated with blockage of 
peripheral M-cholinoceptors and include dry mouth, disorders of 
accommodation, elevation of intraocular pressure, tachycardia, 
constipation, etc.  
  
Table 17 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and mode  
of administration 
Drug product 
Lamotrigine Orally 0.05–0.2 g 1 time   
a day 
Tablets 0.05, 0.1 or 0.2 g 
Dipheninum Orally 0.117 g 3 times a day Tablets 0.117 g  
Carbamazepinum Orally 0.2–0.4 g 1–2 times 
a day 
Tablets 0.1, 0.2 or 0.4 g  
Phenobarbitalum Orally 0.05 g 1–2 times  
a day 
Tablets 0.05 or 0.1 g 
Ethosuximidum Orally 0.25 g 2–3 times  
a day 
Capsules 0.25 g 
Clonazepamum Orally 0.001–0.002 g  
3–4 times a day 
Tablets 0.001 or 0.002 g 
Levodopa Orally 0.25–1.0 g 3 times 
a day 
Tablets 0.25 or 0.5 g; 
capsules 0.25 or 0.5 g 
Midantanum Orally 0.1–0.2 g 2–4 times 
a day 
Coated tablets 0.1 g  
Nacom 1 tablet 1–4 times a day Tablets containing 0.25 g of 
levodopa and 0.025 g of 
carbidopa 
Cyclodolum Orally 0.001–0.005 g  
2–3 times a day 
Tablets 0.001, 0.002 or 
0.005 g 
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Step 1. Tasks for Self -Control  
Anticonvulsants  
 
1. A doctor discusses with colleagues the use of a new antiepileptic 
drug – sodium valproate. What is the mechanism of action of this drug? 
A. Inhibition of MAO. 
B. Inhibition of GABA-transferase activity. 
C. Stimulation of GABA-transferase activity. 
D. Inhibition of Ca
2+
-dependent ATP-ase activity. 
E. Stimulation of Ca
2+
-dependent ATP-ase activity. 
2. A patient complains of muscles rigidity, constant tremor of hands, 
and slowing down of motions. In the result of examination, the doctor 
determined the diagnosis of Parkinson’s disease. Choose the rational drug 
for treatment of this patient.   
A. Ethosuximide. 
B. Diphenine (phenytoin). 
C. Phenobarbital. 
D. Levodopa. 
E. Sibazon (diazepam). 
3. A 58-year-old male complains of Parkinson’s disease. The patient 
also suffers from glaucoma. What drug should be prescribed to the patient? 
A. Cyclodol (trihexyphenidyl).  
B. Levodopa. 
C. Phenobarbital. 
D. Diphenine. 
E. Ethosuximide. 
4. Tremor and disturbances of coordination are observed in a 68-year-
old male. His diagnosis is Parkinson’s disease. What drug should be 
prescribed to the patient? 
A. Ethosuximide. 
B. Phenobarbital. 
C. Diphenine (phenytoin). 
D. Levodopa. 
E. Finlepsin.  
5. Levodopa was prescribed to a 70-year-old male, who suffers from 
Parkinson’s disease. In a week the condition of the patient significantly 
improved. What is the mechanism of levodopa action? 
A. Activation of enkephalinergic system. 
B. Suppression of cholinergic system. 
C. Suppression of histaminergic system.  
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D. Suppression of serotoninergic system. 
E. Activation of dopaminergic system. 
6. Convulsions with the loss of consciousness appear periodically in  
a 5-year-old child. The doctor has diagnosed epilepsy (grand mal). What 
drug should be prescribed in this case? 
A. Phenobarbital. 
B. Amizylum. 
C. Cyclodol (trihexyphenidyl). 
D. Ethosuximide. 
E. Levodopa. 
7. A patient, who suffers from grand mal with loss of consciousness, 
amnesia, and spontaneous outflow of urine, was treated in a neurological 
unit. What drug should be prescribed to him? 
A. Levodopa. 
B. Phenobarbital. 
C. Ethosuximide. 
D. Clonazepam. 
E. Trimethine. 
8. A patient suffers from posttraumatic epilepsy (grand mal). What 
drug should be prescribed to the patient? 
A. Midantanum (amantadine). 
B. Cyclodol. 
C. Levodopa. 
D. Teturamum (disulfiram). 
E. Phenobarbital. 
9. A patient with epilepsy accepted phenobarbital in a daily dose 0.4 g 
for a long time. Recently the attacks of epilepsy became more frequent. 
What is the reason of the patient’s condition deterioration? 
A. Inhibition of glycolysis. 
B. Inhibition of microsomal hepatic enzymes. 
C. Activation of lipolysis. 
D. Induction of microsomal hepatic enzymes.  
E. Activation of gluconeogenesis. 
10. A 42-year-old man who has been injured in a car accident is 
brought into the emergency room. His blood alcohol level on admission is 
250 mg/dl. Hospital records show a prior hospitalization for alcohol related 
seizures. His wife confirms that he has been drinking heavily for 3 weeks. 
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What treatment should be provided to the patient if he goes into 
withdrawal?  
A. Phenytoin. 
B. Diazepam.  
C. Pentobarbital. 
D. None. 
E. Phenobarbital. 
11. A 58-year-old man came to a doctor with complains of trembling, 
akinesia, muscular rigidity. The doctor has diagnosed Parkinson’s disease. 
This patient also suffers from glaucoma. What drug is it necessary to 
prescribe? 
A. Methacinum. 
B. Levodopa.  
C. Cyclodol. 
D. Atropine sulfate. 
E. Scopolamine hydrobromide. 
12. A 70-year-old man with Parkinson’s disease has been appointed a 
levodopa drug. In a week the condition of the patient has considerably 
improved. What is the mechanism of this drug action? 
A. Activation of opiate receptors. 
B. Inhibition of cholinergic receptors. 
C. Inhibition of histaminic receptors. 
D. Inhibition of serotoninergic receptors. 
E. Activation of dopamine receptors. 
13. A 5-year-old child periodically experiences convulsive attacks with 
loss of consciousness. A doctor diagnosed epilepsy. What drug is 
recommended to this child? 
A. Amizylum. 
B. Cyclodol. 
C. Ethosuximide. 
D. Levodopa. 
E. Phenobarbital.  
14. A drug, the derivative of dipropylacetic acid which depresses 
GABA-transferase, raising the content of GABA in the tissues of the brain, 
reduces the excitability and readiness for convulsions of motor zones of the 
brain, has been prescribed to a patient with epilepsy. It is applied at all 
forms of epilepsy. What is this drug? 
A. Sodium bromide. 
B. Diazepam. 
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C. Sodium valproate.  
D. Tinctura Valerianae. 
E. Reserpine. 
15. The significant improvement of motor performance is observed in  
a patient with Parkinson’s disease after the prolonged using of drug which 
is transformed into dopamine in the result of decarboxylation. What drug 
does the patient use? 
A. Aminazine. 
B. Naloxone. 
C. Celecoxib. 
D. Droperidol. 
E. Levodopa. 
16. The prescribing of levodopa to a 60-year-old patient with 
Parkinson’s disease rapidly improves his condition. What is the mechanism 
of the drug action? 
A. Activation of dopamine synthesis. 
B. Stimulation of M-cholinoceptors. 
C. Blockade of M-cholinoceptors. 
D. Stimulation of dopaminergic receptors. 
E. Anticholinesterase action. 
17. A patient has appealed to a doctor with complaints of muscles 
rigidity, tremor, and restraint of movements. In the result of examination 
the doctor made diagnosis of Parkinson’s disease. Make correct choice of  
a drug.  
A. Ethosuximide. 
B. Diphenine. 
C. Phenobarbital. 
D. Levodopa. 
E. Sibazon. 
18. A patient suffers from repeating attacks of epileptic convulsions 
with loss of consciousness. What group of drugs is used first for seizures 
elimination in this case?  
A. Sedative drugs. 
B. Neuroleptics. 
C. Miorelaxants. 
D. Tranquilizers. 
E. Analeptics. 
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19. A patient consulted a physician about muscle rigidity, constrained 
movements, permanent arm tremor. The patient was diagnosed with 
Parkinson’s disease. What drug should be administered? 
A. Levodopa. 
B. Ethosuximide. 
C. Diazepam. 
D. Phenytoin. 
E. Phenobarbital. 
 
Psychotropic Drugs 
 
Psychotropic drugs selectively influence emotions, behavior, and 
cognitive sphere. These drugs are used to treat psychical disorders and 
borderline states. According to the WHO, 1/3 of adults in developed 
countries take psychotropic drugs. Psychotropic drugs are classified as 
follows:  
– neuroleptics (antipsychotic drugs); 
– tranquilizers (anxiolytics);  
– sedative drugs; 
– antidepressants; 
– lithium salts; 
– psychostimulants; 
– nootropics (smart drugs or cognitive enhancers); 
– adaptogens; 
– psychodisleptics (hallucinogens).  
In general, the mechanisms of action of psychotropic drugs are 
associated with their ability to influence neurotransmission in the central 
nervous system. These drugs change synthesis, release, deposition, and 
inactivation of mediators.  
There are the following mediators in the central nervous system: 
amino acids (glutamic and aspartic acids, GABA, and glycin), monoamines 
(dopamine, noradrenaline, and serotonin), acetylcholine, peptides (opioid 
peptides, substance P, etc.), nitrous oxide, etc.  
Amino acids and acetylcholine are mediators which implement “fast 
signalization”. Glutamic acid is the main stimulating mediator in the central 
nervous system. GABA and glycin are the main inhibiting mediators. 
Acetylcholine exhibits mainly the function of an excitating mediator. Its 
main effects are due to excitation of M-cholinergic receptors, the high 
quantity of which is in basal nuclei. These receptors participate in  
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a transmission of ascending cortical stimules and in the processes of 
memory formation.    
Besides the system of “fast signalization”, there is a system of “slow 
signalization” in the brain. Its main mediators are monoamines. The 
function of central monoaminergic system is completely unknown. But its 
disorders pay an important role in pathogenesis of some diseases, such as 
parkinsonism, depression, schizophrenia, migraine, etc. 
 
Antipsychotic Drugs (Neuroleptics)  
 
Neuroleptics are drugs which inhibit central nervous system and 
eliminate or reduce disorders of perception and intellection and decrease 
productive symptoms of psychosis (hallucinations, delirium, and mania). 
Nowadays, these drugs are the main agents in the treatment for psychosis 
and schizophrenia.     
Neuroleptics are divided into typical and atypical drugs. Typical 
neuroleptics often impair functions of the extrapyramidal system (cause 
parkinsonism and other motor disorders). Atypical neuroleptics quite rare 
cause parkinsonism, and it is less expressed. 
1. Typical neuroleptics:  
1.1. Phenothiazine derivatives: aminazine (chlorpromazine ), 
tri f tazine, phthorphenazine, levomepromazine  (Tisercin), 
thioproperazine  (Majepti l ), and frenolon. 
1.2. Thioxanthene derivatives: chlorprothixene and thiothixene. 
1.3. Butyrophenone derivatives: haloperidol, droperidol, and 
tri f luperidol  (Trisedyl).  
1.4. Difluoro diphenylbutane derivatives: pimozide (Orap), 
f luspiri lene (Imap), and penfluridol  (Semap). 
1.5. Alkaloids of Rauwolfia: reserpine.  
2. Atypical neuroleptics:  
2.1. Benzamide derivatives: sulpiride. 
2.2. Dibenzodiazepine derivatives: clozapine.  
Derivatives of phenothiazine, butyrophenone, and difluoro 
diphenylbutane are most commonly used in psychiatric practice. Drugs of 
other groups are of secondary importance.  
The mechanism of action of neuroleptics is associated with their 
ability to block D2-dopaminergic, α-adrenergic, M-cholinergic,  
H1-histaminergic, and serotoninergic receptors in the central nervous 
system. The main factor, determining their psychotropic effect, is ability of 
drugs to block dopaminergic and α-adrenergic receptors. The action of 
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neuroleptics directs mainly to the three brain structures: the ascending 
activating part of reticular formation (controls attention, excitation, and 
anxiety), limbic system (which is responsible for emotions), and 
hypothalamus (performs regulation of endocrine and vegetative nervous 
systems). These structures modify cortex activity by means of ascending 
axons of their neurons. 
There is an evidence that psychical disorders, typical for 
schizophrenia, are associated with hyperfunction of dopaminergic system.  
A therapy with neuroleptics is accompanied by reduction of excessive 
activity of catecholergic system and normalization of pathological changes 
in the modulating systems of the brain.  
On the synaptic level, there are the following components in the 
mechanism of action of neuroleptics: 
– competitive blockage of postsynaptic receptors;  
– inhibition of mediator release into synaptic cleft and reduction of its 
reuptake by presynaptic endings that leads to the increased enzymatic 
degradation of mediator; 
– blockage of inhibiting presynaptic receptors which regulate 
intensivity of synaptic transmission by means of positive feedback. 
Pharmacological effects of neuroleptics are listed below.   
1. Antipsychotic effect is due to the blockage of dopaminergic and 
serotoninergic receptors. This effect is manifested by elimination of stable 
pathological personality changes, antisocial traits of behavior, delirium, 
halucinations, and by an increased interest in the environment, 
amplification of motivation and initiative. Besides, blockage of 
dopaminergic receptors is accompanied by extrapyramidal disorders (drug-
induced parkinsonism).  
2. Sedative effect develops owing to the blockage of α-adrenergic,  
M-cholinergic, and H1-histaminergic receptors in the central nervous 
system, mainly in the ascending part of reticular formation. The main 
manifestations of this effect are elimination of psychomotor excitement, 
flaccidity, drowsiness, impairment of mental function, apathy, collaptoid 
reactions, and reduced interest in the environment. 
Expressivity of sedative and antipsychotic effects of different drugs is 
different. Therefore, neuroleptics are divided into two groups:  
I. Neuroleptics with a marked sedative effect that dominates over 
antipsychotic effect: aminazine (chlorpromazine), droperidol,  
levomepromazine  (Tisercin), etc. These drugs are used to cessate 
psychosis with general excitation, anxiety, and aggression.  
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II. Neuroleptics with a marked antipsychotic effect: 
thioproperazine  (Majepti l ), tri f luperidol  (Trisedyl), 
f luspiri lene (Imap), haloperidol ,  etc. These drugs are used to treat 
patients with stable psychotic symptoms (hallucinations, delirium, and 
mania).  
3. Antiemetic effect of neuroleptics is associated with blockage of  
D2-dopaminergic receptors of a trigger zone, located in the rhomboid fossa 
of the fourth ventricle of the brain. Neuroleptics are effective drugs in the 
treatment for vomiting of the central origin that develops due to 
intoxications, radiation sickness, toxemia of pregnancy, etc.  
4. Reduction of muscular tone and motor activity (myorelaxating 
effect). Neuroleptics provide relaxation of skeletal muscles by means of 
blockage of α-adrenergic receptors of the descending part of reticular 
formation.  
5. Potentiation of general anaesthesia and analgesia. This effect of 
neuroleptics is due to the blockage of α-adrenergic, M-cholinergic, and  
H1-histaminergic receptors of reticular formation that leads to the decrease 
of its influence upon the cortex. Droperidol exhibits the most marked 
ability to potentiate anaesthesia and analgesia. This drug is used to prevent 
cardiogenic, traumatic, and burn shock. Also, droperidol is used for 
neuroleptanalgesia.  
6. Hypotermic effect (lowering of body temperature). Aminazine is 
most commonly used for this purpose. Body temperature is lowered due to 
the increase of heat emission and decrease of heat production. Increased 
heat emission is associated with vasodilation due to the blockage of 
peripheral α-adrenergic receptors and inhibition of hypothalamic centre of 
termoregulation. The decreased heat production is due to inhibition of 
oxidating processes in tissues. Hypotermic effect of neuroleptics is 
fundamentally different from the antipyretic effect of nonsteroid anti-
inflammatory drugs that is expressed only at fever. Aminazine is  
a component of lytic mixtures which are used in surgery for artificial 
cooling. 
7. The decrease of blood pressure is a result of blockage of peripheral 
α-adrenergic receptors, inhibition of vasomotor centre, and direct 
antispasmodic action of neuroleptics.  
8. Neuroleptics inhibit negative emotions (anxiety, fear, and general 
excitation). 
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9. Antiallergic effect is associated with the blockage of  
H1-histaminergic receptors and is most expressed in promethazine (Pipolphen, 
Diprazine).  
10. M-cholinolytic effect is manifested by hyposecretion of salivary, 
bronchial, and digestive glands.  
Aminazin is administered parenterally or taken orally. Its duration of 
action is 6 hours. Only 30 % of the taken dose is absorbed from 
gastrointestinal tract. Aminasine is metabolized in the liver. The drug and 
its metabolites are excreted by kidneys and intestine during several days. 
Haloperidol has a faster onset of action. Its maximal concentration is 
accumulated in the blood in 2–6 hours after an oral intake and is kept at  
a high level up to 3 days.  
Clozapine has a fast but short-time effect. Its maximal concentration in 
the blood is observed in 2 hours after an intake. The main part of the taken 
dose is excreted from the body during a day. 
There are the following indications for the use of neuroleptics:  
1. Schizophrenia, bipolar disorder (manic depression) in a phase of 
mania, psychical disorders in patients with organic damages of the brain, 
epilepsy, etc.  
2. Aggravation of endogenous psychosis with hallucinations, delirium, 
mania, and aggression.  
3. Acute psychical disorders with psychomotor excitement and 
reactive psychosis at traumas, infections, etc.  
4. Delirium and withdrawal syndrome.  
5. Vegetoneurosis at the ischemic heart disease, ulcer disease of the 
stomach, at climacteric period, and hypertensive crisis with 
encephalopathy.   
6. Nausea and vomiting of a central origin and persistent hiccups.  
7. Traumatic and burn shocks (drugs are administered intravenously 
drop-by-drop for improvement of blood perfusion of internal organs).  
8. Neuroleptanalgesia (a type of general anaesthesia that is used during 
operations, severe burns, traumas, etc.). 
Therapy with neuroleptics may be accompanied by the following side 
effects: 
1. Tachycardia, drop of blood pressure (up to ortostatic collapse), 
involuntary contractions of facial muscles and muscles of upper limbs are 
observed during 10–12 hours after a drug intake.  
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2. Short-time transient pain, parastesia, dyspepsy, temporary hypo- or 
hypertermia, disorders of accommodation, hypersalivation or dry mouth 
can occur in 2–3 weeks of a regular drug intake.  
3. Extrapyramidal disorders (parkinsonism, dyskinesia, and muscular 
dystony) occur due to the blockage of inhibitinhg dopaminergic influence 
of substantia nigra upon the globus pallidus and caudate nucleus that leads 
to the increase of facilitating influence upon motoneurons of the spinal 
cord. Muscular rigidity, tremor and other extrapyramidal disorders occur. 
This patology develops in 25–38 % of patients who were treated by 
neuroleptics. Extrapyramidal disorders are less expressed in case of the 
therapy with drugs which block dopaminergic receptors only in a limbic 
system and cortex, and exhibit additional M-cholinolytic properties  
(e. g. clozapine).  
4. Hepatotoxicity is typical for phenothiazine derivatives. Jaundice 
develops owing to cholestasis and focal lesions of hepatic parenchyma. 
5. Allergic reactions: skin rashes, itching, eczema, and angioedema. 
6. Blood dyscrasias: leukopenia, agranulocytosis, increase of 
erythrocyte sedimentation rate (ESR). Erythropenia and dysproteinemia are 
sometimes observed. 
7. Corneal and lens opacities are due to the pigment metabolism 
disorder owing to the increase of melanostimulating hormone secretion.  
8. Endocrine disorders: an increase of secretion of melanostimulating 
hormone and prolactine and decrease of secretion of somatotropin, 
adrenocorticotropin, tyrotropin, gonadotropins, oxytocin, and vasopressin. 
Due to this, galactorhea and amenorrhea develop in women and 
gynecomasty and impotention develop in men. 
9. Sudden cessation of the therapy with phenothiazine derivatives is 
accompanied by the withdrawal syndrome occurring in 30 % of patients. Its 
symptoms include nausea, vomiting, and aggravation of the mental 
condition.     
10. As a result of idiosyncrasy, neuroleptic malignant syndrome occurs 
in about 1 % of patients. Rigidity, sharp increase of the body temperature, 
impaired consciousness, and cardiovascular disorders are observed in these 
patients. About 10–20 % of patients with neuroleptic malignant syndrome 
die. Diazepam, bromocriptine, and dantrolene are used to treat neuroleptic 
malignant syndrome.  
Long-time therapy with neuroleptics can lead to tolerance. Drug 
dependence to neuroleptics does not develop.   
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Antidepressants  
 
Antidepressants are the drugs with the different chemical structure 
used to treat psychical depressions (major depressive disorders) and minor 
depressive disorders. Nowadays, 3–5 % of population in the word suffer 
from depressions. 
Antidepressants are classified as follows:      
1. Drugs inhibiting neuronal reuptake of monoamines (noradrenaline 
and serotonin). 
1.1. Drugs with nonselective action which block neuronal reuptake of 
both serotonin and noradrenaline: imipramine (Tofranil, imizinum), 
amitriptyline, pipofezine  (Azafen), f luacizine (Phtorazisin). 
1.2. Selective serotonin reuptake inhibitors: f luoxetine, 
f luvoxamine, sertraline. 
1.3. Selective inhibitors of the neuronal reuptake of noradrenaline: 
maprotil ine. 
2. MAO inhibitors. 
2.1. Nonselective and irreversible MAO inhibitors (block both  
MAO-A and MAO-B): nialamide, transaminum. 
2.2. Selective and reversible inhibitors of MAO-A: moclobemide, 
pyrasidole, incazanum. 
All antidepressants influence limbic system. Drugs inhibiting neuronal 
reuptake of monoamines slow down reuptake of noradrenaline, dopamine, 
and serotonin. Besides, these drugs sensitize postsynaptic receptors to 
corresponding mediators and block presynaptic α2-adrenergic receptors 
which decrease mediator release by means of a negative feedback. As  
a result, mediator concentration in a synaptic cleft is increased providing 
antidepressive and antiasthenic effects. 
The mechanism of action of MAO inhibitors is associated with 
suppression of MAO activity. MAO is in mitochondria of adrenergic and 
serotoninergic nervous endings and in inner organs (liver, small intestine, 
etc.). MAO inhibition leads to slowing down the inactivation of 
monoamines (serotonin, noradrenaline, and dopamine), accompanied by 
enhanced release of these mediators into the synaptic cleft. Nonselective 
inhibitors of MAO-A and MAO-B block these enzymes irreversibly, 
therefore both activity and toxicity of these drugs are higher than those of 
other antidepressants.  
Pharmacological effects of antidepressants are given below.  
1. These drugs improve mood and eliminate melancholy, depression, 
feeling of hopeless, and suicidal thoughts.  
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2. Some tricyclic antidepressants (e. g., amitriptyline) exhibit also 
sedative and tranquilizing effects associated with their ability to block  
M-cholinergic receptors. These effects are manifested by reduction of 
anxiety and fear. Such drug as fluoxetine lacks these effects but exhibits 
psychostimulating action.  
3. MAO inhibitors exhibit additional psychostimulatory effect 
associated with activation of noradrenergic transmission in the central 
nervous system. These drugs restore initiative and motivation and decrease 
mental and physical tiredness.  
4. Some drugs (e. g., imipramine) exhibit peripheral antihistaminic,  
M-cholinoblocking, and antispasmodic effects.  
Antidepressants are used to treat major depressive disorders, minor 
depressive disorders, neurasthenia with elements of depression, neurosis, 
enuresis, sleep disorders based on depression, and obsessive–compulsive 
disorder.   
As a rule, antidepressants are prescribed 1–2 times a day. Therapeutic 
effect is observed in 7–14 days. The effect of drugs inhibiting neuronal 
reuptake of serotonin (fluoxetine, sertraline, etc.) develops more slowly (in 
1–4 weeks). Course of treatment is individual and lasts from 1 to 6 months. 
It should be noticed that simultaneous treatment with MAO inhibitors and 
tricyclic antidepressants is unacceptable because it can provoke severe 
complications up to the patient death.  
Therapy with tricyclic antidepressants can cause hypotension, cardiac 
arrhythmias, and disturbances of cardiac conduction. MAO inhibitors cause 
hypertension, tachycardia, and mental agitation. Sometimes, allergic 
reactions, jaundice, hematopoietic disorders are possible. Due to the ability 
to block M-cholinergic receptors, tricyclic antidepressants can cause dry 
mouth, urinary retention, constipation, and aggravation of glaucoma.  
Nonselective MAO inhibitors can provoke the so-called “cheese 
syndrome”. Its mechanism is associated with the ability of drugs to increase 
effects of biogenic vasoconstricting monoamines (tyramine and 
phenylethylamine) which are contained in such foodstuffs as cheese, cream, 
beans, coffee, beer, wine, etc. In normal conditions, these monoamines are 
inactivated by MAO of the liver and small intestine. Simultaneous use of 
nonselective MAO inhibitors and eating of the mentioned foodstuffs 
increase concentration of tyramine and phenylethylamine that leads to 
hypertension. Selective inhibitors of MAO-A have less duration of action 
and the possibility of hypertensive crisis is less.  
Due to a psychostimulatory effect, MAO inhibitors can cause euphoria 
and insomnia.             
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Drugs for Mania Treatment  
 
Salts of lithium (l i thium carbonate  and l i thium oxybutirate) 
are used to treat mania. These drugs have the narrow use in medicine 
because they are able to prevent or eliminate maniacal manifestations of 
psychoses (euphoria, carelessness, excessive optimism, maniacal ideas, 
verbal and motor excitement, etc.).   
The mechanism of action of lithium is not clear enough. Lithium ions 
can replace sodium ions in the cells. Lithium ions enter inside of cells 
through fast sodium channels and partly replace sodium. But lithium ions 
are slowly removed from the cells, influencing the processes of membrane 
depolarization. Besides, lithium decreases the release of noradrenaline and 
dopamine in the synapses. Also, lithium influences secondary messendgers 
(inositol and diacylglycerol) which participate in transmission of sygnals 
from α-adrenergic and M-cholinergic receptors. There are evidences that 
lithium blocks adenylyl cyclase and decreases intracellular synthesis of 
cAMP. The mentioned mechanisms normalize processes of depolarization 
and repolarization of cellular membranes, synthesis and release of 
mediators, conjugation of the receptor excitation with changes of cellular 
functions, etc.  
Long-time intake of lithium salts leads to the loss of sodium, 
magnesium, and water and accumulation of calcium in a human body.  
Lithium salts are readily absorbed from gastrointestinal tract and 
slowly penetrate the blood-brain barrier. These drugs are excreted by 
kidneys.  
Lithium carbonate is the most commonly used preparation of lithium. 
The drug effect develops in 2–6 weeks. The duration of therapeutic course 
is at least 2 years. The duration of remission period is 10–12 years and 
more. The success of treatment depends on compliance with accuracy in 
the dosing regimen of the drug. Daily doses are individual and fluctuate 
from 0.6 to 1.6 g. It is necessary to maintain the stable concentration of 
lithium in the blood and in the brain. Lithium concentration in the plasma 
should be within the range 0.6–1 meq/liter.  
The therapeutic indications for lithium salts are prevention and 
treatment of mania.  
Side effects of lithium salts are dyspepsy, tremor, increased tiredness, 
drowsiness, headache, thyroid dysfunction, diarrhea, polyuria, thirst, renal 
disorders, and imbalance of electrolites. It should be noticed that an 
insignificant amount of lithium is excreted by mammary glands.  
Poisoning by lithium salts is possible due to its overdose or reduced 
amount of sodium in the body (salt-free diet, therapy with diuretics, etc.). 
The manifestations of poisoning are vomiting, diarrhea, ataxia, 
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convulsions, etc. In severe cases, coma and death are possible. Treatment of 
lithium poisoning is directed to fast elimination of lithium from the body. 
Osmotic diuretics (mannitol) and sodium hydrocarbonate are prescribed to 
a patient for this purpose. In severe cases, hemodialysis is used.  
                
Table 18 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and route  
of administration 
Drug product 
Aminazinum Orally 0.025–0.05 g 1–3 times 
a day; 
intramuscularly 0.01 g  
1–3 times a day; 
intravenously 1–2 ml of 2.5 % 
solution in 20 ml of 40 % 
glucose solution (at acute 
psycho-motor excitement) 
Dragee 0.025, 0.05 or 0.1 g; 
 
ampoules 1, 2, 5 or 10 ml of 
2.5 % solution 
Triftazinum Orally 0.005–0.01 g  
once a day; 
intramuscularly  
0.001–0.002 g once a day 
Tablets 0.001, 0.005 or  
0.01 g; 
ampoules 1 ml of 0.2 % 
solution 
Haloperidolum Orally 0.0015–0.005 g  
3 times a day; 
intramuscularly 0.002– 
0.005 g   
Tablets 0.0015 or 0.005 g; 
 
ampoules 1 ml of 0.5 % 
solution 
Droperidolum Intramuscularly or 
intravenously 0.0025–0.005 g 
Ampoules 5 or 10 ml of 
0.25 % solution 
Imizinum Orally 0.025–0.05 g  
1–3 times a day; 
intramuscularly 0.025 g  
1–3 times per day 
Tablets 0.025 g; 
 
ampoules 2 ml of 1.25 % 
solution  
Amitriptylinum Orally 0.025–0.05 g  
3–4 times a day; 
intramuscularly or 
intravenously 0.025–0.04 g 
3–4 times per day  
Tablets 0.025 g; 
 
ampoules 2 ml of 1 % solution 
Lithii carbonas  Orally 0.3–0.6 g Tablets 0.3 g 
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Step 1. Tasks for Self -Control  
Antipsychotic Drugs (Neuroleptics) , Antidepressants ,  
and Drugs for Mania Treatment  
 
1. A patient was treated medically for psychosis for 2 weeks. The 
patient’s condition improved but rigidity, tremor, and hypokinesia 
developed. Which of the following drugs can cause such complications? 
A. Sydnocarb. 
B. Imipramine. 
C. Aminazine.  
D. Chlordiazepoxide. 
E. Diphenine. 
2. To eliminate delirium and hallucinations in a patient with 
schizophrenia a doctor used aminazine. What is the mechanism of 
antipsychotic action of the drug? 
A. Blockade of the inverse neuronal capture of catecholamines. 
B. Stimulation of adrenergic and dopaminergic processes in the CNS. 
C. Blockade of adrenergic and dopaminergic processes in the CNS.  
D. Stimulation of cholinergic processes in the CNS. 
E. Blockade of cholinergic processes in the CNS. 
3. A patient with manic-depressive psychosis and manifestations of 
depression complains of anxiety and fear. What antidepressant with 
accompanying psychosedative effect is it necessary to prescribe? 
A. Amitriptyline.  
B. Phenazepam. 
C. Imizinum (imipramine). 
D. Sydnocarb. 
E. Nialamide. 
4. A drug shows a strong, fast, but not long-term neuroleptic action. It 
potentiates the action of analgesic, soporific agents, alcohol. It has anti-
shock and antiemetic action. It belongs to butyrophenone derivatives. What 
is this drug? 
A. Sulpiride. 
B. Triftazine. 
C. Aminazine. 
D. Clozapine (azaleprtin). 
E. Droperidol.  
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5. A patient developed symptoms of medicinal parkinsonism after 
psychosis treatment in a mental hospital. What drug had been used for his 
treatment? 
A. Nialamide. 
B. Mezapam. 
C. Sodium bromide. 
D. Lithium carbonate. 
E. Aminazine.  
6. Acute heart attack is accompanied by retrosternal pain. 
Ineffectiveness of preliminary taken drugs has made the doctor to perform 
neuroleptanalgesia. What neuroleptic is used for this type of anaesthesia? 
A. Aminazine. 
B. Meterazine (prochlorperazine). 
C. Haloperidol. 
D. Droperidol. 
E. Reserpine. 
7. A 38-year-old man suffers from schizophrenia. He has come to 
a doctor with complaints of coordination and movements disorders, tremor 
in his hands, drowsiness. The patient has been taking psychotropic drugs 
for a long period of time. What group of drugs can lead to such complex of 
symptoms? 
A. Adaptogens. 
B. Analgesics. 
C. Neuroleptics.  
D. Antidepressants. 
E. Psychomotor stimulants. 
8. A patient with maniac-depressive psychosis demonstrates inhibition 
of mental and motion activity, agitation, depression. What drug should be 
prescribed to relieve pathological depression? 
A. Triftazine. 
B. Sydnocarb. 
C. Caffeine sodium benzoate. 
D. Amitriptyline.  
E. Pyracetam. 
9. A man is kept under dispensary observation in a psychoneurologic 
clinic because of chronic alcoholism. Alcohol abuse led to acute psychosis. 
What drug can be expediently used? 
A. Adrenaline.  
B. Atropine.  
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C. Aminazine.  
D. Pentamine. 
E. Hygronium. 
10. What neuroleptic is characterized by the following properties: 
phenothiazine derivative, blocks postsynaptic dopamine and adrenergic 
receptors in the CNS, provides a sedative effect on the CNS, prolonged 
application can induce extrapyramidal abnormalities and neuroleptic 
syndrome? 
A. Haloperidol. 
B. Aminazine.  
C. Diazepam. 
D. Triftazine. 
E. Droperidol.  
11. A woman tried to commit suicide. A psychiatrist detected 
a condition of endogenous depression of this patient. What medication is 
expedient to prescribe to the patient for the course of treatment? 
A. Caffeine sodium benzoate. 
B. Sydnocarb. 
C. Aethymizole. 
D. Pyracetam. 
E. Amitriptyline.  
12. A patient with schizophrenia takes aminazine. Which of the listed 
pharmacodynamic effects is the basic one in this case? 
A. Hypotensive. 
B. Antiemetic. 
C. Hypothermic. 
D. Muscle relaxing. 
E. Antipsychotic. 
13. An ambulance has delivered a patient, who tried to commit suicide 
in the condition of severe depression, to a hospital. The diagnosis is 
depressive psychosis. The drug of which pharmacological group is it 
necessary to prescribe to the patient? 
A. Lithium salts. 
B. Antidepressants.  
C. Sedatives. 
D. Neuroleptics. 
E. Tranquilizers. 
14. A patient suffering from Parkinson’s disease needs additional 
treatment concerning accompanied pathology. Indicate the group of drugs 
272 
 
which can cause aggravation of Parkinson’s disease in this patient?  
A. Antidepressants. 
B. Tranquilizers. 
C. Antipsychotic drugs (neuroleptics). 
D. Hypnotics. 
E. M-cholinoblockers. 
15. The first aid brigade has delivered a patient with obvious 
psychomotor disturbances to a hospital. What drug should be administered 
to the patient? 
A. Bisacodyl. 
B. Aminazine. 
C. Piracetam. 
D. Rifampicin. 
E. Heparin. 
16. A surgery patient needs neuroleptanaesthesia. What drug is most 
commonly used for neuroleptanaesthesia together with fentanyl? 
A. Fraxiparine. 
B. Droperidol. 
C. Cholosasum. 
D. Salbutamol. 
E. Pilocarpine. 
17. Pharmacological effects of antidepressants are based upon blocking 
(inhibiting) the enzyme that acts as a catalyst for the breakdown of biogenic 
amines noradrenaline and serotonin in the mitochondria of cephalic 
neurons. What enzyme takes part in this process? 
A. Decarboxylase. 
B. Lyase. 
C. Transaminase. 
D. Peptidase. 
E. Monoamine oxidase. 
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Anxiolytic Drugs  (Tranquilizers)  
 
Anxiolytics (tranquilizers, ataractics) are the drugs which inhibit the 
central nervous system and reduce or eliminate negative emotions: internal 
stress, anxiety and fear. These drugs are effective at neurotic and neurosis-
like disorders. First tranquilizer, meprobamate, was synthesized in the USA 
in 1954. Many other drugs were synthesized later.  
Anxiolytics are classified as follows:   
1. Agonists of benzodiazepine receptors.  
1.1. Long-acting drugs (24–48 hours): phenazepam, mezapam, 
chlordiazepoxide  (chlozepidum), diazepam (sibazon), and  
f lurazepam. 
1.2. Drugs with intermediate duration of action (6–24 hours): 
nitrazepam, oxazepam, and alprazolam.  
1.3. Short-acting drugs (less than 6 hours): midazolam and 
triazolam.  
2. Agonists of serotoninergic receptors: buspirone. 
3. Drugs with different mechanisms of action: amizylum 
(Benactyzine), trimetozine  (Trioxazine), and oxylidine. 
4. Daytime anxiolytics:  
–  agonists of benzodiazepine receptors: mezapam, hydazepam, and 
clorazepate  dipotassium  (Tranxene); 
– α-adrenoblocking drug: pyrroxane;  
–  nootropic drug:  nootropi l; 
– GABAB-receptor agonist: phenibut.  
 
Benzodiazepine Derivatives 
 
Benzodiazepine derivatives are drugs with low toxicity, therefore these 
drugs are widely used in medicine. These drugs act as agonists of 
benzodiazepine receptors which are coupled with GABAA-receptors. 
Stimulation of benzodiazepine receptors leads to allosteric activation of          
GABAA-receptors. The further opening of Cl
–
 channels results in increase 
of chlorine entrance into the neurons, hyperpolarization of their membranes 
and inhibition of neuronal activity.  
Limbic system (amygdalae and their links with hippocampus) and 
cortex are most rich in benzodiazepine receptors. Low density of 
benzodiazepine receptors is in hypothalamus, thalamus, cerebellum, and 
spinal cord. 
The following pharmacological effects are typical for tranquilizers.  
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1. Anxiolytic effect is associated with influence of drugs upon limbic 
system. It is manifested by reduction of emotional lability, decrease of 
psychical stress, anxiety, and fear. Situations, which were estimated earlier 
as stressful, get quieter and sober estimation. The critical attitude to events 
and deeds is completely preserved. Due to anxiolytic effect, vegetative and 
endocrine frustrations of neurosis are also eliminated. 
2. Sedative effect is a result of interaction of benzodiazepines with 
benzodiazepine receptors in reticular formation. Besides, tranquilizers 
increase the activity of intracortical inhibitory neurons. Sedative action is 
manifested by the decrease of reaction on external stimulus, reduction of 
mental and physical serviceability, and drowsiness. Prescription of these 
drugs to outpatients, whose work requires increased attention  
(e. g., dispatchers, drivers, installers), is unacceptable.     
3. Hypnotic action is a result of influence of benzodiazepines upon 
limbic system (hippocampus). A decrease of emothional stress also 
promotes the hypnotic effect. These drugs contribute to falling asleep and 
increase the total duration of sleep. It should be noticed that 
benzodiazepines shorten the frequency and general duration of “fast” or 
desynchronized (REM) sleep. But this undesirable effect is significantly 
less expressed then those of barbituric acid derivatives.  
4. Muscle relaxation is caused by benzodiazepines due to depression 
of spinal intercalary GABA-ergic neurons. Also, benzodiazepines depress 
the activity of descending reticular formation. Therefore, benzodiazepines 
are muscle relaxants with central action.  
5. Anticonvulsive action is due to the ability of benzodiazepines to 
inhibit convulsive discharges in hippocampus which is involved in 
pathogenesis of the most convulsive reactions.  
6. High doses of benzodiazepines cause amnesia due to the marked 
reduction of cortical activity.  
7. Benzodiazepines potentiate the effects of other central nervous 
system depressants (opioid analgesics, barbiturates, neuroleptics, and 
general anaesthetics).  
There are the following therapeutic indications for benzodiazepines:  
1. In psychiatric and neurological practice, benzodiazepines are used 
to treat so-called borderline states: neuroses, neurotic reactions, 
psychopaty, etc.  
2. Tranquilizers are used in a complex therapy of therapeutic diseases, 
pathogenesis of which includes neurotic factor: angina pectoris, myocardial 
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infarction, exacerbation of hypertensive disease, ulcer disease, bronchial 
asthma, etc.  
3. Status epilepticus, epilepsy, muscular hypertone which are due to 
traumas of the central nervous system or insults.  
4. Premedication for patients with high psychoemotional lability.  
5. Ataralgesia. For this type of general anaesthesia, tranquilizer 
(diazepam) is administered together with opioid analgecsic (fentanyl or 
promedol). Ataralgesia is used for anaesthesia of patients with high 
anaesthesiological risk (children, elderly people, etc.).  
6. Treatment of traumas, burns, prevention of traumatic shock. 
7. At stressful situations, for prevention of neurotic disorders in 
healthy people.  
8. Insomnia.  
9. Treatment of the withdrawal syndrome. 
Because benzodiazepines are lipophilic, these drugs are easily 
absorbed from gastrointestinal tract and penetrate the blood-brain barrier 
and other tissue barriers of a body. Short-acting benzodiazepines 
(oxazepam, tofisopam (Grandaxin), etc.) are metabolized by way of 
glucuronization. Long-acting drugs undergo demethylation with formation 
of active metabolites. Non-metabolized drugs and their metabolites are 
excreted mainly through kidneys and partly – through intestine.  
Side effects of benzodiazepines are drowsiness, decreased capacity to 
work, muscular weakness, slow down of psychomotor reactions and mental 
functions, dysmenorrhea, reduced libido, etc. Benzodiazepines are 
contraindicated for outpatients, whose work needs increased attention and 
reaction. Sometimes, benzodiazepines exhibit toxicity for fetus.  
Long-time intake of benzodiazepines leads to the drug dependence 
(psychical and physical). In this case, sudden discontinuation of  
a tranquilizer intake can provoke insomnia, enxiety, depression, and 
convulsions. An increase of sensitivity to light and sound and changes of 
visual perception are also typical. For prevention of the drug dependence, it 
is necessary to prescribe tranquilizers by short courses (7–10 days), to 
avoid sudden drug discontinuation, and to decrease a taken dose bit by bit.  
It should be noticed that a long-time intake of tranquilezers is 
accompanied by development of tolerance that leads to reduction of their 
efficacy.  
Ethyl alcohol potentiates effects of tranquilizers and such combination 
may lead to coma, sharp lowering of blood pressure, respiratory inhibition, 
and other symptoms of acute poisoning. Flumazenil , antagonist of 
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benzodiazepine receptors, is used to treat such poisoning. There is evidence 
about antagonism between benzodiazepine derivatives and euphilline. 
Symptomatic treatment is also provided. It should be noticed that 
hemodialysis is ineffective in case of poisoning by benzodiazepines.                
 
Agonists of  Serotonin Receptors  
 
Buspirone is an agonist of 5-HT1A receptors. Excitation of these 
receptors is accompanied by development of autoinhibitory effect that leads 
to reduction of synthesis and release of serotonin. Buspirone exhibits 
expressive anxiolytic effect which develops during 1–2 weeks. The drug 
has no sedative, muscle relaxant, and anticonvulsive effects. Taken orally 
buspirone is readily absorbed from gastrointestinal tract, biotransformated 
in the liver, and excreted by kidneys. The drug is well tolerated by patients. 
Its side effects are headache, dispepsy, and irritability.  
 
Tranquilizers with Different Mechanisms of  Action 
 
Amizylum (Benactyzine) blocks central M-cholinergic receptors 
in the reticular formation of the brain. The drug exhibits anxiolytic, 
sedative, anticonvulsive, antitussive, anaesthetic, and antihistaminic effects. 
Blockage of peripheral M-cholinergic receptors can cause dry mouth and 
mydriasis. Also, amizylum reduces the spasm of smooth muscles. The drug 
is taken orally 3–4 times a day. Amizylum is easily absorbed from 
gastrointestinal tract and excreted through kidneys.    
Trimetozine  (Trioxazine) has weak tranquilizing effect which is 
associated with stimulating action. The drug improves mood and does not 
cause drowsiness and slowdown of psychomotor reactions. Trioxazine is 
well tolerated by patients. 
Tranquilizing activity is also typical for β-adrenergic antagonists 
which easily penetrate the blood-brain barrier (e. g., propranolol).  
 
Daytime Tranquilizers  
 
Besides anxiolytic, daytime tranquilizers can exhibit sedative, muscle 
relaxant, and anticonvulsive effects. But sedative and muscle relaxant 
effects of these drugs are significantly reduced. Sometimes, the sedative 
effect of drugs is associated with stimulating action. Due to this, daily 
tranquilizers cause insignificant reduction of working capacity. These drugs 
are preferable to treat children, elderly patients, and weakened patients.    
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Sedative Drugs  
 
Sedative agents are drugs which decrease the excitability of the central 
nervous system. These drugs concede to neuroleptics and tranquilizers in  
a degree of inhibitory action upon the CNS. Unlike tranquilizers, sedative 
drugs don’t eliminate negative emotions (like anxiety, fear, etc.). Sedative 
agents are ineffective in psychical disorders.  
Sedative drugs are classified as follows: 
1. Bromides: sodium bromide and potassium bromide.  
2. Sedative drugs of the plant origin: tinctures infusions of 
Valeriana, motherwort (Leonurus ), Passif lora, peony, etc. 
3. Combined drugs: corvalole, barbamil ,  cardiovalen,  
Novopassit ,  Persen,  etc.  
4. Barbiturates in subhypnotic doses (1/3–1/10 hypnotic doses): 
phenobarbital.  
The mechanism of action of sedative drugs is not sufficiently studied. 
It is known, that sedative agents do not influence certain cellular receptors 
and neurotransmitters. The base of sedative action is their influence upon 
cortex due to increase of inhibitory processes without affecting excitation 
processes. Thus, sedative drugs restore the balance in nervous processes.  
Sedative drugs exhibit the following pharmacological effects:  
1. Sedative effect without significant changes of normal functions of 
the central nervous system.  Drugs decrease excessive irritability.  
2. Sedative agents increase the effect of hypnotics and analgesics.   
3. Sedative drugs facilitate the onset of sleep and increase the depth of 
sleep. But these drugs have no own hypnotic effect.  
4. Bromides exhibit antiepileptic properties, but significantly concede 
to other antiepileptic agents.   
There are the following indications for the use of sedative drugs: 
1. Increased irritability, nervousness, and neurosis.  
2. Dystonia of inner smooth muscle organs and discomfort in the heart. 
3. Insomnia.  
4. Initial forms of hypertensive disease.  
5. Epilepsy (for bromides).  
 Bromides are easily absorbed in gastrointestinal tract. Drugs are 
excreted mainly through the kidneys. Because the speed of their elimination 
is rather low (1–2 months), bromides tend to accumulate in the body. Thus, 
long-time administration of bromides can result in chronic poisoning – 
bromism. The main symptoms of bromism are weakness, sleepiness, 
apathy, decreased memory, acneiform eruption on the skin (bromide acne); 
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inflammation of mucous membranes of gastrointestinal tract and 
respiratory system accompanied by cough, rhinitis, conjunctivitis, and 
diarrhea. At occurrence of these sumptoms, bromides intake should be 
interrupted. A treatment of bromism includes intake of high quantity of 
sodium chloride (20–25 grams a day), plentiful drink of water, and intake 
of diuretics.  
Except sedative effect, drugs of Valeriana also exhibit antispasmodic 
action and relax the smooth muscles of inner organs. These drugs have low 
toxicity, therefore a long-time intake is possible.  
 
Table 19 – Drugs for prescription 
 
 
Drug name 
(Latin) 
Single dose and route  
of administration 
Drug product 
Diazepamum Orally 0.005–0.015 g  
3 times a day; 
intramuscularly or 
intravenously 0.01–0.02 g 
1–3 times a day 
Tablets 0.005 g; 
 
ampoules 2 ml of 0.5% 
solution 
Phenazepamum Orally 0.00025–0.001 g  
1–2 times a day 
Tablets 0.0005 or 0.001 g 
Nitrazepamum Orally 0.005–0.01 g  
1–2 times a day 
Tablets 0.005 or 0.01 g 
 
Gidazepamum Orally 0.02–0.05 g 
3 times a day 
Tablets 0.02 or 0.05 g  
Lithii carbonas  Orally 0.3–0.6 g Tablets 0.3 g 
Natrii bromidum Orally 0.5–1.0 g  
3–4 times a day 
Tablets 0.5 g 
Tinctura Valerianae Orally 20–30 drops  
3–4 times a day 
Tinctura 30 ml 
Tinctura Leonuri Orally 30–50 drops  Tinctura 25 ml  
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Step 1. Tasks for Self -Control  
Anxiolytic Drugs  (Tranquilizers) and Sedative Drugs  
 
1. A patient has taken the mixture prescribed by the neuropathologist 
for neurasthenia for 2 weeks. The patient felt better but developed coryza, 
conjunctivitis, rash, inertia, decrease in memory. Bromism was diagnosed. 
What should be prescribed to decrease symptoms? 
A. Diazepam. 
B. Sodium chloride.  
C. Asparcam. 
D. 5 % glucose solution.  
E. Polyglukin. 
2. A patient, receiving diazepam to treat neurosis, complains of 
toothache. A doctor administered him an analgesic, but its dose was lower 
than average therapeutic dose. What phenomenon did the doctor consider 
while prescribing the patient an analgesic drug in a reduced dose? 
A. Drug dependence. 
B. Potentiation.  
C. Cumulation. 
D. Tolerance. 
E. Summation. 
3. A 42-year-old man who has been injured in a car accident is brought 
into the emergency room. His blood alcohol level on admission is 
250 mg/dl. Hospital records show a prior hospitalization for alcohol related 
seizures. His wife confirms that he has been drinking heavily for 3 weeks. 
What treatment should be provided to the patient if he goes into 
withdrawal?  
A. Phenytoin. 
B. Pentobarbital. 
C. None. 
D. Phenobarbital. 
E. Diazepam.  
4. A student asked a doctor to help him to overcome the fear of 
stomatological manipulations. What drug has the doctor advised to take? 
A. Pyracetam. 
B. Aminazine. 
C. Droperidol. 
D. Diazepam.  
E. Dimedrol. 
5. A woman, who leads an active lifestyle, has appealed to a polyclinic 
with complains of bad mood, migraine, emotional lability, heart pain. What 
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drug for neurosis treatment should be prescribed, taking into consideration 
that the patient spends a lot of time at work? 
A. Hydazepam. 
B. Phenobarbital. 
C. Aminazine. 
D. Phenazepam. 
E. Triftazine. 
6. To perform oral surgery a dentist prescribed a combination of drugs 
with the purpose of analgesia. What tranquilizer – the derivative of 
benzodiazepine – is used for this purpose? 
A. Diazepam.  
B. Aminazine. 
C. Droperidol. 
D. Trioxazine. 
E. Sulpiride. 
7. A patient suffers from repeating attacks of epileptic convulsions with 
loss of consciousness. What group of drugs is primarily used to eliminate 
seizures in this case?  
A. Sedative drugs. 
B. Neuroleptics. 
C. Miorelaxants. 
D. Analeptics. 
E. Tranquilizers. 
8. After the psychical trauma, a patient began to complain of alarm, 
anxiety, and fear. What derivative of benzodiazepine may be prescribed to 
the patient?  
A. Heparin. 
B. Analginum. 
C. Bisacodyl. 
D. Nitrazepam. 
E. Metoclopramide. 
9. A 45-year-old patient suffers from neurosis characterized by 
irritability, sleeplessness, and motiveless anxiety. What drug would 
eliminate all the symptoms? 
A. Ethosuximide. 
B. Diazepam. 
C. Pyracetam. 
D. Levodopa. 
E. Caffeine sodium benzoate. 
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Psychostimulants  
 
The psychostimulants are drugs, which increase the psychical and 
physical working capacity, improve the mood, reduce the need of sleep, 
and decrease the feeling of tiredness, hunger, and thirst.  
Psychostimulants are classified as follows: 
1. Phenylalkylamine derivatives: phenamine (amphetamine). 
2. Sidnone imines derivatives: sydnocarb (mesocarb). 
3. Piperidine derivatives: meridilum (methylphenidate), 
pyridrolum. 
4. Methylxanthines (purine derivatives): caffeine.  
 
Phenylalkylamines   
 
The first psychostimulant phenamine (amphetamine) was 
synthesized in 1910. This agent increases motor and psychical activity, 
reduces tiredness, improves mood, and reduces the need for sleep. But 
these effects develop due to the use of reserve capabilities of the body. 
Therefore, systematic intake of such drugs is dangerous. After intake of 
such drugs, the high-grade rest is necessary for restoration of energy 
reserves of the body. 
Phenylalkylamines activate adrenergic transmission in the body (both 
in the central nervous system and in the inner organs) and regulate cellular 
metabolism.  
Mechanism of action of phenylalkylamines is associated with the 
following: 
1. Phenylalkylamines are indirect adrenomimetics. These drugs 
increase the release of catecholamines into synaptic cleft which leads to 
activation of postsynaptic receptors.  
2. Phenylalkylamines slow down reuptake of mediators from the 
synaptic cleft which also increases action of catecholamines upon 
postsynaptic receptors.  
3. Phenylalkylamines are reversible inhibitors of MAO.  
Thus, phenylalkylamines significantly activate transmission of nervous 
impulses by means of noradrenaline, adrenaline, and dopamine. The degree 
of activation is directly proportional to the drug dose.   
Pharmacological effects of phenylalkylamines are given below.  
1. Psychostimulating effect. Phenylalkylamines reduce the mental 
tiredness, eliminate drowsiness, improve mood, cause mild euphoria and 
a desire to work. These drugs increase volume of temporary memory (but 
the transfer of information to long-term memory is not increased). 
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Phenamine improves performance of a stereotyped work. 
Phenylalkylamines temporary suppress the need to sleep (to 10–12 hours). 
But, a long-term high-grade rest is necessary after the drug intake. 
Phenylalkylamines reduce the effects of hypnotics and other central 
nervous system depressants.  
2. Phenylalkylamines exhibit typical doping effect: physical endurance 
and speed of work performance are increased.   
3. Phenylalkylamines stimulate cardiovascular system. Tachycardia, 
icreased stroke volume and cardiac output, vasoconstriction, increased 
blood pressure, and reduced cerebral circulation are observed.  
4. Phenylalkylamines increase concentration of glucose, lactate, 
pyruvate, and free fatty acids in the blood. These effects develop due to 
activation of glycogenolysis in the liver and skeletal muscles and lipolysis 
in the fat tissue. Simultaneously, these drugs slow down gluconeogenesis.  
5. Anorexigenic effect (reduction of appetite) is due to stable 
excitation of saturation centre which, in turn, inhibits hunger centre.  
6. Analeptic effect (stimulation of respiratory centre).  
7. Posibility of drug dependence (psychical and physical) in case of 
repeated drug intake. Therefore, all psychostimulants are considered as 
potential drugs of abuse. 
Repeated phenamine intake is accompanied by its accumulation in the 
body.  
Potentially, phenamine may be used to treat neurotic disorders, 
poisoning by drugs which inhibit the central nervous system, and to 
increase working capacity. But practically, phenamine is not used in 
medicine because it can cause drug dependence.        
  
Sidnone Imines Derivatives  
 
Sydnocarb  is less toxic agent than phenamine. Psychostimulating 
effect of agent develops gradually and lasts long. Peripheral 
sympathomimetic effects of sydnocarb are reduced. This agent does not 
cause marked euphoria and motor excitement. For avoiding insomnia, 
sydnocarb should be prescribed in the first part of a day. An overdose of 
sydnocarb leads to excitement, insomnia, and increase of blood pressure.  
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Piperidine Derivatives  
 
 Meridilum (methylphenidate) and pyridrolum are piperidine 
derivatives which stimulate the central nervous system. Pyridrolum exhibits 
higher psychostimulating effect than meridilum does, but this effect is less 
than that of phenamine. Both drugs do not cause undуsirable cardiovascular 
effects.    
 
Methylxanthines  (Purine Derivatives)  
 
Caffeine  is alkaloid contained in tea leaves, seeds of coffee, cocoa 
and other plants. Caffeine exhibits psychostimulating effect owing to 
blockage of phosphodiesterase – enzyme hydrolyzing cAMP. Inhibition of 
phosphodiesterase leads to accumulation of cAMP both in the cells of 
peripheral tissues (heart, fat tissue, smooth muscles of inner organs, skeletal 
muscles, etc.) and in the central nervous system. cAMP is a second 
messenger participating in transduction of signal from mediator.  
Also, blockage of A1 and A2 adenosine receptors by caffeine plays an 
important role in its mechanism of action. It is known that adenosine 
inhibits the central nervous system activity.  
Caffeine activates psychical activity; increases mental and physical 
capacity to work, and motor activity. The effects of caffeine depend on the 
type of nervous system and drug dose. In low doses it exerts stimulating 
action and in high doses – inhibitory effect. For the “weak” type of the 
nervous system the effect of excitement is reached by introduction of low 
doses of caffeine. Patients with a “strong” type of nervous system require 
higher doses of caffeine.  
The following pharmacological effects are typical for caffeine:   
1. Psychostimulating effect is the result of activation of psychical 
activity, physical and mental capacity to work, and temporary reduction of 
fatigue and drowsiness.  
2. Analeptic effect (stimulation of respiration and blood circulation) is 
the result of direct stimulating influence upon respiratory and vasomotor 
centres of medulla oblongata. The depth and frequency of respiration is 
increased. Stimulation of vasomotor centre results in peripheral 
vasoconstriction and elevation of blood pressure. 
It is necessary to notice, that cardiovascular effects of caffeine are the 
result of both central and peripheral drug’s influence. Caffeine increases the 
tone of vagus nerve that leads to bradycardia. But direct influence of 
caffeine upon heart is accompanied by increase of heart rate and cardiac 
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contraction force. Summary effect depends on the dominant component 
(peripheral or central).  
The increase of vasomotor centre tone (central component) under the 
influence of caffeine is accompanied by the spasm of peripheral vessels and 
by the increase of blood pressure. Direct influence of caffeine upon the 
vessels results in decrease of vessels tone (especially vessels of skeletal 
muscles, of heart, and of kidneys). Summary effect depends on the 
dominant component. In case of marked hypotension, caffeine 
administration results in increase of blood pressure. In healthy persons, 
caffeine does not decrease blood pressure despite of its predominant direct 
influence upon the vessels. It is due to increased heart work. Caffeine 
initially causes relaxation of cerebral vessels replaced by increase of their 
tone.    
3. Diuretic effect of caffeine is the result of kidneys blood flow 
improvement and of the decrease of sodium and water reabsorption in the 
nephron.  
4. Caffeine increases the secretion of gastric juice owing to stimulation 
of parasympathetic nervous system (vagus nerve).  
5. Caffeine increases spinal reflexes due to the improving of 
interneuronal transmission of impulses.  
Caffeine is easily absorbed from gastrointestinal tract. About 90 % of 
absorbed dose is metabolized by oxidation and demethylation. Unchanged 
caffeine and its metabolites are excreted by kidneys.     
There are the following indications for the use of caffeine:  
1. In healthy people, for temporary reduction of need in sleep and for 
increase of mental and physical work capacity.  
2. Hypotension.  
3. Poisoning by ethyl alcohol, opioid analgesics, and hypnotics.  
4. Migraine. Caffeine is prescribed in combination with non-opioid 
analgesics (e. g., tablets “Сitramone”) or alkaloids of uterine horns  
(e. g., tablets “Coffetamine”).  
5. Diagnostics of secretory activity of stomach.  
Arterial hypertension, atherosclerosis, glaucoma, and insomnia are 
contraindications to caffeine intake. Long-time caffeine intake leads to 
development of moderate tolerance and psychical dependence (theism).  
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Nootropic Drugs (Cognitive Enhancers)  
 
Nootropic drugs are agents which stimulate a high integrative activity 
of brain, improve cognitive functions, memory, and capacity to learning. 
Unlike other psychotropic agents, nootropic drugs have no 
psychostimulating or psychosedative effects, do not increase physical work 
activity, and do not affect emotions. The nootropic effect of drugs is 
developed only in case of the long-time drug use (2–5 months).   
Cognitive enhancers are classified as follows.  
1. Pyrolidone derivatives: piracetam (nootropil ) and 
et iracetam. 
2. GABA derivatives: aminalon (Gammalon), picamilon, 
pantogam, and phenibut  (Noofen). 
3. Neuropeptides and their analogues: Synacthen depot
®
, 
thyroliberin, and melatonin.  
4. Cerebrovascular drugs: nicergoline (Sermion), vinpocetine  
(Cavinton), vincamine (Devincan), cinnarizine (Stugeron), 
pentoxifyll ine (Trental ), and xanthinal nicotinate  (Complamin).  
5. Pyridoxine derivatives: pyriditol  (pyrit inol ,  Encefabol). 
6. Antioxidants: nicotinic acid, tocopherol ,  emoxypine  
(Mexidol), and thioctic acid (Berli thion). 
7. Different drugs: Сerebrolysin, Actovegin,  Solcoseryl ,  
potassium orotate , Tanakan, Memoplant ,  glycine,  and glutamic 
acid.   
Mechanism of action of nootropic drugs is mainly associated with 
changes of bioenergetic processes in neurons. Nootropic drugs increase 
synthesis of ATP, proteins, and RNA in neuronal cells; improve glucose 
utilization; increase activity of adenylyl cyclase, phospholipase A2, 
phosphokinase A1 and A2; stimulate metabolism of phosphatidyl choline 
and phosphatidyl ethanolamine; and reduce cortical release of proline. 
Also, nootropic drugs stimulate reparation of neuronal membranes, increase 
GABAergic, adrenergic, dopaminergic, and glutamatergic transmission, 
and increase concentration of acetylcholine and serotonin in the central 
nervous system.  
Nootropic drugs improve memory, verbal functions, and mental 
activity; facilitate training; increase brain tolerance to hypoxia and 
influence of different toxins; decrease vertigo, headache, drowsiness, and 
apathy. It should be noticed that these drugs do not influence higher 
nervous activity of healthy persons.  
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Cognitive enchancers are widely used to treat pathological states 
which are caused or accompanied by disorders of cerebral circulation and 
metabolism in the central nervous system: insults, mental retardation of 
children, cranial traumas, epilepsy, senile dementia, atherosclerosis, 
hypertensive disease, alcoholism, drug dependence, neurosis, cerebral 
ischemia, etc.   
Piracetam (nootropil )  is the most commonly used agent of this 
group. Piracetam is a pyrolidone derivative. The drug is taken orally or 
administered parenterally. Its side effects are sleep disorders, allergic 
reactions, and dyspepsia. Piracetam is contraindicated at pregnancy and 
acute renal failure.  
Aminalon (Gammalon)  is GABA derivative. The drug improves 
cerebral circulation, exhibits anticonvulsive and hypoglycemic (at 
hyperglycemia) effects, reduces blood pressure at arterial hypertension, 
slows down heart rate. Contraindication to aminalon use is individual 
intolerance of the drug. 
Vinpocetine (Cavinton)  is derivative of alkaloid of lesser 
periwinkle (Vinca minor). The drug dilates cerebral vessels, improves 
assimilation of glucose, blood supply, and oxygenation of brain, decreases 
platelets aggregation, and icreases cAMP level. Vinpocetine is 
contraindicated at pregnancy, lactation period, severe ischemic heart 
disease, and cardiac arrhythmias.  
Nicergoline (Sermion)  is α-adrenergic antagonist. The drug 
decreases vascular tone, improves cerebral circulation, activates 
metabolism, increases supply of oxygen and glucose to cerebral tissues, 
decreases blood pressure in patients with hypertensive disease.  
Cinnarizine (Stugeron)  is derivative of piperazine. The drug 
blocks calcium channels. Cinnarizine decreases spasm of cerebral vessels, 
platelets aggregation, and exhibits antihistaminic activity. The drug does 
not decrease systemic blood pressure. Cinnarizine is manufactured in 
combination with piracetame under the trade name “Phezam®” .     
An antispasmodic drug pentoxifyll ine (Trental)  blocks 
phosphodiesterase that leads to accumulation of cAMP. In turn, cAMP 
competes with adenosine for binding with adenosine receptors. Trental 
increases oxygen concentration in the cerebral tissues, improves 
microcirculation, decreases platelets aggregation, increases the elasticity of 
membranes of erythrocytes, improves blood fluidity. Trental is used to treat 
disorders cerebral circulation, disorders of blood supply in eye, heart, 
kidneys, functional hearing impairment, etc.  
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Sodium oxybutyrate  is sodium salt of γ-aminobutyric acid 
(GABA). The drug exhibits some nootropic activity and marked 
antihypoxic effect, icreases resistance of brain, heart, and retina to hypoxia. 
Also, sodium oxybutirate exhibits sedative, hypnotic, and central 
myorelaxating effects. High doses of the drug cause general anaesthesia. 
Sodium oxybutyrate potentiates effects of analgesics and other central 
nervous system depressants.  
Phenibut  (Noofen)  is phenyl derivative of GABA. The drug 
exhibits nootropic and anxiolytic activity.  
Nootropic drugs include also derivatives of some vitamins: 
pantogam, picamilon,  and pyriditol .  Pantogam is a derivative of 
GABA and pantothenic acid. Pyriditol consists of 2 molecules of 
pyridoxine connected by disulphide bond. Both drugs activate brain 
metabolism and exhibit antihypoxic effect. Picamilon contains residues of 
GABA and nicotinic acid in its molecules. The drug exhibits nootropic 
effect and improves cerebral circulation.  
 
Drugs which are Used to Treat Disorders of Crebral Circulation 
 
Disorders of cerebral circulation are one of the main causes of 
mortality and disability of population. This patology develops due to 
functional disorders and organic damages of permeability of cerebral 
vessels (spasm, embolism, thrombosis, atherosclerosis, hemmoragies). 
Disorders of cerebral circulation requires emergency pharmacological care.  
Drugs which improve cerebral circulation are classified as follows: 
1. Drugs influencing platelets aggregation and blood clotting.  
1.1. Antiaggregants: acetylsalicylic acid  and ticlopidine. 
1.2. Anticoagulants: heparin, low-molecular-wheigh heparins , 
syncumar, warfarin, phenylin,  etc.  
2. Drugs increasing cerebral blood flow and brain resistance to 
hypoxia.  
2.1. Blockers of L-type calcium channels: nimodipine, cinnarizine 
(Stugeron), and f lunarizine. 
2.2. Derivatives of alkaloids of lesser periwinkle: vinpocetine. 
2.3. Derivatives of ergot alkaloids: nicergoline (Sermion).  
2.4. Nicotinic acid derivatives: xanthinal nicotinate 
(Complamin). 
2.5. Nootropic drugs: aminalon, piracetam,  etc.  
2.6. Methylxanthine derivatives: pentoxifylline (Trental).  
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2.7. Myotropic spasmolytics: papaverine hydrochloride, Nospa 
(drotaverine), and dibazol  (bendazol).  
2.8. Protein hydrolysates: Сerebrolysin, Actovegin, and 
Solcoseryl. 
Drugs influencing platelets aggregation and blood clotting are 
described in the correspondent chapter.  
 
Drugs Increasing Cerebral Blood Flow and Brain 
Resistance to Hypoxia 
 
Blockers of L-type calcium channels  
 
This group is representated by such drugs as nimodipine, 
cinnarizine (Stugeron), and f lunarizine. These drugs block L-type 
calcium channels in the cellular membranes and prevent calcium entrance 
in the cells of smooth muscles and thrombocytes. It leads to reduction of 
the tone of cerebral arterioles, elimination of their spasm, and decrease of 
platelets aggregation. Cerebral blood flow is increased. Impaired mental 
function is restored. These drugs are well tolerated by patients. Their 
possible side effects are dispepsy, headache, drowsiness, and dry mouth.  
 
Derivatives of alkaloids of lesser periwinkle  
 
Vinpocetine (Cavinton)  is a semisynthetic derivative of alkaloid 
of a periwinkle plant. The drug inhibits phosphodiesterase that results in 
cAMP accumulation. It leads to reduction of vascular tone, decrease of 
platelets aggregation, and increase of erhythrocytes elasticity. Vinpocetine 
normalizes blood flow and metabolism in brain tissues. The drug is taken 
orally or administered intravenously drop-by-drop. Cavinton is used to treat 
neurological and psychical disorders on the background of cerebral 
circulation derangement, hypertensive encephalopathy, memory 
impairment, vertigo, ischemia of eye tissues, in postapoplectic period, etc. 
Its side effects are hypotension, tachycardia, and cardiac arrhythmias.  
 
Derivatives of ergot alkaloids  
 
Nicergoline (Sermion)  is a derivative of ergot alkaloid and 
nicotinic acid. The drug blocks α-adrenergic receptors and exhibits 
myotropic antispasmodic action. Nicergoline dilates cerebral and peripheral 
vessels, improves protein synthesis, and reduces platelets aggregation. 
Sermion is used in the treatment for disorders of cerebral and peripheral 
circulation, migraine, and ischemia of an optic nerve. The drug can cause 
such side effects as dispepsy, hypotension, skin redness, and pruritus.  
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Nicotinic acid derivatives  
 
Xanthinal nicotinate (Complamin)  is a derivative of nicotinic 
acid and theophylline. The drug dilates peripheral vessels, improves 
cerebral blood flow, decreases hypoxia of the central nervous system, and 
inhibits platelets aggregation. Like theophylline, Complamin increases 
myocardial contraction. The drug is taken orally or administered 
intramuscularly and intravenously. Xanthinal nicotinate is used to treat 
obliterating endarteritis, Raynaud’s disease, diabetic angiopaty, disorders of 
cerebral circulation, and migraine. The most commont side effect of 
Complamin is hypotension.  
 
Nootropic drugs  
 
Aminalon  and piracetam  are derivatives of GABA. Picamilon is 
a derivative of GABA and nicotinic acid. These drugs are low toxic agents. 
Nootropic drugs improve cerebral blood flow (aspecially picamilon), 
functional activity of neurons, and exhibit antihypoxic action. Picamilon 
has also anxiolytic effect which is not accompanied by sedation. These 
drugs eliminate spasms of cerebral vessels, increase physical and mental 
capacity in postapoplectic period, after psychoemotional stress and 
overwork.   
 
Methylxanthine derivatives  
 
Pentoxifyll ine (Trental, Agapurin)  is a derivative of 
theobromine. The drug blocks phosphodiesterase that leads to cAMP 
accumulation. Pentoxifylline relaxes vessels, inhibits platelets aggregation, 
reduces blood viscocity, increases erhythrocytes elasticity, and improves 
microcirculation. Trental is used to treat disorders of cerebral circulation 
due to spasms or sclerosis, diabetic angiopaty, disorders of eye blood 
circulation, etc. Its side effects are dizzinness, dispepsy, and face redness.  
   
Myotropic spasmolytics  
 
Papaverine hydrochloride, No-Spa (drotaverine), and 
dibazol  (bendazol)  eliminate spasms of smooth muscles including 
cerebral vessels. These drugs are well tolerated by patients.  
  
Protein hydrolysates  
 
Сerebrolysin, Actovegin, and Solcoseryl  are easily penetrate 
the blood-brain barrier and restore violated metabolism in ischemic regions 
of the brain. These drugs exhibit membranostabilizing and antioxidant 
properties and protect neurons from damages. 
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Drugs for Migraine Treatment  
 
Migraine is widespread form of disorders of cerebral circulation 
caused by dysfunction of vasomotor regulatory mechanisms. Women suffer 
from migraine more often (75 % cases). Migraine is manifested by attacks 
of unilateral headache which is accompanied by nausea, vomiting, visual 
and auditory disordrs, paresthesia, muscular stiffness, etc. Migraine attacks 
repeat during many years; their duration is from 4 to 72 hours.  
Serotonin plays an important role in migraine development. It 
stimulates 5-HT2A-serotoninergic receptors which leads to spasm of arteries 
and veins. Activation of 5-HT1-serotoninergic receptors is accompanied by 
dilation of peripheral vessels and constriction of cerebral vessels. Serotonin 
dilates arterioles and constricts venules which leads to the increase of 
pressure in capillaries. Besides, serotonin increases permeability of capillar 
wall for proteins. Today, 5-HT1D and 5-HT1B serotoninergic receptors are 
considered to play the main role in migraine pathogenesis.  
Drugs used in migraine treatment are classified as follows:  
1. Drugs used to eliminate acute migraine attacks. 
1.1. Alkaloids of ergot: ergotamine  and dihydroergotamine.  
1.2. Indole derivatives: sumatriptan (Imigran).  
1.3. Non-opioid analgesics: paracetamol, acetylsalicylic acid, 
naproxen, indometacin, ibuprofen,  etc.  
2. Drugs used to prevent migraine attacks.  
2.1. β-Adrenergic antagonists: anapril inum (propranolol ), 
atenolol, and metoprolol.  
2.2. Tricyclic compounds: pizoti fen (Sandomigran).  
2.3. Lyserginic acid derivatives: methysergide.  
2.4. Non-opioid analgesics: naproxen.  
2.5. Tricyclic antidepressants: amitriptyline. 
2.6. Antiepileptic drugs: carbamazepine  and clonazepam.  
 
Ergot alkaloids ergotamine  and dihydroergotamine  block  
α-adrenergic, serotoninergic, and dopaminergic receptors which leads to 
reduction of amplitude of oscillation of cerebral vessels.  
Sumatriptan (Imigran)  is a selective agonist of 5-HT1D-receptors. 
Its action leads to an increase of the tone of cerebral vessels and reduction 
of headache. The drug is taken orally and administered subcutaneously or 
intranasaly. Its duration of action is about 12 hours. Side effects of 
sumatriptan are spasm of coronary vesssels, nausea, vomiting, vertigo, 
feeling of heat, etc.  
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Methysergide  is an antagonist of 5-HT2-serotoninergic receptors. 
The drug has high efficacy but its clinical use is restricted owing to its 
toxicity. The intake of methysergide during more than 5–6 weeks can cause 
renal failure and retroperitoneal fibrosis. Nausea, vomiting, and diarrhea 
are also possible side effects of methysergide.     
Pharmacodynamics and pharmacokinetics of other drugs for migraine 
treatment are given in correspondent chapters.     
   
Adaptogens 
 
Adaptogens are drugs of natural origin which exert mild stimulating 
influence upon the central nervous system, endocrine glands, metabolism, 
and increase the body resistance to adverse environmental effects.  
Adaptogens are classifies as follows:  
1. Galenical preparations of plant origin: t inctures and extracts of 
Ginseng,  Schizandra , Aralia,  Leuzea, Eleutherococcus ,  
Rhodiola; Sараrаlum  (complex of ammonium salts of glycosides of 
Aralia mandshurica roots).  
2. Drugs of animal origin: pantocrin  (liquid alcoholic extract from 
antlers of maral) and aquabiotic preparations. 
Adaptogens stimulate synthesis of RNA and proteins, increase activity 
of different enzymes, and improve reparative processes. Owing to this, 
adaptation of an organism to undesirable influence of external environment 
is increased.   
Adaptogens weaken biochemical (catabolism of proteins, lipids, and 
carbohydrates) and functional changes at stress. These drugs increase 
glucose entrance in the cells and improve mobilization and oxidation of 
lipids. Adaptogens prevent stress-induced exhaustion of pituitary-adrenal 
system. Adaptogens cause “economization” of metabolism.  
The following pharmacological effects are typical for adaptogens:  
1. Mild stimulating action which is manifested by the increase of 
physical and mental work capacity, decrease of fatigue, and reduction of 
asthenia symptoms. 
2. Increase of the body resistance to the action of damage factors: high 
temperature, cooling, intoxication, radiation, etc.  
3. Stimulation of immunity.  
4. Improvement of the blood flow, respiration, vision, and hearing.  
5. Cardioprotective action.  
6. Hepatoprotective action.  
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Adaptogens are used to treat asthenia, overstrain, radiation influence, 
and weakening of organism functions. These agents are widely used after 
infective and somatic diseases.  
Side effects of adaptogens are excessive excitation of nervous and 
cardiovascular systems, arterial hypertension, and hyperglycemia.   
Adaptogens are contraindicated at arterial hypertension, hemorrhages, 
menstruation, hemorrhagic diathesis, and increased irritability.  
 
Actoprotectors  
 
Actoprotectors are drugs which increase the resistance of organism to 
hypoxia and high temperature. Actoprotectors also increase working 
capacity.  
Actoprotectors are classified as follows: 
1. Bemethyl.  
2. Vitamins: tocopherol, ascorbic acid, nicotinic acid, etc.  
3. Biogenic stimulants: aloe, etc.  
Bemethyl  exhibits psychostimulating and antihypoxic effects, 
increases body resistance to physical exercise compounds, reduced 
exhaustion of mediators and oxygen demand. The drug also stimulates 
immunity. Bemethyl is used to treat neurosis and asthenia. The drug is 
prescribed after traumas, in increased physical and psychical exercise. Its 
side effects are nausea, vomiting, headache, discomfort in the stomach, and 
congestion.    
 
Table 20 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and route  
of administration 
Drug product 
1 2 3 
Sydnocarbum Orally 0.005–0.025 g  
1–2 times a day (in the first 
part of the day) 
Tablets 0.005, 0.01 or 
0.025 g 
Coffeinum-natrii 
benzoas 
Orally 0.1–0.2 g 1–2 times 
a day; 
subcutaneously 0.1–0.2 g  
1–2 times per day 
Tablets 0.1 or 0.2 g; 
 
ampoules 1 or 2 ml of 10 % 
or 20 % solution 
Pyracetamum Orally, intramuscularly or 
intravenously 0.4–1.2 g  
3 times a day 
Tablets 0.2 g; 
capsules 0.4 g; 
ampoules 5 ml of 20 % 
solution 
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Continuation of the table 20 
1 2 3 
Bemegridum Intravenously slowly  
0.01–0.05 g 
Ampoules 10 ml of 0.5 % 
solution 
Cordiaminum Subcutaneously, 
intramuscularly or 
intravenously 1 ml  
Ampoules 1 ml 
Camphora Subcutaneously 0.2–1 g Ampoules 1 or 2 ml of 20 % 
oil solution 
Aethimizolum Intravenously or 
intramuscularly 0.03– 
0.06 g 1–2 times a day 
Ampoules 3 or 5 ml of 1 % or 
1.5 % solution 
Sulfocampho-
cainum 
Subcutaneously, 
intramuscularly or 
intravenously 0.2 g  
2–3 times a day 
Ampoules 2 ml of 10 % 
solution 
 
Step 1. Tasks for Self -Control  
Psychostimulants, Nootropic Drugs  (Cognitive Enhancers)  
and Analeptics  
 
1. Analeptical remedy of reflective type from the N-cholinomimetics 
group was given to the patient for restoration of breathing after poisoning 
with carbon monoxide. What medicine was prescribed to the patient? 
A. Atropine sulfate. 
B. Mesatonum. 
C. Adrenaline hydrochloride. 
D. Pentamine. 
E. Lobeline hydrochloride.  
2. An aged patient complains of headache, dizziness, quick tiredness, 
memory impairment. Anamnesis: craniocerebral injury. Medicine of what 
group should be prescribed? 
A. Neuroleptics. 
B. Sedatives. 
C. Analgesics. 
D. Nootropics.  
E. Hypnotics. 
3. The CNS stimulation produced by methylxanthines, such as caffeine, 
is most likely due to the antagonism of one of the following receptors: 
A. GABA receptors. 
B. Adenosine receptors.  
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C. Cholinergic muscarinic receptors. 
D. Glycine receptors. 
E. Glutamate receptors. 
4. A patient with respiratory depression has been delivered to a 
hospital. What is the pharmacological group of drugs that can stimulate 
breathing? 
A. Analgesics. 
B. Tranquilizers. 
C. Neuroleptics. 
D. Antidepressants. 
E. Analeptics.  
5. Parents have appealed to a neurologist with complaints of the 
disorder of mental work, reduction of learning abilities of their 9-year-old 
child. Mental decline, memory impairment, and low intellectual work 
capacity were detected. The prescription of what group of psychotropic 
drugs is needed in this case? 
A. Adaptogenes. 
B. Antidepressants. 
C. Nootropic agents. 
D. Tranquilizers. 
E. Neuroleptics. 
6. An elderly man complains of headache, dizziness, rapid fatigability, 
memory impairment. In the anamnesis there is a craniocerebral trauma. 
What group of drugs is needed to be prescribed? 
A. Tranquilizers. 
B. Soporific. 
C. Neuroleptics. 
D. Analgesics. 
E. Nootropic agents.  
7. It is necessary to prescribe a drug, which improves memory and 
mental work in case of organic damages of the brain, to a patient. What 
drug should be prescribed? 
A. Pyracetam.  
B. Caffeine sodium benzoate. 
C. Nitrazepam. 
D. Mezapam. 
E. Diazepam. 
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8. A newborn child has asphyxia. What drug is it necessary to prescribe 
for the stimulation of breathing in the newborn? 
A. Proserinum. 
B. Lobeline hydrochloride. 
C. Prazosin. 
D. Atropine sulfate. 
E. Aethymizole.  
9. During a tooth extraction a patient lost consciousness. What drug is 
it necessary to prescribe to bring the patient out of this condition quickly? 
A. Papaverine hydrochloride. 
B. Amitriptyline. 
C. Analginum. 
D. Novocaine. 
E. Caffeine sodium benzoate.  
10. A 36-year-old male patient has a cardiocerebral trauma 
accompanied by weak breathing and thready pulse, reflexes are absent. 
What is the most expedient way of pyracetam introduction in this case? 
A. Inhalation. 
B. Rectal. 
C. Subcutaneous. 
D. Intravenous.  
E. Peroral. 
11. A patient with complaints of memory impairment and intellectual 
work capacity decrease after a head trauma is hospitalized into the 
neurology department. What medicine can be recommended to improve 
brain tissues metabolism? 
A. Analginum. 
B. Pyracetam. 
C. Meridilum. 
D. Sydnocarb. 
E. Caffeine sodium benzoate. 
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Step 1. Correct Answers to Tasks for Self-Control  
 
General Pharmacology 
 
1. C.  
2. B.  
3. A.  
4. E.  
5. D.  
6. C.  
7. E.  
8. A.  
9. E.  
10. C.  
11. D.  
12. B.  
13. A. 
14. B.  
15. E.  
16. E.  
17. C.  
18. B.  
19. A.  
20. B.  
21. E. 
22. C.  
23. A.  
24. E.  
25. C.  
26. B.  
 
27. E.  
28. D.  
29. A.  
30. C.  
31. E.  
32. C.  
33. A.  
34. D.  
35. B.  
36. E.   
37. C.  
38. E.  
39. B.  
 
40. A.  
41. E.  
42. B.  
43. D.  
44. E.  
45. B.  
46. C.  
47. A.  
48. E.  
49. B.  
50. A.  
51. E.  
52. E.  
 
Drugs Affecting the Afferent Innervation  
 
1. E.  
2. C.  
3. A.  
4. D.  
5. C.  
 
6. E.  
7. B.  
8. E.  
9. B.  
10. D.  
 
11. B.  
12. E.  
13. C.  
14. B.  
15. D.  
 
16. E.  
17. B.  
18. A.  
19. E.  
 
Cholinomimetic Drugs  
 
1. D.  
2.  B.  
3. E.  
4. C.  
5. E.  
6. E.  
7. C.  
8. D.  
9. A.  
10. E.  
 
11. C.  
12. A.  
13. E.  
14. D.  
15. B.  
16. B.  
17. E.  
18. E.  
19. B.  
20. A.  
 
21. C.  
22. D.  
23. B.  
24. E.  
25. B.  
26. E.  
27. B.  
28. E.  
29. B.  
30. E.  
 
 
31. C.  
32. D.  
33. A.  
34. B.  
35. E.  
36. A.  
37. E.  
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M-Cholinoblocking Drugs  
 
1. E.  
2. B.  
3. C.  
4. C.  
5. B.  
6. E.  
7. B.  
 
8. A.  
9. B.  
10. A.  
11. B.  
12. D.  
13. E.  
14. C.  
 
15. B.  
16. E.  
17. A.  
18. C.  
19. E.  
20. B.  
21. E.  
 
22. E.  
23. C.  
24. B.  
25. D.  
26. A.  
27. E.  
28. B. 
 
 
N-Cholinoblocking Drugs  
 
1. D.  
2. E.  
3. C.  
4. A.  
5. E.  
6. C.  
7. E.  
 
8. D.  
9. B.  
10. B.  
11. E.  
12. B.  
13. D.  
14. B.  
 
15. A.  
16. C.  
17. B. 
18. E.  
19. D.  
20. B.  
21. E.  
 
22. A.  
23. E.  
24. C.  
25. B. 
 
Adrenomimetic Drugs and Sympathomimetics  
 
1. A.  
2. C.  
3. D.  
4. E.  
5. B.  
6. D.  
7. A.  
8. C.  
9. E.  
10. C.  
11. B.  
12. C.  
 
13. B.  
14. E.  
15. C.  
16. B.  
17. E.  
18. D.  
19. B.  
20. E.  
21. E.  
22. B.  
23. D.  
24. D.  
 
25. B.  
26. A.   
27. E.  
28. B.  
29. A.  
30. D.  
31. B.  
32. E.  
33. C.  
34. B.  
35. B.  
36. E.  
 
37. C.  
38. E.  
39. C.  
40. B.  
41. E.  
42. A.  
43. A.  
44. D.  
45. D.  
46. C.  
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Antiadrenergic  Drugs 
 
1. E.  
2. C.  
3. B.  
4. A.  
5. E.  
6. E.  
7. C.  
 
8. D.  
9. C.  
10. C.  
11. E.  
12. E.  
13. D.  
14. B.  
 
15. A.  
16. E.  
17. E.  
18. B.  
19. C.  
20. A.  
21. E.  
 
22. A.  
23. D.  
24. D.  
25. C.  
26. A.  
27. E.  
28. C. 
 
General Anaesthetics 
 
1. B.  
2. C.  
3. A.  
 
4. C.  
5. D.  
6. E.  
 
7. B.  
8. C.  
9. E.  
 
 
Hypnotic Drugs. Ethyl Alcohol  
 
1. A.  
2. B.  
3. B.  
 
4. E.  
5. C.  
6. E.  
 
7. D.  
8. B.  
9. C. 
 
 
Opioid Analgesics  
 
1. C.  
2. E.  
3. B.  
4. B.  
5. D.  
6. A.  
7. B.  
8. D.  
 
9. B.  
10. D.  
11. A.  
12. B.  
13. E.  
14. E.  
15. E.  
16. B.  
 
17. B.  
18. E.  
19. B.  
20. A.  
21. E.  
22. D.  
23. D.  
24. B.  
 
25. D.  
26. B.  
27. C.  
28. B.  
29. E. 
30. C.  
 
 
 Non-opioid Analgesics  
 
1. D. 
2. E.  
3. C.  
4. C.  
 
5. B.  
6. E. 
7. E. 
8. A.  
 
9. A.  
10. E. 
11. D.  
12. A.  
 
13. E. 
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Anticonvulsants  
 
1. B.  
2. D.  
3. B.  
4. D.  
5. E.  
 
6. A.  
7. B.  
8. E.  
9. D.  
10. B.  
 
11. B.  
12. E.  
13. E.  
14. C.  
15. E.  
 
16. A.  
17. D.  
18. D.  
19. A. 
 
Antipsychotic  Drugs, Antidepressants,  
and Drugs for Mania Treatment 
 
1. C.  
2. C.  
3. A.  
4. E.  
5. E.  
 
6. D.  
7. C.  
8. D.  
9. C.  
10. B.  
 
11. E.  
12. E. 
13. B.  
14. C.  
15. B.  
 
16. B.  
17. E. 
 
Anxiolytics (Tranquil izers) and Sedative Drugs  
1. B.  
2. B.  
3. E.  
 
4. D.  
5. A.  
6. A.  
 
7. E.  
8. D.  
9. B.  
 
 
 
 
 
Psychostimulants, Nootropic  Drugs (Cognitive 
Enchancers)  and Analeptics  
 
1. E. 
2. D. 
3. B. 
4. E. 
 
5. C. 
6. E. 
7. A. 
8. E. 
 
9. E. 
10. D. 
11. B. 
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INDEX 
 
Acebutalol 160, 178, 181, 182 
Aceclidine 110, 116, 117 
Acetaminophen q.v. paracetamol 
Acetylcholine 103–114, 129, 130, 
145, 146, 162, 259, 285 
Acetylsalicylic acid 64, 230–235, 
287, 290 
Activated carbon 70, 94 
Activated charcoal q.v. activated 
carbon 
Actovegin 285, 288, 289 
Adrenaline 37, 73, 91, 105, 112, 
142, 155–163, 178, 179, 184, 
196, 197, 281 
Aloe 43, 292 
Alprazolam 273 
Alumen 93 
Amantadine 252, 253 
Ambenonium q.v. oxazylum 
Aminalon 285–289 
Aminazine 260, 261 
Amitriptyline 265, 266, 290 
Amizon 230, 240, 241 
Amizylum 273, 276 
Ammonia solution 95, 96 
Amphetamine q.v. phenamine 
Anaesthesine 26, 29, 88–91 
Analginum 148, 230–233, 236, 237 
Anaprilinum 160, 178, 181, 290 
Aplicata of alders 93 
Aralia 291 
Arfonade 110, 141, 143 
Armin 110, 112, 115 
Articaine q.v. ultracaine 
Ascorbic acid 74, 241, 292 
Aspirin q.v. acetylsalicylic acid 
Atenolol 160, 178, 181, 182, 290 
Atropine sulfate, 6, 36, 37, 110, 220 
Atrovent q.v. ipratropium bromide 
Azafen q.v. pipofezine 
Azamethonium q.v. Pentaminum 
Azapropazone q.v. rheumox 
Baclofen 251 
Barbamil 277 
Beclamide q.v. chloracon 
Bemethyl 292 
Benactyzine q.v. amizylum 
Bendazol q.v. dibazol 
Benserazide 253 
Benzobarbital 247 
Benzocaine q.v. anaesthesine 
Benzohexonium 74, 109, 110, 141, 
143 
Benzonal q.v. benzobarbital 
Benztropine 132, 252 
Berlithion q.v. thioctic acid 
Biperiden 252, 253 
Bismuth subnitrate 93 
Blueberry fruits 93 
Bretylium tosilate q.v. ornidum 
Bromisoval 204, 209 
Bromocriptine 252, 253, 264 
Bumecaine q.v. pyromicaine 
Bupivacaine 89, 92 
Buprenorphine 216, 221 
Buspirone 276 
Butadionum 230, 233, 236, 237 
Butorphanol 216, 218 
Caffeine 41, 59, 69, 212, 281–284 
Camphor 42, 95 
Carbacholine 110, 111, 112 
Carbamazepine 52, 247, 248, 250, 
290 
Carbidopa 253 
Cardiovalen 277 
Cardura q.v. doxazosin 
Carvedilol 160, 178 
Cavinton q.v. vinpocetine 
Celecoxib 230–232, 241 
Chamomile flowers 93 
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Chloracon 248 
Chloral hydrate 65, 204, 209, 246 
Chlordiazepoxide 273 
Chlorpromazine q.v. aminazine 
Chlorprothixene 260 
Chlozepidum q.v. chlordiazepoxide 
Cinnarizine, 285–288 
Clonazepam 247–251, 290 
Clorazepate dipotassium 273 
Clozapine 260, 264 
Cocaine 87–91 
Codeine 41, 216, 237 
Complamin q.v. xanthinal nicotinate 
Corvalole 277 
Cyclodol 252, 253 
Cytitonum 110, 118, 119 
Diazepam 52, 90, 148, 200, 204, 
207, 245, 247, 251, 273, 275 
Dibazol 288, 289 
Dicaine 88–91 
Diclofenac sodium q.v. ortophenum 
Diethyl Ether 193–197 
Dihydroergotamine 290 
Dioxonium 110, 145 
Diphenine 247–250 
Distigmine 110, 112, 115 
Disulfiram q.v. teturam 
Dithylinum 64, 110, 145–147 
Dobutamine 159, 166, 167 
Dobutrex q.v. dobutamine 
Donormyl q.v. doxylamine 
Doxazosin 160, 178–180 
Doxylamine 204, 210 
Droperidol 220, 260–262 
Drotaverine q.v. Nospa 
Eleutherococcus 291 
Emoxypine 285 
Encefabol q.v. pyriditol 
Enflurane 193 
Enisamium iodide q.v. amizon 
Enterosgel 94 
Ephedrine 35, 58, 68, 143, 159, 164, 
165, 197 
Epinephrine q.v. adrenaline 
Ergotamine 290 
Esperal 19, 213 
Ethanol 72, 210, 211 
Ethosuximide 247, 248, 250 
Ethyl alcohol q.v. ethanol 
Ethylmorphine hydrochloride 216, 
222 
Etiracetam 285 
Fenoterol 159, 166 
Fentanyl 216, 220, 221, 275 
Fluacizine 265 
Flufenamic acid 230, 239 
Flumazenil 208, 209, 275 
Flunarizine 287, 288 
Fluothane q.v. halothane 
Fluoxetine 265, 266 
Flurazepam 204, 207, 273 
Flurbiprofen 230 
Fluspirilene 260, 262 
Fluvoxamine 265 
Formoterol 159, 166 
Frenolon 260 
Gabapentin 248 
Galantamine 110, 112, 114, 115 
Gammalon q.v. aminalon 
Gastrocepine q.v. pirenzepine 
Gidazepam 273 
Ginseng 291 
Glutamic acid 285 
Glycine 91, 285 
Guanethidine q.v. octadinum 
Halazolinum 159, 165, 166 
Haloperidol 260, 262 
Halothane 165, 193–197 
Heparin 46, 61, 287 
Hexamethonium q.v. 
benzohexonium 
Hexamidine q.v. primidone 
Hexenalum 193, 198, 199 
Hexobarbital q.v. hexenalum 
Homatropine 110, 129, 132, 133 
Hygronium 37, 110, 141, 143 
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Hypericum grass 93 
Ibuprofen 230, 239, 290 
Imap q.v. fluspirilene 
Imigran q.v. sumatriptan 
Imipramine 265, 266 
Imizinum q.v. imipramine 
Imovane q.v. zopiclone 
Incazanum 265 
Indomethacin 290–234, 238, 239 
Inotrex q.v. dobutamine 
Ipratropium bromide 110, 129 
Isadrinum 159, 166 
Isoflurane 193 
Isoprenaline q.v. isadrinum 
Ivadal q.v. zolpidem 
Kaolin q.v. white clay 
Ketalar q.v. ketamine 
Ketamine 193, 198, 199 
Ketoprofen 230 
Ketorolac 230 
Labetalol 160, 178, 183 
Lamotrigine 247, 248 
Leonurus 277 
Leuzea 291 
Levodopa 252, 253 
Levomepromazine 260, 261 
Lidocaine 89, 91 
Lithium carbonate 65, 267 
Lithium oxybutirate 267 
Lobeline 110, 118–120 
Lorasepam 204 
Low-molecular-wheigh heparins 287 
Madopar 252, 253 
Magnesium oxide 94, 95 
Magnesium silicate q.v. talc 
Majeptil q.v. thioproperazine 
Maprotiline 265 
Mefenamic acid 230, 239 
Melatonin 285 
Meloxicam 230–232, 239, 240 
Memoplant 285 
Menthol 96 
Meperidine 216 
Meridilum 281, 283 
Mesatonum 73, 143, 159, 165, 166 
Mesocarb q.v. sydnocarb 
Metacinum 110 
Metamizole q.v. analginum 
Methylphenidate q.v. meridilum 
Methysergide 290, 291 
Metoprolol 160, 178, 182, 290 
Mexidol q.v. emoxypine 
Mezapam 273 
Midazolam 208, 273 
Midodrine 159, 165 
Minipress q.v. prazosin 
Moclobemide 265 
Morphine 6, 48, 53, 54, 59, 65, 69, 
72, 179, 200, 216–221 
Mustard plasters q.v. sinapisms 
Mydocalm q.v. tolperizosone 
Nacom 23, 252–254 
Nadolol 160, 178, 181 
Nalorphine 56, 216 
Naloxone 72, 222 
Naltrexone 72, 217, 222 
Naphazoline q.v. naphthyzinum 
Naphthyzinum 159, 165 
Naproxen 230, 239, 290 
Nebivolol 160, 178, 181 
Neostigmine q.v. proserinum 
Nialamide 265 
Nicergoline 179, 180, 285–288 
Nicotine 64, 66, 106, 110, 118, 119, 
131 
Nicotinic acid 23, 285–289, 292 
Niflumic acid 230 
Nimesulide 230, 231, 240 
Nimodipine 23, 287, 288 
Nitrazepam 52, 204, 207, 247, 273 
Nitrous oxide 193–197, 246, 259 
Noofen q.v. phenibut 
Nootropil 273, 285, 286 
Noradrenaline 58, 73, 103, 105, 108, 
143, 155–160, 163–165, 178, 
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179, 181, 184, 185, 197, 206, 
221, 259, 265, 267, 281 
Norepinephrine q.v. noradrenaline 
Nospa 288, 289 
Novocaine 89–92, 245 
Novopassit 277 
Nozepam 204, 207 
Oak bark 93 
Octadinum 160, 178, 184, 185 
Omnopon 216 
Orap q.v. pimozide 
Orciprenaline 159, 166 
Ornidum 160, 178, 184, 185 
Ortophenum 230 
Oxazepam 273, 275  
Oxazylum 110, 112 
Oxprenolol 160, 178, 181 
Oxybate sodium q.v. sodium 
oxybutyrate 
Oxylidine 273 
Oxymetazoline 159 
Pachycarpine 110, 141, 142, 144 
Pancuronium 110, 145 
Pantocrin 291 
Pantogam 285, 287 
Papaverine hydrochloride 17, 288 
Paracetamol 64, 230, 233, 237, 238, 
290 
Passiflora 277 
Pempidine q.v. pirilenum 
Penfluridol 260 
Pentaminum 110, 141, 143 
Pentazocine 216, 218, 221 
Pentoxifylline 285–287 
Peony 277 
Persen 277 
Phenamine 159, 164, 281–283 
Phenazepam 204, 251, 273 
Phenibut 204, 208, 273, 285, 287 
Phenobarbital 52, 60, 74, 204, 205, 
247–250, 277 
Phentolamine 160, 178, 179, 183 
Phenylbutazone q.v. butadionum 
Phenylephrine q.v. mesatonum 
Phenylin,287 
Phenytoin q.v. diphenine 
Phthorphenazine 260 
Phtorazisin q.v. fluacizine 
Physostigmine 110, 112, 114 
Picamilon 23, 285, 287, 289 
Pilocarpine 22, 23, 32, 110, 112, 
114, 116–118 
Pimozide 260 
Pindolol 160, 178, 181, 182 
Pipecuronium 110, 145 
Pipofezine 265 
Piracetam 285–289 
Pirenzepine 110, 129, 133 
Pirilenum 110, 141, 144 
Piritramide 216 
Piroxicam 230, 239, 240 
Pirroxane 160, 178, 179 
Pizotifen 290 
Plathyphyllin 110, 132 
Polyphepan 94 
Potassium bromide 19, 277 
Potassium orotate 285 
Prazosin 160, 178, 179 
Primidone 247, 248, 250 
Procaine q.v. novocaine 
Promedol 33, 34, 216, 221, 275 
Propanidid 193, 198 
Propranolol q.v. anaprilinum 
Proserinum 55, 110–115, 134, 145–
147 
Proxodol 160, 178 
Pyrasidole 265 
Pyriditol 285, 287 
Pyridostigmine 110, 112, 114, 115 
Pyritinol q.v. pyriditol 
Pyromecaine 88, 89 
Pyrroxane 273 
Radoter 213 
Regitine q.v. phentolamine 
Reserpine 160, 178, 184, 185, 260 
Rheumox 230, 236 
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Rhodiola 291 
Rofecoxib 230, 232, 241 
Romazicon q.v. flumazenil 
Ropinirole 252, 253 
Salbutamol 44, 55, 159, 166 
Salvia leaves 93 
Sandomigran q.v. pizotifen 
Schizandra 291 
Scopolamine 110, 114, 129–133, 
200 
Selegiline 252 
Semap q.v. penfluridol 
Sermion q.v. nicergoline 
Sertraline 265, 266 
Sibazon q.v. diazepam 
Silver nitrate 93 
Sinapisms 95 
Sinemet, 252, 253 
Sirdalud q.v. tizanidine 
Slime of flax seeds 94 
Sodium bromide 19, 41, 44, 277 
Sodium oxybutyrate 193, 198–200, 
204, 208 
Sodium oxybutyrate 199, 208, 287 
Sodium salicylate 230, 234 
Sodium valproate 247, 248, 251 
Solcoseryl 285, 288, 289 
Sombrevin q.v. propanidid 
Sotalol 160, 178, 181 
Starch slime 94 
Stugeron q.v. cinnarizine 
Sulindac 230, 232, 238 
Sulpiride 260 
Sumatriptan 290 
Suxamethonium q.v. dithylinum 
Sydnocarb 281, 282 
Synacthen Depot
®
 285 
Syncumar 287 
Sараrаlum 291 
Talc 15, 20, 21, 26, 27, 94, 95 
Talinolol 160, 178, 181, 182 
Tanakan 285 
Tannalbine 93 
Tannin 93, 94 
Temazepam 204, 208 
Terazosin 160, 178, 179 
Terbutaline 159, 166 
Tetracaine q.v. dicaine 
Teturam 212 
Thioctic acid 285 
Thiopental sodium 90, 193, 198, 
199, 246 
Thioproperazine 260, 262 
Thiothixene 260 
Thyroliberin 285 
Tiagabine 248 
Ticlopidine 287 
Tisercin q.v. levomepromazine 
Tizanidine 251 
Tocopherol 285, 292 
Tofranil q.v. imipramine 
Tolcapone 252 
Tolperizosone 251 
Topiramate 248 
Tramadol 216, 218, 221 
Trandate q.v. labetalol 
Transaminum 265 
Tranxene q.v. clorazepate 
dipotassium 
Trental q.v. pentoxifylline 
Trepirium q.v. hygronium 
Triazolam 204, 207, 273 
Trifluperidol 260, 262 
Triftazine 260 
Trihexyphenidyl q.v. cyclodol 
Trimecaine 89, 92 
Trimeperidine q.v. promedol 
Trimethaphan q.v. arfonade 
Trimetozine, 273, 276 
Trioxazine q.v. trimetozine 
Trisedyl q.v. trifluperidol 
Tropacinum 252 
Tropaphenum 160, 178, 179 
Tropicamide 110, 129, 133 
Tubocurarine 109, 110, 115, 145–
147, 246 
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Turpentine 68, 69, 73, 95 
Ultracaine 89, 92 
Valeriana 39, 44, 277, 278 
Vigabatrine 247, 248 
Vinpocetine 285–288 
Voltaren q.v. ortophenum 
Warfarin 287 
White clay 26, 94 
Xanthinal nicotinate 285, 287 
Xylocaine q.v. lidocaine 
Xylometazoline q.v. halazolinum 
Zinc oxide, 15, 26, 30, 42, 94, 95 
Zinc sulphate 93 
Zolpidem 204, 209 
Zopiclone 204, 209 
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